Section 1 PE Tables - Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ

240429

Table 1.1A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Numbers in Thousands, 2022 and 2023
Drug	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
ILLICIT DRUGS^1,2	143,116	145,076	70,338	70,537	46,603	47,657
Marijuana	132,296	133,529	61,901	61,816	42,317	43,647
Cocaine	42,231	42,280	5,274	5,012	2,015	1,814
Crack	10,167	9,871	918	997	573	507
Heroin	6,558	6,210	1,049^b	660	709^b	376
Hallucinogens	48,850	48,438	8,509	8,795	2,289	2,638
LSD	31,074	30,247	2,322^b	1,698	423	315
PCP	6,394	5,883	204	135	89	21
Ecstasy	22,103	22,276	2,109	2,153	389	471
Inhalants	27,242	26,031	2,254	2,602	842	1,004
Methamphetamine	16,588	16,130	2,705	2,621	1,685	1,596
Misuse of Prescription Psychotherapeutics	nr	nr	14,204	14,435	4,612	4,089
Pain Relievers	nr	nr	8,457	8,578	2,439	2,173
Stimulants	nr	nr	4,298	3,922	1,348	1,163
Tranquilizers or Sedatives	nr	nr	4,848	4,722	1,529	1,236
Tranquilizers	nr	nr	4,153	3,993	1,304	1,053
Sedatives	nr	nr	959	1,063	278	284
Benzodiazepines	--	--	3,681	3,696	--	--
Opioids²	nr	nr	8,918	8,902	2,944	2,442
Central Nervous System Stimulants	nr	nr	10,188	9,659	4,469	4,175
Illicit Drugs Other Than Marijuana^2,3	nr	nr	24,692	24,882	9,560	9,210
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	nr	nr	9,062	9,072	3,052	2,554
Illegally Made Fentanyl	1,607	1,432	686	627	330	311
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.1B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Percentages, 2022 and 2023
Drug	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
ILLICIT DRUGS^1,2	50.7	51.2	24.9	24.9	16.5	16.8
Marijuana	46.9	47.1	22.0	21.8	15.0	15.4
Cocaine	15.0	14.9	1.9	1.8	0.7	0.6
Crack	3.6	3.5	0.3	0.4	0.2	0.2
Heroin	2.3	2.2	0.4^b	0.2	0.3^b	0.1
Hallucinogens	17.3	17.1	3.0	3.1	0.8	0.9
LSD	11.0	10.7	0.8^b	0.6	0.1	0.1
PCP	2.3	2.1	0.1	<0.1	<0.1	<0.1
Ecstasy	7.8	7.9	0.7	0.8	0.1	0.2
Inhalants	9.7	9.2	0.8	0.9	0.3	0.4
Methamphetamine	5.9	5.7	1.0	0.9	0.6	0.6
Misuse of Prescription Psychotherapeutics	nr	nr	5.0	5.1	1.6	1.4
Pain Relievers	nr	nr	3.0	3.0	0.9	0.8
Stimulants	nr	nr	1.5	1.4	0.5	0.4
Tranquilizers or Sedatives	nr	nr	1.7	1.7	0.5	0.4
Tranquilizers	nr	nr	1.5	1.4	0.5	0.4
Sedatives	nr	nr	0.3	0.4	0.1	0.1
Benzodiazepines	--	--	1.3	1.3	--	--
Opioids²	nr	nr	3.2	3.1	1.0	0.9
Central Nervous System Stimulants	nr	nr	3.6	3.4	1.6	1.5
Illicit Drugs Other Than Marijuana^2,3	nr	nr	8.8	8.8	3.4	3.2
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	nr	nr	3.2	3.2	1.1	0.9
Illegally Made Fentanyl	0.6	0.5	0.2	0.2	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.2A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Numbers in Thousands, 2022 and 2023
Drug	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
ILLICIT DRUGS^1,2	5,377	5,332	3,688	3,816	1,884	1,864
Marijuana	3,466	3,462	2,947	2,894	1,647	1,563
Cocaine	65	84	40	63	5	22
Crack	4	9	*	4	*	4
Heroin	10	18	3	4	*	4
Hallucinogens	533	518	358	387	99	110
LSD	283	250	169	144	39	33
PCP	28	33	15	22	2	4
Ecstasy	124	131	63	75	10	18
Inhalants	1,940	1,911	554	564	170	125
Methamphetamine	37	84	18	40	3	29
Misuse of Prescription Psychotherapeutics	nr	nr	640	785	157	206
Pain Relievers	nr	nr	406^a	570	116	143
Stimulants	nr	nr	226	230	33	32
Tranquilizers or Sedatives	nr	nr	137	173	37	44
Tranquilizers	nr	nr	115	119	34	38
Sedatives	nr	nr	27	68	7	14
Benzodiazepines	--	--	113	111	--	--
Opioids²	nr	nr	406^a	574	117	147
Central Nervous System Stimulants	nr	nr	272	285	40	72
Illicit Drugs Other Than Marijuana^2,3	nr	nr	1,343	1,522	399	442
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	nr	nr	420^a	584	127	155
Illegally Made Fentanyl	33	43	20	36	11	9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.2B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Percentages, 2022 and 2023
Drug	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
ILLICIT DRUGS^1,2	20.9	20.6	14.3	14.7	7.3	7.2
Marijuana	13.5	13.4	11.5	11.2	6.4	6.0
Cocaine	0.3	0.3	0.2	0.2	<0.1	0.1
Crack	<0.1	<0.1	*	<0.1	*	<0.1
Heroin	<0.1	0.1	<0.1	<0.1	*	<0.1
Hallucinogens	2.1	2.0	1.4	1.5	0.4	0.4
LSD	1.1	1.0	0.7	0.6	0.1	0.1
PCP	0.1	0.1	0.1	0.1	<0.1	<0.1
Ecstasy	0.5	0.5	0.2	0.3	<0.1	0.1
Inhalants	7.5	7.4	2.2	2.2	0.7	0.5
Methamphetamine	0.1	0.3	0.1	0.2	<0.1	0.1
Misuse of Prescription Psychotherapeutics	nr	nr	2.5	3.0	0.6	0.8
Pain Relievers	nr	nr	1.6^a	2.2	0.5	0.6
Stimulants	nr	nr	0.9	0.9	0.1	0.1
Tranquilizers or Sedatives	nr	nr	0.5	0.7	0.1	0.2
Tranquilizers	nr	nr	0.4	0.5	0.1	0.1
Sedatives	nr	nr	0.1	0.3	<0.1	0.1
Benzodiazepines	--	--	0.4	0.4	--	--
Opioids²	nr	nr	1.6^a	2.2	0.5	0.6
Central Nervous System Stimulants	nr	nr	1.1	1.1	0.2	0.3
Illicit Drugs Other Than Marijuana^2,3	nr	nr	5.2	5.9	1.6	1.7
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	nr	nr	1.6^a	2.3	0.5	0.6
Illegally Made Fentanyl	0.1	0.2	0.1	0.1	<0.1	<0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.3A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Numbers in Thousands, 2022 and 2023
Drug	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
ILLICIT DRUGS^1,2	137,739	139,745	66,650	66,721	44,719	45,794
Marijuana	128,829	130,067	58,955	58,922	40,670	42,083
Cocaine	42,165	42,196	5,235	4,949	2,010	1,792
Crack	10,163	9,862	917	993	572	503
Heroin	6,549	6,191	1,046^b	656	708^b	372
Hallucinogens	48,316	47,920	8,151	8,408	2,190	2,528
LSD	30,791	29,997	2,154^b	1,554	384	282
PCP	6,366	5,849	190	113	87	17
Ecstasy	21,979	22,145	2,046	2,078	379	453
Inhalants	25,302	24,120	1,700	2,038	672	879
Methamphetamine	16,551	16,046	2,687	2,582	1,682	1,566
Misuse of Prescription Psychotherapeutics	nr	nr	13,564	13,651	4,456	3,884
Pain Relievers	nr	nr	8,051	8,008	2,323	2,030
Stimulants	nr	nr	4,072	3,692	1,315	1,131
Tranquilizers or Sedatives	nr	nr	4,711	4,549	1,492	1,192
Tranquilizers	nr	nr	4,038	3,874	1,270	1,015
Sedatives	nr	nr	931	995	271	271
Benzodiazepines	--	--	3,569	3,585	--	--
Opioids²	nr	nr	8,513	8,328	2,827	2,295
Central Nervous System Stimulants	nr	nr	9,916	9,374	4,429	4,103
Illicit Drugs Other Than Marijuana^2,3	nr	nr	23,348	23,361	9,161	8,768
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	nr	nr	8,642	8,487	2,925	2,399
Illegally Made Fentanyl	1,575	1,389	666	591	319	302
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.3B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Percentages, 2022 and 2023
Drug	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
ILLICIT DRUGS^1,2	53.7	54.3	26.0	25.9	17.4	17.8
Marijuana	50.3	50.5	23.0	22.9	15.9	16.3
Cocaine	16.5	16.4	2.0	1.9	0.8	0.7
Crack	4.0	3.8	0.4	0.4	0.2	0.2
Heroin	2.6	2.4	0.4^b	0.3	0.3^b	0.1
Hallucinogens	18.9	18.6	3.2	3.3	0.9	1.0
LSD	12.0	11.6	0.8^b	0.6	0.1	0.1
PCP	2.5	2.3	0.1	<0.1	<0.1	<0.1
Ecstasy	8.6	8.6	0.8	0.8	0.1	0.2
Inhalants	9.9	9.4	0.7	0.8	0.3	0.3
Methamphetamine	6.5	6.2	1.0	1.0	0.7	0.6
Misuse of Prescription Psychotherapeutics	nr	nr	5.3	5.3	1.7	1.5
Pain Relievers	nr	nr	3.1	3.1	0.9	0.8
Stimulants	nr	nr	1.6	1.4	0.5	0.4
Tranquilizers or Sedatives	nr	nr	1.8	1.8	0.6	0.5
Tranquilizers	nr	nr	1.6	1.5	0.5	0.4
Sedatives	nr	nr	0.4	0.4	0.1	0.1
Benzodiazepines	--	--	1.4	1.4	--	--
Opioids²	nr	nr	3.3	3.2	1.1	0.9
Central Nervous System Stimulants	nr	nr	3.9	3.6	1.7	1.6
Illicit Drugs Other Than Marijuana^2,3	nr	nr	9.1	9.1	3.6	3.4
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	nr	nr	3.4	3.3	1.1	0.9
Illegally Made Fentanyl	0.6	0.5	0.3	0.2	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.4A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Numbers in Thousands, 2022 and 2023
Drug	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
ILLICIT DRUGS^1,2	19,121^a	18,285	14,221^b	13,256	9,478^a	8,901
Marijuana	18,053^b	17,033	13,299^a	12,435	9,013	8,562
Cocaine	3,127^a	2,698	1,295^a	1,043	403^b	219
Crack	215	246	39	67	13	5
Heroin	218	224	55	27	11	12
Hallucinogens	5,889^b	5,259	2,676^a	2,276	554	599
LSD	3,583^b	3,000	894^b	501	125^a	69
PCP	180	135	13	*	3	*
Ecstasy	2,628^b	2,151	639	521	99	94
Inhalants	3,073	2,936	647	694	193	231
Methamphetamine	682	569	161	108	54	49
Misuse of Prescription Psychotherapeutics	nr	nr	2,542^b	2,025	654	558
Pain Relievers	nr	nr	1,099^b	841	214	170
Stimulants	nr	nr	1,278	1,066	376	308
Tranquilizers or Sedatives	nr	nr	842^b	576	181	159
Tranquilizers	nr	nr	779^b	522	158	138
Sedatives	nr	nr	93	90	32	23
Benzodiazepines	--	--	747^b	480	--	--
Opioids²	nr	nr	1,120^b	846	221	174
Central Nervous System Stimulants	nr	nr	2,272^a	1,895	767^a	546
Illicit Drugs Other Than Marijuana^2,3	nr	nr	5,092^b	4,343	1,531	1,372
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	nr	nr	1,145^b	868	243	190
Illegally Made Fentanyl	135	181	48	78	28	24
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.4B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Percentages, 2022 and 2023
Drug	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
ILLICIT DRUGS^1,2	55.0	53.7	40.9^a	39.0	27.2	26.2
Marijuana	51.9	50.0	38.2	36.5	25.9	25.2
Cocaine	9.0^a	7.9	3.7	3.1	1.2^b	0.6
Crack	0.6	0.7	0.1	0.2	<0.1	<0.1
Heroin	0.6	0.7	0.2	0.1	<0.1	<0.1
Hallucinogens	16.9^a	15.5	7.7^a	6.7	1.6	1.8
LSD	10.3^b	8.8	2.6^b	1.5	0.4	0.2
PCP	0.5	0.4	<0.1	*	<0.1	*
Ecstasy	7.6^b	6.3	1.8	1.5	0.3	0.3
Inhalants	8.8	8.6	1.9	2.0	0.6	0.7
Methamphetamine	2.0	1.7	0.5	0.3	0.2	0.1
Misuse of Prescription Psychotherapeutics	nr	nr	7.3^b	6.0	1.9	1.6
Pain Relievers	nr	nr	3.2^a	2.5	0.6	0.5
Stimulants	nr	nr	3.7	3.1	1.1	0.9
Tranquilizers or Sedatives	nr	nr	2.4^b	1.7	0.5	0.5
Tranquilizers	nr	nr	2.2^b	1.5	0.5	0.4
Sedatives	nr	nr	0.3	0.3	0.1	0.1
Benzodiazepines	--	--	2.1^b	1.4	--	--
Opioids²	nr	nr	3.2^a	2.5	0.6	0.5
Central Nervous System Stimulants	nr	nr	6.5^a	5.6	2.2^a	1.6
Illicit Drugs Other Than Marijuana^2,3	nr	nr	14.6^b	12.8	4.4	4.0
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	nr	nr	3.3^a	2.6	0.7	0.6
Illegally Made Fentanyl	0.4	0.5	0.1	0.2	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.5A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Numbers in Thousands, 2022 and 2023
Drug	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
ILLICIT DRUGS^1,2	118,618	121,460	52,429	53,465	35,241	36,892
Marijuana	110,776	113,034	45,656	46,487	31,657	33,521
Cocaine	39,038	39,498	3,939	3,907	1,607	1,572
Crack	9,948	9,616	877	926	559	498
Heroin	6,331	5,967	991^a	629	697^b	360
Hallucinogens	42,427	42,661	5,475	6,132	1,636	1,929
LSD	27,207	26,997	1,259	1,053	259	213
PCP	6,186	5,715	177	113	84	17
Ecstasy	19,351	19,995	1,407	1,557	281	359
Inhalants	22,229	21,184	1,053	1,344	479	649
Methamphetamine	15,869	15,478	2,526	2,473	1,628	1,517
Misuse of Prescription Psychotherapeutics	nr	nr	11,022	11,625	3,802	3,326
Pain Relievers	nr	nr	6,953	7,167	2,109	1,860
Stimulants	nr	nr	2,794	2,626	939	823
Tranquilizers or Sedatives	nr	nr	3,869	3,973	1,312	1,033
Tranquilizers	nr	nr	3,259	3,351	1,112	877
Sedatives	nr	nr	839	905	239	248
Benzodiazepines	--	--	2,822	3,105	--	--
Opioids²	nr	nr	7,393	7,482	2,606	2,121
Central Nervous System Stimulants	nr	nr	7,644	7,479	3,662	3,557
Illicit Drugs Other Than Marijuana^2,3	nr	nr	18,256	19,017	7,630	7,396
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	nr	nr	7,497	7,619	2,683	2,209
Illegally Made Fentanyl	1,440	1,208	617	513	291	278
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.5B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Percentages, 2022 and 2023
Drug	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
ILLICIT DRUGS^1,2	53.6	54.3	23.7	23.9	15.9	16.5
Marijuana	50.0	50.6	20.6	20.8	14.3	15.0
Cocaine	17.6	17.7	1.8	1.7	0.7	0.7
Crack	4.5	4.3	0.4	0.4	0.3	0.2
Heroin	2.9	2.7	0.4^b	0.3	0.3^b	0.2
Hallucinogens	19.2	19.1	2.5	2.7	0.7	0.9
LSD	12.3	12.1	0.6	0.5	0.1	0.1
PCP	2.8	2.6	0.1	0.1	<0.1	<0.1
Ecstasy	8.7	8.9	0.6	0.7	0.1	0.2
Inhalants	10.0	9.5	0.5	0.6	0.2	0.3
Methamphetamine	7.2	6.9	1.1	1.1	0.7	0.7
Misuse of Prescription Psychotherapeutics	nr	nr	5.0	5.2	1.7	1.5
Pain Relievers	nr	nr	3.1	3.2	1.0	0.8
Stimulants	nr	nr	1.3	1.2	0.4	0.4
Tranquilizers or Sedatives	nr	nr	1.7	1.8	0.6	0.5
Tranquilizers	nr	nr	1.5	1.5	0.5	0.4
Sedatives	nr	nr	0.4	0.4	0.1	0.1
Benzodiazepines	--	--	1.3	1.4	--	--
Opioids²	nr	nr	3.3	3.3	1.2	0.9
Central Nervous System Stimulants	nr	nr	3.5	3.3	1.7	1.6
Illicit Drugs Other Than Marijuana^2,3	nr	nr	8.2	8.5	3.4	3.3
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	nr	nr	3.4	3.4	1.2	1.0
Illegally Made Fentanyl	0.7	0.5	0.3	0.2	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.6A – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	143,116	145,076	70,338	70,537	46,603	47,657
12-20	11,515	10,801	8,477	8,121	4,954	4,692
21 or Older	131,601	134,276	61,861	62,416	41,649	42,965
12-17	5,377	5,332	3,688	3,816	1,884	1,864
12-13	947	824	531	498	193	160
14-15	1,778	1,899	1,184	1,388	614	674
16-17	2,652	2,609	1,973	1,930	1,076	1,029
18 or Older	137,739	139,745	66,650	66,721	44,719	45,794
18-25	19,121^a	18,285	14,221^b	13,256	9,478^a	8,901
18-20	6,138^a	5,469	4,789	4,305	3,070	2,829
21-25	12,983	12,816	9,431	8,951	6,408	6,072
26 or Older	118,618	121,460	52,429	53,465	35,241	36,892
26-49	60,208	61,175	32,809	33,916	22,656	23,468
26-29	10,536	10,901	6,919	7,130	4,707	5,206
30-34	14,328	14,003	8,837	8,329	6,154	5,711
35-39	12,994	13,927	6,582^a	7,634	4,419^a	5,148
40-44	11,625	12,318	5,537	6,017	3,813	4,020
45-49	10,725	10,027	4,935	4,805	3,563	3,384
50 or Older	58,410	60,285	19,620	19,549	12,585	13,425
50-54	10,264	10,097	4,487	4,189	2,927	2,753
55-59	11,543	11,230	4,482	3,773	3,044	2,657
60-64	13,689	13,542	4,673	4,706	3,144	3,517
65 or Older	22,915^b	25,416	5,978	6,880	3,471^a	4,497
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.6B – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	50.7	51.2	24.9	24.9	16.5	16.8
12-20	29.8	28.4	21.9	21.3	12.8	12.3
21 or Older	54.1	54.7	25.4	25.4	17.1	17.5
12-17	20.9	20.6	14.3	14.7	7.3	7.2
12-13	11.2	10.3	6.3	6.3	2.3	2.0
14-15	19.6	20.8	13.1	15.2	6.8	7.4
16-17	32.3	29.5	24.0	21.9	13.1	11.7
18 or Older	53.7	54.3	26.0	25.9	17.4	17.8
18-25	55.0	53.7	40.9^a	39.0	27.2	26.2
18-20	47.5	45.0	37.0	35.4	23.7	23.3
21-25	59.4	58.6	43.1	40.9	29.3	27.7
26 or Older	53.6	54.3	23.7	23.9	15.9	16.5
26-49	58.7	59.1	32.0	32.8	22.1	22.7
26-29	61.9	62.0	40.6	40.5	27.6	29.6
30-34	61.8	61.8	38.1	36.8	26.5	25.2
35-39	59.0	60.0	29.9^a	32.9	20.0	22.2
40-44	55.9	58.1	26.6	28.4	18.3	19.0
45-49	55.0	53.2	25.3	25.5	18.3	18.0
50 or Older	49.1	50.2	16.5	16.3	10.6	11.2
50-54	51.9	54.1	22.7	22.4	14.8	14.7
55-59	57.7	54.7	22.4^a	18.4	15.2	12.9
60-64	60.4	59.2	20.6	20.6	13.9	15.4
65 or Older	40.6^a	43.9	10.6	11.9	6.1^a	7.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.7A – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	132,296	133,529	61,901	61,816	42,317	43,647
12-20	9,077	8,440	7,422	6,997	4,557	4,310
21 or Older	123,219	125,089	54,479	54,820	37,760	39,337
12-17	3,466	3,462	2,947	2,894	1,647	1,563
12-13	304^a	204	268^a	155	96	80
14-15	1,081	1,199	941	1,035	532	546
16-17	2,081	2,059	1,738	1,705	1,019	937
18 or Older	128,829	130,067	58,955	58,922	40,670	42,083
18-25	18,053^b	17,033	13,299^a	12,435	9,013	8,562
18-20	5,611^a	4,978	4,475	4,102	2,910	2,746
21-25	12,443	12,055	8,824	8,332	6,102	5,816
26 or Older	110,776	113,034	45,656	46,487	31,657	33,521
26-49	56,557	57,466	29,525	30,294	20,726	21,540
26-29	10,112	10,423	6,462	6,524	4,458	4,787
30-34	13,707	13,140	8,067	7,461	5,708	5,231
35-39	12,183	13,035	5,863^a	6,740	3,976^a	4,708
40-44	10,875	11,538	4,883	5,352	3,377	3,656
45-49	9,681	9,330	4,250	4,217	3,207	3,158
50 or Older	54,219	55,568	16,130	16,193	10,931	11,982
50-54	9,337	8,875	3,645	3,516	2,556	2,481
55-59	10,665	10,112	3,744	3,189	2,745	2,429
60-64	13,017	12,784	4,019	3,999	2,680	3,056
65 or Older	21,200^b	23,798	4,723	5,489	2,950^b	4,015
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.7B – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	46.9	47.1	22.0	21.8	15.0	15.4
12-20	23.5	22.2	19.2	18.4	11.8	11.3
21 or Older	50.6	51.0	22.4	22.3	15.5	16.0
12-17	13.5	13.4	11.5	11.2	6.4	6.0
12-13	3.6	2.6	3.2^a	1.9	1.1	1.0
14-15	11.9	13.1	10.4	11.3	5.9	6.0
16-17	25.3	23.3	21.1	19.3	12.4	10.6
18 or Older	50.3	50.5	23.0	22.9	15.9	16.3
18-25	51.9	50.0	38.2	36.5	25.9	25.2
18-20	43.4	41.0	34.6	33.8	22.5	22.6
21-25	56.9	55.1	40.4	38.1	27.9	26.6
26 or Older	50.0	50.6	20.6	20.8	14.3	15.0
26-49	55.1	55.5	28.8	29.3	20.2	20.8
26-29	59.4	59.3	37.9	37.1	26.2	27.2
30-34	59.1	58.0	34.8	32.9	24.6	23.1
35-39	55.3	56.2	26.6	29.1	18.0	20.3
40-44	52.3	54.4	23.5	25.3	16.2	17.2
45-49	49.6	49.5	21.8	22.4	16.4	16.8
50 or Older	45.6	46.3	13.6	13.5	9.2	10.0
50-54	47.2	47.5	18.4	18.8	12.9	13.3
55-59	53.3	49.2	18.7	15.5	13.7	11.8
60-64	57.4	55.9	17.7	17.5	11.8	13.4
65 or Older	37.5^a	41.1	8.4	9.5	5.2^a	6.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.8A – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	42,231	42,280	5,274	5,012	2,015	1,814
12-20	566	564	281	309	75	76
21 or Older	41,664	41,717	4,994	4,703	1,940	1,738
12-17	65	84	40	63	5	22
12-13	26	10	20	7	1	6
14-15	6	17	4	13	*	*
16-17	33	57	16	44	4	16
18 or Older	42,165	42,196	5,235	4,949	2,010	1,792
18-25	3,127^a	2,698	1,295^a	1,043	403^b	219
18-20	501	480	241	246	70	53
21-25	2,626^a	2,218	1,055^a	796	333^b	166
26 or Older	39,038	39,498	3,939	3,907	1,607	1,572
26-49	17,916	17,969	2,824	2,778	1,045	939
26-29	2,779	2,630	863	642	203	229
30-34	4,237	4,060	821	773	300	261
35-39	3,990	4,298	470	620	224	169
40-44	3,663	3,748	352	374	155	122
45-49	3,247	3,233	318	368	163	158
50 or Older	21,122	21,530	1,115	1,129	562	634
50-54	3,829	3,117	289	362	90	109
55-59	4,550	4,360	293	276	98	181
60-64	6,156	6,377	336	232	252	166
65 or Older	6,586^a	7,675	198	259	123	177
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.8B – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	15.0	14.9	1.9	1.8	0.7	0.6
12-20	1.5	1.5	0.7	0.8	0.2	0.2
21 or Older	17.1	17.0	2.1	1.9	0.8	0.7
12-17	0.3	0.3	0.2	0.2	<0.1	0.1
12-13	0.3	0.1	0.2	0.1	<0.1	0.1
14-15	0.1	0.2	<0.1	0.1	*	*
16-17	0.4	0.7	0.2	0.5	<0.1	0.2
18 or Older	16.5	16.4	2.0	1.9	0.8	0.7
18-25	9.0^a	7.9	3.7	3.1	1.2^b	0.6
18-20	3.9	3.9	1.9	2.0	0.5	0.4
21-25	12.0^a	10.1	4.8^a	3.6	1.5^b	0.8
26 or Older	17.6	17.7	1.8	1.7	0.7	0.7
26-49	17.5	17.4	2.8	2.7	1.0	0.9
26-29	16.3	15.0	5.1	3.7	1.2	1.3
30-34	18.3	17.9	3.5	3.4	1.3	1.1
35-39	18.1	18.5	2.1	2.7	1.0	0.7
40-44	17.6	17.7	1.7	1.8	0.7	0.6
45-49	16.6	17.1	1.6	2.0	0.8	0.8
50 or Older	17.8	17.9	0.9	0.9	0.5	0.5
50-54	19.4	16.7	1.5	1.9	0.5	0.6
55-59	22.8	21.2	1.5	1.3	0.5	0.9
60-64	27.2	27.9	1.5	1.0	1.1	0.7
65 or Older	11.7	13.2	0.3	0.4	0.2	0.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.9A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	10,167	9,871	918	997	573	507
12-20	48	54	5	24	4	4
21 or Older	10,119	9,818	912	974	569	503
12-17	4	9	*	4	*	4
12-13	<1	4	<1	4	*	4
14-15	*	*	*	*	*	*
16-17	4	5	<1	*	<1	*
18 or Older	10,163	9,862	917	993	572	503
18-25	215	246	39	67	13	5
18-20	44	45	4	20	4	*
21-25	171	202	35	48	9	5
26 or Older	9,948	9,616	877	926	559	498
26-49	4,557	4,299	426	350	254	183
26-29	347	249	48	20	13	10
30-34	877	676	92	71	44	23
35-39	947	1,002	39	65	19	41
40-44	1,246	1,121	84	88	55	23
45-49	1,140	1,251	164	107	123	87
50 or Older	5,391	5,317	451	576	305	315
50-54	1,108	1,157	59	150	42	57
55-59	1,476	1,236	107	216	84	118
60-64	1,660	1,687	195	133	145	91
65 or Older	1,147	1,237	90	77	33	48
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.9B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	3.6	3.5	0.3	0.4	0.2	0.2
12-20	0.1	0.1	<0.1	0.1	<0.1	<0.1
21 or Older	4.2	4.0	0.4	0.4	0.2	0.2
12-17	<0.1	<0.1	*	<0.1	*	<0.1
12-13	<0.1	0.1	<0.1	0.1	*	0.1
14-15	*	*	*	*	*	*
16-17	<0.1	0.1	<0.1	*	<0.1	*
18 or Older	4.0	3.8	0.4	0.4	0.2	0.2
18-25	0.6	0.7	0.1	0.2	<0.1	<0.1
18-20	0.3	0.4	<0.1	0.2	<0.1	*
21-25	0.8	0.9	0.2	0.2	<0.1	<0.1
26 or Older	4.5	4.3	0.4	0.4	0.3	0.2
26-49	4.4	4.2	0.4	0.3	0.2	0.2
26-29	2.0	1.4	0.3	0.1	0.1	0.1
30-34	3.8	3.0	0.4	0.3	0.2	0.1
35-39	4.3	4.3	0.2	0.3	0.1	0.2
40-44	6.0	5.3	0.4	0.4	0.3	0.1
45-49	5.8	6.6	0.8	0.6	0.6	0.5
50 or Older	4.5	4.4	0.4	0.5	0.3	0.3
50-54	5.6	6.2	0.3	0.8	0.2	0.3
55-59	7.4	6.0	0.5	1.1	0.4	0.6
60-64	7.3	7.4	0.9	0.6	0.6	0.4
65 or Older	2.0	2.1	0.2	0.1	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.10A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	48,850	48,438	8,509	8,795	2,289	2,638
12-20	1,969	1,714	1,152	1,055	259	292
21 or Older	46,881	46,724	7,356	7,740	2,030	2,347
12-17	533	518	358	387	99	110
12-13	60	54	37	31	21	9
14-15	141	161	100	122	19	16
16-17	332	304	221	234	60	85
18 or Older	48,316	47,920	8,151	8,408	2,190	2,528
18-25	5,889^b	5,259	2,676^a	2,276	554	599
18-20	1,435	1,196	795	668	160	182
21-25	4,454	4,063	1,881	1,608	394	417
26 or Older	42,427	42,661	5,475	6,132	1,636	1,929
26-49	23,394	23,802	4,599	5,167	1,308^a	1,728
26-29	3,981	4,017	1,313	1,280	279	365
30-34	5,545	5,358	1,218	1,531	364	444
35-39	4,768^a	5,491	917^a	1,258	282	384
40-44	4,799	4,834	684	598	256	274
45-49	4,302	4,102	468	499	127	262
50 or Older	19,033	18,859	876	965	328	201
50-54	3,950	3,579	353	397	58	58
55-59	3,587	3,262	106	263	51	53
60-64	4,919	4,878	253	167	124	33
65 or Older	6,578	7,139	165	139	96	58
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.10B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	17.3	17.1	3.0	3.1	0.8	0.9
12-20	5.1	4.5	3.0	2.8	0.7	0.8
21 or Older	19.3	19.0	3.0	3.2	0.8	1.0
12-17	2.1	2.0	1.4	1.5	0.4	0.4
12-13	0.7	0.7	0.4	0.4	0.2	0.1
14-15	1.6	1.8	1.1	1.3	0.2	0.2
16-17	4.0	3.4	2.7	2.6	0.7	1.0
18 or Older	18.9	18.6	3.2	3.3	0.9	1.0
18-25	16.9^a	15.5	7.7^a	6.7	1.6	1.8
18-20	11.1	9.8	6.1	5.5	1.2	1.5
21-25	20.4	18.6	8.6	7.3	1.8	1.9
26 or Older	19.2	19.1	2.5	2.7	0.7	0.9
26-49	22.8	23.0	4.5	5.0	1.3^a	1.7
26-29	23.4	22.8	7.7	7.3	1.6	2.1
30-34	23.9	23.6	5.3^a	6.8	1.6	2.0
35-39	21.6	23.7	4.2	5.4	1.3	1.7
40-44	23.1	22.8	3.3	2.8	1.2	1.3
45-49	22.0	21.8	2.4	2.6	0.6^a	1.4
50 or Older	16.0	15.7	0.7	0.8	0.3	0.2
50-54	20.0	19.2	1.8	2.1	0.3	0.3
55-59	17.9	15.9	0.5	1.3	0.3	0.3
60-64	21.7	21.3	1.1	0.7	0.5	0.1
65 or Older	11.6	12.3	0.3	0.2	0.2	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.11A – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	27,242	26,031	2,254	2,602	842	1,004
12-20	2,866	2,694	767	795	253	213
21 or Older	24,377	23,337	1,487	1,808	589	791
12-17	1,940	1,911	554	564	170	125
12-13	534	510	185	194	71	44
14-15	719	741	208	240	46	54
16-17	687	660	160	131	53	27
18 or Older	25,302	24,120	1,700	2,038	672	879
18-25	3,073	2,936	647	694	193	231
18-20	926	783	214	230	83	89
21-25	2,148	2,153	434	463	110	142
26 or Older	22,229	21,184	1,053	1,344	479	649
26-49	12,257	11,378	857	1,108	349	527
26-29	1,787	1,730	249	342	63	187
30-34	2,741	2,421	201	317	88	163
35-39	2,530	2,452	109	195	54	75
40-44	2,538	2,415	174	148	103	59
45-49	2,661	2,359	125	107	40	43
50 or Older	9,972	9,806	196	236	130	121
50-54	2,399	2,269	16	62	3	39
55-59	2,380	2,153	18	15	10	13
60-64	2,758	2,454	89	103	58	32
65 or Older	2,435	2,931	74	56	60	38
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.11B – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	9.7	9.2	0.8	0.9	0.3	0.4
12-20	7.4	7.1	2.0	2.1	0.7	0.6
21 or Older	10.0	9.5	0.6	0.7	0.2	0.3
12-17	7.5	7.4	2.2	2.2	0.7	0.5
12-13	6.3	6.4	2.2	2.4	0.8	0.6
14-15	7.9	8.1	2.3	2.6	0.5	0.6
16-17	8.4	7.5	2.0	1.5	0.6	0.3
18 or Older	9.9	9.4	0.7	0.8	0.3	0.3
18-25	8.8	8.6	1.9	2.0	0.6	0.7
18-20	7.2	6.4	1.7	1.9	0.6	0.7
21-25	9.8	9.8	2.0	2.1	0.5	0.6
26 or Older	10.0	9.5	0.5	0.6	0.2	0.3
26-49	11.9^a	11.0	0.8	1.1	0.3	0.5
26-29	10.5	9.8	1.5	1.9	0.4	1.1
30-34	11.8	10.7	0.9	1.4	0.4	0.7
35-39	11.5	10.6	0.5	0.8	0.2	0.3
40-44	12.2	11.4	0.8	0.7	0.5	0.3
45-49	13.6	12.5	0.6	0.6	0.2	0.2
50 or Older	8.4	8.2	0.2	0.2	0.1	0.1
50-54	12.1	12.2	0.1	0.3	<0.1	0.2
55-59	11.9	10.5	0.1	0.1	<0.1	0.1
60-64	12.2	10.7	0.4	0.5	0.3	0.1
65 or Older	4.3	5.1	0.1	0.1	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.12A – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	16,588	16,130	2,705	2,621	1,685	1,596
12-20	164	198	55	78	16	43
21 or Older	16,425	15,932	2,650	2,543	1,669	1,553
12-17	37	84	18	40	3	29
12-13	11	9	3	6	2	4
14-15	8	18	4	2	*	*
16-17	18	56	11	32	1	25
18 or Older	16,551	16,046	2,687	2,582	1,682	1,566
18-25	682	569	161	108	54	49
18-20	126	114	37	39	13	13
21-25	555	455	124	69	42	36
26 or Older	15,869	15,478	2,526	2,473	1,628	1,517
26-49	7,955	7,456	1,652	1,681	1,011	1,113
26-29	768	576	190	200	131	115
30-34	1,529	1,389	406	355	224	207
35-39	1,909	2,016	390	463	239	362
40-44	1,907	1,738	311	323	200	181
45-49	1,842	1,736	355	338	218	248
50 or Older	7,915	8,022	874	793	616	404
50-54	1,707	1,482	252	282	166	100
55-59	1,685	1,678	146	246	124	132
60-64	1,886	2,180	400	148	278	72
65 or Older	2,636	2,681	76	117	48	100
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.12B – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	5.9	5.7	1.0	0.9	0.6	0.6
12-20	0.4	0.5	0.1	0.2	<0.1	0.1
21 or Older	6.7	6.5	1.1	1.0	0.7	0.6
12-17	0.1	0.3	0.1	0.2	<0.1	0.1
12-13	0.1	0.1	<0.1	0.1	<0.1	0.1
14-15	0.1	0.2	<0.1	<0.1	*	*
16-17	0.2	0.6	0.1	0.4	<0.1	0.3
18 or Older	6.5	6.2	1.0	1.0	0.7	0.6
18-25	2.0	1.7	0.5	0.3	0.2	0.1
18-20	1.0	0.9	0.3	0.3	0.1	0.1
21-25	2.5	2.1	0.6	0.3	0.2	0.2
26 or Older	7.2	6.9	1.1	1.1	0.7	0.7
26-49	7.8	7.2	1.6	1.6	1.0	1.1
26-29	4.5	3.3	1.1	1.1	0.8	0.7
30-34	6.6	6.1	1.7	1.6	1.0	0.9
35-39	8.7	8.7	1.8	2.0	1.1	1.6
40-44	9.2	8.2	1.5	1.5	1.0	0.9
45-49	9.4	9.2	1.8	1.8	1.1	1.3
50 or Older	6.7	6.7	0.7	0.7	0.5	0.3
50-54	8.6	7.9	1.3	1.5	0.8	0.5
55-59	8.4	8.2	0.7	1.2	0.6	0.6
60-64	8.3	9.5	1.8	0.6	1.2	0.3
65 or Older	4.7	4.6	0.1	0.2	0.1	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.13A – Any Use of Prescription Pain Relievers in Past Year and Misuse of Prescription Pain Relievers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	73,833	74,347	8,457	8,578	2,439	2,173
12-20	5,607	6,105	809	826	199	196
21 or Older	68,226	68,242	7,649	7,752	2,240	1,977
12-17	3,191^b	3,800	406^a	570	116	143
12-13	847	898	115	136	27	29
14-15	1,185	1,407	132^a	213	55	76
16-17	1,159^b	1,495	160	221	35	38
18 or Older	70,642	70,547	8,051	8,008	2,323	2,030
18-25	6,489	6,515	1,099^b	841	214	170
18-20	2,416	2,304	403^a	256	83	53
21-25	4,073	4,210	696	585	131	117
26 or Older	64,153	64,032	6,953	7,167	2,109	1,860
26-49	26,540	26,570	4,074	4,029	1,260	1,047
26-29	3,668	3,532	633	564	186	183
30-34	5,762	5,528	991	1,045	240	272
35-39	5,450	6,060	783	913	294	239
40-44	5,902	5,745	927	704	326^a	164
45-49	5,758	5,704	740	803	214	189
50 or Older	37,614	37,462	2,878	3,138	848	813
50-54	6,394	5,458	581	616	197	133
55-59	6,172	6,095	637	525	207	125
60-64	7,455	7,671	674	894	188	321
65 or Older	17,592	18,237	986	1,103	256	234
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.13B – Any Use of Prescription Pain Relievers in Past Year and Misuse of Prescription Pain Relievers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	26.2	26.2	3.0	3.0	0.9	0.8
12-20	14.5^b	16.0	2.1	2.2	0.5	0.5
21 or Older	28.0	27.8	3.1	3.2	0.9	0.8
12-17	12.4^b	14.7	1.6^a	2.2	0.5	0.6
12-13	10.0	11.3	1.4	1.7	0.3	0.4
14-15	13.1^a	15.4	1.5^a	2.3	0.6	0.8
16-17	14.1^a	16.9	1.9	2.5	0.4	0.4
18 or Older	27.6	27.4	3.1	3.1	0.9	0.8
18-25	18.7	19.1	3.2^a	2.5	0.6	0.5
18-20	18.7	19.0	3.1^a	2.1	0.6	0.4
21-25	18.6	19.2	3.2	2.7	0.6	0.5
26 or Older	29.0	28.6	3.1	3.2	1.0	0.8
26-49	25.9	25.7	4.0	3.9	1.2	1.0
26-29	21.5	20.1	3.7	3.2	1.1	1.0
30-34	24.9	24.4	4.3	4.6	1.0	1.2
35-39	24.7	26.1	3.6	3.9	1.3	1.0
40-44	28.4	27.1	4.5	3.3	1.6^a	0.8
45-49	29.5	30.3	3.8	4.3	1.1	1.0
50 or Older	31.6	31.2	2.4	2.6	0.7	0.7
50-54	32.3	29.2	2.9	3.3	1.0	0.7
55-59	30.9	29.7	3.2	2.6	1.0	0.6
60-64	32.9	33.6	3.0	3.9	0.8	1.4
65 or Older	31.1	31.5	1.7	1.9	0.5	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.14A – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	19,674	19,816	4,298	3,922	1,348	1,163
12-20	3,042	3,005	597	491	136	101
21 or Older	16,632	16,811	3,701	3,431	1,212	1,062
12-17	1,845	1,807	226	230	33	32
12-13	461	451	32	35	8	5
14-15	635	659	57	92	11	15
16-17	749	697	137	103	14	12
18 or Older	17,830	18,009	4,072	3,692	1,315	1,131
18-25	3,794	3,660	1,278	1,066	376	308
18-20	1,198	1,198	371	261	103	69
21-25	2,597	2,462	906	805	273	239
26 or Older	14,035	14,349	2,794	2,626	939	823
26-49	9,485	10,101	2,365	2,288	815	709
26-29	1,898	2,187	631	739	200	260
30-34	2,390	2,577	737	601	293	171
35-39	2,063	2,427	462	515	95	137
40-44	1,777	1,707	293	264	144	84
45-49	1,356	1,203	243	169	84	57
50 or Older	4,550	4,248	429	338	123	115
50-54	1,159	1,199	273	169	88	75
55-59	1,167	1,071	49	90	6	15
60-64	887	723	77	53	4	24
65 or Older	1,337	1,256	29	26	25	*
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.14B – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	7.0	7.0	1.5	1.4	0.5	0.4
12-20	7.9	7.9	1.5	1.3	0.4	0.3
21 or Older	6.8	6.9	1.5	1.4	0.5	0.4
12-17	7.2	7.0	0.9	0.9	0.1	0.1
12-13	5.5	5.7	0.4	0.4	0.1	0.1
14-15	7.0	7.2	0.6	1.0	0.1	0.2
16-17	9.1	7.9	1.7	1.2	0.2	0.1
18 or Older	7.0	7.0	1.6	1.4	0.5	0.4
18-25	10.9	10.8	3.7	3.1	1.1	0.9
18-20	9.3	9.9	2.9	2.1	0.8	0.6
21-25	11.9	11.2	4.1	3.7	1.2	1.1
26 or Older	6.3	6.4	1.3	1.2	0.4	0.4
26-49	9.2	9.8	2.3	2.2	0.8	0.7
26-29	11.1	12.4	3.7	4.2	1.2	1.5
30-34	10.3	11.4	3.2	2.7	1.3	0.8
35-39	9.4	10.5	2.1	2.2	0.4	0.6
40-44	8.5	8.1	1.4	1.2	0.7	0.4
45-49	7.0	6.4	1.2	0.9	0.4	0.3
50 or Older	3.8	3.5	0.4	0.3	0.1	0.1
50-54	5.9	6.4	1.4	0.9	0.4	0.4
55-59	5.8	5.2	0.2	0.4	<0.1	0.1
60-64	3.9	3.2	0.3	0.2	<0.1	0.1
65 or Older	2.4	2.2	0.1	<0.1	<0.1	*
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.15A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	41,314	39,679	4,848	4,722	1,529	1,236
12-20	2,078	1,894	387	316	66	98
21 or Older	39,236	37,785	4,461	4,406	1,463	1,139
12-17	1,085	1,181	137	173	37	44
12-13	280	254	11	15	5	*
14-15	414	436	44	42	24	5
16-17	390	491	82	117	8^a	39
18 or Older	40,229	38,498	4,711	4,549	1,492	1,192
18-25	3,227^b	2,726	842^b	576	181	159
18-20	993^b	713	250^a	143	29	53
21-25	2,234	2,014	592^a	433	152	105
26 or Older	37,002	35,772	3,869	3,973	1,312	1,033
26-49	14,552	14,771	2,277	2,561	779	595
26-29	1,795	1,905	355	381	88	98
30-34	3,116	2,815	666	639	202	115
35-39	2,953	3,406	410^a	660	168	123
40-44	3,377	3,407	465	482	197	226
45-49	3,310	3,238	382	399	125^a	32
50 or Older	22,450	21,001	1,591	1,412	532	439
50-54	3,813	3,483	398	330	123	126
55-59	3,758	3,354	325	157	83	89
60-64	4,053	4,333	384	362	119	92
65 or Older	10,826	9,830	485	563	208	131
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.15B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	14.7	14.0	1.7	1.7	0.5	0.4
12-20	5.4	5.0	1.0	0.8	0.2	0.3
21 or Older	16.1	15.4	1.8	1.8	0.6	0.5
12-17	4.2	4.6	0.5	0.7	0.1	0.2
12-13	3.3	3.2	0.1	0.2	0.1	*
14-15	4.6	4.8	0.5	0.5	0.3^a	0.1
16-17	4.7	5.6	1.0	1.3	0.1^a	0.4
18 or Older	15.7	14.9	1.8	1.8	0.6	0.5
18-25	9.3^a	8.0	2.4^b	1.7	0.5	0.5
18-20	7.7^a	5.9	1.9^a	1.2	0.2	0.4
21-25	10.2	9.2	2.7^a	2.0	0.7	0.5
26 or Older	16.7	16.0	1.7	1.8	0.6	0.5
26-49	14.2	14.3	2.2	2.5	0.8	0.6
26-29	10.5	10.8	2.1	2.2	0.5	0.6
30-34	13.4	12.4	2.9	2.8	0.9	0.5
35-39	13.4	14.7	1.9^a	2.8	0.8	0.5
40-44	16.2	16.1	2.2	2.3	0.9	1.1
45-49	17.0	17.2	2.0	2.1	0.6^a	0.2
50 or Older	18.9	17.5	1.3	1.2	0.4	0.4
50-54	19.3	18.7	2.0	1.8	0.6	0.7
55-59	18.8	16.3	1.6^a	0.8	0.4	0.4
60-64	17.9	19.0	1.7	1.6	0.5	0.4
65 or Older	19.2^a	17.0	0.9	1.0	0.4	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.16A – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	32,783	31,384	4,153	3,993	1,304	1,053
12-20	1,443	1,293	330	244	55	81
21 or Older	31,340	30,092	3,823	3,749	1,249	972
12-17	717	731	115	119	34	38
12-13	146	148	9	7	4	*
14-15	288	257	40	32	23^a	3
16-17	284	326	66	81	7^a	34
18 or Older	32,066	30,653	4,038	3,874	1,270	1,015
18-25	2,592^a	2,228	779^b	522	158	138
18-20	726^a	561	215^a	125	20	43
21-25	1,866	1,667	565^a	398	138	95
26 or Older	29,474	28,425	3,259	3,351	1,112	877
26-49	11,929	12,405	2,028	2,314	691	555
26-29	1,493	1,652	318	340	75	95
30-34	2,601	2,313	546	592	157	113
35-39	2,416	2,854	379^a	559	139	103
40-44	2,778	2,868	437	435	197	214
45-49	2,641	2,717	348	388	123^a	29
50 or Older	17,545^a	16,020	1,231	1,037	421	323
50-54	2,919	2,881	348	274	114	38
55-59	3,164	2,571	210	153	53	87
60-64	3,102	3,139	310	269	65	83
65 or Older	8,360	7,429	362	342	189	115
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.16B – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	11.6	11.1	1.5	1.4	0.5	0.4
12-20	3.7	3.4	0.9	0.6	0.1	0.2
21 or Older	12.9	12.3	1.6	1.5	0.5	0.4
12-17	2.8	2.8	0.4	0.5	0.1	0.1
12-13	1.7	1.9	0.1	0.1	<0.1	*
14-15	3.2	2.8	0.4	0.3	0.3^a	<0.1
16-17	3.5	3.7	0.8	0.9	0.1^a	0.4
18 or Older	12.5	11.9	1.6	1.5	0.5	0.4
18-25	7.5^a	6.5	2.2^b	1.5	0.5	0.4
18-20	5.6	4.6	1.7^a	1.0	0.2	0.4
21-25	8.5	7.6	2.6^a	1.8	0.6	0.4
26 or Older	13.3	12.7	1.5	1.5	0.5	0.4
26-49	11.6	12.0	2.0	2.2	0.7	0.5
26-29	8.8	9.4	1.9	1.9	0.4	0.5
30-34	11.2	10.2	2.4	2.6	0.7	0.5
35-39	11.0	12.3	1.7	2.4	0.6	0.4
40-44	13.4	13.5	2.1	2.1	0.9	1.0
45-49	13.5	14.4	1.8	2.1	0.6^a	0.2
50 or Older	14.8^a	13.3	1.0	0.9	0.4	0.3
50-54	14.8	15.4	1.8	1.5	0.6	0.2
55-59	15.8^a	12.5	1.1	0.7	0.3	0.4
60-64	13.7	13.7	1.4	1.2	0.3	0.4
65 or Older	14.8^a	12.8	0.6	0.6	0.3	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.17A – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	15,399	14,666	959	1,063	278	284
12-20	919	847	64	106	16	24
21 or Older	14,481	13,819	894	957	262	260
12-17	521	583	27	68	7	14
12-13	174	134	2	8	1	*
14-15	193	212	8	17	4	2
16-17	153^a	236	18	43	2	12
18 or Older	14,878	14,083	931	995	271	271
18-25	1,082^a	875	93	90	32	23
18-20	398^a	264	37	38	9	10
21-25	684	611	56	53	24	13
26 or Older	13,797	13,208	839	905	239	248
26-49	4,903	4,556	369	401	118	90
26-29	484	505	48	67	12	21
30-34	988	967	141	135	50	20
35-39	944	995	78	121	36	29
40-44	1,227	1,108	56	55	15	12
45-49	1,259	981	45	24	4	8
50 or Older	8,894	8,652	470	504	121	158
50-54	1,575	1,323	74	122	8	88
55-59	1,498	1,342	139^a	5	30	2
60-64	1,727	1,983	94	145	54	51
65 or Older	4,095	4,004	163	232	28	16
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.17B – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	5.5	5.2	0.3	0.4	0.1	0.1
12-20	2.4	2.2	0.2	0.3	<0.1	0.1
21 or Older	6.0	5.6	0.4	0.4	0.1	0.1
12-17	2.0	2.2	0.1	0.3	<0.1	0.1
12-13	2.1	1.7	<0.1	0.1	<0.1	*
14-15	2.1	2.3	0.1	0.2	<0.1	<0.1
16-17	1.9	2.7	0.2	0.5	<0.1	0.1
18 or Older	5.8	5.5	0.4	0.4	0.1	0.1
18-25	3.1	2.6	0.3	0.3	0.1	0.1
18-20	3.1	2.2	0.3	0.3	0.1	0.1
21-25	3.1	2.8	0.3	0.2	0.1	0.1
26 or Older	6.2	5.9	0.4	0.4	0.1	0.1
26-49	4.8	4.4	0.4	0.4	0.1	0.1
26-29	2.8	2.9	0.3	0.4	0.1	0.1
30-34	4.3	4.3	0.6	0.6	0.2	0.1
35-39	4.3	4.3	0.4	0.5	0.2	0.1
40-44	5.9	5.2	0.3	0.3	0.1	0.1
45-49	6.5	5.2	0.2	0.1	<0.1	<0.1
50 or Older	7.5	7.2	0.4	0.4	0.1	0.1
50-54	8.0	7.1	0.4	0.7	<0.1	0.5
55-59	7.5	6.5	0.7^a	<0.1	0.2	<0.1
60-64	7.6	8.7	0.4	0.6	0.2	0.2
65 or Older	7.2	6.9	0.3	0.4	<0.1	<0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.18A – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)
TOTAL	25,703^a	23,894	3,681	3,696
12-20	1,110^b	863	320	229
21 or Older	24,593	23,031	3,362	3,467
12-17	480	456	113	111
12-13	95	57	9	4
14-15	167	158	37	26
16-17	219	241	66	81
18 or Older	25,223^a	23,437	3,569	3,585
18-25	2,178^b	1,739	747^b	480
18-20	630^b	406	207^a	118
21-25	1,548	1,332	540^a	362
26 or Older	23,045	21,699	2,822	3,105
26-49	9,592	9,689	1,845	2,080
26-29	1,266	1,335	307	318
30-34	2,161	1,815	491	514
35-39	1,905	2,208	350	518
40-44	2,204	2,153	386	406
45-49	2,056	2,179	311	323
50 or Older	13,454^a	12,009	976	1,025
50-54	2,225	2,197	246	252
55-59	2,404	1,841	190	139
60-64	2,284	2,236	238	261
65 or Older	6,540	5,735	302	374
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.18B – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)
TOTAL	9.1^a	8.4	1.3	1.3
12-20	2.9^a	2.3	0.8	0.6
21 or Older	10.1^a	9.4	1.4	1.4
12-17	1.9	1.8	0.4	0.4
12-13	1.1	0.7	0.1	<0.1
14-15	1.8	1.7	0.4	0.3
16-17	2.7	2.7	0.8	0.9
18 or Older	9.8^a	9.1	1.4	1.4
18-25	6.3^b	5.1	2.1^b	1.4
18-20	4.9^b	3.3	1.6^a	1.0
21-25	7.1	6.1	2.5^b	1.7
26 or Older	10.4	9.7	1.3	1.4
26-49	9.4	9.4	1.8	2.0
26-29	7.4	7.6	1.8	1.8
30-34	9.3	8.0	2.1	2.3
35-39	8.6	9.5	1.6	2.2
40-44	10.6	10.2	1.9	1.9
45-49	10.5	11.6	1.6	1.7
50 or Older	11.3^a	10.0	0.8	0.9
50-54	11.3	11.8	1.2	1.3
55-59	12.0^a	9.0	0.9	0.7
60-64	10.1	9.8	1.1	1.1
65 or Older	11.6^a	9.9	0.5	0.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.19A – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Any Use in Past Year¹ (2022)	Any Use in Past Year¹ (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	74,052	74,506	8,918	8,902	2,944	2,442
12-20	5,613	6,109	817	830	201	200
21 or Older	68,439	68,398	8,101	8,072	2,743	2,242
12-17	3,191^b	3,804	406^a	574	117	147
12-13	847	902	115	140	27	33
14-15	1,185	1,407	132^a	213	55	76
16-17	1,159^b	1,495	160	221	36	38
18 or Older	70,861	70,702	8,513	8,328	2,827	2,295
18-25	6,504	6,516	1,120^b	846	221	174
18-20	2,423	2,304	411^a	256	84	53
21-25	4,081	4,211	708	590	137	121
26 or Older	64,358	64,187	7,393	7,482	2,606	2,121
26-49	26,624	26,675	4,364	4,291	1,572	1,260
26-29	3,673	3,538	655	594	196	209
30-34	5,773	5,536	1,039	1,066	277	291
35-39	5,480	6,104	842	1,020	375	329
40-44	5,916	5,772	982	762	380^a	208
45-49	5,782	5,724	847	850	344	223
50 or Older	37,734	37,511	3,029	3,191	1,034	861
50-54	6,406	5,476	605	635	236	138
55-59	6,199	6,098	682	531	254	151
60-64	7,528	7,672	747	895	265	321
65 or Older	17,600	18,265	995	1,130	278	251
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Any use of opioids includes the use of heroin or any use of prescription pain relievers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.19B – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Any Use in Past Year¹ (2022)	Any Use in Past Year¹ (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	26.3	26.3	3.2	3.1	1.0	0.9
12-20	14.5^b	16.0	2.1	2.2	0.5	0.5
21 or Older	28.1	27.9	3.3	3.3	1.1	0.9
12-17	12.4^b	14.7	1.6^a	2.2	0.5	0.6
12-13	10.0	11.3	1.4	1.8	0.3	0.4
14-15	13.1^a	15.4	1.5^a	2.3	0.6	0.8
16-17	14.1^a	16.9	1.9	2.5	0.4	0.4
18 or Older	27.6	27.5	3.3	3.2	1.1	0.9
18-25	18.7	19.1	3.2^a	2.5	0.6	0.5
18-20	18.7	19.0	3.2^a	2.1	0.7	0.4
21-25	18.7	19.2	3.2	2.7	0.6	0.6
26 or Older	29.1	28.7	3.3	3.3	1.2	0.9
26-49	26.0	25.8	4.3	4.1	1.5	1.2
26-29	21.6	20.1	3.8	3.4	1.1	1.2
30-34	24.9	24.4	4.5	4.7	1.2	1.3
35-39	24.9	26.3	3.8	4.4	1.7	1.4
40-44	28.4	27.2	4.7	3.6	1.8^a	1.0
45-49	29.6	30.4	4.3	4.5	1.8	1.2
50 or Older	31.7	31.3	2.5	2.7	0.9	0.7
50-54	32.4	29.3	3.1	3.4	1.2	0.7
55-59	31.0	29.7	3.4	2.6	1.3	0.7
60-64	33.2	33.6	3.3	3.9	1.2	1.4
65 or Older	31.2	31.5	1.8	2.0	0.5	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Any use of opioids includes the use of heroin or any use of prescription pain relievers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.20A – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Any Use in Past Year¹ (2022)	Any Use in Past Year¹ (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	24,425	24,686	10,188	9,659	4,469	4,175
12-20	3,220	3,197	794	772	205	206
21 or Older	21,205	21,489	9,394	8,887	4,264	3,969
12-17	1,889	1,835	272	285	40	72
12-13	481	454	54	44	11	11
14-15	640	672	63	106	11	16
16-17	767	709	155	135	18	45
18 or Older	22,536	22,850	9,916	9,374	4,429	4,103
18-25	4,581	4,298	2,272^a	1,895	767^a	546
18-20	1,331	1,362	522	487	165	134
21-25	3,249	2,937	1,750^a	1,408	602^a	412
26 or Older	17,956	18,552	7,644	7,479	3,662	3,557
26-49	12,078	12,837	5,476	5,546	2,443	2,460
26-29	2,506	2,673	1,338	1,314	470	586
30-34	3,026	3,255	1,563	1,417	686	540
35-39	2,587	3,065	1,089	1,294	495	582
40-44	2,145	2,153	751	786	405	341
45-49	1,814	1,691	736	735	388	410
50 or Older	5,877	5,715	2,168	1,933	1,218	1,097
50-54	1,521	1,583	721	636	343	243
55-59	1,485	1,493	464	535	208	326
60-64	1,387	1,046	711	378	489	251
65 or Older	1,485	1,593	272	384	179	278
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.20B – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Any Use in Past Year¹ (2022)	Any Use in Past Year¹ (2023)	Misuse in Past Year (2022)	Misuse in Past Year (2023)	Misuse in Past Month (2022)	Misuse in Past Month (2023)
TOTAL	8.7	8.7	3.6	3.4	1.6	1.5
12-20	8.3	8.4	2.1	2.0	0.5	0.5
21 or Older	8.7	8.8	3.9	3.6	1.8	1.6
12-17	7.3	7.1	1.1	1.1	0.2	0.3
12-13	5.7	5.7	0.6	0.6	0.1	0.1
14-15	7.1	7.4	0.7	1.2	0.1	0.2
16-17	9.3	8.0	1.9	1.5	0.2	0.5
18 or Older	8.8	8.9	3.9	3.6	1.7	1.6
18-25	13.2	12.6	6.5^a	5.6	2.2^a	1.6
18-20	10.3	11.2	4.0	4.0	1.3	1.1
21-25	14.9	13.4	8.0^a	6.4	2.8^a	1.9
26 or Older	8.1	8.3	3.5	3.3	1.7	1.6
26-49	11.8	12.4	5.3	5.4	2.4	2.4
26-29	14.7	15.2	7.9	7.5	2.8	3.3
30-34	13.1	14.4	6.7	6.3	3.0	2.4
35-39	11.7	13.2	4.9	5.6	2.2	2.5
40-44	10.3	10.2	3.6	3.7	1.9	1.6
45-49	9.3	9.0	3.8	3.9	2.0	2.2
50 or Older	4.9	4.8	1.8	1.6	1.0	0.9
50-54	7.7	8.5	3.6	3.4	1.7	1.3
55-59	7.4	7.3	2.3	2.6	1.0	1.6
60-64	6.1	4.6	3.1	1.7	2.2	1.1
65 or Older	2.6	2.7	0.5	0.7	0.3	0.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.21A – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	24,692	24,882	9,560	9,210
12-20	2,846	2,730	825	859
21 or Older	21,846	22,152	8,736	8,351
12-17	1,343	1,522	399	442
12-13	325	367	118	87
14-15	440	558	128	161
16-17	578	596	154	194
18 or Older	23,348	23,361	9,161	8,768
18-25	5,092^b	4,343	1,531	1,372
18-20	1,502^a	1,208	425	417
21-25	3,590^a	3,135	1,106	954
26 or Older	18,256	19,017	7,630	7,396
26-49	11,977	12,711	4,857	5,048
26-29	2,515	2,728	883	1,152
30-34	3,123	3,309	1,221	1,239
35-39	2,373^a	2,998	992	1,121
40-44	2,187	1,916	1,036	823
45-49	1,778	1,758	724	713
50 or Older	6,279	6,307	2,773	2,348
50-54	1,628	1,608	683	485
55-59	1,290	1,107	556	503
60-64	1,592	1,564	812	667
65 or Older	1,769	2,028	722	693
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.21B – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	8.8	8.8	3.4	3.2
12-20	7.4	7.2	2.1	2.3
21 or Older	9.0	9.0	3.6	3.4
12-17	5.2	5.9	1.6	1.7
12-13	3.9	4.6	1.4	1.1
14-15	4.9	6.1	1.4	1.8
16-17	7.0	6.8	1.9	2.2
18 or Older	9.1	9.1	3.6	3.4
18-25	14.6^b	12.8	4.4	4.0
18-20	11.6	9.9	3.3	3.4
21-25	16.4^a	14.3	5.1	4.4
26 or Older	8.2	8.5	3.4	3.3
26-49	11.7	12.3	4.7	4.9
26-29	14.8	15.5	5.2	6.5
30-34	13.5	14.6	5.3	5.5
35-39	10.8^a	12.9	4.5	4.8
40-44	10.5	9.0	5.0	3.9
45-49	9.1	9.3	3.7	3.8
50 or Older	5.3	5.3	2.3	2.0
50-54	8.2	8.6	3.5	2.6
55-59	6.5	5.4	2.8	2.4
60-64	7.0	6.8	3.6	2.9
65 or Older	3.1	3.5	1.3	1.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.22A – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Numbers in Thousands, 2022 and 2023
Prescription Drug/Age Group	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Past Year Any Users (2022)	Misuse in Past Year among Past Year Any Users (2023)
PSYCHOTHERAPEUTICS	101,637	101,916	14,204	14,435	14,204	14,435
12-17	4,920^b	5,503	640	785	640	785
18 or Older	96,717	96,413	13,564	13,651	13,564	13,651
18-25	10,367	10,168	2,542^b	2,025	2,542^b	2,025
26 or Older	86,350	86,245	11,022	11,625	11,022	11,625
PAIN RELIEVERS	73,833	74,347	8,457	8,578	8,457	8,578
12-17	3,191^b	3,800	406^a	570	406^a	570
18 or Older	70,642	70,547	8,051	8,008	8,051	8,008
18-25	6,489	6,515	1,099^b	841	1,099^a	841
26 or Older	64,153	64,032	6,953	7,167	6,953	7,167
STIMULANTS	19,674	19,816	4,298	3,922	4,298	3,922
12-17	1,845	1,807	226	230	226	230
18 or Older	17,830	18,009	4,072	3,692	4,072	3,692
18-25	3,794	3,660	1,278	1,066	1,278	1,066
26 or Older	14,035	14,349	2,794	2,626	2,794	2,626
TRANQUILIZERS OR SEDATIVES	41,314	39,679	4,848	4,722	4,848	4,722
12-17	1,085	1,181	137	173	137	173
18 or Older	40,229	38,498	4,711	4,549	4,711	4,549
18-25	3,227^b	2,726	842^b	576	842^b	576
26 or Older	37,002	35,772	3,869	3,973	3,869	3,973
TRANQUILIZERS	32,783	31,384	4,153	3,993	4,153	3,993
12-17	717	731	115	119	115	119
18 or Older	32,066	30,653	4,038	3,874	4,038	3,874
18-25	2,592^a	2,228	779^b	522	779^b	522
26 or Older	29,474	28,425	3,259	3,351	3,259	3,351
SEDATIVES	15,399	14,666	959	1,063	959	1,063
12-17	521	583	27	68	27	68
18 or Older	14,878	14,083	931	995	931	995
18-25	1,082^a	875	93	90	93	90
26 or Older	13,797	13,208	839	905	839	905
BENZODIAZEPINES	25,703^a	23,894	3,681	3,696	3,681	3,696
12-17	480	456	113	111	113	111
18 or Older	25,223^a	23,437	3,569	3,585	3,569	3,585
18-25	2,178^b	1,739	747^b	480	747^b	480
26 or Older	23,045	21,699	2,822	3,105	2,822	3,105
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.22B – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Percentages, 2022 and 2023
Prescription Drug/Age Group	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Past Year Any Users (2022)	Misuse in Past Year among Past Year Any Users (2023)
PSYCHOTHERAPEUTICS	36.0	36.0	5.0	5.1	14.0	14.2
12-17	19.1^b	21.2	2.5	3.0	13.0	14.3
18 or Older	37.7	37.4	5.3	5.3	14.0	14.2
18-25	29.8	29.9	7.3^b	6.0	24.5^b	19.9
26 or Older	39.0	38.6	5.0	5.2	12.8	13.5
PAIN RELIEVERS	26.2	26.2	3.0	3.0	11.5	11.5
12-17	12.4^b	14.7	1.6^a	2.2	12.7	15.0
18 or Older	27.6	27.4	3.1	3.1	11.4	11.4
18-25	18.7	19.1	3.2^a	2.5	16.9^b	12.9
26 or Older	29.0	28.6	3.1	3.2	10.8	11.2
STIMULANTS	7.0	7.0	1.5	1.4	21.8	19.8
12-17	7.2	7.0	0.9	0.9	12.2	12.8
18 or Older	7.0	7.0	1.6	1.4	22.8	20.5
18-25	10.9	10.8	3.7	3.1	33.7	29.1
26 or Older	6.3	6.4	1.3	1.2	19.9	18.3
TRANQUILIZERS OR SEDATIVES	14.7	14.0	1.7	1.7	11.7	11.9
12-17	4.2	4.6	0.5	0.7	12.6	14.7
18 or Older	15.7	14.9	1.8	1.8	11.7	11.8
18-25	9.3^a	8.0	2.4^b	1.7	26.1^a	21.1
26 or Older	16.7	16.0	1.7	1.8	10.5	11.1
TRANQUILIZERS	11.6	11.1	1.5	1.4	12.7	12.7
12-17	2.8	2.8	0.4	0.5	16.1	16.3
18 or Older	12.5	11.9	1.6	1.5	12.6	12.6
18-25	7.5^a	6.5	2.2^b	1.5	30.1^a	23.4
26 or Older	13.3	12.7	1.5	1.5	11.1	11.8
SEDATIVES	5.5	5.2	0.3	0.4	6.2	7.2
12-17	2.0	2.2	0.1	0.3	5.3	11.6
18 or Older	5.8	5.5	0.4	0.4	6.3	7.1
18-25	3.1	2.6	0.3	0.3	8.6	10.3
26 or Older	6.2	5.9	0.4	0.4	6.1	6.9
BENZODIAZEPINES	9.1^a	8.4	1.3	1.3	14.3	15.5
12-17	1.9	1.8	0.4	0.4	23.5	24.4
18 or Older	9.8^a	9.1	1.4	1.4	14.1	15.3
18-25	6.3^b	5.1	2.1^b	1.4	34.3^a	27.6
26 or Older	10.4	9.7	1.3	1.4	12.2	14.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.23A – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	143,116	145,076	5,377	5,332	137,739	139,745	19,121^a	18,285	118,618	121,460
SEX
Male	74,761	75,280	2,431	2,500	72,330	72,781	9,689^b	9,036	62,641	63,745
Female	68,355	69,796	2,946	2,832	65,409	66,964	9,432	9,249	55,978	57,715
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	122,138	123,879	3,891	3,920	118,247	119,959	14,846^b	14,007	103,401	105,952
AIAN	785	762	48	52	737	711	*	*	618	632
Asian	4,436	4,248	212	187	4,224	4,061	837	642	3,387	3,419
Black or African American	16,512	16,848	778	806	15,734	16,042	2,398	2,384	13,336	13,657
NHOPI	*	*	*	*	*	*	*	*	*	*
White	96,397	97,504	2,650	2,598	93,747	94,906	10,851	10,133	82,895	84,773
Two or More Races	3,476	3,961	195	249	3,281	3,712	592	716	2,689	2,996
Hispanic or Latino	20,978	21,198	1,486	1,412	19,492	19,786	4,275	4,278	15,217	15,508
EDUCATION LEVEL
< High School	da	da	da	da	10,001	10,144	1,842	1,757	8,159	8,386
High School Graduate	da	da	da	da	34,400	35,613	5,901	5,845	28,500	29,768
Some College/Associate’s Degree	da	da	da	da	46,557	45,391	7,919	7,305	38,638	38,086
College Graduate	da	da	da	da	46,780^a	48,597	3,459	3,378	43,321	45,220
EMPLOYMENT STATUS
Full-Time	da	da	da	da	69,646	71,262	8,709	8,242	60,937	63,020
Part-Time	da	da	da	da	17,962	18,268	4,624	4,550	13,338	13,719
Unemployed	da	da	da	da	6,102	6,345	1,777	1,693	4,326	4,652
Other¹	da	da	da	da	44,028	43,870	4,011	3,800	40,018	40,070
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.23B – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	50.7	51.2	20.9	20.6	53.7	54.3	55.0	53.7	53.6	54.3
SEX
Male	54.1	54.3	18.5	18.9	57.8	58.1	55.4	52.9	58.2	58.9
Female	47.5	48.2	23.4	22.4	49.9	50.7	54.5	54.5	49.1	50.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	52.8	53.6	20.4	20.5	55.8	56.6	56.0	54.3	55.7	56.9
AIAN	53.6	56.9	21.6	21.9	59.3	64.4	*	*	59.8	65.7
Asian	26.1	24.3	13.2	12.8	27.4	25.3	37.0^a	29.0	25.8	24.7
Black or African American	47.9	48.5	22.2	22.4	50.9	51.5	51.4	52.3	50.8	51.3
NHOPI	*	*	*	*	*	*	*	*	*	*
White	56.4	57.2	20.6	20.3	59.3	60.3	59.5	57.4	59.2	60.6
Two or More Races	59.1	63.9	23.4	26.8	65.0	70.5	59.0	65.4	66.5	71.8
Hispanic or Latino	41.2	40.6	22.4	20.8	44.0	43.5	51.8	51.8	42.3	41.7
EDUCATION LEVEL
< High School	da	da	da	da	41.1	41.4	51.4	49.2	39.3	40.1
High School Graduate	da	da	da	da	49.8	51.3	50.8	50.6	49.5	51.4
Some College/Associate’s Degree	da	da	da	da	59.9	58.9	57.0	55.5	60.5	59.6
College Graduate	da	da	da	da	55.0	56.2	60.7	58.7	54.6	56.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	58.8	58.9	61.9	59.6	58.4	58.8
Part-Time	da	da	da	da	54.7^a	57.9	52.6	54.5	55.5	59.2
Unemployed	da	da	da	da	55.4	55.5	55.4	50.7	55.4	57.4
Other¹	da	da	da	da	46.8	46.9	46.0	44.7	46.9	47.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.24A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	70,338	70,537	3,688	3,816	66,650	66,721	14,221^b	13,256	52,429	53,465
SEX
Male	37,740	37,581	1,708	1,731	36,033	35,850	7,281^a	6,754	28,752	29,096
Female	32,598	32,957	1,980	2,086	30,618	30,871	6,940^a	6,503	23,678	24,368
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	58,392	59,250	2,680	2,806	55,712	56,444	11,020^a	10,325	44,693	46,119
AIAN	464	491	38	38	426	453	*	*	326	393
Asian	2,322	2,176	144	95	2,178	2,080	585	466	1,593	1,614
Black or African American	9,188	9,613	535	590	8,653	9,023	1,881	1,868	6,773	7,155
NHOPI	*	*	*	*	*	*	*	*	*	*
White	44,085	44,397	1,832	1,879	42,252	42,518	7,941	7,359	34,312	35,159
Two or More Races	2,064	2,240	124^a	187	1,940	2,053	469	543	1,471	1,510
Hispanic or Latino	11,946	11,287	1,008	1,010	10,938	10,277	3,201	2,931	7,737	7,346
EDUCATION LEVEL
< High School	da	da	da	da	5,355	5,252	1,402	1,285	3,953	3,968
High School Graduate	da	da	da	da	17,447	17,956	4,426	4,413	13,021	13,542
Some College/Associate’s Degree	da	da	da	da	23,869	22,687	5,957	5,317	17,912	17,370
College Graduate	da	da	da	da	19,979	20,826	2,436	2,241	17,543	18,585
EMPLOYMENT STATUS
Full-Time	da	da	da	da	33,245	34,937	6,400	5,922	26,845^a	29,015
Part-Time	da	da	da	da	10,266	9,265	3,681	3,371	6,585	5,893
Unemployed	da	da	da	da	3,981	4,341	1,321	1,347	2,660	2,995
Other¹	da	da	da	da	19,159	18,178	2,819	2,616	16,340	15,562
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.24B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	24.9	24.9	14.3	14.7	26.0	25.9	40.9^a	39.0	23.7	23.9
SEX
Male	27.3	27.1	13.0	13.1	28.8	28.6	41.6	39.6	26.7	26.9
Female	22.7	22.8	15.8	16.5	23.3	23.4	40.1	38.3	20.8	21.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	25.3	25.6	14.0	14.7	26.3	26.6	41.5	40.1	24.1	24.8
AIAN	31.7	36.7	17.4	16.0	34.3	41.1	*	*	31.6	40.8
Asian	13.6	12.4	9.0	6.5	14.1	13.0	25.8	21.1	12.1	11.7
Black or African American	26.7	27.7	15.2	16.4	28.0	29.0	40.3	41.0	25.8	26.9
NHOPI	*	*	*	*	*	*	*	*	*	*
White	25.8	26.1	14.3	14.7	26.7	27.0	43.5	41.7	24.5	25.1
Two or More Races	35.1	36.2	14.8	20.1	38.4	39.0	46.7	49.7	36.4	36.2
Hispanic or Latino	23.5	21.6	15.2	14.9	24.7	22.6	38.8	35.5	21.5	19.8
EDUCATION LEVEL
< High School	da	da	da	da	22.0	21.5	39.1	35.9	19.0	19.0
High School Graduate	da	da	da	da	25.2	25.8	38.1	38.2	22.6	23.4
Some College/Associate’s Degree	da	da	da	da	30.7	29.4	42.9	40.4	28.0	27.2
College Graduate	da	da	da	da	23.5	24.1	42.8	39.0	22.1	23.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	28.1	28.9	45.5	42.8	25.7	27.1
Part-Time	da	da	da	da	31.3	29.4	41.9	40.3	27.4	25.4
Unemployed	da	da	da	da	36.1	37.9	41.2	40.3	34.1	37.0
Other¹	da	da	da	da	20.4	19.4	32.4	30.7	19.1	18.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.25A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	46,603	47,657	1,884	1,864	44,719	45,794	9,478^a	8,901	35,241	36,892
SEX
Male	26,081	26,541	827	846	25,254	25,695	5,047^a	4,629	20,207	21,066
Female	20,522	21,117	1,057	1,017	19,465	20,099	4,431	4,273	15,034	15,827
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	39,143	40,321	1,371	1,309	37,771	39,011	7,318	7,093	30,453	31,919
AIAN	275	365	25	11	250	355	*	*	183	314
Asian	1,255	1,189	62	29	1,193	1,161	340	243	853	917
Black or African American	6,392	6,753	314	270	6,078	6,483	1,304	1,420	4,774	5,063
NHOPI	200	*	*	*	*	*	*	*	*	*
White	29,447	30,210	881	883	28,565	29,327	5,248	4,969	23,317	24,358
Two or More Races	1,575	1,559	83	112	1,492	1,448	319	402	1,173	1,045
Hispanic or Latino	7,461	7,337	513	554	6,948	6,782	2,160^a	1,808	4,788	4,974
EDUCATION LEVEL
< High School	da	da	da	da	3,885	3,874	1,034	920	2,851	2,953
High School Graduate	da	da	da	da	12,288	13,125	3,020	3,135	9,268	9,990
Some College/Associate’s Degree	da	da	da	da	16,213	15,774	3,905	3,529	12,309	12,244
College Graduate	da	da	da	da	12,333	13,022	1,520	1,317	10,813	11,704
EMPLOYMENT STATUS
Full-Time	da	da	da	da	22,295	23,679	4,363	4,055	17,932^a	19,625
Part-Time	da	da	da	da	6,820	6,422	2,371	2,166	4,450	4,255
Unemployed	da	da	da	da	2,859	3,180	907	1,029	1,952	2,151
Other¹	da	da	da	da	12,745	12,513	1,838	1,651	10,908	10,862
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.25B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	16.5	16.8	7.3	7.2	17.4	17.8	27.2	26.2	15.9	16.5
SEX
Male	18.9	19.1	6.3	6.4	20.2	20.5	28.9	27.1	18.8	19.5
Female	14.3	14.6	8.4	8.0	14.8	15.2	25.6	25.2	13.2	13.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	16.9	17.4	7.2	6.8	17.8	18.4	27.6	27.5	16.4	17.1
AIAN	18.8^a	27.3	11.4	4.5	20.1^b	32.1	*	*	17.7^b	32.6
Asian	7.4	6.8	3.8	2.0	7.7	7.2	15.0	11.0	6.5	6.6
Black or African American	18.6	19.4	8.9	7.5	19.7	20.8	27.9	31.1	18.2	19.0
NHOPI	15.7	*	*	*	*	*	*	*	*	*
White	17.2	17.7	6.9	6.9	18.1	18.6	28.8	28.2	16.7	17.4
Two or More Races	26.8	25.2	10.0	12.0	29.5	27.5	31.8	36.8	29.0	25.1
Hispanic or Latino	14.7	14.0	7.7	8.2	15.7	14.9	26.2^a	21.9	13.3	13.4
EDUCATION LEVEL
< High School	da	da	da	da	15.9	15.8	28.8	25.7	13.7	14.1
High School Graduate	da	da	da	da	17.8	18.9	26.0	27.2	16.1	17.2
Some College/Associate’s Degree	da	da	da	da	20.8	20.5	28.1	26.8	19.3	19.2
College Graduate	da	da	da	da	14.5	15.0	26.7	22.9	13.6	14.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	18.8	19.6	31.0	29.3	17.2	18.3
Part-Time	da	da	da	da	20.8	20.4	27.0	25.9	18.5	18.3
Unemployed	da	da	da	da	26.0	27.8	28.3	30.8	25.0	26.6
Other¹	da	da	da	da	13.6	13.4	21.1	19.4	12.8	12.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.26A – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	132,296	133,529	3,466	3,462	128,829	130,067	18,053^b	17,033	110,776	113,034
SEX
Male	69,667	69,100	1,553	1,550	68,114	67,550	9,058^b	8,370	59,056	59,180
Female	62,629	64,429	1,913	1,913	60,715	62,517	8,996	8,663	51,720^a	53,854
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	113,865	114,665	2,422	2,505	111,443	112,160	13,987^b	13,126	97,456	99,034
AIAN	700	635	32	*	668	601	*	*	552	530
Asian	3,889	3,579	88	75	3,800	3,504	750^a	541	3,050	2,963
Black or African American	15,213	15,503	491	510	14,722	14,993	2,284	2,232	12,438	12,761
NHOPI	*	*	*	*	*	*	*	*	*	*
White	90,413	90,714	1,677	1,697	88,736	89,017	10,231	9,559	78,505	79,457
Two or More Races	3,206	3,730	126	170	3,080	3,559	558	675	2,522	2,885
Hispanic or Latino	18,431	18,864	1,044	957	17,386	17,907	4,066	3,906	13,320	14,000
EDUCATION LEVEL
< High School	da	da	da	da	9,042	9,180	1,687	1,580	7,355	7,600
High School Graduate	da	da	da	da	31,969	33,181	5,577	5,447	26,391	27,734
Some College/Associate’s Degree	da	da	da	da	44,025	42,537	7,460	6,834	36,565	35,702
College Graduate	da	da	da	da	43,793	45,169	3,328	3,171	40,464	41,998
EMPLOYMENT STATUS
Full-Time	da	da	da	da	65,482	66,653	8,341	7,831	57,141	58,822
Part-Time	da	da	da	da	17,012	17,000	4,364	4,170	12,647	12,830
Unemployed	da	da	da	da	5,784	5,836	1,674	1,607	4,110	4,230
Other¹	da	da	da	da	40,552	40,578	3,675	3,425	36,877	37,153
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.26B – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	46.9	47.1	13.5	13.4	50.3	50.5	51.9	50.0	50.0	50.6
SEX
Male	50.4	49.9	11.8	11.7	54.5	53.9	51.8^a	49.0	54.9	54.6
Female	43.6	44.5	15.2	15.1	46.3	47.3	52.0	51.1	45.4	46.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	49.3	49.6	12.7	13.1	52.6	52.9	52.7	50.9	52.5	53.2
AIAN	47.8	47.4	14.3	*	53.7	54.4	*	*	53.5	55.1
Asian	22.9	20.5	5.5	5.2	24.7	21.9	33.1^a	24.4	23.2	21.4
Black or African American	44.2	44.6	14.0	14.2	47.6	48.1	49.0	48.9	47.4	48.0
NHOPI	*	*	*	*	*	*	*	*	*	*
White	52.9	53.3	13.1	13.2	56.1	56.5	56.1	54.2	56.1	56.8
Two or More Races	54.5^a	60.2	15.1	18.4	61.0^a	67.6	55.7	61.7	62.4	69.1
Hispanic or Latino	36.2	36.1	15.7	14.1	39.3	39.4	49.2	47.3	37.0	37.7
EDUCATION LEVEL
< High School	da	da	da	da	37.1	37.5	47.0	44.2	35.4	36.3
High School Graduate	da	da	da	da	46.2	47.8	48.0	47.2	45.9	47.9
Some College/Associate’s Degree	da	da	da	da	56.6	55.2	53.7	51.9	57.2	55.9
College Graduate	da	da	da	da	51.5	52.2	58.4	55.1	51.0	52.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	55.3	55.1	59.3	56.6	54.8	54.9
Part-Time	da	da	da	da	51.8	53.9	49.6	49.9	52.6	55.3
Unemployed	da	da	da	da	52.5	51.0	52.1	48.1	52.6	52.2
Other¹	da	da	da	da	43.1	43.4	42.2	40.3	43.2	43.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.27A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	61,901	61,816	2,947	2,894	58,955	58,922	13,299^a	12,435	45,656	46,487
SEX
Male	33,475	33,187	1,319	1,291	32,156	31,896	6,800^a	6,323	25,355	25,573
Female	28,427	28,629	1,628	1,603	26,799	27,026	6,499	6,112	20,300	20,914
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	51,562	52,310	2,080	2,131	49,481	50,179	10,333^a	9,741	39,148	40,438
AIAN	399	405	29	*	371	374	*	52	275	322
Asian	1,905	1,751	72	60	1,833	1,691	538	421	1,295	1,269
Black or African American	8,090	8,519	431	427	7,659	8,092	1,789	1,770	5,869	6,322
NHOPI	*	*	*	*	*	*	*	*	*	*
White	39,132	39,287	1,443	1,446	37,690	37,841	7,428	6,963	30,262	30,878
Two or More Races	1,827	2,040	100	153	1,727	1,888	439	510	1,288	1,378
Hispanic or Latino	10,340	9,506	866	763	9,473	8,743	2,966	2,694	6,507	6,049
EDUCATION LEVEL
< High School	da	da	da	da	4,474	4,502	1,283	1,209	3,192	3,293
High School Graduate	da	da	da	da	15,555	15,953	4,134	4,162	11,421	11,791
Some College/Associate’s Degree	da	da	da	da	21,425	20,204	5,628	4,990	15,796	15,214
College Graduate	da	da	da	da	17,501	18,263	2,255	2,074	15,246	16,189
EMPLOYMENT STATUS
Full-Time	da	da	da	da	29,999	31,222	6,013	5,604	23,986	25,619
Part-Time	da	da	da	da	9,285	8,551	3,466	3,199	5,819	5,352
Unemployed	da	da	da	da	3,607	3,947	1,244	1,286	2,363	2,661
Other¹	da	da	da	da	16,063	15,202	2,575	2,346	13,488	12,856
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.27B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	22.0	21.8	11.5	11.2	23.0	22.9	38.2	36.5	20.6	20.8
SEX
Male	24.2	23.9	10.0	9.7	25.7	25.4	38.9	37.0	23.6	23.6
Female	19.8	19.8	13.0	12.7	20.4	20.4	37.6	36.0	17.8	18.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22.3	22.6	10.9	11.1	23.3	23.7	39.0	37.8	21.1	21.7
AIAN	27.3	30.2	13.0	*	29.8	33.9	*	36.8	26.6	33.5
Asian	11.2	10.0	4.5	4.1	11.9	10.5	23.8	19.0	9.8	9.2
Black or African American	23.5	24.5	12.3	11.9	24.8	26.0	38.4	38.8	22.3	23.8
NHOPI	*	*	*	*	*	*	*	*	*	*
White	22.9	23.1	11.2	11.3	23.8	24.0	40.7	39.5	21.6	22.1
Two or More Races	31.1	32.9	12.0	16.4	34.2	35.8	43.7	46.6	31.8	33.0
Hispanic or Latino	20.3^a	18.2	13.0	11.2	21.4	19.2	35.9	32.6	18.1	16.3
EDUCATION LEVEL
< High School	da	da	da	da	18.4	18.4	35.8	33.8	15.4	15.7
High School Graduate	da	da	da	da	22.5	23.0	35.6	36.1	19.9	20.4
Some College/Associate’s Degree	da	da	da	da	27.5	26.2	40.5	37.9	24.7	23.8
College Graduate	da	da	da	da	20.6	21.1	39.6	36.1	19.2	20.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	25.3	25.8	42.7	40.5	23.0	23.9
Part-Time	da	da	da	da	28.3	27.1	39.4	38.3	24.2	23.1
Unemployed	da	da	da	da	32.7	34.5	38.8	38.5	30.3	32.9
Other¹	da	da	da	da	17.1	16.2	29.6	27.6	15.8	15.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.28A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	42,317	43,647	1,647	1,563	40,670	42,083	9,013	8,562	31,657	33,521
SEX
Male	23,578	24,161	697	706	22,881	23,455	4,777	4,434	18,104	19,021
Female	18,739	19,486	950	858	17,789	18,628	4,235	4,128	13,554	14,500
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	35,449	37,160	1,170	1,138	34,279	36,022	6,952	6,824	27,327^a	29,198
AIAN	263	338	25	9	238	329	*	*	171	289
Asian	1,060	1,007	30	26	1,030	982	308	230	721	751
Black or African American	5,797	6,308	264	212	5,533	6,096	1,270	1,396	4,263	4,699
NHOPI	118	*	*	*	112	*	*	*	73	*
White	26,764	27,772	775	784	25,989	26,988	4,955	4,746	21,034	22,242
Two or More Races	1,447	1,496	71	103	1,376	1,393	312	394	1,064	999
Hispanic or Latino	6,868	6,487	477	425	6,392	6,062	2,061^a	1,738	4,331	4,323
EDUCATION LEVEL
< High School	da	da	da	da	3,439	3,509	976	883	2,464	2,625
High School Graduate	da	da	da	da	11,117	11,995	2,874	3,055	8,243	8,940
Some College/Associate’s Degree	da	da	da	da	14,936	14,623	3,739	3,387	11,197	11,236
College Graduate	da	da	da	da	11,177	11,956	1,424	1,236	9,754	10,720
EMPLOYMENT STATUS
Full-Time	da	da	da	da	20,548	21,842	4,174	3,919	16,374^a	17,923
Part-Time	da	da	da	da	6,296	5,976	2,270	2,079	4,026	3,896
Unemployed	da	da	da	da	2,516	2,948	822	992	1,694	1,956
Other¹	da	da	da	da	11,311	11,318	1,747	1,572	9,564	9,746
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.28B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	15.0	15.4	6.4	6.0	15.9	16.3	25.9	25.2	14.3	15.0
SEX
Male	17.1	17.4	5.3	5.3	18.3	18.7	27.3	26.0	16.8	17.6
Female	13.0	13.5	7.6	6.8	13.6	14.1	24.5	24.3	11.9	12.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.3	16.1	6.1	6.0	16.2	17.0	26.2	26.5	14.7	15.7
AIAN	18.0	25.2	11.2^a	3.8	19.2^a	29.8	*	*	16.6^a	30.0
Asian	6.2	5.8	1.9	1.8	6.7	6.1	13.6	10.4	5.5	5.4
Black or African American	16.8	18.1	7.5	5.9	17.9	19.6	27.2	30.6	16.2	17.7
NHOPI	9.3	*	*	*	9.3	*	*	*	6.8	*
White	15.6	16.3	6.0	6.1	16.4	17.1	27.1	26.9	15.0	15.9
Two or More Races	24.6	24.2	8.5	11.1	27.3	26.5	31.1	36.1	26.3	24.0
Hispanic or Latino	13.5	12.4	7.2	6.3	14.4	13.3	25.0^a	21.0	12.0	11.6
EDUCATION LEVEL
< High School	da	da	da	da	14.1	14.3	27.2	24.7	11.9	12.6
High School Graduate	da	da	da	da	16.1	17.3	24.7	26.5	14.3	15.4
Some College/Associate’s Degree	da	da	da	da	19.2	19.0	26.9	25.7	17.5	17.6
College Graduate	da	da	da	da	13.1	13.8	25.0	21.5	12.3	13.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	17.4	18.1	29.7	28.3	15.7	16.7
Part-Time	da	da	da	da	19.2	18.9	25.8	24.9	16.7	16.8
Unemployed	da	da	da	da	22.8	25.8	25.6	29.7	21.7	24.1
Other¹	da	da	da	da	12.0	12.1	20.1	18.5	11.2	11.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.29A – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	42,231	42,280	65	84	42,165	42,196	3,127^a	2,698	39,038	39,498
SEX
Male	25,205	24,366	21	29	25,184	24,337	1,591	1,372	23,593	22,964
Female	17,026	17,915	44	55	16,981	17,860	1,536	1,326	15,445	16,534
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	36,276	36,456	50	55	36,227	36,401	2,456^a	2,154	33,770	34,247
AIAN	278	257	*	<1	276	257	*	7	256	250
Asian	907	754	2	1	905	753	55	45	850	707
Black or African American	2,957	2,910	5	2	2,952	2,908	170	107	2,782	2,801
NHOPI	*	*	*	*	*	*	*	*	*	*
White	30,766	31,089	39	45	30,726	31,043	2,112	1,852	28,615	29,191
Two or More Races	1,088	1,288	1	7	1,086	1,281	84	139	1,002	1,142
Hispanic or Latino	5,954	5,825	15	29	5,939	5,796	671	544	5,268	5,251
EDUCATION LEVEL
< High School	da	da	da	da	3,564	3,070	266	225	3,299	2,846
High School Graduate	da	da	da	da	10,909	11,594	813	852	10,096	10,742
Some College/Associate’s Degree	da	da	da	da	15,566	14,455	1,293^b	972	14,272	13,483
College Graduate	da	da	da	da	12,126	13,077	755	649	11,371	12,428
EMPLOYMENT STATUS
Full-Time	da	da	da	da	20,863	21,803	1,565	1,403	19,297	20,400
Part-Time	da	da	da	da	5,791	4,983	675	516	5,116	4,467
Unemployed	da	da	da	da	2,184	1,883	365^a	239	1,819	1,644
Other¹	da	da	da	da	13,327	13,528	522	541	12,806	12,988
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.29B – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	15.0	14.9	0.3	0.3	16.5	16.4	9.0^a	7.9	17.6	17.7
SEX
Male	18.2	17.6	0.2	0.2	20.1	19.4	9.1	8.0	21.9	21.2
Female	11.8	12.4	0.4	0.4	12.9	13.5	8.9	7.8	13.6	14.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.7	15.8	0.3	0.3	17.1	17.2	9.3	8.4	18.2	18.4
AIAN	19.0	19.2	*	0.1	22.2	23.3	*	4.8	24.8	26.0
Asian	5.3	4.3	0.1	0.1	5.9	4.7	2.4	2.1	6.5	5.1
Black or African American	8.6	8.4	0.2	<0.1	9.5	9.3	3.6	2.4	10.6	10.5
NHOPI	*	*	*	*	*	*	*	*	*	*
White	18.0	18.3	0.3	0.4	19.4	19.7	11.6	10.5	20.4	20.9
Two or More Races	18.5	20.8	0.2	0.7	21.5	24.3	8.4	12.7	24.8	27.4
Hispanic or Latino	11.7	11.1	0.2	0.4	13.4	12.8	8.1	6.6	14.6	14.1
EDUCATION LEVEL
< High School	da	da	da	da	14.6	12.5	7.4	6.3	15.9	13.6
High School Graduate	da	da	da	da	15.8	16.7	7.0	7.4	17.6	18.5
Some College/Associate’s Degree	da	da	da	da	20.0	18.8	9.3^a	7.4	22.3	21.1
College Graduate	da	da	da	da	14.3	15.1	13.3	11.3	14.3	15.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	17.6	18.0	11.1	10.1	18.5	19.0
Part-Time	da	da	da	da	17.6	15.8	7.7	6.2	21.3	19.3
Unemployed	da	da	da	da	19.8	16.5	11.4^a	7.1	23.3	20.3
Other¹	da	da	da	da	14.2	14.5	6.0	6.4	15.0	15.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.30A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	5,274	5,012	40	63	5,235	4,949	1,295^a	1,043	3,939	3,907
SEX
Male	3,601	3,220	9	26	3,592	3,194	716	578	2,877	2,616
Female	1,673	1,792	31	37	1,642	1,755	580	465	1,063	1,290
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4,283	3,969	27	38	4,256	3,931	1,041^a	819	3,215	3,112
AIAN	33	24	*	<1	31	24	*	5	19	19
Asian	156	129	*	1	156	128	35	36	121	92
Black or African American	543	488	1	*	542	488	57	38	486	450
NHOPI	*	*	*	*	*	*	*	*	*	*
White	3,369	3,185	25	32	3,345	3,154	898^a	699	2,447	2,455
Two or More Races	132	127	*	5	132	122	24	41	108	81
Hispanic or Latino	992	1,043	13	25	979	1,018	255	224	724	794
EDUCATION LEVEL
< High School	da	da	da	da	455	494	81	78	374	415
High School Graduate	da	da	da	da	1,288	1,259	256	270	1,032	989
Some College/Associate’s Degree	da	da	da	da	1,934	1,672	545	445	1,389	1,227
College Graduate	da	da	da	da	1,557	1,525	414^a	249	1,144	1,275
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,593	2,658	666	557	1,926	2,101
Part-Time	da	da	da	da	815	706	290	239	525	467
Unemployed	da	da	da	da	658	478	163	99	495	378
Other¹	da	da	da	da	1,169	1,107	177	147	992	960
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.30B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.9	1.8	0.2	0.2	2.0	1.9	3.7	3.1	1.8	1.7
SEX
Male	2.6	2.3	0.1	0.2	2.9	2.5	4.1	3.4	2.7	2.4
Female	1.2	1.2	0.2	0.3	1.3	1.3	3.4	2.7	0.9	1.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.9	1.7	0.1	0.2	2.0	1.9	3.9	3.2	1.7	1.7
AIAN	2.3	1.8	*	<0.1	2.5	2.1	*	3.7	1.9	1.9
Asian	0.9	0.7	*	0.1	1.0	0.8	1.5	1.6	0.9	0.7
Black or African American	1.6	1.4	<0.1	*	1.8	1.6	1.2	0.8	1.8	1.7
NHOPI	*	*	*	*	*	*	*	*	*	*
White	2.0	1.9	0.2	0.2	2.1	2.0	4.9	4.0	1.7	1.8
Two or More Races	2.2	2.1	*	0.6	2.6	2.3	2.3	3.7	2.7	1.9
Hispanic or Latino	1.9	2.0	0.2	0.4	2.2	2.2	3.1	2.7	2.0	2.1
EDUCATION LEVEL
< High School	da	da	da	da	1.9	2.0	2.3	2.2	1.8	2.0
High School Graduate	da	da	da	da	1.9	1.8	2.2	2.3	1.8	1.7
Some College/Associate’s Degree	da	da	da	da	2.5	2.2	3.9	3.4	2.2	1.9
College Graduate	da	da	da	da	1.8	1.8	7.3^a	4.3	1.4	1.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2.2	2.2	4.7	4.0	1.8	2.0
Part-Time	da	da	da	da	2.5	2.2	3.3	2.9	2.2	2.0
Unemployed	da	da	da	da	6.0	4.2	5.1	3.0	6.3	4.7
Other¹	da	da	da	da	1.2	1.2	2.0	1.7	1.2	1.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.31A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	2,015	1,814	5	22	2,010	1,792	403^b	219	1,607	1,572
SEX
Male	1,450	1,183	2	4	1,448	1,179	240^b	118	1,208	1,061
Female	565	631	3	18	562	612	163	101	399	511
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,633	1,487	3	15	1,631	1,472	308^a	189	1,323	1,283
AIAN	10	8	*	*	10	8	*	*	4	6
Asian	95	46	*	1	95	44	14	4	81	40
Black or African American	329	249	1	*	328	249	23	7	305	242
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1,142	1,128	2	10	1,140	1,118	259	169	881	949
Two or More Races	27	40	*	*	27	36	4	7	23	29
Hispanic or Latino	382	327	2	8	379	320	95^a	30	285	290
EDUCATION LEVEL
< High School	da	da	da	da	173	266	43	22	130	244
High School Graduate	da	da	da	da	658	404	93	49	565	354
Some College/Associate’s Degree	da	da	da	da	696	642	157^a	77	539	566
College Graduate	da	da	da	da	483	479	110	71	373	408
EMPLOYMENT STATUS
Full-Time	da	da	da	da	805	861	194	141	611	720
Part-Time	da	da	da	da	341	204	85	43	256	161
Unemployed	da	da	da	da	278	232	67^a	17	211	215
Other¹	da	da	da	da	585	495	56	19	529	476
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.31B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.7	0.6	<0.1	0.1	0.8	0.7	1.2^b	0.6	0.7	0.7
SEX
Male	1.0	0.9	<0.1	<0.1	1.2	0.9	1.4^a	0.7	1.1	1.0
Female	0.4	0.4	<0.1	0.1	0.4	0.5	0.9	0.6	0.4	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.7	0.6	<0.1	0.1	0.8	0.7	1.2^a	0.7	0.7	0.7
AIAN	0.7	0.6	*	*	0.8	0.7	*	*	0.3	0.7
Asian	0.6	0.3	*	0.1	0.6	0.3	0.6	0.2	0.6	0.3
Black or African American	1.0	0.7	<0.1	*	1.1	0.8	0.5	0.2	1.2	0.9
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.7	0.7	<0.1	0.1	0.7	0.7	1.4	1.0	0.6	0.7
Two or More Races	0.5	0.6	*	*	0.5	0.7	0.4	0.6	0.6	0.7
Hispanic or Latino	0.7	0.6	<0.1	0.1	0.9	0.7	1.1^a	0.4	0.8	0.8
EDUCATION LEVEL
< High School	da	da	da	da	0.7	1.1	1.2	0.6	0.6	1.2
High School Graduate	da	da	da	da	1.0	0.6	0.8	0.4	1.0	0.6
Some College/Associate’s Degree	da	da	da	da	0.9	0.8	1.1^a	0.6	0.8	0.9
College Graduate	da	da	da	da	0.6	0.6	1.9	1.2	0.5	0.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.7	0.7	1.4	1.0	0.6	0.7
Part-Time	da	da	da	da	1.0	0.6	1.0	0.5	1.1	0.7
Unemployed	da	da	da	da	2.5	2.0	2.1^a	0.5	2.7	2.7
Other¹	da	da	da	da	0.6	0.5	0.6	0.2	0.6	0.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.32A – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	10,167	9,871	4	9	10,163	9,862	215	246	9,948	9,616
SEX
Male	6,513	5,873	*	4	6,513	5,868	113	129	6,400	5,739
Female	3,654	3,999	4	5	3,650	3,994	102	117	3,548	3,877
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8,840	8,659	2	8	8,838	8,652	148	197	8,690	8,454
AIAN	89	104	*	<1	89	104	*	1	82	103
Asian	102	65	*	*	102	65	5	*	97	65
Black or African American	1,503	1,369	*	*	1,503	1,369	15	19	1,488	1,350
NHOPI	85	*	*	*	85	*	*	*	*	*
White	6,699	6,778	1	4	6,699	6,774	111	156	6,587	6,618
Two or More Races	361	238	1	*	360	234	9	22	351	212
Hispanic or Latino	1,326	1,212	2	2	1,324	1,210	66	49	1,258	1,161
EDUCATION LEVEL
< High School	da	da	da	da	1,654^a	1,234	50	40	1,604	1,194
High School Graduate	da	da	da	da	3,516	3,829	100	115	3,416	3,714
Some College/Associate’s Degree	da	da	da	da	3,664	3,556	59	85	3,605	3,471
College Graduate	da	da	da	da	1,329	1,244	5	7	1,324	1,237
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4,091	4,546	100	109	3,991	4,436
Part-Time	da	da	da	da	1,464^a	999	27	56	1,437^a	943
Unemployed	da	da	da	da	842	741	41	29	801	712
Other¹	da	da	da	da	3,766	3,577	47	52	3,720	3,524
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.32B – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	3.6	3.5	<0.1	<0.1	4.0	3.8	0.6	0.7	4.5	4.3
SEX
Male	4.7	4.2	*	<0.1	5.2	4.7	0.6	0.8	5.9	5.3
Female	2.5	2.8	<0.1	<0.1	2.8	3.0	0.6	0.7	3.1	3.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.8	3.7	<0.1	<0.1	4.2	4.1	0.6	0.8	4.7	4.5
AIAN	6.1	7.8	*	<0.1	7.2	9.4	*	0.5	7.9	10.7
Asian	0.6	0.4	*	*	0.7	0.4	0.2	*	0.7	0.5
Black or African American	4.4	3.9	*	*	4.9	4.4	0.3	0.4	5.7	5.1
NHOPI	6.7	*	*	*	7.0	*	*	*	*	*
White	3.9	4.0	<0.1	<0.1	4.2	4.3	0.6	0.9	4.7	4.7
Two or More Races	6.1	3.8	0.2	*	7.1	4.4	0.9	2.0	8.7	5.1
Hispanic or Latino	2.6	2.3	<0.1	<0.1	3.0	2.7	0.8	0.6	3.5	3.1
EDUCATION LEVEL
< High School	da	da	da	da	6.8^a	5.0	1.4	1.1	7.7^a	5.7
High School Graduate	da	da	da	da	5.1	5.5	0.9	1.0	5.9	6.4
Some College/Associate’s Degree	da	da	da	da	4.7	4.6	0.4	0.6	5.6	5.4
College Graduate	da	da	da	da	1.6	1.4	0.1	0.1	1.7	1.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.5	3.8	0.7	0.8	3.8	4.1
Part-Time	da	da	da	da	4.5^a	3.2	0.3^a	0.7	6.0^a	4.1
Unemployed	da	da	da	da	7.6	6.5	1.3	0.9	10.3	8.8
Other¹	da	da	da	da	4.0	3.8	0.5	0.6	4.4	4.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.33A – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	918	997	*	4	917	993	39	67	877	926
SEX
Male	640	635	*	4	639	631	30	39	609	592
Female	278	362	*	*	277	362	9	28	268	334
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	853	876	*	4	853	872	37	40	815	831
AIAN	5	10	*	<1	5	10	*	<1	2	10
Asian	*	*	*	*	*	*	*	*	*	*
Black or African American	295	254	*	*	295	254	10	5	285	249
NHOPI	*	*	*	*	*	*	*	*	*	*
White	488	571	1	*	487	571	21	35	466	536
Two or More Races	37	26	*	*	37	22	3	<1	34	22
Hispanic or Latino	64	122	*	*	64	122	2	27	62	95
EDUCATION LEVEL
< High School	da	da	da	da	195	153	12	10	183	143
High School Graduate	da	da	da	da	358	399	19	47	339	352
Some College/Associate’s Degree	da	da	da	da	272	354	8	8	263	345
College Graduate	da	da	da	da	92	87	*	1	92	86
EMPLOYMENT STATUS
Full-Time	da	da	da	da	183	334	15	49	168	285
Part-Time	da	da	da	da	131	81	4	12	126	69
Unemployed	da	da	da	da	228	211	16	2	211	210
Other¹	da	da	da	da	375	367	4	5	371	362
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.33B – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.3	0.4	*	<0.1	0.4	0.4	0.1	0.2	0.4	0.4
SEX
Male	0.5	0.5	*	<0.1	0.5	0.5	0.2	0.2	0.6	0.5
Female	0.2	0.2	*	*	0.2	0.3	0.1	0.2	0.2	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.4	*	<0.1	0.4	0.4	0.1	0.2	0.4	0.4
AIAN	0.3	0.8	*	<0.1	0.4	0.9	*	<0.1	0.2	1.0
Asian	*	*	*	*	*	*	*	*	*	*
Black or African American	0.9	0.7	*	*	1.0	0.8	0.2	0.1	1.1	0.9
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.3	0.3	<0.1	*	0.3	0.4	0.1	0.2	0.3	0.4
Two or More Races	0.6	0.4	*	*	0.7	0.4	0.3	<0.1	0.8	0.5
Hispanic or Latino	0.1	0.2	*	*	0.1	0.3	<0.1	0.3	0.2	0.3
EDUCATION LEVEL
< High School	da	da	da	da	0.8	0.6	0.3	0.3	0.9	0.7
High School Graduate	da	da	da	da	0.5	0.6	0.2	0.4	0.6	0.6
Some College/Associate’s Degree	da	da	da	da	0.3	0.5	0.1	0.1	0.4	0.5
College Graduate	da	da	da	da	0.1	0.1	*	<0.1	0.1	0.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.2	0.3	0.1	0.4	0.2	0.3
Part-Time	da	da	da	da	0.4	0.3	<0.1	0.1	0.5	0.3
Unemployed	da	da	da	da	2.1	1.8	0.5	<0.1	2.7	2.6
Other¹	da	da	da	da	0.4	0.4	0.1	0.1	0.4	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.34A – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	573	507	*	4	572	503	13	5	559	498
SEX
Male	420	341	*	4	420	337	8	*	412	337
Female	153	166	*	*	152	166	5	5	147	161
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	528	449	*	4	528	445	12	5	516	440
AIAN	5	3	*	*	5	3	*	*	2	3
Asian	*	*	*	*	*	*	*	*	*	*
Black or African American	213	141	*	*	213	141	1	*	211	141
NHOPI	*	*	*	*	*	*	*	*	*	*
White	277	272	*	*	276	272	8	5	269	267
Two or More Races	5	19	*	*	5	15	<1	*	5	15
Hispanic or Latino	44	58	*	*	44	58	1	*	44	58
EDUCATION LEVEL
< High School	da	da	da	da	79	117	5	1	74	116
High School Graduate	da	da	da	da	281	145	8	2	274	143
Some College/Associate’s Degree	da	da	da	da	164	216	*	*	163	216
College Graduate	da	da	da	da	48	25	*	1	48	24
EMPLOYMENT STATUS
Full-Time	da	da	da	da	87	188	3	5	84	184
Part-Time	da	da	da	da	71	20	1	*	71	20
Unemployed	da	da	da	da	140	107	5	*	136	107
Other¹	da	da	da	da	274	187	4	*	269	187
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.34B – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.2	0.2	*	<0.1	0.2	0.2	<0.1	<0.1	0.3	0.2
SEX
Male	0.3	0.2	*	<0.1	0.3	0.3	<0.1	*	0.4	0.3
Female	0.1	0.1	*	*	0.1	0.1	<0.1	<0.1	0.1	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.2	0.2	*	<0.1	0.2	0.2	<0.1	<0.1	0.3	0.2
AIAN	0.3	0.2	*	*	0.4	0.3	*	*	0.2	0.3
Asian	*	*	*	*	*	*	*	*	*	*
Black or African American	0.6	0.4	*	*	0.7	0.5	<0.1	*	0.8	0.5
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.2	0.2	*	*	0.2	0.2	<0.1	<0.1	0.2	0.2
Two or More Races	0.1	0.3	*	*	0.1	0.3	<0.1	*	0.1	0.3
Hispanic or Latino	0.1	0.1	*	*	0.1	0.1	<0.1	*	0.1	0.2
EDUCATION LEVEL
< High School	da	da	da	da	0.3	0.5	0.1	<0.1	0.4	0.6
High School Graduate	da	da	da	da	0.4	0.2	0.1	<0.1	0.5	0.2
Some College/Associate’s Degree	da	da	da	da	0.2	0.3	*	*	0.3	0.3
College Graduate	da	da	da	da	0.1	<0.1	*	<0.1	0.1	<0.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.1	0.2	<0.1	<0.1	0.1	0.2
Part-Time	da	da	da	da	0.2	0.1	<0.1	*	0.3	0.1
Unemployed	da	da	da	da	1.3	0.9	0.1	*	1.7	1.3
Other¹	da	da	da	da	0.3	0.2	0.1	*	0.3	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.35A – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	48,850	48,438	533	518	48,316	47,920	5,889^b	5,259	42,427	42,661
SEX
Male	28,664	28,507	234	275	28,430	28,231	3,277^b	2,762	25,152	25,469
Female	20,186	19,932	299	243	19,886	19,689	2,612	2,497	17,275	17,192
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	42,306	41,887	367	355	41,938	41,531	4,634^a	4,138	37,305	37,393
AIAN	299	306	5	2	294	304	36	*	257	281
Asian	1,280	1,077	11	14	1,268	1,063	249	166	1,020	897
Black or African American	3,393	3,270	52	39	3,341	3,231	478	467	2,863	2,765
NHOPI	*	*	*	*	*	*	*	*	*	*
White	35,796	35,382	283	270	35,513	35,111	3,637	3,239	31,876	31,873
Two or More Races	1,340	1,663	16	29	1,324	1,634	225	236	1,099	1,398
Hispanic or Latino	6,544	6,552	166	163	6,378	6,389	1,255	1,121	5,122	5,268
EDUCATION LEVEL
< High School	da	da	da	da	3,288	2,829	582	493	2,706	2,336
High School Graduate	da	da	da	da	11,555	11,664	1,661	1,638	9,894	10,026
Some College/Associate’s Degree	da	da	da	da	17,819	17,107	2,501^a	2,133	15,318	14,973
College Graduate	da	da	da	da	15,654	16,320	1,146	995	14,508	15,326
EMPLOYMENT STATUS
Full-Time	da	da	da	da	25,250	26,067	2,958	2,572	22,292	23,495
Part-Time	da	da	da	da	6,970	6,265	1,353	1,246	5,617	5,018
Unemployed	da	da	da	da	2,413	2,229	593	513	1,820	1,717
Other¹	da	da	da	da	13,683	13,359	986	928	12,698	12,431
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.35B – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	17.3	17.1	2.1	2.0	18.9	18.6	16.9^a	15.5	19.2	19.1
SEX
Male	20.7	20.6	1.8	2.1	22.7	22.5	18.7^b	16.2	23.4	23.5
Female	14.0	13.8	2.4	1.9	15.2	14.9	15.1	14.7	15.2	14.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	18.3	18.1	1.9	1.9	19.8	19.6	17.5	16.1	20.1	20.1
AIAN	20.4	22.9	2.4	0.9	23.6	27.6	17.3	*	24.9	29.2
Asian	7.5	6.2	0.7	1.0	8.2	6.6	11.0	7.5	7.8	6.5
Black or African American	9.9	9.4	1.5	1.1	10.8	10.4	10.2	10.2	10.9	10.4
NHOPI	*	*	*	*	*	*	*	*	*	*
White	20.9	20.8	2.2	2.1	22.5	22.3	19.9	18.4	22.8	22.8
Two or More Races	22.8	26.9	1.9	3.1	26.2	31.0	22.4	21.6	27.2	33.5
Hispanic or Latino	12.9	12.5	2.5	2.4	14.4	14.1	15.2	13.6	14.2	14.2
EDUCATION LEVEL
< High School	da	da	da	da	13.5	11.6	16.2	13.8	13.0	11.2
High School Graduate	da	da	da	da	16.7	16.8	14.3	14.2	17.2	17.3
Some College/Associate’s Degree	da	da	da	da	22.9	22.2	18.0	16.2	24.0	23.4
College Graduate	da	da	da	da	18.4	18.9	20.1	17.3	18.3	19.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	21.3	21.5	21.0^a	18.6	21.4	21.9
Part-Time	da	da	da	da	21.2	19.9	15.4	14.9	23.4	21.6
Unemployed	da	da	da	da	21.9	19.5	18.5	15.3	23.3	21.2
Other¹	da	da	da	da	14.5	14.3	11.3	10.9	14.9	14.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.36A – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	8,509	8,795	358	387	8,151	8,408	2,676^a	2,276	5,475	6,132
SEX
Male	5,163	5,294	169	220	4,994	5,074	1,509^a	1,240	3,485	3,834
Female	3,346	3,501	189	167	3,157	3,334	1,166	1,036	1,990	2,298
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,083	7,290	256	268	6,827	7,022	2,118	1,840	4,708	5,182
AIAN	32	54	2	1	30	52	16	5	15	*
Asian	378	348	2	4	376	344	132	105	244	239
Black or African American	723	925	27	21	696	904	214	246	481	657
NHOPI	*	5	*	*	*	4	*	*	*	4
White	5,629	5,692	211	220	5,418	5,471	1,659^a	1,375	3,759	4,096
Two or More Races	267	267	14	20	254	247	90	108	163	139
Hispanic or Latino	1,426	1,505	102	119	1,324	1,386	557	436	767	950
EDUCATION LEVEL
< High School	da	da	da	da	527	513	278^a	168	249	346
High School Graduate	da	da	da	da	1,742	1,808	725	708	1,017	1,100
Some College/Associate’s Degree	da	da	da	da	3,052	2,838	1,200	981	1,851	1,857
College Graduate	da	da	da	da	2,830	3,249	472	420	2,358	2,829
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4,570	5,038	1,249	1,094	3,321^a	3,944
Part-Time	da	da	da	da	1,441	1,379	727	629	714	750
Unemployed	da	da	da	da	575	625	266	226	309	399
Other¹	da	da	da	da	1,565	1,365	434	326	1,132	1,039
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.36B – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	3.0	3.1	1.4	1.5	3.2	3.3	7.7^a	6.7	2.5	2.7
SEX
Male	3.7	3.8	1.3	1.7	4.0	4.0	8.6	7.3	3.2	3.5
Female	2.3	2.4	1.5	1.3	2.4	2.5	6.7	6.1	1.7	2.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.1	3.2	1.3	1.4	3.2	3.3	8.0	7.1	2.5	2.8
AIAN	2.2	4.0	0.7	0.6	2.5	4.7	7.4	3.6	1.5	*
Asian	2.2	2.0	0.1	0.3	2.4	2.1	5.8	4.7	1.9	1.7
Black or African American	2.1	2.7	0.8	0.6	2.2	2.9	4.6	5.4	1.8	2.5
NHOPI	*	0.4	*	*	*	0.4	*	*	*	0.4
White	3.3	3.3	1.6	1.7	3.4	3.5	9.1	7.8	2.7	2.9
Two or More Races	4.5	4.3	1.6	2.2	5.0	4.7	9.0	9.9	4.0	3.3
Hispanic or Latino	2.8	2.9	1.5	1.7	3.0	3.1	6.7	5.3	2.1	2.6
EDUCATION LEVEL
< High School	da	da	da	da	2.2	2.1	7.8^a	4.7	1.2	1.7
High School Graduate	da	da	da	da	2.5	2.6	6.2	6.1	1.8	1.9
Some College/Associate’s Degree	da	da	da	da	3.9	3.7	8.6	7.4	2.9	2.9
College Graduate	da	da	da	da	3.3	3.8	8.3	7.3	3.0	3.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.9	4.2	8.9	7.9	3.2	3.7
Part-Time	da	da	da	da	4.4	4.4	8.3	7.5	3.0	3.2
Unemployed	da	da	da	da	5.2	5.5	8.3	6.8	4.0	4.9
Other¹	da	da	da	da	1.7	1.5	5.0	3.8	1.3	1.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.37A – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	2,289	2,638	99	110	2,190	2,528	554	599	1,636	1,929
SEX
Male	1,458	1,601	54	66	1,404	1,535	353	309	1,052	1,226
Female	831	1,037	46	44	786	993	202	290	584	703
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,995	2,193	79	85	1,916	2,108	425	517	1,490	1,591
AIAN	17	*	*	1	17	*	4	<1	13	*
Asian	135	115	2	1	133	114	37	38	96	76
Black or African American	228	319	6	11	221	308	29^a	86	192	222
NHOPI	*	4	*	*	*	*	*	*	*	*
White	1,549	1,674	66	61	1,483	1,612	339	372	1,145	1,240
Two or More Races	67	63	5	9	62	54	17	20	45	33
Hispanic or Latino	294	445	20	25	274	420	129	82	145^a	338
EDUCATION LEVEL
< High School	da	da	da	da	127	206	34	38	93	168
High School Graduate	da	da	da	da	502	536	184	194	318	342
Some College/Associate’s Degree	da	da	da	da	819	782	204	226	614	555
College Graduate	da	da	da	da	743^a	1,005	132	141	610^a	864
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,197	1,509	289	310	908	1,198
Part-Time	da	da	da	da	361	352	127	163	234	190
Unemployed	da	da	da	da	181	194	65	72	115	121
Other¹	da	da	da	da	451	473	73	54	378	420
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.37B – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.8	0.9	0.4	0.4	0.9	1.0	1.6	1.8	0.7	0.9
SEX
Male	1.1	1.2	0.4	0.5	1.1	1.2	2.0	1.8	1.0	1.1
Female	0.6	0.7	0.4	0.3	0.6	0.8	1.2	1.7	0.5	0.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.9	0.9	0.4	0.4	0.9	1.0	1.6	2.0	0.8	0.9
AIAN	1.1	*	*	0.5	1.3	*	1.7	0.1	1.3	*
Asian	0.8	0.7	0.1	0.1	0.9	0.7	1.6	1.7	0.7	0.5
Black or African American	0.7	0.9	0.2	0.3	0.7	1.0	0.6^b	1.9	0.7	0.8
NHOPI	*	0.4	*	*	*	*	*	*	*	*
White	0.9	1.0	0.5	0.5	0.9	1.0	1.9	2.1	0.8	0.9
Two or More Races	1.1	1.0	0.6	1.0	1.2	1.0	1.7	1.9	1.1	0.8
Hispanic or Latino	0.6	0.9	0.3	0.4	0.6	0.9	1.6	1.0	0.4^a	0.9
EDUCATION LEVEL
< High School	da	da	da	da	0.5	0.8	1.0	1.1	0.4	0.8
High School Graduate	da	da	da	da	0.7	0.8	1.6	1.7	0.6	0.6
Some College/Associate’s Degree	da	da	da	da	1.1	1.0	1.5	1.7	1.0	0.9
College Graduate	da	da	da	da	0.9	1.2	2.3	2.4	0.8	1.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.0	1.2	2.1	2.2	0.9	1.1
Part-Time	da	da	da	da	1.1	1.1	1.4	1.9	1.0	0.8
Unemployed	da	da	da	da	1.6	1.7	2.0	2.2	1.5	1.5
Other¹	da	da	da	da	0.5	0.5	0.8	0.6	0.4	0.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.38A – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	27,242	26,031	1,940	1,911	25,302	24,120	3,073	2,936	22,229	21,184
SEX
Male	17,127	15,982	879	927	16,248	15,055	1,714	1,588	14,534	13,467
Female	10,115	10,049	1,061	984	9,054	9,065	1,359	1,348	7,695	7,717
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	23,324	22,316	1,497	1,461	21,827	20,855	2,474	2,378	19,353	18,477
AIAN	141	115	23	21	119	94	16	8	102	86
Asian	712	600	103	92	609	508	151	154	458	354
Black or African American	1,500	1,473	257	275	1,243	1,197	210	244	1,033	953
NHOPI	*	*	*	*	*	*	*	*	*	*
White	20,154	19,135	1,055	982	19,099	18,154	1,989	1,831	17,110	16,322
Two or More Races	700	844	59	86	640	758	105	134	535	624
Hispanic or Latino	3,918	3,715	443	450	3,475	3,265	599	558	2,876	2,707
EDUCATION LEVEL
< High School	da	da	da	da	1,602	1,333	299	284	1,303	1,049
High School Graduate	da	da	da	da	6,087	5,308	892	831	5,195	4,477
Some College/Associate’s Degree	da	da	da	da	8,748	8,270	1,316	1,211	7,432	7,059
College Graduate	da	da	da	da	8,866	9,209	566	611	8,299	8,599
EMPLOYMENT STATUS
Full-Time	da	da	da	da	13,681	13,548	1,443	1,295	12,238	12,253
Part-Time	da	da	da	da	3,667	3,247	671	822	2,997	2,425
Unemployed	da	da	da	da	1,103	1,211	266	261	837	949
Other¹	da	da	da	da	6,851	6,114	694	558	6,157	5,556
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.38B – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	9.7	9.2	7.5	7.4	9.9	9.4	8.8	8.6	10.0	9.5
SEX
Male	12.4	11.5	6.7	7.0	13.0	12.0	9.8	9.3	13.5	12.4
Female	7.0	6.9	8.4	7.8	6.9	6.9	7.9	7.9	6.8	6.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	10.1	9.7	7.8	7.6	10.3	9.8	9.3	9.2	10.4	9.9
AIAN	9.7	8.6	10.3	8.9	9.5	8.5	7.8	5.7	9.9	9.0
Asian	4.2	3.4	6.4	6.3	4.0	3.2	6.7	7.0	3.5	2.6
Black or African American	4.4	4.2	7.3	7.7	4.0	3.8	4.5	5.4	3.9	3.6
NHOPI	*	*	*	*	*	*	*	*	*	*
White	11.8	11.2	8.2	7.7	12.1	11.5	10.9	10.4	12.2	11.7
Two or More Races	11.9	13.6	7.1	9.3	12.7	14.4	10.5	12.3	13.2	15.0
Hispanic or Latino	7.7	7.1	6.7	6.6	7.9	7.2	7.3	6.8	8.0	7.3
EDUCATION LEVEL
< High School	da	da	da	da	6.6	5.4	8.3	7.9	6.3	5.0
High School Graduate	da	da	da	da	8.8	7.6	7.7	7.2	9.0	7.7
Some College/Associate’s Degree	da	da	da	da	11.2	10.7	9.5	9.2	11.6	11.1
College Graduate	da	da	da	da	10.4	10.6	9.9	10.6	10.5	10.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	11.6	11.2	10.3	9.4	11.7	11.4
Part-Time	da	da	da	da	11.2	10.3	7.6^a	9.8	12.5	10.5
Unemployed	da	da	da	da	10.0	10.6	8.3	7.8	10.7	11.7
Other¹	da	da	da	da	7.3	6.5	8.0	6.6	7.2	6.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.39A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	2,254	2,602	554	564	1,700	2,038	647	694	1,053	1,344
SEX
Male	1,522	1,711	298	261	1,224	1,451	389	393	835	1,057
Female	732	891	256	304	476	587	258	300	218	287
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,859	2,068	458	439	1,401	1,630	463	550	938	1,079
AIAN	10	7	8	3	1	4	1	1	1	3
Asian	171	171	58	17	113	154	28	53	85	102
Black or African American	157^a	295	58	89	100	207	27^a	103	73	104
NHOPI	<1	2	*	*	<1	1	*	*	<1	*
White	1,453	1,520	328	303	1,125	1,217	401	370	725	847
Two or More Races	68	73	7^a	26	62	46	8^a	23	54	23
Hispanic or Latino	395	534	96	126	299	408	184	143	115^a	265
EDUCATION LEVEL
< High School	da	da	da	da	110	68	64	43	46	25
High School Graduate	da	da	da	da	259	342	168	194	91	148
Some College/Associate’s Degree	da	da	da	da	720	799	290	318	431	481
College Graduate	da	da	da	da	612	829	126	139	485	691
EMPLOYMENT STATUS
Full-Time	da	da	da	da	874	1,071	269	257	604	814
Part-Time	da	da	da	da	343	383	197	217	146	166
Unemployed	da	da	da	da	95^a	221	45	71	50	149
Other¹	da	da	da	da	389	363	136	148	253	215
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.39B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.8	0.9	2.2	2.2	0.7	0.8	1.9	2.0	0.5	0.6
SEX
Male	1.1	1.2	2.3	2.0	1.0	1.2	2.2	2.3	0.8	1.0
Female	0.5	0.6	2.0	2.4	0.4	0.4	1.5	1.8	0.2	0.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.8	0.9	2.4	2.3	0.7	0.8	1.7	2.1	0.5	0.6
AIAN	0.7	0.5	3.7	1.2	0.1	0.4	0.4	0.7	0.1	0.3
Asian	1.0	1.0	3.6	1.2	0.7	1.0	1.2	2.4	0.6	0.7
Black or African American	0.5^a	0.8	1.6	2.5	0.3	0.7	0.6^a	2.3	0.3	0.4
NHOPI	<0.1	0.2	*	*	<0.1	0.1	*	*	<0.1	*
White	0.8	0.9	2.6	2.4	0.7	0.8	2.2	2.1	0.5	0.6
Two or More Races	1.2	1.2	0.8^a	2.8	1.2	0.9	0.8	2.1	1.3	0.6
Hispanic or Latino	0.8	1.0	1.4	1.9	0.7	0.9	2.2	1.7	0.3	0.7
EDUCATION LEVEL
< High School	da	da	da	da	0.5	0.3	1.8	1.2	0.2	0.1
High School Graduate	da	da	da	da	0.4	0.5	1.4	1.7	0.2	0.3
Some College/Associate’s Degree	da	da	da	da	0.9	1.0	2.1	2.4	0.7	0.8
College Graduate	da	da	da	da	0.7	1.0	2.2	2.4	0.6	0.9
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.7	0.9	1.9	1.9	0.6	0.8
Part-Time	da	da	da	da	1.0	1.2	2.2	2.6	0.6	0.7
Unemployed	da	da	da	da	0.9	1.9	1.4	2.1	0.6	1.8
Other¹	da	da	da	da	0.4	0.4	1.6	1.7	0.3	0.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.40A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	842	1,004	170	125	672	879	193	231	479	649
SEX
Male	636	748	87	60	549	688	116	106	433	582
Female	206	256	83	65	123	191	78	125	46	67
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	715	736	152^a	80	563	656	162	181	401	475
AIAN	4	4	*	1	1	3	<1	<1	1	2
Asian	59	107	31	2	28	105	13	36	16	69
Black or African American	68	129	26	37	42	92	17	18	24	74
NHOPI	*	1	*	*	*	*	*	*	*	*
White	560	481	90^b	33	470	448	128	122	342	326
Two or More Races	24	13	2	5	22	8	4	5	18	3
Hispanic or Latino	127^a	268	18	45	109	223	31	49	78	173
EDUCATION LEVEL
< High School	da	da	da	da	50	38	27	25	23	13
High School Graduate	da	da	da	da	86	164	39	70	47	95
Some College/Associate’s Degree	da	da	da	da	308	347	98	94	210	253
College Graduate	da	da	da	da	228	330	29	42	199	288
EMPLOYMENT STATUS
Full-Time	da	da	da	da	348	458	63	89	285	369
Part-Time	da	da	da	da	120	139	76	87	45	52
Unemployed	da	da	da	da	44	87	26	19	19	68
Other¹	da	da	da	da	159	195	29	36	130	159
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.40B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.3	0.4	0.7	0.5	0.3	0.3	0.6	0.7	0.2	0.3
SEX
Male	0.5	0.5	0.7	0.5	0.4	0.5	0.7	0.6	0.4	0.5
Female	0.1	0.2	0.7	0.5	0.1	0.1	0.4	0.7	<0.1	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.3	0.3	0.8^a	0.4	0.3	0.3	0.6	0.7	0.2	0.3
AIAN	0.3	0.3	*	0.5	0.1	0.2	0.1	0.1	0.1	0.3
Asian	0.3	0.6	1.9	0.1	0.2	0.7	0.6	1.6	0.1	0.5
Black or African American	0.2	0.4	0.7	1.0	0.1	0.3	0.4	0.4	0.1	0.3
NHOPI	*	0.1	*	*	*	*	*	*	*	*
White	0.3	0.3	0.7^b	0.3	0.3	0.3	0.7	0.7	0.2	0.2
Two or More Races	0.4	0.2	0.2	0.6	0.4	0.2	0.4	0.4	0.4	0.1
Hispanic or Latino	0.2^a	0.5	0.3	0.7	0.2	0.5	0.4	0.6	0.2	0.5
EDUCATION LEVEL
< High School	da	da	da	da	0.2	0.2	0.8	0.7	0.1	0.1
High School Graduate	da	da	da	da	0.1	0.2	0.3	0.6	0.1	0.2
Some College/Associate’s Degree	da	da	da	da	0.4	0.5	0.7	0.7	0.3	0.4
College Graduate	da	da	da	da	0.3	0.4	0.5	0.7	0.3	0.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.3	0.4	0.4	0.6	0.3	0.3
Part-Time	da	da	da	da	0.4	0.4	0.9	1.0	0.2	0.2
Unemployed	da	da	da	da	0.4	0.8	0.8	0.6	0.2	0.8
Other¹	da	da	da	da	0.2	0.2	0.3	0.4	0.2	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.41A – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	16,588	16,130	37	84	16,551	16,046	682	569	15,869	15,478
SEX
Male	10,274	9,613	19	22	10,256	9,591	361	312	9,895	9,279
Female	6,314	6,517	19^a	61	6,295	6,455	321	257	5,975	6,198
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14,278	14,112	28	60	14,250	14,052	579	469	13,671	13,582
AIAN	153	215	*	<1	153	214	11	3	142	211
Asian	235	180	*	*	229	180	6	6	224	173
Black or African American	619	549	2	2	617	548	50	37	567	511
NHOPI	*	*	*	*	*	*	*	*	*	*
White	12,708	12,510	17	54	12,690	12,456	496	377	12,194	12,079
Two or More Races	434	530	4	4	430	526	15	46	415	480
Hispanic or Latino	2,310	2,018	9	23	2,301	1,995	103	99	2,199	1,896
EDUCATION LEVEL
< High School	da	da	da	da	1,952	1,625	178	135	1,774	1,490
High School Graduate	da	da	da	da	5,447	5,481	265	237	5,182	5,244
Some College/Associate’s Degree	da	da	da	da	6,272	5,866	207	177	6,065	5,689
College Graduate	da	da	da	da	2,881	3,074	32	20	2,849	3,054
EMPLOYMENT STATUS
Full-Time	da	da	da	da	7,381	7,319	322	245	7,058	7,074
Part-Time	da	da	da	da	2,243^a	1,628	105	109	2,138^a	1,519
Unemployed	da	da	da	da	1,036	987	78	69	958	918
Other¹	da	da	da	da	5,891	6,112	176	146	5,715	5,967
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.41B – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	5.9	5.7	0.1	0.3	6.5	6.2	2.0	1.7	7.2	6.9
SEX
Male	7.4	6.9	0.1	0.2	8.2	7.7	2.1	1.8	9.2	8.6
Female	4.4	4.5	0.1^a	0.5	4.8	4.9	1.9	1.5	5.2	5.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6.2	6.1	0.1	0.3	6.7	6.6	2.2	1.8	7.4	7.3
AIAN	10.5	16.0	*	0.2	12.3	19.4	5.1	2.3	13.8	21.9
Asian	1.4	1.0	*	*	1.5	1.1	0.3	0.3	1.7	1.3
Black or African American	1.8	1.6	0.1	<0.1	2.0	1.8	1.1	0.8	2.2	1.9
NHOPI	*	*	*	*	*	*	*	*	*	*
White	7.4	7.3	0.1	0.4	8.0	7.9	2.7	2.1	8.7	8.6
Two or More Races	7.4	8.6	0.4	0.5	8.5	10.0	1.5	4.2	10.3	11.5
Hispanic or Latino	4.5	3.9	0.1	0.3	5.2	4.4	1.2	1.2	6.1	5.1
EDUCATION LEVEL
< High School	da	da	da	da	8.0	6.6	5.0	3.8	8.5	7.1
High School Graduate	da	da	da	da	7.9	7.9	2.3	2.1	9.0	9.1
Some College/Associate’s Degree	da	da	da	da	8.1	7.6	1.5	1.3	9.5	8.9
College Graduate	da	da	da	da	3.4	3.6	0.6	0.3	3.6	3.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	6.2	6.0	2.3	1.8	6.8	6.6
Part-Time	da	da	da	da	6.8^a	5.2	1.2	1.3	8.9^a	6.5
Unemployed	da	da	da	da	9.4	8.6	2.4	2.1	12.3	11.3
Other¹	da	da	da	da	6.3	6.5	2.0	1.7	6.7	7.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.42A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	2,705	2,621	18	40	2,687	2,582	161	108	2,526	2,473
SEX
Male	1,794	1,637	7	20	1,787	1,617	90	54	1,697	1,562
Female	911	984	11	19	900	965	71	54	829	911
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,280	2,129	13	23	2,267	2,107	136	84	2,131	2,023
AIAN	25	58	*	<1	25	58	*	2	22	56
Asian	82	28	*	*	82	28	*	*	82	28
Black or African American	124	135	*	1	124	134	13	4	111	130
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1,902	1,744	12	17	1,890	1,727	117	75	1,773	1,653
Two or More Races	87	63	2	4	85	58	2	4	83	55
Hispanic or Latino	425	492	5	17	420	475	25	24	395	451
EDUCATION LEVEL
< High School	da	da	da	da	497	423	59	43	439	380
High School Graduate	da	da	da	da	800	972	52	42	748	930
Some College/Associate’s Degree	da	da	da	da	1,166	935	39	21	1,128	914
College Graduate	da	da	da	da	223	251	12	2	212	249
EMPLOYMENT STATUS
Full-Time	da	da	da	da	774	868	47	28	727	841
Part-Time	da	da	da	da	414	281	28	30	385	252
Unemployed	da	da	da	da	317	418	31	18	286	400
Other¹	da	da	da	da	1,183	1,014	55	33	1,128	982
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.42B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.0	0.9	0.1	0.2	1.0	1.0	0.5	0.3	1.1	1.1
SEX
Male	1.3	1.2	0.1	0.2	1.4	1.3	0.5	0.3	1.6	1.4
Female	0.6	0.7	0.1	0.2	0.7	0.7	0.4	0.3	0.7	0.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.0	0.9	0.1	0.1	1.1	1.0	0.5	0.3	1.1	1.1
AIAN	1.7	4.3	*	0.2	2.0	5.2	*	1.3	2.1	5.8
Asian	0.5	0.2	*	*	0.5	0.2	*	*	0.6	0.2
Black or African American	0.4	0.4	*	<0.1	0.4	0.4	0.3	0.1	0.4	0.5
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1.1	1.0	0.1	0.1	1.2	1.1	0.6	0.4	1.3	1.2
Two or More Races	1.5	1.0	0.2	0.5	1.7	1.1	0.2	0.3	2.1	1.3
Hispanic or Latino	0.8	0.9	0.1	0.2	0.9	1.0	0.3	0.3	1.1	1.2
EDUCATION LEVEL
< High School	da	da	da	da	2.0	1.7	1.6	1.2	2.1	1.8
High School Graduate	da	da	da	da	1.2	1.4	0.4	0.4	1.3	1.6
Some College/Associate’s Degree	da	da	da	da	1.5	1.2	0.3	0.2	1.8	1.4
College Graduate	da	da	da	da	0.3	0.3	0.2	<0.1	0.3	0.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.7	0.7	0.3	0.2	0.7	0.8
Part-Time	da	da	da	da	1.3	0.9	0.3	0.4	1.6	1.1
Unemployed	da	da	da	da	2.9	3.7	1.0	0.5	3.7	4.9
Other¹	da	da	da	da	1.3	1.1	0.6	0.4	1.3	1.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.43A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1,685	1,596	3	29	1,682	1,566	54	49	1,628	1,517
SEX
Male	1,045	996	1	18	1,044	978	19	32	1,024	945
Female	640	600	2	11	638	589	35	17	603	572
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,462	1,253	2	18	1,460	1,235	44	37	1,416	1,198
AIAN	9	21	*	<1	9	21	*	<1	5	21
Asian	59	25	*	*	59	25	*	*	59	25
Black or African American	55	75	*	*	55	75	3	*	51	75
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1,205	1,036	2	14	1,203	1,022	37	35	1,166	986
Two or More Races	75	40	*	*	75	36	<1	2	75	34
Hispanic or Latino	223	343	1	11	222	331	10	12	212	320
EDUCATION LEVEL
< High School	da	da	da	da	328	220	21	23	307	197
High School Graduate	da	da	da	da	490	601	27	22	464	579
Some College/Associate’s Degree	da	da	da	da	757	583	6	2	750	582
College Graduate	da	da	da	da	107	162	*	2	107	160
EMPLOYMENT STATUS
Full-Time	da	da	da	da	480	571	15	15	465	555
Part-Time	da	da	da	da	199	162	12	9	187	153
Unemployed	da	da	da	da	219	192	9	9	210	183
Other¹	da	da	da	da	785	641	19	16	767	625
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.43B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.6	0.6	<0.1	0.1	0.7	0.6	0.2	0.1	0.7	0.7
SEX
Male	0.8	0.7	<0.1	0.1	0.8	0.8	0.1	0.2	1.0	0.9
Female	0.4	0.4	<0.1	0.1	0.5	0.4	0.2	0.1	0.5	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6	0.5	<0.1	0.1	0.7	0.6	0.2	0.1	0.8	0.6
AIAN	0.6	1.6	*	<0.1	0.7	1.9	*	<0.1	0.5	2.2
Asian	0.3	0.1	*	*	0.4	0.2	*	*	0.4	0.2
Black or African American	0.2	0.2	*	*	0.2	0.2	0.1	*	0.2	0.3
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.7	0.6	<0.1	0.1	0.8	0.6	0.2	0.2	0.8	0.7
Two or More Races	1.3	0.6	*	*	1.5	0.7	<0.1	0.2	1.8	0.8
Hispanic or Latino	0.4	0.7	<0.1	0.2	0.5	0.7	0.1	0.1	0.6	0.9
EDUCATION LEVEL
< High School	da	da	da	da	1.3	0.9	0.6	0.6	1.5	0.9
High School Graduate	da	da	da	da	0.7	0.9	0.2	0.2	0.8	1.0
Some College/Associate’s Degree	da	da	da	da	1.0	0.8	<0.1	<0.1	1.2	0.9
College Graduate	da	da	da	da	0.1	0.2	*	<0.1	0.1	0.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.4	0.5	0.1	0.1	0.4	0.5
Part-Time	da	da	da	da	0.6	0.5	0.1	0.1	0.8	0.7
Unemployed	da	da	da	da	2.0	1.7	0.3	0.3	2.7	2.3
Other¹	da	da	da	da	0.8	0.7	0.2	0.2	0.9	0.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.44A – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	73,833	74,347	3,191^b	3,800	70,642	70,547	6,489	6,515	64,153	64,032
SEX
Male	33,489	33,213	1,516^a	1,788	31,973	31,425	2,784	2,926	29,189	28,498
Female	40,345	41,134	1,675^b	2,012	38,670	39,122	3,705	3,589	34,964	35,533
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	62,625	62,665	2,344^b	2,683	60,281	59,982	5,025	4,916	55,257	55,066
AIAN	493	418	34	37	459	381	*	37	420	344
Asian	2,863	2,703	112	108	2,751	2,595	326	268	2,424	2,327
Black or African American	9,765	10,120	556	562	9,209	9,558	923	964	8,286	8,594
NHOPI	317	*	*	*	*	*	*	*	*	*
White	47,316	47,216	1,524^a	1,821	45,793	45,394	3,480	3,381	42,312	42,013
Two or More Races	1,871	1,886	108	141	1,763	1,745	224	246	1,538	1,499
Hispanic or Latino	11,208	11,682	847^b	1,117	10,361	10,565	1,465	1,599	8,897	8,966
EDUCATION LEVEL
< High School	da	da	da	da	7,119	6,879	803	658	6,316	6,221
High School Graduate	da	da	da	da	20,090	19,348	2,097	2,233	17,993	17,115
Some College/Associate’s Degree	da	da	da	da	23,904	24,506	2,755	2,718	21,149	21,788
College Graduate	da	da	da	da	19,530	19,814	835	907	18,695	18,907
EMPLOYMENT STATUS
Full-Time	da	da	da	da	29,597	29,503	2,742	2,629	26,855	26,874
Part-Time	da	da	da	da	8,218	8,066	1,541	1,527	6,676	6,538
Unemployed	da	da	da	da	2,991	2,822	634	603	2,357	2,219
Other¹	da	da	da	da	29,837	30,156	1,572	1,755	28,265	28,401
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.44B – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	26.2	26.2	12.4^b	14.7	27.6	27.4	18.7	19.1	29.0	28.6
SEX
Male	24.2	24.0	11.5^a	13.5	25.6	25.1	15.9	17.1	27.1	26.3
Female	28.1	28.4	13.3^b	15.9	29.5	29.6	21.4	21.2	30.7	30.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	27.1	27.1	12.3^b	14.0	28.4	28.3	18.9	19.1	29.8	29.6
AIAN	33.7	31.2	15.7	15.9	36.9	34.5	*	26.0	40.7	35.8
Asian	16.8	15.5	7.0	7.4	17.8	16.2	14.4	12.1	18.4	16.8
Black or African American	28.4	29.1	15.8	15.6	29.8	30.7	19.8	21.1	31.5	32.3
NHOPI	24.9	*	*	*	*	*	*	*	*	*
White	27.7	27.7	11.9^b	14.2	28.9	28.8	19.1	19.2	30.2	30.0
Two or More Races	31.8	30.4	13.0	15.2	34.9	33.1	22.4	22.5	38.0	35.9
Hispanic or Latino	22.0	22.4	12.7^b	16.4	23.4	23.2	17.7	19.4	24.7	24.1
EDUCATION LEVEL
< High School	da	da	da	da	29.2	28.1	22.4^a	18.4	30.4	29.8
High School Graduate	da	da	da	da	29.1	27.8	18.1	19.3	31.3	29.5
Some College/Associate’s Degree	da	da	da	da	30.7	31.8	19.8	20.6	33.1	34.1
College Graduate	da	da	da	da	23.0	22.9	14.7	15.8	23.6	23.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	25.0	24.4	19.5	19.0	25.7	25.1
Part-Time	da	da	da	da	25.0	25.6	17.5	18.3	27.8	28.2
Unemployed	da	da	da	da	27.1	24.7	19.7	18.0	30.2	27.4
Other¹	da	da	da	da	31.7	32.2	18.0	20.6	33.1	33.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.45A – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	8,457	8,578	406^a	570	8,051	8,008	1,099^b	841	6,953	7,167
SEX
Male	4,302	4,360	150^a	238	4,152	4,122	562	428	3,590	3,694
Female	4,155	4,218	256	332	3,900	3,886	537^a	413	3,363	3,473
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6,780	7,032	296	388	6,484	6,644	818^a	632	5,666	6,012
AIAN	75	76	1	5	73	71	*	*	54	63
Asian	236	296	4	18	231	278	50	21	181	257
Black or African American	1,315	1,285	84	99	1,231	1,186	157	136	1,074	1,051
NHOPI	23	39	*	*	23	*	*	*	20	*
White	4,874	5,089	176	252	4,697	4,837	536	422	4,162	4,415
Two or More Races	258	248	30	12	227	235	53	43	175	193
Hispanic or Latino	1,677	1,546	110	182	1,567	1,364	281	209	1,287	1,155
EDUCATION LEVEL
< High School	da	da	da	da	955	946	192	125	763	821
High School Graduate	da	da	da	da	2,317	2,505	407	304	1,910	2,201
Some College/Associate’s Degree	da	da	da	da	2,926	2,731	378	308	2,548	2,423
College Graduate	da	da	da	da	1,853	1,825	121	103	1,732	1,722
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3,539	3,663	493	361	3,046	3,302
Part-Time	da	da	da	da	960^a	693	193	171	767^a	522
Unemployed	da	da	da	da	657	461	157^b	73	501	389
Other¹	da	da	da	da	2,895	3,191	256	236	2,639	2,955
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.45B – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	3.0	3.0	1.6^a	2.2	3.1	3.1	3.2^a	2.5	3.1	3.2
SEX
Male	3.1	3.1	1.1^a	1.8	3.3	3.3	3.2	2.5	3.3	3.4
Female	2.9	2.9	2.0	2.6	3.0	2.9	3.1	2.4	3.0	3.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2.9	3.0	1.6	2.0	3.1	3.1	3.1	2.5	3.1	3.2
AIAN	5.1	5.7	0.6	2.2	5.9	6.4	*	*	5.2	6.5
Asian	1.4	1.7	0.3	1.2	1.5	1.7	2.2	0.9	1.4	1.9
Black or African American	3.8	3.7	2.4	2.7	4.0	3.8	3.4	3.0	4.1	4.0
NHOPI	1.8	3.5	*	*	1.9	*	*	*	1.9	*
White	2.8	3.0	1.4	2.0	3.0	3.1	2.9	2.4	3.0	3.2
Two or More Races	4.4	4.0	3.6	1.3	4.5	4.5	5.3	3.9	4.3	4.6
Hispanic or Latino	3.3	3.0	1.6	2.7	3.5	3.0	3.4	2.5	3.6	3.1
EDUCATION LEVEL
< High School	da	da	da	da	3.9	3.9	5.4	3.5	3.7	3.9
High School Graduate	da	da	da	da	3.4	3.6	3.5	2.6	3.3	3.8
Some College/Associate’s Degree	da	da	da	da	3.8	3.5	2.7	2.3	4.0	3.8
College Graduate	da	da	da	da	2.2	2.1	2.1	1.8	2.2	2.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.0	3.0	3.5	2.6	2.9	3.1
Part-Time	da	da	da	da	2.9	2.2	2.2	2.0	3.2	2.2
Unemployed	da	da	da	da	6.0^a	4.0	4.9^b	2.2	6.4	4.8
Other¹	da	da	da	da	3.1	3.4	2.9	2.8	3.1	3.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.46A – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	2,439	2,173	116	143	2,323	2,030	214	170	2,109	1,860
SEX
Male	1,312	1,096	47	72	1,264	1,024	103	97	1,162	927
Female	1,128	1,077	69	71	1,059	1,006	112	72	947	933
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,011	1,722	94	62	1,918	1,659	157	126	1,760	1,533
AIAN	23	16	<1	1	22	15	*	<1	11	15
Asian	82	93	3	2	79	91	8	3	71	88
Black or African American	425	319	35	20	390	299	27	27	363	271
NHOPI	19	2	*	*	19	2	*	*	16	2
White	1,370	1,258	44	36	1,325	1,222	98	86	1,227	1,136
Two or More Races	93	35	11	4	82	31	10	9	72	22
Hispanic or Latino	428	451	23^a	81	406	370	57	44	348	327
EDUCATION LEVEL
< High School	da	da	da	da	243	273	54	25	189	248
High School Graduate	da	da	da	da	803	778	99^a	49	704	728
Some College/Associate’s Degree	da	da	da	da	778	597	41	89	737	508
College Graduate	da	da	da	da	498	382	19	6	479	376
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,199	947	109	77	1,090	870
Part-Time	da	da	da	da	127	160	27	20	100	139
Unemployed	da	da	da	da	172	109	30	16	142	92
Other¹	da	da	da	da	825	814	48	56	777	758
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.46B – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.9	0.8	0.5	0.6	0.9	0.8	0.6	0.5	1.0	0.8
SEX
Male	0.9	0.8	0.4	0.5	1.0	0.8	0.6	0.6	1.1	0.9
Female	0.8	0.7	0.5	0.6	0.8	0.8	0.6	0.4	0.8	0.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.9	0.7	0.5	0.3	0.9	0.8	0.6	0.5	0.9	0.8
AIAN	1.6	1.2	0.1	0.4	1.8	1.4	*	0.2	1.1	1.5
Asian	0.5	0.5	0.2	0.1	0.5	0.6	0.3	0.1	0.5	0.6
Black or African American	1.2	0.9	1.0	0.6	1.3	1.0	0.6	0.6	1.4	1.0
NHOPI	1.5	0.1	*	*	1.5	0.2	*	*	1.5	0.2
White	0.8	0.7	0.3	0.3	0.8	0.8	0.5	0.5	0.9	0.8
Two or More Races	1.6	0.6	1.3	0.5	1.6	0.6	1.0	0.8	1.8	0.5
Hispanic or Latino	0.8	0.9	0.3^a	1.2	0.9	0.8	0.7	0.5	1.0	0.9
EDUCATION LEVEL
< High School	da	da	da	da	1.0	1.1	1.5	0.7	0.9	1.2
High School Graduate	da	da	da	da	1.2	1.1	0.9^a	0.4	1.2	1.3
Some College/Associate’s Degree	da	da	da	da	1.0	0.8	0.3	0.7	1.2	0.8
College Graduate	da	da	da	da	0.6	0.4	0.3	0.1	0.6	0.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.0	0.8	0.8	0.6	1.0	0.8
Part-Time	da	da	da	da	0.4	0.5	0.3	0.2	0.4	0.6
Unemployed	da	da	da	da	1.6	0.9	0.9	0.5	1.8	1.1
Other¹	da	da	da	da	0.9	0.9	0.6	0.7	0.9	0.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.47A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	19,674	19,816	1,845	1,807	17,830	18,009	3,794	3,660	14,035	14,349
SEX
Male	9,416	8,771	993	981	8,424	7,790	1,893	1,720	6,531	6,070
Female	10,258	11,045	852	826	9,406	10,219	1,901	1,940	7,505	8,279
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	16,826	17,391	1,503	1,494	15,324	15,897	3,177	3,060	12,147	12,837
AIAN	83	93	16	22	67	71	8	*	59	56
Asian	438	707	31	45	407	663	117	84	289	578
Black or African American	1,662	1,582	176^b	76	1,486	1,506	274	259	1,213	1,247
NHOPI	53	30	*	*	53	25	*	*	*	16
White	13,993	14,511	1,197	1,283	12,797	13,227	2,624	2,582	10,172	10,645
Two or More Races	597	468	83	63	514	405	148	111	366	295
Hispanic or Latino	2,848	2,425	342	313	2,506	2,112	618	600	1,888	1,512
EDUCATION LEVEL
< High School	da	da	da	da	1,264	1,157	354	262	910	895
High School Graduate	da	da	da	da	3,844	3,587	1,018	977	2,826	2,610
Some College/Associate’s Degree	da	da	da	da	6,292	6,413	1,703	1,718	4,589	4,695
College Graduate	da	da	da	da	6,430	6,852	720	702	5,710	6,150
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9,473	9,568	1,645^a	1,371	7,828	8,196
Part-Time	da	da	da	da	2,626	2,635	1,031	1,042	1,595	1,593
Unemployed	da	da	da	da	1,119	1,178	311	367	808	811
Other¹	da	da	da	da	4,611	4,628	808	879	3,804	3,749
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.47B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	7.0	7.0	7.2	7.0	7.0	7.0	10.9	10.8	6.3	6.4
SEX
Male	6.8	6.3	7.5	7.4	6.7	6.2	10.8	10.1	6.1	5.6
Female	7.1	7.6	6.8	6.5	7.2	7.7	11.0	11.4	6.6	7.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7.3	7.5	7.9	7.8	7.2	7.5	12.0	11.9	6.5	6.9
AIAN	5.6	7.0	7.1	9.3	5.4	6.4	3.6	*	5.7	5.8
Asian	2.6	4.0	2.0	3.1	2.6	4.1	5.2	3.8	2.2	4.2
Black or African American	4.8	4.6	5.0^b	2.1	4.8	4.8	5.9	5.7	4.6	4.7
NHOPI	4.2	2.7	*	*	4.4	2.4	*	*	*	1.7
White	8.2	8.5	9.3	10.0	8.1	8.4	14.4	14.6	7.3	7.6
Two or More Races	10.1	7.6	9.9	6.7	10.2	7.7	14.8	10.1	9.0	7.1
Hispanic or Latino	5.6	4.6	5.1	4.6	5.7	4.6	7.5	7.3	5.2	4.1
EDUCATION LEVEL
< High School	da	da	da	da	5.2	4.7	9.9	7.3	4.4	4.3
High School Graduate	da	da	da	da	5.6	5.2	8.8	8.5	4.9	4.5
Some College/Associate’s Degree	da	da	da	da	8.1	8.3	12.3	13.1	7.2	7.3
College Graduate	da	da	da	da	7.6	7.9	12.6	12.2	7.2	7.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	8.0	7.9	11.7^a	9.9	7.5	7.6
Part-Time	da	da	da	da	8.0	8.4	11.7	12.5	6.6	6.9
Unemployed	da	da	da	da	10.2	10.3	9.7	11.0	10.3	10.0
Other¹	da	da	da	da	4.9	4.9	9.3	10.3	4.5	4.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.48A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	4,298	3,922	226	230	4,072	3,692	1,278	1,066	2,794	2,626
SEX
Male	2,437^a	2,001	136	102	2,301^a	1,898	597	505	1,704	1,393
Female	1,861	1,922	90	128	1,771	1,794	681	561	1,090	1,233
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,575	3,457	178	177	3,396	3,281	1,039	892	2,358	2,388
AIAN	14	16	2	4	12	12	6	1	6	11
Asian	120	141	*	11	109	130	54	35	55	95
Black or African American	324	270	24	12	300	258	98	73	203	185
NHOPI	*	5	*	*	*	5	*	*	*	*
White	2,951	2,942	125	141	2,826	2,802	827	769	1,999	2,033
Two or More Races	135	84	17	9	118	75	55	14	63	61
Hispanic or Latino	723^a	465	47	54	676^a	411	239	174	437^a	237
EDUCATION LEVEL
< High School	da	da	da	da	267	188	89	57	178	132
High School Graduate	da	da	da	da	866	696	284	210	582	485
Some College/Associate’s Degree	da	da	da	da	1,399	1,289	581	526	817	763
College Graduate	da	da	da	da	1,540	1,519	323	273	1,217	1,246
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,450	2,188	661^b	432	1,789	1,756
Part-Time	da	da	da	da	658	566	325	312	333	254
Unemployed	da	da	da	da	327	225	117	98	210	128
Other¹	da	da	da	da	636	713	175	225	462	488
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.48B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.5	1.4	0.9	0.9	1.6	1.4	3.7	3.1	1.3	1.2
SEX
Male	1.8^a	1.4	1.0	0.8	1.8^a	1.5	3.4	3.0	1.6	1.3
Female	1.3	1.3	0.7	1.0	1.3	1.4	3.9	3.3	1.0	1.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.5	1.5	0.9	0.9	1.6	1.5	3.9	3.5	1.3	1.3
AIAN	0.9	1.2	0.7	1.5	1.0	1.1	2.7	1.0	0.6	1.1
Asian	0.7	0.8	*	0.8	0.7	0.8	2.4	1.6	0.4	0.7
Black or African American	0.9	0.8	0.7	0.3	1.0	0.8	2.1	1.6	0.8	0.7
NHOPI	*	0.4	*	*	*	0.5	*	*	*	*
White	1.7	1.7	1.0	1.1	1.8	1.8	4.5	4.4	1.4	1.5
Two or More Races	2.3	1.4	2.1	1.0	2.3	1.4	5.5	1.2	1.6	1.5
Hispanic or Latino	1.4^a	0.9	0.7	0.8	1.5^a	0.9	2.9	2.1	1.2^a	0.6
EDUCATION LEVEL
< High School	da	da	da	da	1.1	0.8	2.5	1.6	0.9	0.6
High School Graduate	da	da	da	da	1.3	1.0	2.4	1.8	1.0	0.8
Some College/Associate’s Degree	da	da	da	da	1.8	1.7	4.2	4.0	1.3	1.2
College Graduate	da	da	da	da	1.8	1.8	5.7	4.7	1.5	1.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2.1	1.8	4.7^b	3.1	1.7	1.6
Part-Time	da	da	da	da	2.0	1.8	3.7	3.7	1.4	1.1
Unemployed	da	da	da	da	3.0	2.0	3.7	2.9	2.7	1.6
Other¹	da	da	da	da	0.7	0.8	2.0	2.6	0.5	0.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.49A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1,348	1,163	33	32	1,315	1,131	376	308	939	823
SEX
Male	727	641	18	16	710	624	199	154	511	470
Female	620	522	15	15	605	507	177	154	428	353
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,122	1,019	28	30	1,094	989	316	267	779	722
AIAN	1	*	<1	<1	1	*	*	*	1	*
Asian	12	33	*	*	12	33	12	14	*	19
Black or African American	72	81	4	4	68	77	33	32	35	46
NHOPI	*	*	*	*	*	*	*	*	*	*
White	966	867	23	25	944	842	264	219	680	624
Two or More Races	44	37	<1	<1	44	36	7	2	37	34
Hispanic or Latino	226	144	6	2	220	142	60	41	160	101
EDUCATION LEVEL
< High School	da	da	da	da	80	82	28	19	52	63
High School Graduate	da	da	da	da	267	221	87	40	180	180
Some College/Associate’s Degree	da	da	da	da	480	435	172	200	308	236
College Graduate	da	da	da	da	488	393	89	49	398	344
EMPLOYMENT STATUS
Full-Time	da	da	da	da	781	635	190^a	95	592	540
Part-Time	da	da	da	da	170	185	74	122	96	63
Unemployed	da	da	da	da	164^a	53	50	19	113	34
Other¹	da	da	da	da	199	258	62	72	137	186
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.49B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.5	0.4	0.1	0.1	0.5	0.4	1.1	0.9	0.4	0.4
SEX
Male	0.5	0.5	0.1	0.1	0.6	0.5	1.1	0.9	0.5	0.4
Female	0.4	0.4	0.1	0.1	0.5	0.4	1.0	0.9	0.4	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5	0.4	0.1	0.2	0.5	0.5	1.2	1.0	0.4	0.4
AIAN	0.1	*	0.1	<0.1	0.1	*	*	*	0.1	*
Asian	0.1	0.2	*	*	0.1	0.2	0.5	0.7	*	0.1
Black or African American	0.2	0.2	0.1	0.1	0.2	0.2	0.7	0.7	0.1	0.2
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.6	0.5	0.2	0.2	0.6	0.5	1.4	1.2	0.5	0.4
Two or More Races	0.7	0.6	0.1	<0.1	0.9	0.7	0.7	0.2	0.9	0.8
Hispanic or Latino	0.4	0.3	0.1	<0.1	0.5	0.3	0.7	0.5	0.4	0.3
EDUCATION LEVEL
< High School	da	da	da	da	0.3	0.3	0.8	0.5	0.3	0.3
High School Graduate	da	da	da	da	0.4	0.3	0.8	0.3	0.3	0.3
Some College/Associate’s Degree	da	da	da	da	0.6	0.6	1.2	1.5	0.5	0.4
College Graduate	da	da	da	da	0.6	0.5	1.6	0.8	0.5	0.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.7	0.5	1.3^a	0.7	0.6	0.5
Part-Time	da	da	da	da	0.5	0.6	0.8	1.5	0.4	0.3
Unemployed	da	da	da	da	1.5^a	0.5	1.6	0.6	1.5	0.4
Other¹	da	da	da	da	0.2	0.3	0.7	0.8	0.2	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.50A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	41,314	39,679	1,085	1,181	40,229	38,498	3,227^b	2,726	37,002	35,772
SEX
Male	15,606	14,834	452	473	15,154	14,360	1,332^a	1,059	13,822	13,301
Female	25,708	24,846	633	708	25,076	24,138	1,896	1,667	23,180	22,470
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	36,405^a	34,357	828	907	35,576^a	33,450	2,634^b	2,226	32,942	31,224
AIAN	146	241	3	10	143	232	*	*	131	219
Asian	1,117	1,267	27	32	1,090	1,235	63	57	1,027	1,178
Black or African American	3,344	3,260	129	127	3,215	3,133	253	247	2,962	2,887
NHOPI	*	73	*	*	*	73	*	*	*	66
White	30,599^a	28,604	624	689	29,975	27,915	2,187^a	1,798	27,788	26,117
Two or More Races	995	911	42	49	954	863	108	106	846	756
Hispanic or Latino	4,910	5,322	257	275	4,653	5,048	593	500	4,060	4,547
EDUCATION LEVEL
< High School	da	da	da	da	3,184	2,922	334	311	2,850	2,611
High School Graduate	da	da	da	da	9,662	9,112	983	819	8,679	8,293
Some College/Associate’s Degree	da	da	da	da	13,811^a	12,446	1,376^a	1,059	12,435	11,387
College Graduate	da	da	da	da	13,572	14,018	534	537	13,038	13,481
EMPLOYMENT STATUS
Full-Time	da	da	da	da	15,521	16,292	1,335	1,127	14,186	15,166
Part-Time	da	da	da	da	5,036	4,705	859^a	665	4,178	4,040
Unemployed	da	da	da	da	1,878	1,477	323	326	1,555	1,151
Other¹	da	da	da	da	17,794^a	16,023	711	609	17,083^a	15,414
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.50B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	14.7	14.0	4.2	4.6	15.7	14.9	9.3^a	8.0	16.7	16.0
SEX
Male	11.3	10.7	3.4	3.6	12.1	11.5	7.6^a	6.2	12.8	12.3
Female	17.9	17.2	5.0	5.6	19.1	18.3	11.0	9.8	20.4	19.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.8^a	14.9	4.3	4.7	16.8^a	15.8	9.9^a	8.6	17.8	16.8
AIAN	10.0^a	18.0	1.6	4.1	11.5^a	21.0	*	*	12.6^a	22.8
Asian	6.6	7.2	1.7	2.2	7.1	7.7	2.8	2.6	7.8	8.5
Black or African American	9.7	9.4	3.7	3.5	10.4	10.1	5.4	5.4	11.3	10.9
NHOPI	*	6.6	*	*	*	7.1	*	*	*	7.3
White	17.9^a	16.8	4.9	5.4	18.9^a	17.7	12.0^a	10.2	19.9	18.7
Two or More Races	16.9	14.7	5.0	5.2	18.9	16.4	10.7	9.7	20.9	18.1
Hispanic or Latino	9.6	10.2	3.9	4.0	10.5	11.1	7.2	6.1	11.3	12.2
EDUCATION LEVEL
< High School	da	da	da	da	13.1	11.9	9.3	8.7	13.7	12.5
High School Graduate	da	da	da	da	14.0	13.1	8.5	7.1	15.1	14.3
Some College/Associate’s Degree	da	da	da	da	17.8^a	16.2	9.9^a	8.0	19.5	17.8
College Graduate	da	da	da	da	16.0	16.2	9.4	9.3	16.4	16.7
EMPLOYMENT STATUS
Full-Time	da	da	da	da	13.1	13.5	9.5	8.1	13.6	14.2
Part-Time	da	da	da	da	15.3	14.9	9.8	8.0	17.4	17.4
Unemployed	da	da	da	da	17.0^a	12.9	10.1	9.7	19.9^a	14.2
Other¹	da	da	da	da	18.9^a	17.1	8.2	7.2	20.0^a	18.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.51A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	4,848	4,722	137	173	4,711	4,549	842^b	576	3,869	3,973
SEX
Male	2,096	2,284	51	63	2,044	2,221	394^a	271	1,651	1,950
Female	2,752	2,439	85	111	2,667	2,328	449^a	305	2,218	2,023
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4,088	3,929	94	135	3,994	3,794	695^b	461	3,299	3,333
AIAN	21	10	<1	<1	21	10	3	2	18	7
Asian	114	120	1	4	112	116	17	9	95	107
Black or African American	371	382	14	14	358	368	74	46	283	322
NHOPI	*	*	*	*	*	*	*	*	*	*
White	3,406	3,265	72	106	3,334	3,159	584^b	366	2,750	2,793
Two or More Races	149	134	*	11	142	122	16	37	126	85
Hispanic or Latino	760	793	43	38	717	755	147	114	569	641
EDUCATION LEVEL
< High School	da	da	da	da	475	288	91	79	384	209
High School Graduate	da	da	da	da	1,216	1,202	251^a	169	965	1,033
Some College/Associate’s Degree	da	da	da	da	1,660	1,451	364^a	228	1,296	1,223
College Graduate	da	da	da	da	1,360	1,607	136	100	1,224	1,507
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,030	2,252	362	268	1,668	1,984
Part-Time	da	da	da	da	715	576	207	142	508	435
Unemployed	da	da	da	da	409	262	110	73	300	189
Other¹	da	da	da	da	1,556	1,458	163^a	93	1,393	1,366
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.51B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.7	1.7	0.5	0.7	1.8	1.8	2.4^b	1.7	1.7	1.8
SEX
Male	1.5	1.6	0.4	0.5	1.6	1.8	2.3^a	1.6	1.5	1.8
Female	1.9	1.7	0.7	0.9	2.0	1.8	2.6^a	1.8	1.9	1.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.8	1.7	0.5	0.7	1.9	1.8	2.6^b	1.8	1.8	1.8
AIAN	1.5	0.7	0.1	0.1	1.7	0.9	1.4	1.5	1.8	0.8
Asian	0.7	0.7	0.1	0.3	0.7	0.7	0.7	0.4	0.7	0.8
Black or African American	1.1	1.1	0.4	0.4	1.2	1.2	1.6	1.0	1.1	1.2
NHOPI	*	*	*	*	*	*	*	*	*	*
White	2.0	1.9	0.6	0.8	2.1	2.0	3.2^b	2.1	2.0	2.0
Two or More Races	2.5	2.2	*	1.2	2.8	2.3	1.6	3.4	3.1	2.0
Hispanic or Latino	1.5	1.5	0.6	0.6	1.6	1.7	1.8	1.4	1.6	1.7
EDUCATION LEVEL
< High School	da	da	da	da	1.9	1.2	2.5	2.2	1.8	1.0
High School Graduate	da	da	da	da	1.8	1.7	2.2	1.5	1.7	1.8
Some College/Associate’s Degree	da	da	da	da	2.1	1.9	2.6^a	1.7	2.0	1.9
College Graduate	da	da	da	da	1.6	1.9	2.4	1.7	1.5	1.9
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.7	1.9	2.6	1.9	1.6	1.9
Part-Time	da	da	da	da	2.2	1.8	2.4	1.7	2.1	1.9
Unemployed	da	da	da	da	3.7^a	2.3	3.4	2.2	3.8	2.3
Other¹	da	da	da	da	1.7	1.6	1.9^a	1.1	1.6	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.52A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1,529	1,236	37	44	1,492	1,192	181	159	1,312	1,033
SEX
Male	710	521	14	10	696	511	78	81	617	430
Female	819	715	22	34	797	681	102	78	694	603
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,329^a	960	34	29	1,295^a	930	155	129	1,140^a	802
AIAN	3	1	*	<1	3	1	*	<1	3	1
Asian	24	2	*	*	24	2	*	*	24	2
Black or African American	91	60	11	1	80	60	17	9	63	51
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1,133^a	846	23	24	1,110^a	821	133	103	977	719
Two or More Races	53	37	<1	*	53	32	5	17	48	16
Hispanic or Latino	200	276	3	15	197	261	25	30	172	231
EDUCATION LEVEL
< High School	da	da	da	da	140	138	17	39	123	99
High School Graduate	da	da	da	da	425	339	53	42	372	297
Some College/Associate’s Degree	da	da	da	da	527	336	88	47	440	289
College Graduate	da	da	da	da	400	379	23	31	377	348
EMPLOYMENT STATUS
Full-Time	da	da	da	da	629	461	82	75	548	386
Part-Time	da	da	da	da	251	195	43	47	208	148
Unemployed	da	da	da	da	130	93	10	22	120	71
Other¹	da	da	da	da	482	443	46	14	436	428
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.52B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.5	0.4	0.1	0.2	0.6	0.5	0.5	0.5	0.6	0.5
SEX
Male	0.5	0.4	0.1	0.1	0.6	0.4	0.4	0.5	0.6	0.4
Female	0.6	0.5	0.2	0.3	0.6	0.5	0.6	0.5	0.6	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6^a	0.4	0.2	0.2	0.6^a	0.4	0.6	0.5	0.6^a	0.4
AIAN	0.2	0.1	*	<0.1	0.2	0.1	*	0.2	0.2	0.1
Asian	0.1	<0.1	*	*	0.2	<0.1	*	*	0.2	<0.1
Black or African American	0.3	0.2	0.3	<0.1	0.3	0.2	0.4	0.2	0.2	0.2
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.7	0.5	0.2	0.2	0.7^a	0.5	0.7	0.6	0.7	0.5
Two or More Races	0.9	0.6	<0.1	*	1.0	0.6	0.5	1.5	1.2	0.4
Hispanic or Latino	0.4	0.5	<0.1	0.2	0.4	0.6	0.3	0.4	0.5	0.6
EDUCATION LEVEL
< High School	da	da	da	da	0.6	0.6	0.5	1.1	0.6	0.5
High School Graduate	da	da	da	da	0.6	0.5	0.5	0.4	0.6	0.5
Some College/Associate’s Degree	da	da	da	da	0.7	0.4	0.6	0.4	0.7	0.5
College Graduate	da	da	da	da	0.5	0.4	0.4	0.5	0.5	0.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.5	0.4	0.6	0.5	0.5	0.4
Part-Time	da	da	da	da	0.8	0.6	0.5	0.6	0.9	0.6
Unemployed	da	da	da	da	1.2	0.8	0.3	0.7	1.5	0.9
Other¹	da	da	da	da	0.5	0.5	0.5	0.2	0.5	0.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.53A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	32,783	31,384	717	731	32,066	30,653	2,592^a	2,228	29,474	28,425
SEX
Male	11,927	11,088	295	259	11,632	10,829	1,012	857	10,620	9,973
Female	20,856	20,296	422	473	20,433	19,824	1,580	1,372	18,853	18,452
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	28,883^a	26,973	533	563	28,350^a	26,410	2,135^a	1,813	26,216^a	24,598
AIAN	88^a	215	1	4	87^a	210	4	*	83^a	199
Asian	840	944	20	30	821	914	41	47	779	867
Black or African American	2,414	2,398	87	71	2,328	2,327	203	205	2,125	2,122
NHOPI	*	66	*	*	*	66	*	*	*	59
White	24,549^b	22,649	393	431	24,155^a	22,219	1,779^a	1,448	22,376	20,770
Two or More Races	835	701	31	26	803	675	95	94	708	580
Hispanic or Latino	3,900	4,411	184	168	3,716	4,242	458	416	3,258	3,827
EDUCATION LEVEL
< High School	da	da	da	da	2,533	2,343	251	263	2,283	2,080
High School Graduate	da	da	da	da	7,848	7,268	800	686	7,048	6,582
Some College/Associate’s Degree	da	da	da	da	11,059^a	9,951	1,095^a	839	9,964	9,112
College Graduate	da	da	da	da	10,626	11,090	447	440	10,179	10,650
EMPLOYMENT STATUS
Full-Time	da	da	da	da	12,189	12,772	1,073	954	11,116	11,818
Part-Time	da	da	da	da	4,008	3,862	697	528	3,311	3,334
Unemployed	da	da	da	da	1,448	1,147	282	260	1,166	887
Other¹	da	da	da	da	14,420^a	12,872	540	487	13,880^a	12,385
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.53B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	11.6	11.1	2.8	2.8	12.5	11.9	7.5^a	6.5	13.3	12.7
SEX
Male	8.6	8.0	2.2	2.0	9.3	8.6	5.8	5.0	9.9	9.2
Female	14.5	14.0	3.4	3.7	15.6	15.0	9.1	8.1	16.6	16.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	12.5^a	11.7	2.8	2.9	13.4^a	12.5	8.0^a	7.0	14.1^a	13.2
AIAN	6.0^b	16.0	0.4	1.9	7.0^b	19.0	1.9	*	8.0^b	20.7
Asian	4.9	5.4	1.2	2.0	5.3	5.7	1.8	2.1	5.9	6.3
Black or African American	7.0	6.9	2.5	2.0	7.5	7.5	4.3	4.5	8.1	8.0
NHOPI	*	6.0	*	*	*	6.4	*	*	*	6.6
White	14.4^a	13.3	3.1	3.4	15.3^a	14.1	9.7^a	8.2	16.0^a	14.8
Two or More Races	14.2	11.3	3.8	2.8	15.9	12.8	9.5	8.6	17.5	13.9
Hispanic or Latino	7.7	8.4	2.8	2.5	8.4	9.3	5.5	5.0	9.1	10.3
EDUCATION LEVEL
< High School	da	da	da	da	10.4	9.6	7.0	7.3	11.0	10.0
High School Graduate	da	da	da	da	11.4	10.5	6.9	5.9	12.3	11.4
Some College/Associate’s Degree	da	da	da	da	14.2	12.9	7.9^a	6.4	15.6	14.3
College Graduate	da	da	da	da	12.5	12.8	7.8	7.7	12.8	13.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	10.3	10.6	7.6	6.9	10.7	11.0
Part-Time	da	da	da	da	12.2	12.2	7.9	6.3	13.8	14.4
Unemployed	da	da	da	da	13.1^a	10.0	8.8	7.8	14.9^a	11.0
Other¹	da	da	da	da	15.3^a	13.8	6.2	5.7	16.3^a	14.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.54A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	4,153	3,993	115	119	4,038	3,874	779^b	522	3,259	3,351
SEX
Male	1,796	1,885	34	40	1,762	1,845	376^a	248	1,386	1,597
Female	2,358	2,108	82	80	2,276	2,028	404^a	274	1,872	1,754
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,514	3,225	78	87	3,436	3,138	638^b	409	2,798	2,729
AIAN	16	10	<1	<1	16	10	*	2	13	7
Asian	112	116	*	*	112	116	17	9	95	107
Black or African American	348	296	12	8	336	288	70	41	265	247
NHOPI	*	*	*	*	*	*	*	*	*	*
White	2,889	2,679	59	69	2,830	2,609	531^b	321	2,298	2,288
Two or More Races	121	106	*	9	115	97	16	36	99	62
Hispanic or Latino	640	768	37	33	602	735	141	113	461	622
EDUCATION LEVEL
< High School	da	da	da	da	392	257	77	76	314	181
High School Graduate	da	da	da	da	1,065	1,110	236^a	144	830	967
Some College/Associate’s Degree	da	da	da	da	1,384	1,263	341^a	210	1,043	1,053
College Graduate	da	da	da	da	1,197	1,243	126	92	1,071	1,151
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,771	1,921	338	239	1,433	1,682
Part-Time	da	da	da	da	636	511	191	129	445	382
Unemployed	da	da	da	da	363	252	104	73	258	179
Other¹	da	da	da	da	1,268	1,190	146^a	81	1,122	1,109
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.54B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.5	1.4	0.4	0.5	1.6	1.5	2.2^b	1.5	1.5	1.5
SEX
Male	1.3	1.4	0.3	0.3	1.4	1.5	2.1^a	1.5	1.3	1.5
Female	1.6	1.5	0.6	0.6	1.7	1.5	2.3^a	1.6	1.6	1.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.5	1.4	0.4	0.5	1.6	1.5	2.4^b	1.6	1.5	1.5
AIAN	1.1	0.7	0.1	<0.1	1.3	0.9	*	1.5	1.3	0.8
Asian	0.7	0.7	*	*	0.7	0.7	0.7	0.4	0.7	0.8
Black or African American	1.0	0.9	0.4	0.2	1.1	0.9	1.5	0.9	1.0	0.9
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1.7	1.6	0.5	0.5	1.8	1.7	2.9^b	1.8	1.6	1.6
Two or More Races	2.1	1.7	*	1.0	2.3	1.8	1.6	3.3	2.5	1.5
Hispanic or Latino	1.3	1.5	0.6	0.5	1.4	1.6	1.7	1.4	1.3	1.7
EDUCATION LEVEL
< High School	da	da	da	da	1.6	1.0	2.1	2.1	1.5	0.9
High School Graduate	da	da	da	da	1.5	1.6	2.0^a	1.2	1.4	1.7
Some College/Associate’s Degree	da	da	da	da	1.8	1.6	2.5^a	1.6	1.6	1.6
College Graduate	da	da	da	da	1.4	1.4	2.2	1.6	1.4	1.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.5	1.6	2.4	1.7	1.4	1.6
Part-Time	da	da	da	da	1.9	1.6	2.2	1.5	1.9	1.6
Unemployed	da	da	da	da	3.3	2.2	3.3	2.2	3.3	2.2
Other¹	da	da	da	da	1.3	1.3	1.7	0.9	1.3	1.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.55A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1,304	1,053	34	38	1,270	1,015	158	138	1,112	877
SEX
Male	630	440	14	10	617	431	75	67	542	364
Female	674	612	21	28	653	584	83	70	570	514
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,160^a	820	32	23	1,129^a	797	133	111	996^a	687
AIAN	3	1	*	<1	3	1	*	<1	3	1
Asian	24	2	*	*	24	2	*	*	24	2
Black or African American	76	52	10	1	65	51	17	3	48	48
NHOPI	*	*	*	*	*	*	*	*	*	*
White	990^a	719	22	18	968^a	701	110	90	858	611
Two or More Races	43	32	<1	*	43	28	5	17	38	12
Hispanic or Latino	144	233	3	15	141	218	25	27	116	191
EDUCATION LEVEL
< High School	da	da	da	da	101	113	14	39	88	75
High School Graduate	da	da	da	da	378	284	50	30	327	254
Some College/Associate’s Degree	da	da	da	da	422	308	71	42	351	266
College Graduate	da	da	da	da	369	310	23	27	346	283
EMPLOYMENT STATUS
Full-Time	da	da	da	da	544	404	71	62	473	342
Part-Time	da	da	da	da	206	171	35	42	171	128
Unemployed	da	da	da	da	130	93	10	22	120	71
Other¹	da	da	da	da	390	347	41	12	348	336
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.55B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.5	0.4	0.1	0.1	0.5	0.4	0.5	0.4	0.5	0.4
SEX
Male	0.5	0.3	0.1	0.1	0.5	0.3	0.4	0.4	0.5	0.3
Female	0.5	0.4	0.2	0.2	0.5	0.4	0.5	0.4	0.5	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5^a	0.4	0.2	0.1	0.5^a	0.4	0.5	0.4	0.5^a	0.4
AIAN	0.2	0.1	*	<0.1	0.2	0.1	*	0.2	0.2	0.1
Asian	0.1	<0.1	*	*	0.2	<0.1	*	*	0.2	<0.1
Black or African American	0.2	0.1	0.3	<0.1	0.2	0.2	0.4	0.1	0.2	0.2
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.6^a	0.4	0.2	0.1	0.6	0.4	0.6	0.5	0.6	0.4
Two or More Races	0.7	0.5	<0.1	*	0.8	0.5	0.5	1.5	0.9	0.3
Hispanic or Latino	0.3	0.4	<0.1	0.2	0.3	0.5	0.3	0.3	0.3	0.5
EDUCATION LEVEL
< High School	da	da	da	da	0.4	0.5	0.4	1.1	0.4	0.4
High School Graduate	da	da	da	da	0.5	0.4	0.4	0.3	0.6	0.4
Some College/Associate’s Degree	da	da	da	da	0.5	0.4	0.5	0.3	0.5	0.4
College Graduate	da	da	da	da	0.4	0.4	0.4	0.5	0.4	0.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.5	0.3	0.5	0.4	0.5	0.3
Part-Time	da	da	da	da	0.6	0.5	0.4	0.5	0.7	0.6
Unemployed	da	da	da	da	1.2	0.8	0.3	0.7	1.5	0.9
Other¹	da	da	da	da	0.4	0.4	0.5	0.1	0.4	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.56A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	15,399	14,666	521	583	14,878	14,083	1,082^a	875	13,797	13,208
SEX
Male	5,982	5,955	244	260	5,738	5,695	451^a	296	5,287	5,399
Female	9,417	8,711	277	323	9,140	8,388	631	579	8,509	7,809
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	13,415	12,895	387	435	13,027	12,460	897^a	707	12,131	11,752
AIAN	74	72	3	6	72	65	*	*	63	58
Asian	402	405	9	19	393	386	25	12	368	374
Black or African American	1,465	1,432	59	64	1,406	1,368	92	72	1,313	1,297
NHOPI	*	*	*	*	*	*	*	*	*	*
White	11,054	10,564	292	317	10,762	10,248	746	587	10,015	9,661
Two or More Races	341	400	22	30	320	370	25	28	294	342
Hispanic or Latino	1,984	1,771	133	148	1,851	1,624	185	168	1,666	1,456
EDUCATION LEVEL
< High School	da	da	da	da	1,280	1,088	127	90	1,153	997
High School Graduate	da	da	da	da	3,515	3,376	320	242	3,195	3,134
Some College/Associate’s Degree	da	da	da	da	5,078	4,347	499	384	4,579	3,962
College Graduate	da	da	da	da	5,005	5,273	136	159	4,869	5,114
EMPLOYMENT STATUS
Full-Time	da	da	da	da	5,556	5,886	446^a	308	5,111	5,579
Part-Time	da	da	da	da	1,905	1,703	279	228	1,625	1,476
Unemployed	da	da	da	da	695	549	96	110	599	439
Other¹	da	da	da	da	6,722	5,945	261	231	6,461	5,715
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.56B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	5.5	5.2	2.0	2.2	5.8	5.5	3.1	2.6	6.2	5.9
SEX
Male	4.3	4.3	1.9	2.0	4.6	4.5	2.6^a	1.7	4.9	5.0
Female	6.5	6.0	2.2	2.6	7.0	6.3	3.6	3.4	7.5	6.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	5.8	5.6	2.0	2.3	6.1	5.9	3.4	2.7	6.5	6.3
AIAN	5.1	5.4	1.2	2.7	5.8	5.9	*	*	6.1	6.0
Asian	2.4	2.3	0.6	1.3	2.5	2.4	1.1	0.6	2.8	2.7
Black or African American	4.3	4.1	1.7	1.8	4.5	4.4	2.0	1.6	5.0	4.9
NHOPI	*	*	*	*	*	*	*	*	*	*
White	6.5	6.2	2.3	2.5	6.8	6.5	4.1	3.3	7.2	6.9
Two or More Races	5.8	6.5	2.6	3.2	6.3	7.0	2.5	2.6	7.3	8.2
Hispanic or Latino	3.9	3.4	2.0	2.2	4.2	3.6	2.2	2.0	4.6	3.9
EDUCATION LEVEL
< High School	da	da	da	da	5.3	4.4	3.5	2.5	5.6	4.8
High School Graduate	da	da	da	da	5.1	4.9	2.8	2.1	5.6	5.4
Some College/Associate’s Degree	da	da	da	da	6.5	5.6	3.6	2.9	7.2	6.2
College Graduate	da	da	da	da	5.9	6.1	2.4	2.8	6.1	6.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4.7	4.9	3.2^a	2.2	4.9	5.2
Part-Time	da	da	da	da	5.8	5.4	3.2	2.7	6.8	6.4
Unemployed	da	da	da	da	6.3	4.8	3.0	3.3	7.7	5.4
Other¹	da	da	da	da	7.1	6.4	3.0	2.7	7.6	6.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.57A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	959	1,063	27	68	931	995	93	90	839	905
SEX
Male	364	603	19	31	345	572	27	40	318	532
Female	595	460	9^a	37	586	423	66	50	520	373
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	744	907	21	54	722	853	86	85	636	768
AIAN	7	3	*	<1	7	3	<1	<1	6	3
Asian	2	4	1	4	*	*	*	*	*	*
Black or African American	51	92	2	5	49	86	6	10	42	77
NHOPI	*	<1	*	*	*	<1	*	*	*	<1
White	656	774	18	42	638	732	78	73	559	659
Two or More Races	29	34	<1	2	29	31	1	3	28	29
Hispanic or Latino	215	156	6	14	209	142	7	5	202	137
EDUCATION LEVEL
< High School	da	da	da	da	121	41	17	7	104	34
High School Graduate	da	da	da	da	203	221	18	42	185	179
Some College/Associate’s Degree	da	da	da	da	376	271	44	34	332	238
College Graduate	da	da	da	da	232	462	13	9	218	454
EMPLOYMENT STATUS
Full-Time	da	da	da	da	346	455	38	40	308	415
Part-Time	da	da	da	da	110	125	23	14	88	110
Unemployed	da	da	da	da	61	19	10	6	51	12
Other¹	da	da	da	da	414	397	22	30	392	367
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.57B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.3	0.4	0.1	0.3	0.4	0.4	0.3	0.3	0.4	0.4
SEX
Male	0.3	0.4	0.1	0.2	0.3	0.5	0.2	0.2	0.3	0.5
Female	0.4	0.3	0.1^a	0.3	0.4	0.3	0.4	0.3	0.5	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.3	0.4	0.1	0.3	0.3	0.4	0.3	0.3	0.3	0.4
AIAN	0.4	0.2	*	0.1	0.5	0.3	0.2	0.2	0.6	0.3
Asian	<0.1	<0.1	0.1	0.3	*	*	*	*	*	*
Black or African American	0.1	0.3	0.1	0.2	0.2	0.3	0.1	0.2	0.2	0.3
NHOPI	*	<0.1	*	*	*	<0.1	*	*	*	<0.1
White	0.4	0.5	0.1	0.3	0.4	0.5	0.4	0.4	0.4	0.5
Two or More Races	0.5	0.5	<0.1	0.2	0.6	0.6	0.1	0.3	0.7	0.7
Hispanic or Latino	0.4	0.3	0.1	0.2	0.5	0.3	0.1	0.1	0.6	0.4
EDUCATION LEVEL
< High School	da	da	da	da	0.5	0.2	0.5	0.2	0.5	0.2
High School Graduate	da	da	da	da	0.3	0.3	0.2	0.4	0.3	0.3
Some College/Associate’s Degree	da	da	da	da	0.5	0.4	0.3	0.3	0.5	0.4
College Graduate	da	da	da	da	0.3	0.5	0.2	0.1	0.3	0.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.3	0.4	0.3	0.3	0.3	0.4
Part-Time	da	da	da	da	0.3	0.4	0.3	0.2	0.4	0.5
Unemployed	da	da	da	da	0.6	0.2	0.3	0.2	0.7	0.2
Other¹	da	da	da	da	0.4	0.4	0.3	0.3	0.5	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.58A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	278	284	7	14	271	271	32	23	239	248
SEX
Male	87	147	1	4	86	143	5	15	81	128
Female	191	138	6	10	185	128	28	8	157	119
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	220	196	7	11	213	185	32	20	181	165
AIAN	*	<1	*	*	*	<1	*	<1	*	*
Asian	*	*	*	*	*	*	*	*	*	*
Black or African American	17	9	1	*	15	9	*	7	15	3
NHOPI	*	*	*	*	*	*	*	*	*	*
White	194	181	6	11	188	170	32	14	156	157
Two or More Races	10	5	*	*	10	5	*	*	10	5
Hispanic or Latino	58	88	*	3	58	85	*	3	58	83
EDUCATION LEVEL
< High School	da	da	da	da	41	25	4	*	37	25
High School Graduate	da	da	da	da	54	87	3	13	51	75
Some College/Associate’s Degree	da	da	da	da	121^a	40	25	7	96	33
College Graduate	da	da	da	da	55	118	*	3	55	115
EMPLOYMENT STATUS
Full-Time	da	da	da	da	107	89	19	14	87	75
Part-Time	da	da	da	da	59	66	8	5	51	61
Unemployed	da	da	da	da	*	*	*	*	*	*
Other¹	da	da	da	da	105	115	5	4	100	111
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.58B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.1	0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SEX
Male	0.1	0.1	<0.1	<0.1	0.1	0.1	<0.1	0.1	0.1	0.1
Female	0.1	0.1	<0.1	0.1	0.1	0.1	0.2	<0.1	0.1	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.1	0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
AIAN	*	<0.1	*	*	*	<0.1	*	0.2	*	*
Asian	*	*	*	*	*	*	*	*	*	*
Black or African American	<0.1	<0.1	<0.1	*	<0.1	<0.1	*	0.1	0.1	<0.1
NHOPI	*	*	*	*	*	*	*	*	*	*
White	0.1	0.1	<0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1
Two or More Races	0.2	0.1	*	*	0.2	0.1	*	*	0.3	0.1
Hispanic or Latino	0.1	0.2	*	<0.1	0.1	0.2	*	<0.1	0.2	0.2
EDUCATION LEVEL
< High School	da	da	da	da	0.2	0.1	0.1	*	0.2	0.1
High School Graduate	da	da	da	da	0.1	0.1	<0.1	0.1	0.1	0.1
Some College/Associate’s Degree	da	da	da	da	0.2^a	0.1	0.2	0.1	0.1	0.1
College Graduate	da	da	da	da	0.1	0.1	*	0.1	0.1	0.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.1	0.1	0.1	0.1	0.1	0.1
Part-Time	da	da	da	da	0.2	0.2	0.1	0.1	0.2	0.3
Unemployed	da	da	da	da	*	*	*	*	*	*
Other¹	da	da	da	da	0.1	0.1	0.1	<0.1	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.59A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	25,703^a	23,894	480	456	25,223^a	23,437	2,178^b	1,739	23,045	21,699
SEX
Male	9,309	8,472	201	181	9,108	8,291	864	697	8,243	7,594
Female	16,395	15,421	279	275	16,116	15,146	1,314^b	1,042	14,802	14,104
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22,792^b	20,544	368	355	22,423^b	20,189	1,803^b	1,442	20,620^a	18,747
AIAN	62^a	168	2	2	60^a	166	4	*	56^a	155
Asian	686	626	18	23	669	603	37	32	632	571
Black or African American	1,627	1,507	57	54	1,570	1,452	169	144	1,401	1,309
NHOPI	*	36	*	*	*	36	*	*	*	29
White	19,574^b	17,640	269	251	19,304^a	17,389	1,501^b	1,168	17,803^a	16,222
Two or More Races	698	567	22	24	676	543	82	81	594	462
Hispanic or Latino	2,912	3,349	112	101	2,800	3,248	375	297	2,425	2,951
EDUCATION LEVEL
< High School	da	da	da	da	2,117	1,762	214	201	1,904	1,561
High School Graduate	da	da	da	da	6,212	5,627	688^a	521	5,524	5,107
Some College/Associate’s Degree	da	da	da	da	8,614^a	7,622	908^a	667	7,707	6,955
College Graduate	da	da	da	da	8,280	8,426	369	350	7,911	8,076
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9,487	9,691	887	742	8,600	8,948
Part-Time	da	da	da	da	3,308	2,938	570^a	413	2,738	2,526
Unemployed	da	da	da	da	1,327^a	921	261	211	1,066^a	709
Other¹	da	da	da	da	11,101	9,888	460	373	10,641	9,515
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.59B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	9.1^a	8.4	1.9	1.8	9.8^a	9.1	6.3^b	5.1	10.4	9.7
SEX
Male	6.7	6.1	1.5	1.4	7.3	6.6	4.9	4.1	7.7	7.0
Female	11.4	10.6	2.2	2.2	12.3	11.5	7.6^a	6.1	13.0	12.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9.9^b	8.9	1.9	1.9	10.6^b	9.5	6.8^b	5.6	11.1^b	10.1
AIAN	4.2^a	12.5	0.7	0.9	4.8^b	15.0	1.9	*	5.4^a	16.1
Asian	4.0	3.6	1.1	1.6	4.3	3.8	1.6	1.4	4.8	4.1
Black or African American	4.7	4.3	1.6	1.5	5.1	4.7	3.6	3.2	5.3	4.9
NHOPI	*	3.3	*	*	*	3.5	*	*	*	3.3
White	11.4^b	10.4	2.1	2.0	12.2^b	11.0	8.2^b	6.6	12.7^a	11.6
Two or More Races	11.9	9.2	2.6	2.6	13.4	10.3	8.2	7.4	14.7	11.1
Hispanic or Latino	5.7	6.4	1.7	1.5	6.3	7.1	4.5	3.6	6.7	7.9
EDUCATION LEVEL
< High School	da	da	da	da	8.7	7.2	6.0	5.6	9.2	7.5
High School Graduate	da	da	da	da	9.0	8.1	5.9^a	4.5	9.6	8.8
Some College/Associate’s Degree	da	da	da	da	11.1^a	9.9	6.5^a	5.1	12.1	10.9
College Graduate	da	da	da	da	9.7	9.7	6.5	6.1	10.0	10.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	8.0	8.0	6.3	5.4	8.2	8.4
Part-Time	da	da	da	da	10.1	9.3	6.5	4.9	11.4	10.9
Unemployed	da	da	da	da	12.0^b	8.0	8.1	6.3	13.7^a	8.8
Other¹	da	da	da	da	11.8^a	10.6	5.3	4.4	12.5	11.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.60A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	3,681	3,696	113	111	3,569	3,585	747^b	480	2,822	3,105
SEX
Male	1,667	1,859	29	39	1,638	1,820	359^a	238	1,279	1,583
Female	2,014	1,837	83	73	1,931	1,765	388^b	242	1,543	1,522
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,130	3,016	76	79	3,054	2,937	611^b	380	2,442	2,557
AIAN	12	8	<1	<1	11	8	*	2	9	7
Asian	98	116	*	*	98	116	17	9	81	107
Black or African American	241	244	12	8	228	236	68	26	161	210
NHOPI	*	4	*	*	*	4	*	*	*	4
White	2,638	2,550	57	63	2,581	2,487	510^b	308	2,071	2,179
Two or More Races	116	93	*	8	109	86	14	35	95	51
Hispanic or Latino	552	681	37	33	515	648	136	100	379	548
EDUCATION LEVEL
< High School	da	da	da	da	371	233	78	76	294	157
High School Graduate	da	da	da	da	979	1,010	223^a	140	756	870
Some College/Associate’s Degree	da	da	da	da	1,151	1,123	323^b	186	829	938
College Graduate	da	da	da	da	1,067	1,219	123	79	944	1,141
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,606	1,783	322	222	1,284	1,561
Part-Time	da	da	da	da	588	482	184	119	404	363
Unemployed	da	da	da	da	350	238	99	64	252	174
Other¹	da	da	da	da	1,024	1,081	142^a	74	882	1,007
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.60B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.3	1.3	0.4	0.4	1.4	1.4	2.1^b	1.4	1.3	1.4
SEX
Male	1.2	1.3	0.2	0.3	1.3	1.5	2.1^a	1.4	1.2	1.5
Female	1.4	1.3	0.7	0.6	1.5	1.3	2.2^a	1.4	1.4	1.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.4	1.3	0.4	0.4	1.4	1.4	2.3^b	1.5	1.3	1.4
AIAN	0.8	0.6	0.1	<0.1	0.9	0.8	*	1.2	0.9	0.7
Asian	0.6	0.7	*	*	0.6	0.7	0.7	0.4	0.6	0.8
Black or African American	0.7	0.7	0.4	0.2	0.7	0.8	1.4	0.6	0.6	0.8
NHOPI	*	0.3	*	*	*	0.4	*	*	*	0.4
White	1.5	1.5	0.4	0.5	1.6	1.6	2.8^b	1.7	1.5	1.6
Two or More Races	2.0	1.5	*	0.8	2.2	1.6	1.4	3.2	2.3	1.2
Hispanic or Latino	1.1	1.3	0.6	0.5	1.2	1.4	1.6	1.2	1.1	1.5
EDUCATION LEVEL
< High School	da	da	da	da	1.5	1.0	2.2	2.1	1.4	0.7
High School Graduate	da	da	da	da	1.4	1.5	1.9^a	1.2	1.3	1.5
Some College/Associate’s Degree	da	da	da	da	1.5	1.5	2.3^a	1.4	1.3	1.5
College Graduate	da	da	da	da	1.3	1.4	2.2	1.4	1.2	1.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.4	1.5	2.3	1.6	1.2	1.5
Part-Time	da	da	da	da	1.8	1.5	2.1	1.4	1.7	1.6
Unemployed	da	da	da	da	3.2	2.1	3.1	1.9	3.2	2.1
Other¹	da	da	da	da	1.1	1.2	1.6^a	0.9	1.0	1.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.61A – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	74,052	74,506	3,191^b	3,804	70,861	70,702	6,504	6,516	64,358	64,187
SEX
Male	33,618	33,347	1,516^a	1,792	32,102	31,555	2,792	2,926	29,310	28,629
Female	40,434	41,159	1,675^b	2,012	38,759	39,147	3,712	3,589	35,047	35,558
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	62,839	62,808	2,344^b	2,687	60,494	60,121	5,039	4,917	55,455	55,205
AIAN	498	421	34	37	463	384	*	37	425	347
Asian	2,863	2,703	112	108	2,751	2,595	326	268	2,424	2,327
Black or African American	9,838	10,167	556	562	9,283	9,604	923	964	8,359	8,641
NHOPI	317	*	*	*	*	*	*	*	*	*
White	47,450	47,301	1,524^a	1,821	45,926	45,479	3,494	3,382	42,433	42,098
Two or More Races	1,872	1,894	108	145	1,764	1,750	225	246	1,539	1,503
Hispanic or Latino	11,214	11,698	847^b	1,117	10,367	10,581	1,465	1,599	8,902	8,982
EDUCATION LEVEL
< High School	da	da	da	da	7,218	6,905	813	658	6,406	6,247
High School Graduate	da	da	da	da	20,153	19,425	2,099	2,234	18,054	17,191
Some College/Associate’s Degree	da	da	da	da	23,932	24,550	2,756	2,718	21,176	21,833
College Graduate	da	da	da	da	19,558	19,823	836	907	18,721	18,916
EMPLOYMENT STATUS
Full-Time	da	da	da	da	29,615	29,561	2,744	2,630	26,871	26,932
Part-Time	da	da	da	da	8,236	8,081	1,541	1,527	6,695	6,554
Unemployed	da	da	da	da	3,025	2,824	636	603	2,390	2,221
Other¹	da	da	da	da	29,985	30,235	1,583	1,755	28,403	28,480
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription pain relievers. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.61B – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	26.3	26.3	12.4^b	14.7	27.6	27.5	18.7	19.1	29.1	28.7
SEX
Male	24.3	24.1	11.5^a	13.5	25.7	25.2	16.0	17.1	27.2	26.4
Female	28.1	28.4	13.3^b	15.9	29.5	29.6	21.5	21.2	30.8	30.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	27.2	27.2	12.3^b	14.1	28.5	28.3	19.0	19.1	29.9	29.6
AIAN	34.0	31.4	15.7	15.9	37.3	34.8	*	26.0	41.1	36.1
Asian	16.8	15.5	7.0	7.4	17.8	16.2	14.4	12.1	18.4	16.8
Black or African American	28.6	29.3	15.8	15.6	30.0	30.8	19.8	21.1	31.8	32.5
NHOPI	24.9	*	*	*	*	*	*	*	*	*
White	27.7	27.8	11.9^b	14.2	29.0	28.9	19.1	19.2	30.3	30.1
Two or More Races	31.8	30.6	13.0	15.6	34.9	33.2	22.5	22.5	38.0	36.0
Hispanic or Latino	22.0	22.4	12.7^b	16.4	23.4	23.3	17.7	19.4	24.7	24.2
EDUCATION LEVEL
< High School	da	da	da	da	29.6	28.2	22.7^a	18.4	30.8	29.9
High School Graduate	da	da	da	da	29.1	28.0	18.1	19.4	31.4	29.7
Some College/Associate’s Degree	da	da	da	da	30.8	31.9	19.8	20.6	33.1	34.2
College Graduate	da	da	da	da	23.0	22.9	14.7	15.8	23.6	23.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	25.0	24.4	19.5	19.0	25.8	25.1
Part-Time	da	da	da	da	25.1	25.6	17.5	18.3	27.9	28.3
Unemployed	da	da	da	da	27.5	24.7	19.8	18.0	30.6	27.4
Other¹	da	da	da	da	31.9	32.3	18.2	20.6	33.3	33.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription pain relievers. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.62A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	8,918	8,902	406^a	574	8,513	8,328	1,120^b	846	7,393	7,482
SEX
Male	4,615	4,568	150^a	242	4,465	4,326	570	430	3,895	3,896
Female	4,303	4,334	256	332	4,048	4,002	550^a	416	3,498	3,586
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,198	7,270	296	392	6,901	6,877	838^a	637	6,064	6,241
AIAN	79	79	1	5	78	74	*	*	59	66
Asian	249	296	4	18	244	278	50	21	194	257
Black or African American	1,421	1,332	84	99	1,338	1,233	157	136	1,180	1,098
NHOPI	64	53	*	*	64	51	*	*	*	*
White	5,117	5,253	176	252	4,941	5,001	554	426	4,387	4,575
Two or More Races	267	257	30	16	236	241	54	43	183	197
Hispanic or Latino	1,721	1,632	110	182	1,611	1,451	282	209	1,329	1,241
EDUCATION LEVEL
< High School	da	da	da	da	1,087	1,001	203^a	128	883	873
High School Graduate	da	da	da	da	2,482	2,640	413	307	2,070	2,333
Some College/Associate’s Degree	da	da	da	da	3,048	2,853	381	308	2,668	2,545
College Graduate	da	da	da	da	1,895	1,834	123	103	1,772	1,731
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3,607	3,807	497	363	3,110	3,444
Part-Time	da	da	da	da	999^a	722	193	171	806^a	551
Unemployed	da	da	da	da	732^a	469	161^b	73	571	396
Other¹	da	da	da	da	3,175	3,330	269	239	2,906	3,091
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.62B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	3.2	3.1	1.6^a	2.2	3.3	3.2	3.2^a	2.5	3.3	3.3
SEX
Male	3.3	3.3	1.1^a	1.8	3.6	3.5	3.3	2.5	3.6	3.6
Female	3.0	3.0	2.0	2.6	3.1	3.0	3.2^a	2.5	3.1	3.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.1	3.1	1.6	2.1	3.3	3.2	3.2^a	2.5	3.3	3.3
AIAN	5.4	5.9	0.6	2.2	6.3	6.7	*	*	5.7	6.8
Asian	1.5	1.7	0.3	1.2	1.6	1.7	2.2	0.9	1.5	1.9
Black or African American	4.1	3.8	2.4	2.7	4.3	4.0	3.4	3.0	4.5	4.1
NHOPI	5.0	4.8	*	*	5.3	5.0	*	*	*	*
White	3.0	3.1	1.4	2.0	3.1	3.2	3.0	2.4	3.1	3.3
Two or More Races	4.5	4.1	3.6	1.7	4.7	4.6	5.3	4.0	4.5	4.7
Hispanic or Latino	3.4	3.1	1.6	2.7	3.6	3.2	3.4	2.5	3.7	3.3
EDUCATION LEVEL
< High School	da	da	da	da	4.5	4.1	5.7^a	3.6	4.3	4.2
High School Graduate	da	da	da	da	3.6	3.8	3.6	2.7	3.6	4.0
Some College/Associate’s Degree	da	da	da	da	3.9	3.7	2.7	2.3	4.2	4.0
College Graduate	da	da	da	da	2.2	2.1	2.2	1.8	2.2	2.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.0	3.1	3.5	2.6	3.0	3.2
Part-Time	da	da	da	da	3.0	2.3	2.2	2.0	3.4	2.4
Unemployed	da	da	da	da	6.6^b	4.1	5.0^b	2.2	7.3	4.9
Other¹	da	da	da	da	3.4	3.6	3.1	2.8	3.4	3.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.63A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	2,944	2,442	117	147	2,827	2,295	221	174	2,606	2,121
SEX
Male	1,639	1,282	47	76	1,591	1,207	104	98	1,488	1,108
Female	1,305	1,160	69	71	1,236	1,088	117	75	1,119	1,013
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,475^a	1,890	94	66	2,381^a	1,824	164	130	2,218^a	1,693
AIAN	23	19	<1	1	22	18	*	<1	11	18
Asian	95	93	3	2	92	91	8	3	84	88
Black or African American	533	334	35	20	498	314	27	27	471	287
NHOPI	59	2	*	*	*	2	*	*	*	2
White	1,668	1,400	45	36	1,623	1,364	104	90	1,519	1,274
Two or More Races	97	43	11	8	86	34	10	10	76	25
Hispanic or Latino	468	552	23^a	81	446	471	58	44	388	428
EDUCATION LEVEL
< High School	da	da	da	da	374	317	55	27	319	289
High School Graduate	da	da	da	da	951	903	104^a	50	848	853
Some College/Associate’s Degree	da	da	da	da	959	685	43	91	916^a	594
College Graduate	da	da	da	da	543	390	19	6	523	384
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,257	1,055	109	79	1,148	976
Part-Time	da	da	da	da	165	164	31	20	134	144
Unemployed	da	da	da	da	272	143	31	16	241	127
Other¹	da	da	da	da	1,133	933	50	58	1,083	875
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.63B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.0	0.9	0.5	0.6	1.1	0.9	0.6	0.5	1.2	0.9
SEX
Male	1.2	0.9	0.4	0.6	1.3	1.0	0.6	0.6	1.4	1.0
Female	0.9	0.8	0.6	0.6	0.9	0.8	0.7	0.4	1.0	0.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.1^a	0.8	0.5	0.3	1.1^a	0.9	0.6	0.5	1.2^a	0.9
AIAN	1.6	1.4	0.1	0.4	1.8	1.7	*	0.2	1.1	1.9
Asian	0.6	0.5	0.2	0.1	0.6	0.6	0.3	0.1	0.6	0.6
Black or African American	1.5	1.0	1.0	0.6	1.6	1.0	0.6	0.6	1.8	1.1
NHOPI	4.7	0.1	*	*	*	0.2	*	*	*	0.2
White	1.0	0.8	0.3	0.3	1.0	0.9	0.6	0.5	1.1	0.9
Two or More Races	1.7	0.7	1.3	0.9	1.7	0.7	1.0	0.9	1.9	0.6
Hispanic or Latino	0.9	1.1	0.3^a	1.2	1.0	1.0	0.7	0.5	1.1	1.2
EDUCATION LEVEL
< High School	da	da	da	da	1.5	1.3	1.5	0.8	1.5	1.4
High School Graduate	da	da	da	da	1.4	1.3	0.9^a	0.4	1.5	1.5
Some College/Associate’s Degree	da	da	da	da	1.2	0.9	0.3	0.7	1.4^a	0.9
College Graduate	da	da	da	da	0.6	0.5	0.3	0.1	0.7	0.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.1	0.9	0.8	0.6	1.1	0.9
Part-Time	da	da	da	da	0.5	0.5	0.3	0.2	0.6	0.6
Unemployed	da	da	da	da	2.5^a	1.3	1.0	0.5	3.1	1.6
Other¹	da	da	da	da	1.2	1.0	0.6	0.7	1.3	1.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.64A – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	24,425	24,686	1,889	1,835	22,536	22,850	4,581	4,298	17,956	18,552
SEX
Male	12,687	12,035	1,006	995	11,681	11,041	2,338	2,099	9,343	8,942
Female	11,738	12,650	883	841	10,855	11,810	2,243	2,200	8,613^a	9,610
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	20,680	21,237	1,535	1,509	19,144	19,728	3,773	3,538	15,371	16,190
AIAN	118	160	18	22	100	138	17	22	83	116
Asian	558	803	31	46	526	757	136	112	390	645
Black or African American	2,177	2,071	177^b	76	2,000	1,996	323	279	1,677	1,716
NHOPI	*	*	*	*	*	*	*	*	*	*
White	16,963	17,492	1,226	1,296	15,736	16,197	3,106	2,970	12,630	13,227
Two or More Races	742	577	83	64	660	513	170	146	490	366
Hispanic or Latino	3,746	3,449	354	326	3,392	3,123	808	760	2,584	2,362
EDUCATION LEVEL
< High School	da	da	da	da	1,907	1,809	435	339	1,472	1,471
High School Graduate	da	da	da	da	5,102	5,177	1,201	1,204	3,901	3,973
Some College/Associate’s Degree	da	da	da	da	8,134	8,014	1,999	1,936	6,136	6,078
College Graduate	da	da	da	da	7,392	7,850	945	819	6,447	7,031
EMPLOYMENT STATUS
Full-Time	da	da	da	da	11,353	11,807	2,023	1,747	9,331	10,060
Part-Time	da	da	da	da	3,295	3,224	1,174	1,158	2,120	2,066
Unemployed	da	da	da	da	1,694	1,677	441	408	1,252	1,269
Other¹	da	da	da	da	6,195	6,142	942	985	5,252	5,157
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.64B – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	8.7	8.7	7.3	7.1	8.8	8.9	13.2	12.6	8.1	8.3
SEX
Male	9.2	8.7	7.6	7.5	9.3	8.8	13.4	12.3	8.7	8.3
Female	8.2	8.7	7.0	6.6	8.3	8.9	13.0	13.0	7.6	8.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8.9	9.2	8.0	7.9	9.0	9.3	14.2	13.7	8.3	8.7
AIAN	8.1	12.0	8.1	9.5	8.1	12.5	8.1	15.3	8.1	12.1
Asian	3.3	4.6	2.0	3.1	3.4	4.7	6.0	5.1	3.0	4.7
Black or African American	6.3	6.0	5.0^b	2.1	6.5	6.4	6.9	6.1	6.4	6.5
NHOPI	*	*	*	*	*	*	*	*	*	*
White	9.9	10.3	9.6	10.1	9.9	10.3	17.0	16.8	9.0	9.5
Two or More Races	12.6	9.3	9.9	6.9	13.1	9.7	16.9	13.4	12.1	8.8
Hispanic or Latino	7.4	6.6	5.3	4.8	7.7	6.9	9.8	9.2	7.2	6.4
EDUCATION LEVEL
< High School	da	da	da	da	7.8	7.4	12.1	9.5	7.1	7.0
High School Graduate	da	da	da	da	7.4	7.5	10.3	10.4	6.8	6.9
Some College/Associate’s Degree	da	da	da	da	10.5	10.4	14.4	14.7	9.6	9.5
College Graduate	da	da	da	da	8.7	9.1	16.6	14.2	8.1	8.7
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9.6	9.8	14.4	12.6	8.9	9.4
Part-Time	da	da	da	da	10.0	10.2	13.4	13.9	8.8	8.9
Unemployed	da	da	da	da	15.4	14.7	13.8	12.2	16.0	15.7
Other¹	da	da	da	da	6.6	6.6	10.8	11.6	6.2	6.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.65A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	10,188	9,659	272	285	9,916	9,374	2,272^a	1,895	7,644	7,479
SEX
Male	6,462	5,795	149	136	6,313	5,659	1,169	977	5,143	4,682
Female	3,726	3,864	123	149	3,603	3,715	1,102	918	2,500	2,797
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8,332	7,988	213	217	8,119	7,770	1,810	1,530	6,309	6,241
AIAN	50	86	4	4	47	82	15	8	31	74
Asian	259	239	*	12	248	226	74	63	174	163
Black or African American	887	782	24	13	863	769	148	97	715	673
NHOPI	*	*	*	*	*	*	*	*	*	*
White	6,729	6,544	157	173	6,572	6,371	1,478	1,308	5,095	5,063
Two or More Races	292	228	17	15	275	214	78	52	197	162
Hispanic or Latino	1,856	1,672	59	68	1,797	1,604	462	365	1,335	1,238
EDUCATION LEVEL
< High School	da	da	da	da	983	896	201	157	782	739
High School Graduate	da	da	da	da	2,365	2,467	517	480	1,848	1,988
Some College/Associate’s Degree	da	da	da	da	3,760	3,215	929	827	2,831	2,388
College Graduate	da	da	da	da	2,807	2,796	624^a	431	2,183	2,364
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4,778	4,899	1,143^a	889	3,635	4,010
Part-Time	da	da	da	da	1,573	1,289	522	469	1,051	820
Unemployed	da	da	da	da	994	824	260	181	734	644
Other¹	da	da	da	da	2,572	2,362	347	356	2,224	2,005
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.65B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	3.6	3.4	1.1	1.1	3.9	3.6	6.5^a	5.6	3.5	3.3
SEX
Male	4.7	4.2	1.1	1.0	5.0	4.5	6.7	5.7	4.8	4.3
Female	2.6	2.7	1.0	1.2	2.7	2.8	6.4	5.4	2.2	2.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.6	3.5	1.1	1.1	3.8	3.7	6.8	5.9	3.4	3.3
AIAN	3.4	6.4	1.6	1.7	3.7	7.4	7.2	5.9	3.0	7.7
Asian	1.5	1.4	*	0.8	1.6	1.4	3.3	2.8	1.3	1.2
Black or African American	2.6	2.3	0.7	0.4	2.8	2.5	3.2	2.1	2.7	2.5
NHOPI	*	*	*	*	*	*	*	*	*	*
White	3.9	3.8	1.2	1.4	4.2	4.0	8.1	7.4	3.6	3.6
Two or More Races	5.0	3.7	2.1	1.6	5.4	4.1	7.8	4.7	4.9	3.9
Hispanic or Latino	3.6	3.2	0.9	1.0	4.1	3.5	5.6	4.4	3.7	3.3
EDUCATION LEVEL
< High School	da	da	da	da	4.0	3.7	5.6	4.4	3.8	3.5
High School Graduate	da	da	da	da	3.4	3.6	4.5	4.2	3.2	3.4
Some College/Associate’s Degree	da	da	da	da	4.8	4.2	6.7	6.3	4.4	3.7
College Graduate	da	da	da	da	3.3	3.2	11.0^a	7.5	2.8	2.9
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4.0	4.0	8.1^a	6.4	3.5	3.7
Part-Time	da	da	da	da	4.8	4.1	5.9	5.6	4.4	3.5
Unemployed	da	da	da	da	9.0	7.2	8.1	5.4	9.4	7.9
Other¹	da	da	da	da	2.7	2.5	4.0	4.2	2.6	2.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.66A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	4,469	4,175	40	72	4,429	4,103	767^a	546	3,662	3,557
SEX
Male	2,836	2,629	20	34	2,816	2,595	425^a	287	2,391	2,308
Female	1,632	1,546	20	38	1,613	1,509	342	260	1,271	1,249
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,698	3,401	32	58	3,666	3,343	606	466	3,060	2,877
AIAN	15	28	<1	<1	15	28	*	*	8	26
Asian	113	85	*	1	113	84	25	18	88	65
Black or African American	425	351	5	4	420	347	57	39	363	308
NHOPI	*	*	*	*	*	*	*	*	*	*
White	2,930	2,755	26	48	2,904	2,707	505	395	2,400	2,312
Two or More Races	123	110	<1	4	123	105	11	11	112	94
Hispanic or Latino	771	774	8	13	763	760	161	81	602	680
EDUCATION LEVEL
< High School	da	da	da	da	538	501	86	60	452	441
High School Graduate	da	da	da	da	1,199	1,139	191	109	1,008	1,030
Some College/Associate’s Degree	da	da	da	da	1,729	1,515	297	269	1,432	1,247
College Graduate	da	da	da	da	963	948	192	108	770	840
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,851	1,870	383^a	232	1,467	1,638
Part-Time	da	da	da	da	645	543	152	169	493	374
Unemployed	da	da	da	da	543	388	106^a	42	437	347
Other¹	da	da	da	da	1,390	1,303	125	104	1,265	1,199
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.66B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.6	1.5	0.2	0.3	1.7	1.6	2.2^a	1.6	1.7	1.6
SEX
Male	2.1	1.9	0.2	0.3	2.3	2.1	2.4	1.7	2.2	2.1
Female	1.1	1.1	0.2	0.3	1.2	1.1	2.0	1.5	1.1	1.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.6	1.5	0.2	0.3	1.7	1.6	2.3	1.8	1.6	1.5
AIAN	1.0	2.1	0.1	<0.1	1.2	2.5	*	*	0.8	2.7
Asian	0.7	0.5	*	0.1	0.7	0.5	1.1	0.8	0.7	0.5
Black or African American	1.2	1.0	0.1	0.1	1.4	1.1	1.2	0.9	1.4	1.2
NHOPI	*	*	*	*	*	*	*	*	*	*
White	1.7	1.6	0.2	0.4	1.8	1.7	2.8	2.2	1.7	1.7
Two or More Races	2.1	1.8	0.1	0.5	2.4	2.0	1.1	1.0	2.8	2.3
Hispanic or Latino	1.5	1.5	0.1	0.2	1.7	1.7	2.0	1.0	1.7	1.8
EDUCATION LEVEL
< High School	da	da	da	da	2.2	2.0	2.4	1.7	2.2	2.1
High School Graduate	da	da	da	da	1.7	1.6	1.6	0.9	1.8	1.8
Some College/Associate’s Degree	da	da	da	da	2.2	2.0	2.1	2.0	2.2	2.0
College Graduate	da	da	da	da	1.1	1.1	3.4	1.9	1.0	1.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.6	1.5	2.7^a	1.7	1.4	1.5
Part-Time	da	da	da	da	2.0	1.7	1.7	2.0	2.0	1.6
Unemployed	da	da	da	da	4.9	3.4	3.3^a	1.2	5.6	4.3
Other¹	da	da	da	da	1.5	1.4	1.4	1.2	1.5	1.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.67A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	24,692	24,882	1,343	1,522	23,348	23,361	5,092^b	4,343	18,256	19,017
SEX
Male	14,019	13,979	664	704	13,355	13,275	2,670^a	2,321	10,686	10,954
Female	10,673	10,903	680	818	9,993	10,086	2,423^b	2,022	7,570	8,064
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	20,175	20,473	1,043	1,114	19,132	19,359	3,961^a	3,465	15,171	15,895
AIAN	156	198	14	12	142	186	*	21	106	165
Asian	881	846	76	46	805	800	217	168	587	632
Black or African American	2,704	2,864	167	214	2,537	2,650	476	502	2,061	2,148
NHOPI	*	*	*	*	*	*	*	*	*	*
White	15,579	15,712	733	771	14,846	14,941	3,036^a	2,581	11,811	12,360
Two or More Races	710	703	53	67	657	636	172	189	486	447
Hispanic or Latino	4,516	4,409	300	408	4,217	4,001	1,132^a	879	3,085	3,123
EDUCATION LEVEL
< High School	da	da	da	da	2,189	1,941	545^a	377	1,644	1,564
High School Graduate	da	da	da	da	5,578	5,884	1,422	1,289	4,156	4,595
Some College/Associate’s Degree	da	da	da	da	8,408	7,994	2,140	1,835	6,269	6,159
College Graduate	da	da	da	da	7,173	7,541	986	842	6,187	6,699
EMPLOYMENT STATUS
Full-Time	da	da	da	da	11,339	12,093	2,382^a	1,941	8,957^a	10,151
Part-Time	da	da	da	da	3,516	3,035	1,212	1,135	2,303	1,901
Unemployed	da	da	da	da	1,767	1,558	507	405	1,260	1,153
Other¹	da	da	da	da	6,727	6,675	991	862	5,736	5,812
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.67B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	8.8	8.8	5.2	5.9	9.1	9.1	14.6^b	12.8	8.2	8.5
SEX
Male	10.1	10.1	5.0	5.3	10.7	10.6	15.3	13.6	9.9	10.1
Female	7.4	7.5	5.4	6.5	7.6	7.6	14.0^a	11.9	6.6	7.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8.7	8.9	5.5	5.8	9.0	9.1	14.9	13.4	8.2	8.5
AIAN	10.7	14.8	6.4	5.3	11.4	16.9	*	14.8	10.3	17.2
Asian	5.2	4.8	4.8	3.1	5.2	5.0	9.6	7.6	4.5	4.6
Black or African American	7.9	8.2	4.8	5.9	8.2	8.5	10.2	11.0	7.8	8.1
NHOPI	*	*	*	*	*	*	*	*	*	*
White	9.1	9.2	5.7	6.0	9.4	9.5	16.6^a	14.6	8.4	8.8
Two or More Races	12.1	11.3	6.3	7.2	13.0	12.1	17.1	17.2	12.0	10.7
Hispanic or Latino	8.9	8.4	4.5	6.0	9.5	8.8	13.7^a	10.6	8.6	8.4
EDUCATION LEVEL
< High School	da	da	da	da	9.0	7.9	15.2^b	10.6	7.9	7.5
High School Graduate	da	da	da	da	8.1	8.5	12.2	11.2	7.2	7.9
Some College/Associate’s Degree	da	da	da	da	10.8	10.4	15.4	13.9	9.8	9.6
College Graduate	da	da	da	da	8.4	8.7	17.3	14.6	7.8	8.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9.6	10.0	16.9^b	14.0	8.6	9.5
Part-Time	da	da	da	da	10.7	9.6	13.8	13.6	9.6	8.2
Unemployed	da	da	da	da	16.0	13.6	15.8	12.1	16.1	14.2
Other¹	da	da	da	da	7.2	7.1	11.4	10.1	6.7	6.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.68A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	9,560	9,210	399	442	9,161	8,768	1,531	1,372	7,630	7,396
SEX
Male	5,750	5,409	195	213	5,555	5,196	881	735	4,674	4,461
Female	3,810	3,800	205	228	3,606	3,572	650	636	2,956	2,936
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8,143	7,428	338	280	7,805	7,149	1,192	1,144	6,613	6,005
AIAN	55	62	*	3	51	59	*	3	33	57
Asian	341	343	36	4	305	339	67	69	238	270
Black or African American	1,097	963	67	72	1,030	890	114	145	916	746
NHOPI	*	*	*	*	*	*	*	*	*	*
White	6,256	5,749	213	177	6,043	5,572	951	870	5,092	4,702
Two or More Races	282	235	18	23	264	212	39	58	225	154
Hispanic or Latino	1,417	1,781	62^b	162	1,356	1,619	339^a	227	1,017	1,392
EDUCATION LEVEL
< High School	da	da	da	da	970	878	170	156	800	723
High School Graduate	da	da	da	da	2,429	2,460	453	377	1,976	2,083
Some College/Associate’s Degree	da	da	da	da	3,303	2,939	582	576	2,721	2,363
College Graduate	da	da	da	da	2,458	2,491	326	264	2,132	2,227
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4,254	4,336	758	635	3,496	3,701
Part-Time	da	da	da	da	1,282	1,165	339	382	943	783
Unemployed	da	da	da	da	800	660	183	141	617	520
Other¹	da	da	da	da	2,825	2,607	251	214	2,574	2,393
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.68B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	3.4	3.2	1.6	1.7	3.6	3.4	4.4	4.0	3.4	3.3
SEX
Male	4.2	3.9	1.5	1.6	4.4	4.1	5.0	4.3	4.3	4.1
Female	2.7	2.6	1.6	1.8	2.7	2.7	3.8	3.8	2.6	2.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.5	3.2	1.8	1.5	3.7	3.4	4.5	4.4	3.6	3.2
AIAN	3.7	4.6	*	1.1	4.1	5.4	*	1.8	3.2	5.9
Asian	2.0	2.0	2.2	0.3	2.0	2.1	3.0	3.1	1.8	2.0
Black or African American	3.2	2.8	1.9	2.0	3.3	2.9	2.4	3.2	3.5	2.8
NHOPI	*	*	*	*	*	*	*	*	*	*
White	3.7	3.4	1.7	1.4	3.8	3.5	5.2	4.9	3.6	3.4
Two or More Races	4.8	3.8	2.1	2.4	5.2	4.0	3.9	5.3	5.6	3.7
Hispanic or Latino	2.8	3.4	0.9^b	2.4	3.1	3.6	4.1^a	2.8	2.8	3.7
EDUCATION LEVEL
< High School	da	da	da	da	4.0	3.6	4.7	4.4	3.9	3.5
High School Graduate	da	da	da	da	3.5	3.5	3.9	3.3	3.4	3.6
Some College/Associate’s Degree	da	da	da	da	4.2	3.8	4.2	4.4	4.3	3.7
College Graduate	da	da	da	da	2.9	2.9	5.7	4.6	2.7	2.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.6	3.6	5.4	4.6	3.4	3.5
Part-Time	da	da	da	da	3.9	3.7	3.9	4.6	3.9	3.4
Unemployed	da	da	da	da	7.3	5.8	5.7	4.2	7.9	6.4
Other¹	da	da	da	da	3.0	2.8	2.9	2.5	3.0	2.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.69A – Any Use and Misuse of Fentanyl in Past Year and Use of Illegally Made Fentanyl (IMF) in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic	Any Fentanyl Use¹ (2022)	Any Fentanyl Use¹ (2023)	Fentanyl Misuse² (2022)	Fentanyl Misuse² (2023)	IMF Use (2022)	IMF Use (2023)
TOTAL	3,086	2,894	991	828	686	627
AGE GROUP
12-17	149	150	34	50	20	36
18 or Older	2,937	2,743	957	779	666	591
18-25	271	325	75	110	48	78
26 or Older	2,667	2,418	882	668	617	513
SEX
Male	1,409	1,346	657^a	405	472	339
Female	1,677	1,548	333	424	214	287
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,673	2,419	854	725	654	534
AIAN	18	23	8	11	8	7
Asian	59	37	*	14	*	14
Black or African American	405	295	152	106	130	63
NHOPI	*	6	*	*	*	*
White	2,053	1,949	636	562	481	429
Two or More Races	96	109	58	29	35	17
Hispanic or Latino	413	475	136	103	32^a	93
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.69B – Any Use and Misuse of Fentanyl in Past Year and Use of Illegally Made Fentanyl (IMF) in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic	Any Fentanyl Use¹ (2022)	Any Fentanyl Use¹ (2023)	Fentanyl Misuse² (2022)	Fentanyl Misuse² (2023)	IMF Use (2022)	IMF Use (2023)
TOTAL	1.1	1.0	0.4	0.3	0.2	0.2
AGE GROUP
12-17	0.6	0.6	0.1	0.2	0.1	0.1
18 or Older	1.1	1.1	0.4	0.3	0.3	0.2
18-25	0.8	1.0	0.2	0.3	0.1	0.2
26 or Older	1.2	1.1	0.4	0.3	0.3	0.2
SEX
Male	1.0	1.0	0.5^a	0.3	0.3	0.2
Female	1.2	1.1	0.2	0.3	0.1	0.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.2	1.0	0.4	0.3	0.3	0.2
AIAN	1.2	1.7	0.5	0.8	0.5	0.5
Asian	0.3	0.2	*	0.1	*	0.1
Black or African American	1.2	0.8	0.4	0.3	0.4	0.2
NHOPI	*	0.5	*	*	*	*
White	1.2	1.1	0.4	0.3	0.3	0.3
Two or More Races	1.6	1.8	1.0	0.5	0.6	0.3
Hispanic or Latino	0.8	0.9	0.3	0.2	0.1^a	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.70A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	70,338	70,537	3,688	3,816	66,650	66,721	14,221^b	13,256	52,429	53,465
GEOGRAPHIC REGION
Northeast	12,579	12,933	607	594	11,972	12,339	2,456	2,553	9,515	9,786
Midwest	14,731	15,083	741	769	13,989	14,314	3,076	2,938	10,914	11,377
South	23,167	24,497	1,372	1,540	21,794	22,957	4,889^a	4,458	16,906^a	18,499
West	19,862^b	18,024	967	913	18,895^a	17,111	3,800^b	3,308	15,095^a	13,803
COUNTY TYPE
Large Metro	39,876	39,750	2,049	2,084	37,827	37,666	7,962^a	7,061	29,865	30,604
Small Metro	22,422	22,376	1,283	1,253	21,139	21,123	4,802	4,645	16,337	16,479
Nonmetro	8,040	8,412	356^a	480	7,684	7,932	1,456	1,550	6,228	6,382
Urbanized	3,688	3,622	162	168	3,526	3,454	726	792	2,800	2,662
Less Urbanized	3,793	4,247	148^b	262	3,646	3,985	687	679	2,959	3,306
Completely Rural	559	543	*	*	512	493	44	79	469	414
POVERTY LEVEL¹
Less Than 100%	11,951	12,549	771	762	11,181	11,788	3,205	3,102	7,976	8,686
100-199%	14,412	13,525	882	912	13,530	12,612	3,643	3,258	9,887	9,354
200% or More	43,971	44,451	2,035	2,143	41,936	42,309	7,370	6,884	34,566	35,425
HEALTH INSURANCE²
Private	40,302	40,294	1,925	1,958	38,377	38,336	8,390^a	7,582	29,986	30,754
Medicaid/CHIP	18,399	18,368	1,642	1,765	16,757	16,603	3,728	3,783	13,029	12,821
Other³	13,445	12,869	217	204	13,228	12,665	1,091	1,001	12,136	11,665
No Coverage	7,366	7,538	123	113	7,243	7,425	1,712	1,582	5,530	5,844
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.70B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	24.9	24.9	14.3	14.7	26.0	25.9	40.9^a	39.0	23.7	23.9
GEOGRAPHIC REGION
Northeast	25.7	26.4	14.9	14.6	26.6	27.5	41.5	44.4	24.4	25.0
Midwest	25.3	25.9	13.7	14.2	26.5	27.1	42.1	41.2	24.0	24.9
South	21.4	22.4	13.6	15.0	22.2	23.2	36.6	34.0	20.0	21.5
West	29.8^b	26.9	15.7	14.8	31.2^b	28.1	46.2^a	41.2	28.8^a	26.1
COUNTY TYPE
Large Metro	25.6	25.3	13.8	14.6	26.8	26.4	41.7^a	38.5	24.5	24.6
Small Metro	25.1	25.1	16.1	15.1	26.0	26.2	41.1	40.6	23.5	23.8
Nonmetro	21.9	22.4	12.1	14.2	22.7	23.2	36.6	36.4	20.9	21.3
Urbanized	23.8	23.9	13.1	13.8	24.8	24.8	41.2	42.1	22.5	22.1
Less Urbanized	20.6	22.0	10.4	14.1	21.4	22.8	34.8	32.6	19.7	21.5
Completely Rural	19.6	17.5	*	*	19.9	17.6	17.6	26.9	20.1	16.5
POVERTY LEVEL¹
Less Than 100%	28.8	27.8	14.6	13.3	30.9	29.9	39.8	36.9	28.3	28.0
100-199%	25.9	24.9	15.2	17.0	27.2	25.7	42.9	41.4	23.9	22.8
200% or More	23.8	24.2	13.9	14.4	24.6	25.0	40.4	38.8	22.7	23.4
HEALTH INSURANCE²
Private	23.7	23.6	13.7	14.0	24.6	24.4	42.2^a	39.8	22.0	22.3
Medicaid/CHIP	31.3	30.2	15.4	16.1	34.8	33.3	40.2	39.7	33.6	31.8
Other³	17.2	16.4	14.4	14.6	17.2	16.4	38.9	35.5	16.4	15.7
No Coverage	30.4	31.7	12.2	9.0	31.2	33.0	37.0	35.3	29.7	32.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.71A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	46,603	47,657	1,884	1,864	44,719	45,794	9,478^a	8,901	35,241	36,892
GEOGRAPHIC REGION
Northeast	8,713	8,934	329	273	8,384	8,661	1,723	1,732	6,661	6,930
Midwest	9,695	10,506	366	388	9,329	10,117	2,009	1,948	7,320	8,169
South	14,785	15,840	728	677	14,056	15,163	3,175	2,965	10,882^a	12,198
West	13,411	12,377	462	525	12,950	11,852	2,571^a	2,256	10,378	9,596
COUNTY TYPE
Large Metro	26,425	26,642	1,079	1,009	25,347	25,632	5,265	4,781	20,081	20,851
Small Metro	14,687	15,035	650	633	14,037	14,402	3,261	3,061	10,776	11,340
Nonmetro	5,491	5,981	156	221	5,336	5,760	952	1,059	4,384	4,701
Urbanized	2,605	2,618	89	81	2,517	2,537	462	526	2,054	2,011
Less Urbanized	2,522	3,033	64^a	131	2,457	2,902	468	480	1,989	2,422
Completely Rural	364	330	2	10	362	320	21	53	340	268
POVERTY LEVEL¹
Less Than 100%	8,149	8,881	406	401	7,743	8,480	2,115	2,071	5,628	6,409
100-199%	10,144	9,701	424	411	9,720	9,290	2,650	2,303	7,070	6,988
200% or More	28,309	29,068	1,054	1,052	27,255	28,016	4,712	4,520	22,543	23,495
HEALTH INSURANCE²
Private	25,474	26,089	997	953	24,476	25,135	5,476	4,970	19,001	20,165
Medicaid/CHIP	13,076	13,327	837	885	12,238	12,441	2,597	2,670	9,641	9,772
Other³	8,609	8,689	92	88	8,517	8,601	693	665	7,824	7,936
No Coverage	5,235	5,567	71	57	5,164	5,509	1,190	1,082	3,975	4,427
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.71B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	16.5	16.8	7.3	7.2	17.4	17.8	27.2	26.2	15.9	16.5
GEOGRAPHIC REGION
Northeast	17.8	18.2	8.1	6.7	18.6	19.3	29.1	30.1	17.1	17.7
Midwest	16.7	18.0	6.8	7.1	17.7	19.2	27.5	27.3	16.1	17.9
South	13.7	14.5	7.2	6.6	14.3	15.3	23.8	22.6	12.9	14.2
West	20.1	18.5	7.5	8.5	21.4	19.5	31.2	28.1	19.8	18.2
COUNTY TYPE
Large Metro	16.9	17.0	7.3	7.1	18.0	18.0	27.5	26.1	16.5	16.8
Small Metro	16.4	16.9	8.2	7.7	17.3	17.8	27.9	26.8	15.5	16.4
Nonmetro	14.9	15.9	5.3	6.5	15.8	16.8	23.9	24.9	14.7	15.7
Urbanized	16.8	17.3	7.2	6.6	17.7	18.2	26.3	27.9	16.5	16.7
Less Urbanized	13.7	15.7	4.6	7.0	14.5	16.6	23.8	23.0	13.2	15.7
Completely Rural	12.8	10.6	0.9	3.1	14.0	11.4	8.5^a	18.0	14.6	10.7
POVERTY LEVEL¹
Less Than 100%	19.6	19.7	7.7	7.0	21.4	21.5	26.3	24.6	20.0	20.6
100-199%	18.2	17.9	7.3	7.7	19.5	19.0	31.2	29.2	17.1	17.0
200% or More	15.3	15.8	7.2	7.1	16.0	16.6	25.8	25.5	14.8	15.5
HEALTH INSURANCE²
Private	15.0	15.2	7.1	6.8	15.7	16.0	27.5	26.1	14.0	14.6
Medicaid/CHIP	22.3	21.9	7.8	8.1	25.5	25.0	28.0	28.0	24.8	24.3
Other³	11.0	11.1	6.1	6.3	11.1	11.1	24.7	23.6	10.6	10.7
No Coverage	21.6	23.4	7.0	4.6	22.2	24.5	25.7	24.1	21.3	24.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.72A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	61,901	61,816	2,947	2,894	58,955	58,922	13,299^a	12,435	45,656	46,487
GEOGRAPHIC REGION
Northeast	11,259	11,615	507	463	10,752	11,152	2,319	2,409	8,433	8,743
Midwest	13,147	13,574	606	604	12,542	12,970	2,915	2,810	9,626	10,159
South	19,783	20,586	1,058	1,073	18,726	19,513	4,474	4,128	14,251	15,385
West	17,712^a	16,041	776	754	16,936^a	15,287	3,590^b	3,087	13,345	12,200
COUNTY TYPE
Large Metro	35,226	34,699	1,643	1,582	33,583	33,117	7,461^a	6,611	26,122	26,506
Small Metro	19,704	19,769	1,042	954	18,661	18,815	4,513	4,377	14,149	14,437
Nonmetro	6,972	7,349	262^a	358	6,710	6,991	1,325	1,447	5,385	5,544
Urbanized	3,275	3,250	136	128	3,139	3,122	666	761	2,473	2,361
Less Urbanized	3,230	3,641	99^b	195	3,131	3,447	624	615	2,507	2,831
Completely Rural	467	457	*	35	440	422	35	70	405	352
POVERTY LEVEL¹
Less Than 100%	10,283	10,939	630	558	9,653	10,380	2,998	2,881	6,655	7,499
100-199%	12,661	11,843	702	710	11,959	11,133	3,442	3,042	8,517	8,090
200% or More	38,955	39,024	1,614	1,625	37,341	37,398	6,857	6,500	30,483	30,898
HEALTH INSURANCE²
Private	35,745	35,571	1,505	1,508	34,239	34,063	7,849	7,148	26,390	26,915
Medicaid/CHIP	15,906	16,165	1,372	1,355	14,534	14,810	3,481	3,510	11,052	11,300
Other³	11,215	10,638	154	133	11,060	10,505	1,032	928	10,028	9,577
No Coverage	6,568	6,699	92	74	6,476	6,625	1,591	1,458	4,885	5,167
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.72B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	22.0	21.8	11.5	11.2	23.0	22.9	38.2	36.5	20.6	20.8
GEOGRAPHIC REGION
Northeast	23.0	23.7	12.5	11.4	23.9	24.8	39.2	41.9	21.6	22.3
Midwest	22.6	23.3	11.2	11.1	23.8	24.6	39.9	39.4	21.2	22.2
South	18.3	18.8	10.4	10.5	19.1	19.7	33.5	31.5	16.8	17.9
West	26.5^a	23.9	12.6	12.3	28.0^a	25.1	43.6^a	38.4	25.5	23.1
COUNTY TYPE
Large Metro	22.6	22.1	11.1	11.1	23.8	23.2	39.0^a	36.0	21.4	21.3
Small Metro	22.1	22.2	13.1	11.5	22.9	23.3	38.6	38.3	20.3	20.8
Nonmetro	19.0	19.5	8.9	10.6	19.8	20.4	33.3	34.0	18.1	18.5
Urbanized	21.2	21.4	11.0	10.5	22.1	22.4	37.8	40.4	19.8	19.6
Less Urbanized	17.5	18.8	7.0^a	10.5	18.4	19.7	31.7	29.5	16.7	18.4
Completely Rural	16.3	14.7	*	11.5	17.1	15.1	14.1	23.9	17.4	14.0
POVERTY LEVEL¹
Less Than 100%	24.8	24.2	12.0	9.8	26.7	26.3	37.2	34.3	23.6	24.2
100-199%	22.8	21.8	12.1	13.3	24.0	22.7	40.6	38.6	20.6	19.7
200% or More	21.1	21.2	11.0	10.9	21.9	22.1	37.6	36.7	20.1	20.4
HEALTH INSURANCE²
Private	21.0	20.8	10.7	10.8	22.0	21.7	39.5	37.5	19.4	19.5
Medicaid/CHIP	27.1	26.6	12.8	12.4	30.2	29.7	37.6	36.8	28.5	28.0
Other³	14.3	13.5	10.2	9.6	14.4	13.6	36.8	32.9	13.6	12.9
No Coverage	27.1	28.2	9.1	6.0	27.9	29.4	34.4	32.5	26.2	28.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.73A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	42,317	43,647	1,647	1,563	40,670	42,083	9,013	8,562	31,657	33,521
GEOGRAPHIC REGION
Northeast	7,932	8,237	303	242	7,629	7,995	1,652	1,664	5,977	6,331
Midwest	8,831^a	9,857	327	331	8,504^a	9,527	1,902	1,877	6,602^a	7,650
South	13,183	14,170	604	524	12,579	13,646	2,995	2,841	9,584^a	10,805
West	12,371	11,382	413	467	11,958	10,915	2,464	2,180	9,494	8,735
COUNTY TYPE
Large Metro	23,936	24,322	944	867	22,992	23,456	5,039	4,614	17,954	18,842
Small Metro	13,426	13,861	577	503	12,849	13,358	3,093	2,918	9,756	10,440
Nonmetro	4,954	5,464	126^a	194	4,828	5,270	881	1,031	3,947	4,239
Urbanized	2,332	2,404	76	71	2,256	2,334	435	517	1,822	1,817
Less Urbanized	2,281	2,733	48^b	115	2,233	2,618	428	461	1,805	2,157
Completely Rural	341	326	2	8	339	318	19^a	53	320	265
POVERTY LEVEL¹
Less Than 100%	7,133	7,988	344	320	6,790^a	7,668	2,024	1,956	4,765^a	5,712
100-199%	9,221	8,877	379	349	8,842	8,528	2,521	2,241	6,321	6,287
200% or More	25,962	26,774	924	895	25,038	25,879	4,467	4,357	20,571	21,522
HEALTH INSURANCE²
Private	23,479	24,046	871	815	22,608	23,232	5,227	4,767	17,380	18,464
Medicaid/CHIP	11,425	12,074	751	729	10,674	11,344	2,462	2,570	8,212	8,774
Other³	7,562	7,775	81	78	7,482	7,696	666	648	6,815	7,048
No Coverage	4,836	5,147	51	39	4,786	5,109	1,110	1,041	3,675	4,068
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.73B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	15.0	15.4	6.4	6.0	15.9	16.3	25.9	25.2	14.3	15.0
GEOGRAPHIC REGION
Northeast	16.2	16.8	7.5	5.9	17.0	17.8	27.9	29.0	15.3	16.2
Midwest	15.2^a	16.9	6.1	6.1	16.1^a	18.0	26.1	26.3	14.5^a	16.7
South	12.2	13.0	6.0	5.1	12.8	13.8	22.4	21.7	11.3	12.6
West	18.5	17.0	6.7	7.6	19.7	17.9	29.9	27.1	18.1	16.5
COUNTY TYPE
Large Metro	15.3	15.5	6.4	6.1	16.3	16.4	26.4	25.2	14.7	15.2
Small Metro	15.0	15.6	7.2	6.1	15.8	16.6	26.5	25.5	14.0	15.1
Nonmetro	13.5	14.5	4.3	5.7	14.3	15.4	22.1	24.2	13.2	14.1
Urbanized	15.1	15.8	6.1	5.8	15.9	16.7	24.7	27.4	14.6	15.1
Less Urbanized	12.4	14.1	3.4^a	6.2	13.1	15.0	21.7	22.1	12.0	14.0
Completely Rural	12.0	10.5	0.9	2.7	13.2	11.3	7.4^a	18.0	13.8	10.6
POVERTY LEVEL¹
Less Than 100%	17.2	17.7	6.5	5.6	18.8	19.4	25.1	23.3	16.9	18.4
100-199%	16.6	16.3	6.5	6.5	17.7	17.4	29.7	28.5	15.3	15.3
200% or More	14.0	14.6	6.3	6.0	14.7	15.3	24.5	24.6	13.5	14.2
HEALTH INSURANCE²
Private	13.8	14.1	6.2	5.8	14.5	14.8	26.3	25.0	12.8	13.4
Medicaid/CHIP	19.4	19.9	7.0	6.7	22.2	22.8	26.6	27.0	21.2	21.8
Other³	9.7	9.9	5.3	5.6	9.8	10.0	23.7	23.0	9.2	9.5
No Coverage	19.9	21.6	5.0	3.1	20.6	22.7	24.0	23.2	19.7	22.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.74A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	5,274	5,012	40	63	5,235	4,949	1,295^a	1,043	3,939	3,907
GEOGRAPHIC REGION
Northeast	1,083	924	10	4	1,073	921	212	197	860	723
Midwest	1,011	919	3	19	1,008	901	303^a	201	705	699
South	1,606	1,637	11	24	1,596	1,614	376	320	1,220	1,294
West	1,575	1,531	16	17	1,558	1,514	404	324	1,154	1,190
COUNTY TYPE
Large Metro	3,236	2,989	31	33	3,205	2,956	775^a	563	2,430	2,392
Small Metro	1,577	1,503	4^a	27	1,573	1,476	394	364	1,179	1,112
Nonmetro	461	521	5	3	457	518	126	115	330	402
Urbanized	208	231	2	<1	206	231	63	51	143	180
Less Urbanized	252	280	2	3	250	278	63	62	187	216
Completely Rural	1^a	9	*	*	1^a	9	1	2	<1	7
POVERTY LEVEL¹
Less Than 100%	1,000	1,064	4	7	996	1,058	300	209	696	849
100-199%	1,103	836	4	15	1,099	821	282	266	817	555
200% or More	3,171	3,112	32	42	3,139	3,070	713	568	2,426	2,502
HEALTH INSURANCE²
Private	2,732	2,515	24	36	2,708	2,479	848	646	1,860	1,833
Medicaid/CHIP	1,762	1,540	15	26	1,746	1,514	263	207	1,484	1,307
Other³	839	706	1	*	838	706	93	93	746	613
No Coverage	593	733	1	3	592	730	126	127	466	602
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.74B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.9	1.8	0.2	0.2	2.0	1.9	3.7	3.1	1.8	1.7
GEOGRAPHIC REGION
Northeast	2.2	1.9	0.2	0.1	2.4	2.0	3.6	3.4	2.2	1.8
Midwest	1.7	1.6	0.1	0.3	1.9	1.7	4.2^a	2.8	1.6	1.5
South	1.5	1.5	0.1	0.2	1.6	1.6	2.8	2.4	1.4	1.5
West	2.4	2.3	0.3	0.3	2.6	2.5	4.9	4.0	2.2	2.3
COUNTY TYPE
Large Metro	2.1	1.9	0.2	0.2	2.3	2.1	4.1	3.1	2.0	1.9
Small Metro	1.8	1.7	<0.1^a	0.3	1.9	1.8	3.4	3.2	1.7	1.6
Nonmetro	1.3	1.4	0.2	0.1	1.4	1.5	3.2	2.7	1.1	1.3
Urbanized	1.3	1.5	0.2	<0.1	1.4	1.7	3.6	2.7	1.1	1.5
Less Urbanized	1.4	1.4	0.2	0.2	1.5	1.6	3.2	3.0	1.2	1.4
Completely Rural	<0.1	0.3	*	*	<0.1	0.3	0.3	0.8	<0.1	0.3
POVERTY LEVEL¹
Less Than 100%	2.4	2.4	0.1	0.1	2.8	2.7	3.7^a	2.5	2.5	2.7
100-199%	2.0	1.5	0.1	0.3	2.2	1.7	3.3	3.4	2.0	1.4
200% or More	1.7	1.7	0.2	0.3	1.8	1.8	3.9	3.2	1.6	1.7
HEALTH INSURANCE²
Private	1.6	1.5	0.2	0.3	1.7	1.6	4.3	3.4	1.4	1.3
Medicaid/CHIP	3.0	2.5	0.1	0.2	3.6	3.0	2.8	2.2	3.8	3.2
Other³	1.1	0.9	0.1	*	1.1	0.9	3.3	3.3	1.0	0.8
No Coverage	2.4	3.1	0.1	0.2	2.5	3.2	2.7	2.8	2.5	3.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.75A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	2,015	1,814	5	22	2,010	1,792	403^b	219	1,607	1,572
GEOGRAPHIC REGION
Northeast	426	365	*	*	426	365	51	51	375	314
Midwest	407	342	<1	5	407	337	104^a	32	303	304
South	566	531	4	17	563	514	145^a	70	418	444
West	616	576	1	*	615	576	103	66	512	510
COUNTY TYPE
Large Metro	1,326	1,109	5	12	1,321	1,097	261^b	128	1,060	969
Small Metro	496	489	*	11	496	479	107	73	389	405
Nonmetro	193	216	1	*	193	216	35	18	158	198
Urbanized	77	121	<1	*	77	121	12	10	65	111
Less Urbanized	116	93	<1	*	116	93	*	8	93	85
Completely Rural	*	2	*	*	*	2	*	*	*	2
POVERTY LEVEL¹
Less Than 100%	489	459	1	1	487	458	84^a	37	404	421
100-199%	453^a	250	*	10	453^a	240	85	59	368^a	181
200% or More	1,073	1,105	4	11	1,070	1,094	234^a	123	836	970
HEALTH INSURANCE²
Private	836	923	2	15	834	908	252^a	149	582	759
Medicaid/CHIP	922	618	3	8	920	611	86	37	833	573
Other³	398	413	1	*	397	413	16	19	381	394
No Coverage	206	199	1	*	205	199	59	28	146	172
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.75B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.7	0.6	<0.1	0.1	0.8	0.7	1.2^b	0.6	0.7	0.7
GEOGRAPHIC REGION
Northeast	0.9	0.7	*	*	0.9	0.8	0.9	0.9	1.0	0.8
Midwest	0.7	0.6	<0.1	0.1	0.8	0.6	1.4^a	0.5	0.7	0.7
South	0.5	0.5	<0.1	0.2	0.6	0.5	1.1^a	0.5	0.5	0.5
West	0.9	0.9	<0.1	*	1.0	0.9	1.2	0.8	1.0	1.0
COUNTY TYPE
Large Metro	0.9	0.7	<0.1	0.1	0.9	0.8	1.4^a	0.7	0.9	0.8
Small Metro	0.6	0.6	*	0.1	0.6	0.6	0.9	0.6	0.6	0.6
Nonmetro	0.5	0.6	<0.1	*	0.6	0.6	0.9	0.4	0.5	0.7
Urbanized	0.5	0.8	<0.1	*	0.5	0.9	0.7	0.5	0.5	0.9
Less Urbanized	0.6	0.5	<0.1	*	0.7	0.5	*	0.4	0.6	0.6
Completely Rural	*	0.1	*	*	*	0.1	*	*	*	0.1
POVERTY LEVEL¹
Less Than 100%	1.2	1.0	<0.1	<0.1	1.3	1.2	1.0^a	0.4	1.4	1.4
100-199%	0.8^a	0.5	*	0.2	0.9^a	0.5	1.0	0.7	0.9^a	0.4
200% or More	0.6	0.6	<0.1	0.1	0.6	0.6	1.3^a	0.7	0.5	0.6
HEALTH INSURANCE²
Private	0.5	0.5	<0.1	0.1	0.5	0.6	1.3	0.8	0.4	0.5
Medicaid/CHIP	1.6^a	1.0	<0.1	0.1	1.9^a	1.2	0.9	0.4	2.1	1.4
Other³	0.5	0.5	0.1	*	0.5	0.5	0.6	0.7	0.5	0.5
No Coverage	0.8	0.8	0.1	*	0.9	0.9	1.3	0.6	0.8	1.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.76A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	10,167	9,871	918	997	573	507
GEOGRAPHIC REGION
Northeast	1,871	1,719	313	248	194	162
Midwest	2,017	1,910	208	221	168	113
South	3,565	3,677	292	362	167	145
West	2,714	2,566	105	167	44	87
COUNTY TYPE
Large Metro	4,934	4,823	561	557	394	332
Small Metro	3,692	3,510	258	327	104	107
Nonmetro	1,540	1,538	99	113	75	68
Urbanized	666	750	38	41	31	23
Less Urbanized	735	707	60	68	44	45
Completely Rural	140	81	<1	3	*	*
POVERTY LEVEL¹
Less Than 100%	2,659	2,815	358	457	246	234
100-199%	2,627	2,095	359^a	176	225^a	60
200% or More	4,881	4,961	200	364	102	213
HEALTH INSURANCE²
Private	3,839	3,873	169	237	84	170
Medicaid/CHIP	4,138	3,719	642	479	418^a	206
Other³	2,690	2,663	381	298	248	179
No Coverage	1,218	1,333	60	128	21	36
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.76B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	3.6	3.5	0.3	0.4	0.2	0.2
GEOGRAPHIC REGION
Northeast	3.8	3.5	0.6	0.5	0.4	0.3
Midwest	3.5	3.3	0.4	0.4	0.3	0.2
South	3.3	3.4	0.3	0.3	0.2	0.1
West	4.1	3.8	0.2	0.2	0.1	0.1
COUNTY TYPE
Large Metro	3.2	3.1	0.4	0.4	0.3	0.2
Small Metro	4.1	3.9	0.3	0.4	0.1	0.1
Nonmetro	4.2	4.1	0.3	0.3	0.2	0.2
Urbanized	4.3	4.9	0.2	0.3	0.2	0.2
Less Urbanized	4.0	3.7	0.3	0.4	0.2	0.2
Completely Rural	4.9	2.6	<0.1	0.1	*	*
POVERTY LEVEL¹
Less Than 100%	6.4	6.2	0.9	1.0	0.6	0.5
100-199%	4.7	3.9	0.6	0.3	0.4^a	0.1
200% or More	2.6	2.7	0.1	0.2	0.1	0.1
HEALTH INSURANCE²
Private	2.3	2.3	0.1	0.1	<0.1	0.1
Medicaid/CHIP	7.0	6.1	1.1	0.8	0.7^a	0.3
Other³	3.4	3.4	0.5	0.4	0.3	0.2
No Coverage	5.0	5.6	0.2	0.5	0.1	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.77A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	48,850	48,438	8,509	8,795	2,289	2,638
GEOGRAPHIC REGION
Northeast	7,852	8,219	1,348^b	1,756	412	521
Midwest	9,928	9,164	1,461	1,342	327	398
South	15,532^a	16,990	2,504	2,664	746	843
West	15,537^a	14,066	3,195	3,032	805	876
COUNTY TYPE
Large Metro	26,684	26,072	5,074	5,289	1,446	1,623
Small Metro	16,175	16,197	2,639	2,696	626	805
Nonmetro	5,991	6,170	795	810	217	211
Urbanized	2,967	2,609	452	407	112	82
Less Urbanized	2,578	3,148	315	356	83	113
Completely Rural	446	412	28	47	22	16
POVERTY LEVEL¹
Less Than 100%	6,527	6,951	1,219	1,435	324	416
100-199%	8,943	8,016	1,669	1,470	402	444
200% or More	33,379	33,460	5,620	5,882	1,562	1,774
HEALTH INSURANCE²
Private	29,765	29,623	4,972	5,203	1,236	1,484
Medicaid/CHIP	10,534	10,628	2,213	2,260	718	723
Other³	11,097	11,237	831	927	303	265
No Coverage	4,688	4,158	1,073	1,034	269	366
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.77B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Lifetime (2022)	Lifetime (2023)	Past Year (2022)	Past Year (2023)	Past Month (2022)	Past Month (2023)
TOTAL	17.3	17.1	3.0	3.1	0.8	0.9
GEOGRAPHIC REGION
Northeast	16.0	16.8	2.7^b	3.6	0.8	1.1
Midwest	17.1	15.7	2.5	2.3	0.6	0.7
South	14.4	15.6	2.3	2.4	0.7	0.8
West	23.3^a	21.0	4.8	4.5	1.2	1.3
COUNTY TYPE
Large Metro	17.1	16.6	3.3	3.4	0.9	1.0
Small Metro	18.1	18.2	3.0	3.0	0.7	0.9
Nonmetro	16.3	16.4	2.2	2.2	0.6	0.6
Urbanized	19.2	17.2	2.9	2.7	0.7	0.5
Less Urbanized	14.0	16.3	1.7	1.8	0.5	0.6
Completely Rural	15.6	13.3	1.0	1.5	0.8	0.5
POVERTY LEVEL¹
Less Than 100%	15.7	15.4	2.9	3.2	0.8	0.9
100-199%	16.1	14.7	3.0	2.7	0.7	0.8
200% or More	18.1	18.2	3.0	3.2	0.8	1.0
HEALTH INSURANCE²
Private	17.5	17.3	2.9	3.0	0.7	0.9
Medicaid/CHIP	17.9	17.5	3.8	3.7	1.2	1.2
Other³	14.2	14.3	1.1	1.2	0.4	0.3
No Coverage	19.3	17.5	4.4	4.3	1.1	1.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.78A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	2,254	2,602	554	564	1,700	2,038	647	694	1,053	1,344
GEOGRAPHIC REGION
Northeast	432	469	64	90	368	379	159	127	209	252
Midwest	410	435	110	104	301	331	90	124	210	207
South	687^a	929	221	273	467	656	174	206	293	450
West	724	769	159	98	565	672	224	237	341	435
COUNTY TYPE
Large Metro	1,373	1,686	309	306	1,064	1,380	390	430	674	950
Small Metro	582	735	164	182	418	553	185	228	233	325
Nonmetro	299	181	81	76	219	105	72^a	35	147	70
Urbanized	97	94	26	31	71	63	47	29	24	34
Less Urbanized	139	71	41	32	98	39	25	6	73	33
Completely Rural	64	16	*	*	50	3	*	*	50	3
POVERTY LEVEL¹
Less Than 100%	307^a	446	116	105	191^a	341	106^a	200	85	141
100-199%	458	506	117	166	341	340	164	135	177	204
200% or More	1,489	1,650	321	293	1,168	1,357	377	358	791	999
HEALTH INSURANCE²
Private	1,409	1,553	313	276	1,096	1,277	414	448	682	828
Medicaid/CHIP	544	690	201	247	343	443	143	139	200	304
Other³	237	214	33	60	204	154	51	52	153	103
No Coverage	226	245	29	25	197	220	63	68	134	152
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.78B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.8	0.9	2.2	2.2	0.7	0.8	1.9	2.0	0.5	0.6
GEOGRAPHIC REGION
Northeast	0.9	1.0	1.6	2.2	0.8	0.8	2.7	2.2	0.5	0.6
Midwest	0.7	0.7	2.0	1.9	0.6	0.6	1.2	1.7	0.5	0.5
South	0.6^a	0.9	2.2	2.7	0.5	0.7	1.3	1.6	0.3	0.5
West	1.1	1.1	2.6	1.6	0.9	1.1	2.7	3.0	0.7	0.8
COUNTY TYPE
Large Metro	0.9	1.1	2.1	2.1	0.8	1.0	2.0	2.3	0.6	0.8
Small Metro	0.7	0.8	2.1	2.2	0.5	0.7	1.6	2.0	0.3	0.5
Nonmetro	0.8	0.5	2.8	2.3	0.6^a	0.3	1.8^b	0.8	0.5	0.2
Urbanized	0.6	0.6	2.1	2.6	0.5	0.5	2.7	1.5	0.2	0.3
Less Urbanized	0.8	0.4	2.9	1.7	0.6	0.2	1.3	0.3	0.5	0.2
Completely Rural	2.2	0.5	*	*	1.9	0.1	*	*	2.2	0.1
POVERTY LEVEL¹
Less Than 100%	0.7	1.0	2.2	1.8	0.5^a	0.9	1.3^a	2.4	0.3	0.5
100-199%	0.8	0.9	2.0	3.1	0.7	0.7	1.9	1.7	0.4	0.5
200% or More	0.8	0.9	2.2	2.0	0.7	0.8	2.1	2.0	0.5	0.7
HEALTH INSURANCE²
Private	0.8	0.9	2.2	2.0	0.7	0.8	2.1	2.4	0.5	0.6
Medicaid/CHIP	0.9	1.1	1.9	2.3	0.7	0.9	1.5	1.5	0.5	0.8
Other³	0.3	0.3	2.2	4.3	0.3	0.2	1.8	1.8	0.2	0.1
No Coverage	0.9	1.0	2.9	2.0	0.8	1.0	1.4	1.5	0.7	0.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.79A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	842	1,004	170	125	672	879	193	231	479	649
GEOGRAPHIC REGION
Northeast	196	130	22	11	174	120	48	29	127	90
Midwest	198	183	32	36	166	147	31	50	134	97
South	279	365	70	53	209	312	71	54	138	258
West	169^a	326	46	25	123^a	301	43	97	80^a	203
COUNTY TYPE
Large Metro	528	641	100	51	428	590	103	135	324	455
Small Metro	216	301	44	58	171	243	70	84	101	158
Nonmetro	98	63	25	16	73	47	20	11	53	36
Urbanized	41	34	13	4	28	30	17	9	11	20
Less Urbanized	29	28	12	11	17	17	3	2	14	15
Completely Rural	*	1	*	*	*	1	*	*	*	1
POVERTY LEVEL¹
Less Than 100%	140	173	43	34	97	140	42	66	55	73
100-199%	152	222	22	32	130	191	44	58	86	133
200% or More	549	608	104	59	445	549	107	107	338	442
HEALTH INSURANCE²
Private	531	550	86	58	445	492	123	137	322	355
Medicaid/CHIP	171	287	53	61	118	226	33	59	85	168
Other³	137	103	17	9	121	94	14	20	107	74
No Coverage	90	98	19	9	71	89	28	18	42	71
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.79B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.3	0.4	0.7	0.5	0.3	0.3	0.6	0.7	0.2	0.3
GEOGRAPHIC REGION
Northeast	0.4	0.3	0.5	0.3	0.4	0.3	0.8	0.5	0.3	0.2
Midwest	0.3	0.3	0.6	0.7	0.3	0.3	0.4	0.7	0.3	0.2
South	0.3	0.3	0.7	0.5	0.2	0.3	0.5	0.4	0.2	0.3
West	0.3^a	0.5	0.7	0.4	0.2^a	0.5	0.5	1.2	0.2^a	0.4
COUNTY TYPE
Large Metro	0.3	0.4	0.7	0.4	0.3	0.4	0.5	0.7	0.3	0.4
Small Metro	0.2	0.3	0.6	0.7	0.2	0.3	0.6	0.7	0.1	0.2
Nonmetro	0.3	0.2	0.9	0.5	0.2	0.1	0.5	0.3	0.2	0.1
Urbanized	0.3	0.2	1.0	0.4	0.2	0.2	0.9	0.5	0.1	0.2
Less Urbanized	0.2	0.1	0.9	0.6	0.1	0.1	0.2	0.1	0.1	0.1
Completely Rural	*	<0.1	*	*	*	<0.1	*	*	*	<0.1
POVERTY LEVEL¹
Less Than 100%	0.3	0.4	0.8	0.6	0.3	0.4	0.5	0.8	0.2	0.2
100-199%	0.3	0.4	0.4	0.6	0.3	0.4	0.5	0.7	0.2	0.3
200% or More	0.3	0.3	0.7	0.4	0.3	0.3	0.6	0.6	0.2	0.3
HEALTH INSURANCE²
Private	0.3	0.3	0.6	0.4	0.3	0.3	0.6	0.7	0.2	0.3
Medicaid/CHIP	0.3	0.5	0.5	0.6	0.2	0.5	0.4	0.6	0.2	0.4
Other³	0.2	0.1	1.1	0.7	0.2	0.1	0.5	0.7	0.1	0.1
No Coverage	0.4	0.4	1.9	0.7	0.3	0.4	0.6	0.4	0.2	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.80A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	2,705	2,621	18	40	2,687	2,582	161	108	2,526	2,473
GEOGRAPHIC REGION
Northeast	139	276	5	1	134^a	275	7	17	127	258
Midwest	697^a	442	5	7	693^a	435	83^a	22	610	413
South	867	1,137	3	24	864	1,114	45	41	819	1,073
West	1,002	767	5	9	997	758	27	28	970	730
COUNTY TYPE
Large Metro	1,215	1,252	5	35	1,209	1,217	79	51	1,131	1,166
Small Metro	916	811	5	5	912	807	55^a	19	856	788
Nonmetro	574	558	8	*	566	558	27	39	539	519
Urbanized	230	200	4	*	226	200	11	11	215	189
Less Urbanized	286	317	4	*	282	317	14	26	268	290
Completely Rural	58	41	*	*	58	41	*	*	*	40
POVERTY LEVEL¹
Less Than 100%	926	936	1	3	925	933	59	45	866	888
100-199%	866	775	9	8	857	766	29	17	827	749
200% or More	913	911	8	29	905	882	73	46	832	836
HEALTH INSURANCE²
Private	494	519	9	35	485	485	51	39	434	446
Medicaid/CHIP	1,491	1,280	12	5	1,479	1,275	85	50	1,394	1,225
Other³	711	436	*	*	711	436	7	8	704	427
No Coverage	389	617	*	<1	389	616	23	18	365	599
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.80B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.0	0.9	0.1	0.2	1.0	1.0	0.5	0.3	1.1	1.1
GEOGRAPHIC REGION
Northeast	0.3	0.6	0.1	<0.1	0.3^a	0.6	0.1	0.3	0.3	0.7
Midwest	1.2^a	0.8	0.1	0.1	1.3^a	0.8	1.1^a	0.3	1.3	0.9
South	0.8	1.0	<0.1	0.2	0.9	1.1	0.3	0.3	1.0	1.2
West	1.5	1.1	0.1	0.1	1.6	1.2	0.3	0.4	1.9	1.4
COUNTY TYPE
Large Metro	0.8	0.8	<0.1	0.2	0.9	0.9	0.4	0.3	0.9	0.9
Small Metro	1.0	0.9	0.1	0.1	1.1	1.0	0.5^a	0.2	1.2	1.1
Nonmetro	1.6	1.5	0.3	*	1.7	1.6	0.7	0.9	1.8	1.7
Urbanized	1.5	1.3	0.3	*	1.6	1.4	0.6	0.6	1.7	1.6
Less Urbanized	1.6	1.6	0.3	*	1.7	1.8	0.7	1.3	1.8	1.9
Completely Rural	2.0	1.3	*	*	2.3	1.5	*	*	*	1.6
POVERTY LEVEL¹
Less Than 100%	2.2	2.1	<0.1	<0.1	2.6	2.4	0.7	0.5	3.1	2.9
100-199%	1.6	1.4	0.2	0.2	1.7	1.6	0.3	0.2	2.0	1.8
200% or More	0.5	0.5	0.1	0.2	0.5	0.5	0.4	0.3	0.5	0.6
HEALTH INSURANCE²
Private	0.3	0.3	0.1	0.2	0.3	0.3	0.3	0.2	0.3	0.3
Medicaid/CHIP	2.5	2.1	0.1	<0.1	3.1	2.6	0.9	0.5	3.6	3.0
Other³	0.9	0.6	*	*	0.9	0.6	0.2	0.3	1.0	0.6
No Coverage	1.6	2.6	*	<0.1	1.7^a	2.7	0.5	0.4	2.0^a	3.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.81A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1,685	1,596	3	29	1,682	1,566	54	49	1,628	1,517
GEOGRAPHIC REGION
Northeast	96	148	*	<1	96	147	3	3	93	145
Midwest	312	288	1	4	311	284	16	7	295	277
South	580	623	1	23	579	600	18	25	561	575
West	697	536	1	2	697	534	18	14	679	521
COUNTY TYPE
Large Metro	780	874	1	27	779	848	10	22	769	825
Small Metro	531	422	1	3	530	419	34^b	6	497	413
Nonmetro	374	299	1	*	373	299	11	21	362	278
Urbanized	151	129	<1	*	151	129	6	4	145	125
Less Urbanized	178	163	1	*	177	163	5	16	173	146
Completely Rural	*	7	*	*	*	7	*	*	*	7
POVERTY LEVEL¹
Less Than 100%	551	589	*	*	551	589	27	27	524	562
100-199%	538	487	1	8	538	479	12	6	526	473
200% or More	596	519	2	21	594	498	16	15	578	483
HEALTH INSURANCE²
Private	277	291	3	25	274	266	20	12	255	254
Medicaid/CHIP	950	767	1	5	950	762	23	26	927	737
Other³	466	276	*	*	466	276	5	5	461	270
No Coverage	238	353	*	<1	238	353	11	9	226	344
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.81B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.6	0.6	<0.1	0.1	0.7	0.6	0.2	0.1	0.7	0.7
GEOGRAPHIC REGION
Northeast	0.2	0.3	*	<0.1	0.2	0.3	<0.1	0.1	0.2	0.4
Midwest	0.5	0.5	<0.1	0.1	0.6	0.5	0.2	0.1	0.6	0.6
South	0.5	0.6	<0.1	0.2	0.6	0.6	0.1	0.2	0.7	0.7
West	1.0	0.8	<0.1	<0.1	1.1	0.9	0.2	0.2	1.3	1.0
COUNTY TYPE
Large Metro	0.5	0.6	<0.1	0.2	0.6	0.6	0.1	0.1	0.6	0.7
Small Metro	0.6	0.5	<0.1	<0.1	0.7	0.5	0.3^b	0.1	0.7	0.6
Nonmetro	1.0	0.8	<0.1	*	1.1	0.9	0.3	0.5	1.2	0.9
Urbanized	1.0	0.8	<0.1	*	1.1	0.9	0.3	0.2	1.2	1.0
Less Urbanized	1.0	0.8	<0.1	*	1.0	0.9	0.2	0.8	1.1	0.9
Completely Rural	*	0.2	*	*	*	0.3	*	*	*	0.3
POVERTY LEVEL¹
Less Than 100%	1.3	1.3	*	*	1.5	1.5	0.3	0.3	1.9	1.8
100-199%	1.0	0.9	<0.1	0.2	1.1	1.0	0.1	0.1	1.3	1.2
200% or More	0.3	0.3	<0.1	0.1	0.3	0.3	0.1	0.1	0.4	0.3
HEALTH INSURANCE²
Private	0.2	0.2	<0.1	0.2	0.2	0.2	0.1	0.1	0.2	0.2
Medicaid/CHIP	1.6	1.3	<0.1	<0.1	2.0	1.5	0.2	0.3	2.4	1.8
Other³	0.6	0.4	*	*	0.6	0.4	0.2	0.2	0.6	0.4
No Coverage	1.0	1.5	*	<0.1	1.0	1.6	0.2	0.2	1.2	1.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.82A – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	73,833	74,347	3,191^b	3,800	70,642	70,547	6,489	6,515	64,153	64,032
GEOGRAPHIC REGION
Northeast	10,781	11,335	395^b	611	10,386	10,724	891^a	1,129	9,495	9,594
Midwest	15,978	15,383	684	754	15,294	14,628	1,452^a	1,233	13,842	13,395
South	30,013	30,843	1,366^b	1,713	28,647	29,130	2,690	2,697	25,957	26,433
West	17,062	16,786	746	722	16,315	16,064	1,457	1,455	14,858	14,610
COUNTY TYPE
Large Metro	38,843	38,522	1,624^b	2,076	37,219	36,446	3,475	3,433	33,744	33,014
Small Metro	23,863	24,814	1,139	1,241	22,723	23,573	2,220	2,229	20,503	21,344
Nonmetro	11,128	11,011	428	484	10,700	10,527	794	853	9,906	9,674
Urbanized	4,563	4,520	176	188	4,386	4,332	369	366	4,017	3,966
Less Urbanized	5,600	5,611	213	252	5,386	5,360	374	434	5,013	4,926
Completely Rural	965	879	38	*	928	836	*	*	877	783
POVERTY LEVEL¹
Less Than 100%	11,508	12,558	682	827	10,826	11,731	1,455	1,658	9,371	10,073
100-199%	15,866	14,951	782	831	15,084	14,120	1,680	1,529	13,405	12,591
200% or More	46,458	46,835	1,726^b	2,142	44,731	44,693	3,354	3,325	41,378	41,368
HEALTH INSURANCE²
Private	41,440	43,555	1,622^a	1,957	39,819	41,598	3,693	3,708	36,126	37,890
Medicaid/CHIP	18,027	18,298	1,484	1,701	16,542	16,597	1,949	2,011	14,593	14,586
Other³	25,880	25,456	209	242	25,671	25,214	496	547	25,175	24,667
No Coverage	5,030	4,469	134	173	4,896	4,297	747	717	4,149	3,580
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.82B – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	26.2	26.2	12.4^b	14.7	27.6	27.4	18.7	19.1	29.0	28.6
GEOGRAPHIC REGION
Northeast	22.0	23.1	9.7^b	15.0	23.1	23.9	15.1^b	19.7	24.3	24.5
Midwest	27.5	26.4	12.7	13.9	29.0	27.7	19.9^a	17.3	30.5	29.3
South	27.8	28.2	13.5^b	16.7	29.2	29.4	20.2	20.6	30.7	30.8
West	25.6	25.1	12.2	11.7	26.9	26.4	17.7	18.1	28.4	27.7
COUNTY TYPE
Large Metro	24.9	24.6	11.0^b	14.6	26.4	25.6	18.2	18.7	27.7	26.6
Small Metro	26.7	27.9	14.3	15.0	27.9	29.2	19.0	19.5	29.4	30.8
Nonmetro	30.3	29.3	14.6	14.3	31.6	30.8	19.9	20.0	33.2	32.3
Urbanized	29.5	29.8	14.2	15.4	30.8	31.1	21.0	19.4	32.2	32.9
Less Urbanized	30.4	29.0	15.1	13.5	31.7	30.7	19.0	20.8	33.3	32.0
Completely Rural	33.8	28.3	13.6	*	36.0	29.8	*	*	37.7	31.2
POVERTY LEVEL¹
Less Than 100%	27.7	27.8	12.9	14.5	29.9	29.7	18.1	19.7	33.3	32.4
100-199%	28.5	27.5	13.5	15.5	30.3	28.8	19.8	19.4	32.4	30.6
200% or More	25.1	25.5	11.8^b	14.4	26.3	26.4	18.4	18.8	27.2	27.3
HEALTH INSURANCE²
Private	24.4	25.5	11.5^b	14.0	25.5	26.5	18.6	19.4	26.6	27.5
Medicaid/CHIP	30.7	30.1	13.9	15.5	34.4	33.3	21.0	21.1	37.6	36.2
Other³	33.1	32.4	13.9	17.4	33.5	32.7	17.7	19.4	34.1	33.2
No Coverage	20.7	18.8	13.3	13.8	21.1	19.1	16.1	16.0	22.3	19.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.83A – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	8,457	8,578	406^a	570	8,051	8,008	1,099^b	841	6,953	7,167
GEOGRAPHIC REGION
Northeast	1,265	1,223	49	77	1,216	1,146	144	117	1,072	1,030
Midwest	1,628	1,656	65	110	1,563	1,546	239^a	146	1,324	1,400
South	3,428	3,708	189	271	3,239	3,437	448	390	2,791	3,047
West	2,137	1,991	103	111	2,034	1,879	269	188	1,765	1,691
COUNTY TYPE
Large Metro	4,625	4,638	203^a	309	4,422	4,329	587	451	3,835	3,878
Small Metro	2,764	2,672	165	186	2,600	2,486	399^a	287	2,200	2,199
Nonmetro	1,067	1,268	38	75	1,030	1,193	112	103	917	1,091
Urbanized	441	490	12	29	429	461	47	49	382	413
Less Urbanized	544	684	21	44	524	640	57	52	467	589
Completely Rural	82	94	*	2	77	92	8	2	69	90
POVERTY LEVEL¹
Less Than 100%	1,946	1,745	92	136	1,853	1,609	245	243	1,608	1,366
100-199%	1,901	1,735	110	124	1,791	1,611	269	225	1,522	1,386
200% or More	4,610	5,098	203^a	310	4,407	4,788	584^b	373	3,823	4,415
HEALTH INSURANCE²
Private	3,992	4,274	211	268	3,781	4,006	570^a	405	3,211	3,601
Medicaid/CHIP	3,122	2,619	187^a	290	2,935^a	2,330	347	301	2,587^a	2,029
Other³	2,059	2,101	23	41	2,036	2,060	78	74	1,958	1,986
No Coverage	859	823	8	9	851	814	162	139	689	675
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.83B – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	3.0	3.0	1.6^a	2.2	3.1	3.1	3.2^a	2.5	3.1	3.2
GEOGRAPHIC REGION
Northeast	2.6	2.5	1.2	1.9	2.7	2.6	2.4	2.0	2.7	2.6
Midwest	2.8	2.8	1.2	2.0	3.0	2.9	3.3^a	2.0	2.9	3.1
South	3.2	3.4	1.9	2.6	3.3	3.5	3.4	3.0	3.3	3.5
West	3.2	3.0	1.7	1.8	3.4	3.1	3.3	2.3	3.4	3.2
COUNTY TYPE
Large Metro	3.0	3.0	1.4^a	2.2	3.1	3.0	3.1	2.5	3.1	3.1
Small Metro	3.1	3.0	2.1	2.2	3.2	3.1	3.4	2.5	3.2	3.2
Nonmetro	2.9	3.4	1.3	2.2	3.0	3.5	2.8	2.4	3.1	3.6
Urbanized	2.8	3.2	0.9	2.4	3.0	3.3	2.7	2.6	3.1	3.4
Less Urbanized	3.0	3.5	1.5	2.3	3.1	3.7	2.9	2.5	3.1	3.8
Completely Rural	2.9	3.0	*	0.7	3.0	3.3	3.3	0.7	3.0	3.6
POVERTY LEVEL¹
Less Than 100%	4.7	3.9	1.8	2.4	5.1^a	4.1	3.0	2.9	5.7^a	4.4
100-199%	3.4	3.2	1.9	2.3	3.6	3.3	3.2	2.9	3.7	3.4
200% or More	2.5	2.8	1.4^a	2.1	2.6	2.8	3.2^b	2.1	2.5	2.9
HEALTH INSURANCE²
Private	2.3	2.5	1.5	1.9	2.4	2.6	2.9	2.1	2.4	2.6
Medicaid/CHIP	5.3^a	4.3	1.8^a	2.6	6.1^b	4.7	3.7	3.2	6.7^b	5.0
Other³	2.6	2.7	1.5	2.9	2.7	2.7	2.8	2.6	2.6	2.7
No Coverage	3.5	3.5	0.8	0.7	3.7	3.6	3.5	3.1	3.7	3.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.84A – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	2,439	2,173	116	143	2,323	2,030	214	170	2,109	1,860
GEOGRAPHIC REGION
Northeast	419	266	10	19	409	247	22	8	387	239
Midwest	463	370	14	31	449	339	45	26	404	313
South	1,007	963	60	59	947	904	113	90	835	814
West	550	574	31	34	518	540	35	45	483	494
COUNTY TYPE
Large Metro	1,293	1,170	68	70	1,225	1,101	93	92	1,132	1,009
Small Metro	795	676	39	61	757	615	86	60	670	555
Nonmetro	351	327	10	13	342	314	35	18	306	296
Urbanized	138	120	1^a	11	137	110	11	3	126	107
Less Urbanized	191	200	9	1	182	199	22	15	160	184
Completely Rural	23	7	*	1	*	6	*	*	*	6
POVERTY LEVEL¹
Less Than 100%	610	501	41	53	569	448	52	56	518	392
100-199%	559	492	17	24	543	468	72	42	471	426
200% or More	1,269	1,180	58	66	1,211	1,114	91	72	1,120	1,042
HEALTH INSURANCE²
Private	1,008	1,002	61	55	947	946	99	80	848	867
Medicaid/CHIP	1,074	880	50	97	1,024	782	54	63	970	720
Other³	574	421	5	7	569	414	20	14	549	400
No Coverage	245	197	6	3	239	194	46	27	193	166
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.84B – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.9	0.8	0.5	0.6	0.9	0.8	0.6	0.5	1.0	0.8
GEOGRAPHIC REGION
Northeast	0.9	0.5	0.3	0.5	0.9	0.6	0.4	0.1	1.0	0.6
Midwest	0.8	0.6	0.3	0.6	0.9	0.6	0.6	0.4	0.9	0.7
South	0.9	0.9	0.6	0.6	1.0	0.9	0.8	0.7	1.0	0.9
West	0.8	0.9	0.5	0.6	0.9	0.9	0.4	0.6	0.9	0.9
COUNTY TYPE
Large Metro	0.8	0.7	0.5	0.5	0.9	0.8	0.5	0.5	0.9	0.8
Small Metro	0.9	0.8	0.5	0.7	0.9	0.8	0.7	0.5	1.0	0.8
Nonmetro	1.0	0.9	0.3	0.4	1.0	0.9	0.9	0.4	1.0	1.0
Urbanized	0.9	0.8	0.1^a	0.9	1.0	0.8	0.6	0.1	1.0	0.9
Less Urbanized	1.0	1.0	0.6	<0.1	1.1	1.1	1.1	0.7	1.1	1.2
Completely Rural	0.8	0.2	*	0.4	*	0.2	*	*	*	0.2
POVERTY LEVEL¹
Less Than 100%	1.5	1.1	0.8	0.9	1.6	1.1	0.6	0.7	1.8	1.3
100-199%	1.0	0.9	0.3	0.4	1.1	1.0	0.8	0.5	1.1	1.0
200% or More	0.7	0.6	0.4	0.4	0.7	0.7	0.5	0.4	0.7	0.7
HEALTH INSURANCE²
Private	0.6	0.6	0.4	0.4	0.6	0.6	0.5	0.4	0.6	0.6
Medicaid/CHIP	1.8	1.4	0.5	0.9	2.1	1.6	0.6	0.7	2.5	1.8
Other³	0.7	0.5	0.3	0.5	0.7	0.5	0.7	0.5	0.7	0.5
No Coverage	1.0	0.8	0.6	0.2	1.0	0.9	1.0	0.6	1.0	0.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.85A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	19,674	19,816	1,845	1,807	17,830	18,009	3,794	3,660	14,035	14,349
GEOGRAPHIC REGION
Northeast	3,046	3,299	215	281	2,832	3,019	637	655	2,194	2,363
Midwest	4,681	4,207	429	403	4,252	3,805	1,039	883	3,214	2,922
South	7,730	8,072	826	757	6,905	7,315	1,338	1,273	5,567	6,042
West	4,217	4,237	376	366	3,841	3,871	780	849	3,061	3,022
COUNTY TYPE
Large Metro	10,622	10,765	1,038	968	9,584	9,797	1,995	1,844	7,589	7,954
Small Metro	6,700	6,492	596	650	6,105	5,842	1,371	1,425	4,733	4,417
Nonmetro	2,352	2,559	211	189	2,141	2,369	428	391	1,713	1,979
Urbanized	1,055	1,060	97	76	957	984	225	236	732	748
Less Urbanized	1,137	1,338	95	95	1,043	1,243	176	134	866	1,109
Completely Rural	160	161	19	18	141	142	27	21	114	122
POVERTY LEVEL¹
Less Than 100%	2,649	2,782	233	230	2,416	2,552	742	812	1,675	1,740
100-199%	3,569	3,555	423	310	3,146	3,246	777	822	2,369	2,424
200% or More	13,453	13,474	1,189	1,267	12,264	12,207	2,273	2,022	9,992	10,185
HEALTH INSURANCE²
Private	12,457	12,851	1,139	1,154	11,318	11,697	2,611	2,466	8,707	9,231
Medicaid/CHIP	4,738	4,724	666	588	4,072	4,136	879	838	3,194	3,299
Other³	3,394	3,123	144	130	3,250	2,993	278	314	2,971	2,680
No Coverage	1,451	1,367	29	49	1,422	1,319	222	271	1,199	1,048
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.85B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	7.0	7.0	7.2	7.0	7.0	7.0	10.9	10.8	6.3	6.4
GEOGRAPHIC REGION
Northeast	6.2	6.7	5.3	6.9	6.3	6.7	10.8	11.4	5.6	6.0
Midwest	8.0	7.2	7.9	7.4	8.1	7.2	14.2	12.4	7.1	6.4
South	7.2	7.4	8.2	7.4	7.0	7.4	10.0	9.7	6.6	7.0
West	6.3	6.3	6.1	6.0	6.3	6.4	9.5	10.6	5.8	5.7
COUNTY TYPE
Large Metro	6.8	6.9	7.0	6.8	6.8	6.9	10.4	10.1	6.2	6.4
Small Metro	7.5	7.3	7.5	7.9	7.5	7.2	11.7	12.5	6.8	6.4
Nonmetro	6.4	6.8	7.2	5.6	6.3	6.9	10.8	9.2	5.7	6.6
Urbanized	6.8	7.0	7.9	6.2	6.7	7.1	12.8	12.5	5.9	6.2
Less Urbanized	6.2	6.9	6.7	5.1	6.1	7.1	8.9	6.4	5.8	7.2
Completely Rural	5.6	5.2	6.7	6.0	5.5	5.1	10.9	7.0	4.9	4.9
POVERTY LEVEL¹
Less Than 100%	6.4	6.2	4.4	4.0	6.7	6.5	9.2	9.7	5.9	5.6
100-199%	6.4	6.5	7.3	5.8	6.3	6.6	9.2	10.4	5.7	5.9
200% or More	7.3	7.3	8.1	8.5	7.2	7.2	12.5	11.4	6.6	6.7
HEALTH INSURANCE²
Private	7.3	7.5	8.1	8.2	7.3	7.4	13.1	12.9	6.4	6.7
Medicaid/CHIP	8.1	7.8	6.2	5.4	8.5	8.3	9.5	8.8	8.2	8.2
Other³	4.3	4.0	9.6	9.3	4.2	3.9	9.9	11.1	4.0	3.6
No Coverage	6.0	5.7	2.9	3.9	6.1	5.9	4.8	6.0	6.4	5.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.86A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	4,298	3,922	226	230	4,072	3,692	1,278	1,066	2,794	2,626
GEOGRAPHIC REGION
Northeast	718	708	42	29	676	679	224	170	452	509
Midwest	997	903	31	46	967	858	352	251	614	607
South	1,552	1,468	84	104	1,469	1,365	427	385	1,042	980
West	1,031	843	70	53	961	791	274	261	687	530
COUNTY TYPE
Large Metro	2,563	2,267	114	139	2,449	2,128	727	589	1,722	1,539
Small Metro	1,332	1,298	97	77	1,234	1,222	456	396	778	825
Nonmetro	403	358	14	15	389	343	95	81	294	262
Urbanized	158	136	1	7	157	129	50	42	107	87
Less Urbanized	211	197	7	5	205	192	38	28	166	164
Completely Rural	33	24	*	*	27	22	*	11	*	11
POVERTY LEVEL¹
Less Than 100%	563	573	17	23	546	550	252	258	294	292
100-199%	760	660	63	44	697	616	249	268	448	349
200% or More	2,972	2,688	146	164	2,826	2,524	773^b	539	2,053	1,985
HEALTH INSURANCE²
Private	2,733	2,464	144	151	2,589	2,313	920	736	1,669	1,577
Medicaid/CHIP	1,002	932	70	66	933	866	225	207	707	659
Other³	450	425	25	26	425	399	113	98	312	301
No Coverage	366	363	4	3	362	360	73	98	290	262
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.86B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.5	1.4	0.9	0.9	1.6	1.4	3.7	3.1	1.3	1.2
GEOGRAPHIC REGION
Northeast	1.5	1.4	1.0	0.7	1.5	1.5	3.8	3.0	1.2	1.3
Midwest	1.7	1.6	0.6	0.8	1.8	1.6	4.8	3.5	1.4	1.3
South	1.4	1.3	0.8	1.0	1.5	1.4	3.2	2.9	1.2	1.1
West	1.5	1.3	1.1	0.9	1.6	1.3	3.3	3.2	1.3	1.0
COUNTY TYPE
Large Metro	1.6	1.4	0.8	1.0	1.7	1.5	3.8	3.2	1.4	1.2
Small Metro	1.5	1.5	1.2	0.9	1.5	1.5	3.9	3.5	1.1	1.2
Nonmetro	1.1	1.0	0.5	0.4	1.2	1.0	2.4	1.9	1.0	0.9
Urbanized	1.0	0.9	0.1	0.6	1.1	0.9	2.8	2.3	0.9	0.7
Less Urbanized	1.1	1.0	0.5	0.3	1.2	1.1	1.9	1.3	1.1	1.1
Completely Rural	1.2	0.8	*	*	1.1	0.8	*	3.6	*	0.4
POVERTY LEVEL¹
Less Than 100%	1.4	1.3	0.3	0.4	1.5	1.4	3.1	3.1	1.0	0.9
100-199%	1.4	1.2	1.1	0.8	1.4	1.3	2.9	3.4	1.1	0.8
200% or More	1.6	1.5	1.0	1.1	1.7	1.5	4.2^a	3.0	1.4	1.3
HEALTH INSURANCE²
Private	1.6	1.4	1.0	1.1	1.7	1.5	4.6	3.9	1.2	1.1
Medicaid/CHIP	1.7	1.5	0.7	0.6	1.9	1.7	2.4	2.2	1.8	1.6
Other³	0.6	0.5	1.7	1.8	0.6	0.5	4.0	3.5	0.4	0.4
No Coverage	1.5	1.5	0.4	0.2	1.6	1.6	1.6	2.2	1.6	1.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.87A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1,348	1,163	33	32	1,315	1,131	376	308	939	823
GEOGRAPHIC REGION
Northeast	286	239	7	4	279	235	92	55	186	180
Midwest	315	300	6	11	309	289	103	86	205	203
South	502	413	12	9	490	404	130	115	360	289
West	245	211	8	8	237	203	50	52	187	150
COUNTY TYPE
Large Metro	835	624	14	11	821	613	207	173	614	440
Small Metro	403	431	18	21	385	410	142	118	243	292
Nonmetro	110	108	1	<1	109	108	27	17	82	91
Urbanized	48	41	*	<1	48	41	14	14	34	26
Less Urbanized	61	67	1	<1	60	67	12	3	48	64
Completely Rural	<1	*	*	*	<1	*	*	*	<1	*
POVERTY LEVEL¹
Less Than 100%	155	207	1	1	154	206	77	101	78	104
100-199%	265	167	8	11	257	156	92	63	165	93
200% or More	927	788	24	19	903	769	207	144	696	625
HEALTH INSURANCE²
Private	871	704	21	15	849	689	270	204	580	485
Medicaid/CHIP	313	346	14	14	299	332	74	59	225	273
Other³	138	118	<1	1	137	117	29	38	108	79
No Coverage	116	93	*	3	116	91	11	28	105	63
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.87B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.5	0.4	0.1	0.1	0.5	0.4	1.1	0.9	0.4	0.4
GEOGRAPHIC REGION
Northeast	0.6	0.5	0.2	0.1	0.6	0.5	1.6	1.0	0.5	0.5
Midwest	0.5	0.5	0.1	0.2	0.6	0.5	1.4	1.2	0.5	0.4
South	0.5	0.4	0.1	0.1	0.5	0.4	1.0	0.9	0.4	0.3
West	0.4	0.3	0.1	0.1	0.4	0.3	0.6	0.7	0.4	0.3
COUNTY TYPE
Large Metro	0.5	0.4	0.1	0.1	0.6	0.4	1.1	0.9	0.5	0.4
Small Metro	0.5	0.5	0.2	0.2	0.5	0.5	1.2	1.0	0.3	0.4
Nonmetro	0.3	0.3	<0.1	<0.1	0.3	0.3	0.7	0.4	0.3	0.3
Urbanized	0.3	0.3	*	<0.1	0.3	0.3	0.8	0.8	0.3	0.2
Less Urbanized	0.3	0.3	0.1	<0.1	0.4	0.4	0.6	0.1	0.3	0.4
Completely Rural	<0.1	*	*	*	<0.1	*	*	*	<0.1	*
POVERTY LEVEL¹
Less Than 100%	0.4	0.5	<0.1	<0.1	0.4	0.5	1.0	1.2	0.3	0.3
100-199%	0.5	0.3	0.1	0.2	0.5	0.3	1.1	0.8	0.4	0.2
200% or More	0.5	0.4	0.2	0.1	0.5	0.5	1.1	0.8	0.5	0.4
HEALTH INSURANCE²
Private	0.5	0.4	0.2	0.1	0.5	0.4	1.4	1.1	0.4	0.4
Medicaid/CHIP	0.5	0.6	0.1	0.1	0.6	0.7	0.8	0.6	0.6	0.7
Other³	0.2	0.1	<0.1	0.1	0.2	0.2	1.0	1.3	0.1	0.1
No Coverage	0.5	0.4	*	0.2	0.5	0.4	0.2	0.6	0.6	0.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.88A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	41,314	39,679	1,085	1,181	40,229	38,498	3,227^b	2,726	37,002	35,772
GEOGRAPHIC REGION
Northeast	6,740	6,884	101^b	188	6,639	6,697	547	449	6,092	6,247
Midwest	9,125^a	8,129	235	235	8,890^a	7,894	787^b	569	8,103	7,325
South	16,631	16,591	452	526	16,179	16,065	1,295^a	1,051	14,883	15,014
West	8,818	8,075	296	233	8,522	7,842	598	657	7,923	7,185
COUNTY TYPE
Large Metro	21,376	20,250	584	597	20,792	19,653	1,665	1,363	19,126	18,290
Small Metro	13,876	13,855	361	399	13,515	13,456	1,143	1,026	12,372	12,430
Nonmetro	6,063	5,574	140	185	5,923	5,390	419	338	5,504	5,051
Urbanized	2,530	2,121	53	59	2,477	2,062	185	136	2,292	1,925
Less Urbanized	3,078	2,995	74	76	3,005	2,919	214	183	2,791	2,735
Completely Rural	455	459	*	*	441	409	20	19	421	390
POVERTY LEVEL¹
Less Than 100%	5,514	5,829	213	210	5,302	5,620	725	606	4,577	5,014
100-199%	7,920	7,593	235	220	7,685	7,374	777	639	6,907	6,735
200% or More	27,879	26,254	637	752	27,242	25,502	1,724	1,480	25,518	24,023
HEALTH INSURANCE²
Private	25,467	23,996	588	684	24,879	23,312	2,029^a	1,652	22,850	21,660
Medicaid/CHIP	9,180	8,947	458	464	8,722	8,483	859	734	7,862	7,749
Other³	15,664^a	13,986	77	79	15,587^a	13,907	290	235	15,298^a	13,672
No Coverage	1,989	1,960	29	40	1,959	1,920	278	270	1,682	1,650
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.88B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	14.7	14.0	4.2	4.6	15.7	14.9	9.3^a	8.0	16.7	16.0
GEOGRAPHIC REGION
Northeast	13.7	14.1	2.5^b	4.6	14.8	14.9	9.2	7.8	15.6	16.0
Midwest	15.7^a	14.0	4.3	4.3	16.9^a	14.9	10.8^b	8.0	17.8	16.0
South	15.4	15.2	4.5	5.1	16.5	16.2	9.7^a	8.0	17.6	17.5
West	13.2	12.1	4.8	3.8	14.1	12.9	7.3	8.2	15.1	13.6
COUNTY TYPE
Large Metro	13.7	12.9	3.9	4.2	14.7	13.8	8.7	7.4	15.7	14.7
Small Metro	15.5	15.6	4.5	4.8	16.6	16.7	9.8	9.0	17.8	17.9
Nonmetro	16.5	14.8	4.8	5.5	17.5	15.7	10.5^a	7.9	18.5	16.9
Urbanized	16.4	14.0	4.3	4.8	17.4	14.8	10.5^a	7.2	18.4	16.0
Less Urbanized	16.7	15.5	5.2	4.1	17.7	16.7	10.9	8.8	18.6	17.8
Completely Rural	15.9	14.8	*	*	17.1	14.6	8.0	6.3	18.1	15.6
POVERTY LEVEL¹
Less Than 100%	13.3	12.9	4.0	3.7	14.6	14.2	9.0	7.2	16.3	16.2
100-199%	14.2	14.0	4.1	4.1	15.4	15.1	9.2	8.1	16.7	16.4
200% or More	15.1	14.3	4.3	5.1	16.0	15.1	9.5	8.3	16.8	15.9
HEALTH INSURANCE²
Private	15.0^a	14.0	4.2	4.9	16.0^a	14.8	10.2^a	8.7	16.8	15.7
Medicaid/CHIP	15.6	14.7	4.3	4.2	18.1	17.0	9.3	7.7	20.3	19.2
Other³	20.0^a	17.8	5.1	5.7	20.3^a	18.0	10.3	8.3	20.7^a	18.4
No Coverage	8.2	8.2	2.9	3.2	8.4	8.5	6.0	6.0	9.0	9.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.89A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	4,848	4,722	137	173	4,711	4,549	842^b	576	3,869	3,973
GEOGRAPHIC REGION
Northeast	785	845	9	15	776	831	121	81	655	750
Midwest	941	782	26	31	915	751	207^b	110	708	641
South	2,031	2,164	62	72	1,968	2,092	333	246	1,635	1,846
West	1,091	931	39	56	1,052	875	180	139	871	736
COUNTY TYPE
Large Metro	2,546	2,693	71	99	2,474	2,595	433	308	2,041	2,287
Small Metro	1,582	1,519	50	63	1,532	1,456	310^a	203	1,222	1,253
Nonmetro	720	510	15	12	705	498	100	65	605	433
Urbanized	336	229	8	6	328	224	42	22	287	202
Less Urbanized	329	269	8	6	322	262	54	41	268	221
Completely Rural	55	12	*	*	55	12	*	2	51	10
POVERTY LEVEL¹
Less Than 100%	890	761	28	25	862	736	203^a	130	659	607
100-199%	1,065	971	42	40	1,022	931	193	133	830	798
200% or More	2,893	2,989	66	108	2,826	2,881	446^a	313	2,380	2,568
HEALTH INSURANCE²
Private	2,601	2,580	71	112	2,529	2,467	505^b	327	2,025	2,140
Medicaid/CHIP	1,575^a	1,162	66	49	1,509^a	1,113	226	158	1,283	955
Other³	1,182	1,026	5	20	1,177	1,006	76	39	1,102	967
No Coverage	404	546	*	2	404	544	72	82	331	462
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.89B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.7	1.7	0.5	0.7	1.8	1.8	2.4^b	1.7	1.7	1.8
GEOGRAPHIC REGION
Northeast	1.6	1.7	0.2	0.4	1.7	1.8	2.0	1.4	1.7	1.9
Midwest	1.6	1.3	0.5	0.6	1.7	1.4	2.8^a	1.5	1.6	1.4
South	1.9	2.0	0.6	0.7	2.0	2.1	2.5	1.9	1.9	2.2
West	1.6	1.4	0.6	0.9	1.7	1.4	2.2	1.7	1.7	1.4
COUNTY TYPE
Large Metro	1.6	1.7	0.5	0.7	1.8	1.8	2.3	1.7	1.7	1.8
Small Metro	1.8	1.7	0.6	0.8	1.9	1.8	2.6^a	1.8	1.8	1.8
Nonmetro	2.0	1.4	0.5	0.3	2.1	1.5	2.5	1.5	2.0	1.4
Urbanized	2.2	1.5	0.6	0.5	2.3	1.6	2.4	1.1	2.3	1.7
Less Urbanized	1.8	1.4	0.5	0.3	1.9	1.5	2.7	2.0	1.8	1.4
Completely Rural	1.9	0.4	*	*	2.1	0.4	*	0.7	2.2	0.4
POVERTY LEVEL¹
Less Than 100%	2.1	1.7	0.5	0.4	2.4	1.9	2.5^a	1.5	2.3	2.0
100-199%	1.9	1.8	0.7	0.7	2.1	1.9	2.3	1.7	2.0	1.9
200% or More	1.6	1.6	0.5	0.7	1.7	1.7	2.4^a	1.8	1.6	1.7
HEALTH INSURANCE²
Private	1.5	1.5	0.5	0.8	1.6	1.6	2.5^a	1.7	1.5	1.6
Medicaid/CHIP	2.7^a	1.9	0.6	0.4	3.1^a	2.2	2.4	1.7	3.3^a	2.4
Other³	1.5	1.3	0.3	1.5	1.5	1.3	2.7	1.4	1.5	1.3
No Coverage	1.7	2.3	*	0.2	1.7	2.4	1.6	1.8	1.8	2.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.90A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1,529	1,236	37	44	1,492	1,192	181	159	1,312	1,033
GEOGRAPHIC REGION
Northeast	203	202	2	2	201	200	35	17	166	183
Midwest	281	237	8	2	273	235	47	24	225	211
South	697	569	18	23	679	546	75	65	604	481
West	348	228	8	17	339	211	23	53	316^a	158
COUNTY TYPE
Large Metro	794	650	19	21	775	629	64	77	711	552
Small Metro	450	411	11	21	439	390	90	71	348	319
Nonmetro	285	175	7	2	279	173	26	11	252	162
Urbanized	173	86	4	*	168	86	6	4	162	82
Less Urbanized	85	89	2	2	83	87	20	7	63	80
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	268	203	11	4	257	199	47	48	211	151
100-199%	399	250	9	12	390	238	40	34	350	205
200% or More	862	783	17	28	846	755	94	77	751	678
HEALTH INSURANCE²
Private	716	598	15	32	702	566	119	68	583	498
Medicaid/CHIP	505	380	27	12	478	368	40	59	438	310
Other³	415	284	<1	*	414	284	13	17	401	267
No Coverage	163	142	*	*	163	142	15	21	148	121
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.90B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.5	0.4	0.1	0.2	0.6	0.5	0.5	0.5	0.6	0.5
GEOGRAPHIC REGION
Northeast	0.4	0.4	0.1	0.1	0.4	0.4	0.6	0.3	0.4	0.5
Midwest	0.5	0.4	0.2	<0.1	0.5	0.4	0.7	0.3	0.5	0.5
South	0.6	0.5	0.2	0.2	0.7	0.6	0.6	0.5	0.7	0.6
West	0.5	0.3	0.1	0.3	0.6	0.3	0.3	0.7	0.6^a	0.3
COUNTY TYPE
Large Metro	0.5	0.4	0.1	0.1	0.5	0.4	0.3	0.4	0.6	0.4
Small Metro	0.5	0.5	0.1	0.3	0.5	0.5	0.8	0.6	0.5	0.5
Nonmetro	0.8	0.5	0.2	0.1	0.8	0.5	0.7	0.3	0.8	0.5
Urbanized	1.1	0.6	0.4	*	1.2	0.6	0.3	0.2	1.3	0.7
Less Urbanized	0.5	0.5	0.2	0.1	0.5	0.5	1.0	0.3	0.4	0.5
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.6	0.4	0.2	0.1	0.7	0.5	0.6	0.6	0.7	0.5
100-199%	0.7	0.5	0.2	0.2	0.8	0.5	0.5	0.4	0.8	0.5
200% or More	0.5	0.4	0.1	0.2	0.5	0.4	0.5	0.4	0.5	0.4
HEALTH INSURANCE²
Private	0.4	0.3	0.1	0.2	0.5	0.4	0.6	0.4	0.4	0.4
Medicaid/CHIP	0.9	0.6	0.3	0.1	1.0	0.7	0.4	0.6	1.1	0.8
Other³	0.5	0.4	<0.1	*	0.5	0.4	0.5	0.6	0.5	0.4
No Coverage	0.7	0.6	*	*	0.7	0.6	0.3	0.5	0.8	0.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.91A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	32,783	31,384	717	731	32,066	30,653	2,592^a	2,228	29,474	28,425
GEOGRAPHIC REGION
Northeast	5,455	5,504	59^a	109	5,396	5,395	424	339	4,972	5,056
Midwest	7,341^a	6,544	149	157	7,193^a	6,387	672^b	479	6,521	5,908
South	13,313	13,240	308	313	13,005	12,927	1,044	866	11,960	12,061
West	6,674	6,095	201	152	6,473	5,943	452	544	6,020	5,400
COUNTY TYPE
Large Metro	16,335	15,985	388	384	15,947	15,601	1,265	1,100	14,682	14,501
Small Metro	11,433	10,970	235	252	11,197	10,718	991	833	10,206	9,885
Nonmetro	5,015	4,429	94	95	4,921	4,334	336	295	4,585	4,039
Urbanized	2,023	1,660	40	35	1,983	1,626	148	114	1,836	1,512
Less Urbanized	2,616	2,409	52	37	2,564	2,372	172	164	2,392	2,208
Completely Rural	375	359	*	23	373	336	16	17	357	319
POVERTY LEVEL¹
Less Than 100%	4,474	4,886	149	128	4,325	4,758	581	510	3,744	4,248
100-199%	6,413	6,088	148	118	6,265	5,970	653	533	5,612	5,437
200% or More	21,895	20,408	420	486	21,475	19,923	1,357	1,183	20,118	18,740
HEALTH INSURANCE²
Private	20,049	18,746	393	436	19,656	18,310	1,597	1,333	18,058	16,977
Medicaid/CHIP	7,749	7,380	290	263	7,459	7,117	717	581	6,742	6,536
Other³	12,054	10,901	54	54	12,000	10,846	219	192	11,781	10,654
No Coverage	1,592	1,714	22	28	1,569	1,686	238	248	1,332	1,439
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.91B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	11.6	11.1	2.8	2.8	12.5	11.9	7.5^a	6.5	13.3	12.7
GEOGRAPHIC REGION
Northeast	11.1	11.2	1.5^a	2.7	12.0	12.0	7.2	5.9	12.7	12.9
Midwest	12.6^a	11.2	2.8	2.9	13.6^a	12.1	9.2^a	6.7	14.3	12.9
South	12.3	12.1	3.0	3.0	13.3	13.1	7.8	6.6	14.1	14.0
West	10.0	9.1	3.3	2.5	10.7	9.8	5.5	6.8	11.5	10.2
COUNTY TYPE
Large Metro	10.5	10.2	2.6	2.7	11.3	10.9	6.6	6.0	12.0	11.7
Small Metro	12.8	12.3	3.0	3.1	13.8	13.3	8.5	7.3	14.7	14.3
Nonmetro	13.6^a	11.8	3.2	2.8	14.6^a	12.7	8.4	6.9	15.4	13.5
Urbanized	13.1	10.9	3.2	2.8	13.9	11.7	8.4	6.0	14.7	12.5
Less Urbanized	14.2	12.5	3.7	2.0	15.1	13.6	8.7	7.9	15.9	14.3
Completely Rural	13.2	11.6	*	7.6	14.5	12.0	6.5	6.0	15.4	12.7
POVERTY LEVEL¹
Less Than 100%	10.8	10.8	2.8	2.2	11.9	12.1	7.2	6.1	13.3	13.7
100-199%	11.5	11.2	2.6	2.2	12.6	12.2	7.7	6.8	13.6	13.2
200% or More	11.8	11.1	2.9	3.3	12.6	11.8	7.4	6.7	13.2	12.4
HEALTH INSURANCE²
Private	11.8^a	11.0	2.8	3.1	12.6^a	11.7	8.0	7.0	13.3	12.3
Medicaid/CHIP	13.2	12.1	2.7	2.4	15.5	14.3	7.7^a	6.1	17.4	16.2
Other³	15.4	13.9	3.5	3.9	15.6^a	14.1	7.8	6.8	15.9	14.3
No Coverage	6.6	7.2	2.2	2.2	6.8	7.5	5.1	5.5	7.2	8.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.92A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	4,153	3,993	115	119	4,038	3,874	779^b	522	3,259	3,351
GEOGRAPHIC REGION
Northeast	738	727	5	8	733	719	111	73	622	646
Midwest	777	678	24	26	753	652	191^a	101	562	551
South	1,682	1,790	49	47	1,633	1,742	307	220	1,326	1,522
West	957	797	38	38	919	760	169	128	750	631
COUNTY TYPE
Large Metro	2,158	2,275	55	64	2,103	2,212	400	285	1,703	1,927
Small Metro	1,400	1,264	46	48	1,353	1,217	290^b	172	1,063	1,044
Nonmetro	595	453	13	8	582	445	90	65	492	380
Urbanized	307	207	8	5	299	202	41	22	258	180
Less Urbanized	258	235	6	3	252	232	45	41	208	191
Completely Rural	30	12	*	*	30	12	*	2	26	10
POVERTY LEVEL¹
Less Than 100%	798	685	25	17	773	668	188^a	112	585	556
100-199%	936	851	39	33	897	818	185	116	712	702
200% or More	2,419	2,456	51	70	2,367	2,387	406	294	1,961	2,093
HEALTH INSURANCE²
Private	2,178	2,165	57	78	2,122	2,088	469^a	310	1,653	1,777
Medicaid/CHIP	1,429^a	1,035	58	37	1,371^a	999	208	142	1,163	856
Other³	918	732	5	11	913	721	61	35	852	686
No Coverage	376	471	*	2	376	469	69	61	307	408
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.92B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.5	1.4	0.4	0.5	1.6	1.5	2.2^b	1.5	1.5	1.5
GEOGRAPHIC REGION
Northeast	1.5	1.5	0.1	0.2	1.6	1.6	1.9	1.3	1.6	1.7
Midwest	1.3	1.2	0.4	0.5	1.4	1.2	2.6^a	1.4	1.2	1.2
South	1.6	1.6	0.5	0.5	1.7	1.8	2.3	1.7	1.6	1.8
West	1.4	1.2	0.6	0.6	1.5	1.2	2.1	1.6	1.4	1.2
COUNTY TYPE
Large Metro	1.4	1.5	0.4	0.4	1.5	1.6	2.1	1.6	1.4	1.6
Small Metro	1.6	1.4	0.6	0.6	1.7	1.5	2.5^b	1.5	1.5	1.5
Nonmetro	1.6	1.2	0.5	0.2	1.7	1.3	2.3	1.5	1.6	1.3
Urbanized	2.0	1.4	0.6	0.4	2.1	1.4	2.3	1.1	2.1	1.5
Less Urbanized	1.4	1.2	0.4	0.2	1.5	1.3	2.3	2.0	1.4	1.2
Completely Rural	1.1	0.4	*	*	1.2	0.4	*	0.7	1.1	0.4
POVERTY LEVEL¹
Less Than 100%	1.9	1.5	0.5	0.3	2.1	1.7	2.3^a	1.3	2.1	1.8
100-199%	1.7	1.6	0.7	0.6	1.8	1.7	2.2	1.5	1.7	1.7
200% or More	1.3	1.3	0.3	0.5	1.4	1.4	2.2	1.7	1.3	1.4
HEALTH INSURANCE²
Private	1.3	1.3	0.4	0.6	1.4	1.3	2.4^a	1.6	1.2	1.3
Medicaid/CHIP	2.4^a	1.7	0.5	0.3	2.9^a	2.0	2.2	1.5	3.0^a	2.1
Other³	1.2	0.9	0.3	0.8	1.2	0.9	2.2	1.2	1.2	0.9
No Coverage	1.6	2.0	*	0.2	1.6	2.1	1.5	1.4	1.7	2.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.93A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1,304	1,053	34	38	1,270	1,015	158	138	1,112	877
GEOGRAPHIC REGION
Northeast	179	190	2	1	177	189	34	15	143	174
Midwest	249	143	8	1	240	142	43	16	198	126
South	569	516	16	23	554	493	61	54	492	439
West	307	204	8	13	299	191	20	53	279	138
COUNTY TYPE
Large Metro	700	563	18	20	682	543	61	75	621	469
Small Metro	368	343	11	16	357	327	73	55	285	272
Nonmetro	236	146	6	1	230	145	24	8	206	137
Urbanized	153	85	4	*	148	85	6	4	142	82
Less Urbanized	81	61	2	1	79	60	18	5	61	55
Completely Rural	2	*	*	*	2	*	*	*	2	*
POVERTY LEVEL¹
Less Than 100%	237	190	10	4	227	186	36	39	191	147
100-199%	347	234	9	11	338	223	38	33	300	190
200% or More	721	628	15	22	705	607	84	66	622	541
HEALTH INSURANCE²
Private	601	505	13	26	588	478	106	55	481	423
Medicaid/CHIP	457	324	25	11	432	313	31	55	400	258
Other³	327	231	<1	*	326	231	9	15	317	216
No Coverage	145	133	*	*	145	133	12	16	132	117
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.93B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.5	0.4	0.1	0.1	0.5	0.4	0.5	0.4	0.5	0.4
GEOGRAPHIC REGION
Northeast	0.4	0.4	0.1	<0.1	0.4	0.4	0.6	0.3	0.4	0.4
Midwest	0.4	0.2	0.2	<0.1	0.5	0.3	0.6	0.2	0.4	0.3
South	0.5	0.5	0.2	0.2	0.6	0.5	0.5	0.4	0.6	0.5
West	0.5	0.3	0.1	0.2	0.5	0.3	0.2	0.7	0.5	0.3
COUNTY TYPE
Large Metro	0.4	0.4	0.1	0.1	0.5	0.4	0.3	0.4	0.5	0.4
Small Metro	0.4	0.4	0.1	0.2	0.4	0.4	0.6	0.5	0.4	0.4
Nonmetro	0.6	0.4	0.2	<0.1	0.7	0.4	0.6	0.2	0.7	0.5
Urbanized	1.0	0.6	0.4	*	1.0	0.6	0.3	0.2	1.1	0.7
Less Urbanized	0.4	0.3	0.1	0.1	0.5	0.3	0.9	0.2	0.4	0.4
Completely Rural	0.1	*	*	*	0.1	*	*	*	0.1	*
POVERTY LEVEL¹
Less Than 100%	0.6	0.4	0.2	0.1	0.6	0.5	0.4	0.5	0.7	0.5
100-199%	0.6	0.4	0.2	0.2	0.7	0.5	0.4	0.4	0.7	0.5
200% or More	0.4	0.3	0.1	0.1	0.4	0.4	0.5	0.4	0.4	0.4
HEALTH INSURANCE²
Private	0.4	0.3	0.1	0.2	0.4	0.3	0.5	0.3	0.4	0.3
Medicaid/CHIP	0.8	0.5	0.2	0.1	0.9	0.6	0.3	0.6	1.0	0.6
Other³	0.4	0.3	<0.1	*	0.4	0.3	0.3	0.5	0.4	0.3
No Coverage	0.6	0.6	*	*	0.6	0.6	0.3	0.4	0.7	0.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.94A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	15,399	14,666	521	583	14,878	14,083	1,082^a	875	13,797	13,208
GEOGRAPHIC REGION
Northeast	2,269	2,410	52	88	2,217	2,322	228	140	1,989	2,183
Midwest	3,036	2,736	96	104	2,940	2,632	204	176	2,736	2,456
South	6,427	6,085	232	268	6,195	5,817	454	343	5,741	5,474
West	3,667	3,435	141	123	3,527	3,312	196	217	3,331	3,094
COUNTY TYPE
Large Metro	8,402	7,475	260	287	8,141	7,188	581	427	7,561	6,762
Small Metro	4,970	5,184	187	196	4,783	4,988	355	350	4,428	4,639
Nonmetro	2,028	2,006	74	100	1,954	1,907	146	99	1,808	1,807
Urbanized	873	832	19	33	854	800	65	48	788	752
Less Urbanized	989	1,048	43	40	946	1,008	73	47	874	961
Completely Rural	165	126	*	27	154	99	*	5	146	94
POVERTY LEVEL¹
Less Than 100%	2,091	1,994	108	103	1,983	1,891	250	182	1,734	1,709
100-199%	2,950	2,661	144	131	2,806	2,530	248	214	2,558	2,316
200% or More	10,358	10,009	269	349	10,089	9,661	584	478	9,505	9,182
HEALTH INSURANCE²
Private	9,365	9,005	256	303	9,109	8,702	718	539	8,390	8,163
Medicaid/CHIP	3,297	3,281	257	254	3,039	3,026	290	252	2,750	2,775
Other³	6,256	5,594	32	56	6,224	5,538	103	100	6,121	5,438
No Coverage	730	534	9	20	721	514	83	67	638	447
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.94B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	5.5	5.2	2.0	2.2	5.8	5.5	3.1	2.6	6.2	5.9
GEOGRAPHIC REGION
Northeast	4.6	4.9	1.3	2.2	4.9	5.2	3.8	2.4	5.1	5.6
Midwest	5.2	4.7	1.8	1.9	5.6	5.0	2.8	2.5	6.0	5.4
South	5.9	5.6	2.3	2.6	6.3	5.9	3.4	2.6	6.8	6.4
West	5.5	5.1	2.3	2.0	5.8	5.4	2.4	2.7	6.4	5.9
COUNTY TYPE
Large Metro	5.4	4.8	1.8	2.0	5.8	5.0	3.0	2.3	6.2	5.4
Small Metro	5.6	5.8	2.3	2.4	5.9	6.2	3.0	3.1	6.4	6.7
Nonmetro	5.5	5.3	2.5	2.9	5.8	5.6	3.7	2.3	6.1	6.0
Urbanized	5.6	5.5	1.5	2.7	6.0	5.7	3.7	2.6	6.3	6.2
Less Urbanized	5.4	5.4	3.0	2.2	5.6	5.8	3.7	2.2	5.8	6.2
Completely Rural	5.8	4.0	*	8.8	6.0	3.5	*	1.6	6.3	3.8
POVERTY LEVEL¹
Less Than 100%	5.0	4.4	2.0	1.8	5.5	4.8	3.1	2.2	6.2	5.5
100-199%	5.3	4.9	2.5	2.4	5.6	5.2	2.9	2.7	6.2	5.6
200% or More	5.6	5.4	1.8	2.3	5.9	5.7	3.2	2.7	6.3	6.1
HEALTH INSURANCE²
Private	5.5	5.3	1.8	2.2	5.8	5.5	3.6	2.8	6.2	5.9
Medicaid/CHIP	5.6	5.4	2.4	2.3	6.3	6.1	3.1	2.6	7.1	6.9
Other³	8.0	7.1	2.1	4.0	8.1	7.2	3.7	3.5	8.3	7.3
No Coverage	3.0	2.2	0.9	1.6	3.1	2.3	1.8	1.5	3.4	2.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.95A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	959	1,063	27	68	931	995	93	90	839	905
GEOGRAPHIC REGION
Northeast	102	174	4	7	98	167	21	10	77	157
Midwest	213	169	3	7	210	163	20	16	190	147
South	466	499	15	24	451	475	36	52	415	423
West	177	221	6^a	30	172	191	16	13	156	178
COUNTY TYPE
Large Metro	515	544	16	47	498	497	44	32	455	465
Small Metro	274	426	9	16	265	409	39	48	226	362
Nonmetro	170	93	2	4	168	89	10	11	158	78
Urbanized	40	34	*	1	40	33	1	1	40	32
Less Urbanized	104	57	2	4	102	54	9	8	93	46
Completely Rural	*	1	*	*	*	1	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	167	120	7	12	160	109	25	23	134	86
100-199%	170	160	4	12	166	147	9	35	157	112
200% or More	622	782	16	44	606	738	58	32	548	707
HEALTH INSURANCE²
Private	521	587	16	43	505	544	61	34	443	510
Medicaid/CHIP	258	242	13	18	245	224	19	26	226	198
Other³	330	382	*	14	330	367	15	11	315	357
No Coverage	51	100	*	<1	51	100	7	25	44	76
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.95B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.3	0.4	0.1	0.3	0.4	0.4	0.3	0.3	0.4	0.4
GEOGRAPHIC REGION
Northeast	0.2	0.4	0.1	0.2	0.2	0.4	0.4	0.2	0.2	0.4
Midwest	0.4	0.3	<0.1	0.1	0.4	0.3	0.3	0.2	0.4	0.3
South	0.4	0.5	0.1	0.2	0.5	0.5	0.3	0.4	0.5	0.5
West	0.3	0.3	0.1^a	0.5	0.3	0.3	0.2	0.2	0.3	0.3
COUNTY TYPE
Large Metro	0.3	0.3	0.1	0.3	0.4	0.3	0.2	0.2	0.4	0.4
Small Metro	0.3	0.5	0.1	0.2	0.3	0.5	0.3	0.4	0.3	0.5
Nonmetro	0.5	0.2	0.1	0.1	0.5	0.3	0.2	0.3	0.5	0.3
Urbanized	0.3	0.2	*	0.1	0.3	0.2	<0.1	0.1	0.3	0.3
Less Urbanized	0.6	0.3	0.1	0.2	0.6	0.3	0.5	0.4	0.6	0.3
Completely Rural	*	<0.1	*	*	*	0.1	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.4	0.3	0.1	0.2	0.4	0.3	0.3	0.3	0.5	0.3
100-199%	0.3	0.3	0.1	0.2	0.3	0.3	0.1	0.4	0.4	0.3
200% or More	0.3	0.4	0.1	0.3	0.4	0.4	0.3	0.2	0.4	0.5
HEALTH INSURANCE²
Private	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.2	0.3	0.4
Medicaid/CHIP	0.4	0.4	0.1	0.2	0.5	0.5	0.2	0.3	0.6	0.5
Other³	0.4	0.5	*	1.0	0.4	0.5	0.5	0.4	0.4	0.5
No Coverage	0.2	0.4	*	<0.1	0.2	0.4	0.1	0.5	0.2	0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.96A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	278	284	7	14	271	271	32	23	239	248
GEOGRAPHIC REGION
Northeast	36	54	*	2	36	53	11	2	25	51
Midwest	42	94	*	1	41	93	5	8	37	85
South	131	103	3	*	128	103	14	12	115	91
West	69	33	4	11	65	22	3	1	62	21
COUNTY TYPE
Large Metro	124	108	1	7	122	101	4	3	118	97
Small Metro	105	137	5	5	100	132	26	17	74	115
Nonmetro	49	39	1	1	49	38	2	3	47	35
Urbanized	20	*	*	*	20	*	*	*	20	*
Less Urbanized	4	39	1	1	4	37	2	3	2	35
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	41	33	5	3	37	29	11	8	26	21
100-199%	55	21	1	1	55	20	2	2	53	18
200% or More	182	230	2	9	180	221	20	13	160	208
HEALTH INSURANCE²
Private	146	129	2	9	144	120	21	13	122	108
Medicaid/CHIP	60	106	6	5	54	101	9	5	45	97
Other³	98	96	*	*	98	96	4	3	94	93
No Coverage	21	28	*	*	21	28	2	7	19	21
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.96B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	0.1	0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
GEOGRAPHIC REGION
Northeast	0.1	0.1	*	<0.1	0.1	0.1	0.2	<0.1	0.1	0.1
Midwest	0.1	0.2	*	<0.1	0.1	0.2	0.1	0.1	0.1	0.2
South	0.1	0.1	<0.1	*	0.1	0.1	0.1	0.1	0.1	0.1
West	0.1	<0.1	0.1	0.2	0.1	<0.1	<0.1	<0.1	0.1	<0.1
COUNTY TYPE
Large Metro	0.1	0.1	<0.1	0.1	0.1	0.1	<0.1	<0.1	0.1	0.1
Small Metro	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2
Nonmetro	0.1	0.1	<0.1	<0.1	0.1	0.1	0.1	0.1	0.2	0.1
Urbanized	0.1	*	*	*	0.1	*	*	*	0.2	*
Less Urbanized	<0.1	0.2	<0.1	0.1	<0.1	0.2	0.1	0.1	<0.1	0.2
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
100-199%	0.1	<0.1	<0.1	<0.1	0.1	<0.1	<0.1	<0.1	0.1	<0.1
200% or More	0.1	0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
HEALTH INSURANCE²
Private	0.1	0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Medicaid/CHIP	0.1	0.2	0.1	<0.1	0.1	0.2	0.1	0.1	0.1	0.2
Other³	0.1	0.1	*	*	0.1	0.1	0.1	0.1	0.1	0.1
No Coverage	0.1	0.1	*	*	0.1	0.1	<0.1	0.1	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.97A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	25,703^a	23,894	480	456	25,223^a	23,437	2,178^b	1,739	23,045	21,699
GEOGRAPHIC REGION
Northeast	4,373	4,289	34	67	4,339	4,222	342	281	3,997	3,941
Midwest	5,853^b	4,758	92	113	5,761^b	4,645	582^b	378	5,178^b	4,267
South	10,308	10,307	186	184	10,121	10,123	869^a	675	9,252	9,448
West	5,170	4,541	168^a	93	5,002	4,448	385	405	4,617	4,043
COUNTY TYPE
Large Metro	12,943	12,286	265	214	12,678	12,072	1,066^a	832	11,612	11,241
Small Metro	8,956	8,370	171	179	8,785	8,191	824	678	7,962	7,512
Nonmetro	3,805	3,238	45	64	3,760	3,174	289	229	3,472	2,946
Urbanized	1,535	1,217	30	19	1,505	1,198	132	94	1,373	1,105
Less Urbanized	1,920	1,769	13	28	1,907	1,742	148	118	1,759	1,623
Completely Rural	350	252	*	*	348	235	9	17	339	218
POVERTY LEVEL¹
Less Than 100%	3,543	3,748	87	92	3,456	3,656	470	357	2,986	3,299
100-199%	5,076	4,628	112	74	4,964	4,554	568	433	4,396	4,121
200% or More	17,084^a	15,515	281	290	16,803^a	15,225	1,139	947	15,664	14,278
HEALTH INSURANCE²
Private	15,965^a	14,116	268	263	15,697^b	13,853	1,322^b	1,024	14,375^a	12,829
Medicaid/CHIP	5,829	5,687	188	183	5,641	5,504	613	485	5,027	5,019
Other³	9,288	8,256	33	25	9,255	8,231	187	143	9,067	8,088
No Coverage	1,326	1,404	16	16	1,310	1,388	206	179	1,103	1,209
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.97B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	9.1^a	8.4	1.9	1.8	9.8^a	9.1	6.3^b	5.1	10.4	9.7
GEOGRAPHIC REGION
Northeast	8.9	8.8	0.8	1.6	9.7	9.4	5.8	4.9	10.2	10.1
Midwest	10.1^b	8.2	1.7	2.1	10.9^b	8.8	8.0^b	5.3	11.4^b	9.3
South	9.5	9.4	1.8	1.8	10.3	10.2	6.5^a	5.1	10.9	11.0
West	7.7	6.8	2.7^a	1.5	8.3	7.3	4.7	5.0	8.8	7.7
COUNTY TYPE
Large Metro	8.3	7.8	1.8	1.5	9.0	8.5	5.6	4.5	9.5	9.0
Small Metro	10.0	9.4	2.1	2.2	10.8	10.1	7.0	5.9	11.4	10.8
Nonmetro	10.4^a	8.6	1.5	1.9	11.1^a	9.3	7.3	5.4	11.6	9.8
Urbanized	9.9	8.0	2.4	1.5	10.6	8.6	7.5	5.0	11.0	9.2
Less Urbanized	10.4	9.1	0.9	1.5	11.2	10.0	7.5	5.7	11.7	10.5
Completely Rural	12.3	8.1	*	*	13.5	8.4	3.5	5.8	14.6	8.7
POVERTY LEVEL¹
Less Than 100%	8.5	8.3	1.7	1.6	9.5	9.3	5.8^a	4.2	10.6	10.6
100-199%	9.1	8.5	1.9	1.4	10.0	9.3	6.7	5.5	10.6	10.0
200% or More	9.2^a	8.4	1.9	2.0	9.9^a	9.0	6.2	5.3	10.3^a	9.4
HEALTH INSURANCE²
Private	9.4^b	8.3	1.9	1.9	10.1^b	8.8	6.6^a	5.4	10.6^b	9.3
Medicaid/CHIP	9.9	9.4	1.8	1.7	11.7	11.0	6.6^a	5.1	13.0	12.5
Other³	11.9	10.5	2.2	1.8	12.1	10.7	6.7	5.1	12.3	10.9
No Coverage	5.5	5.9	1.6	1.3	5.6	6.2	4.5	4.0	5.9	6.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.98A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	3,681	3,696	113	111	3,569	3,585	747^b	480	2,822	3,105
GEOGRAPHIC REGION
Northeast	672	642	5	8	667	633	106	71	560	562
Midwest	714	589	23	26	690	563	184^a	97	506	466
South	1,481	1,738	48	40	1,434	1,699	295	200	1,139	1,498
West	814	727	36	37	778	690	161	111	617	579
COUNTY TYPE
Large Metro	1,971	2,151	53	63	1,918	2,087	381^a	251	1,537	1,836
Small Metro	1,156	1,139	45	41	1,111	1,097	276^b	169	834	928
Nonmetro	554	407	14	7	540	400	90	59	451	341
Urbanized	279	194	8	3	271	191	38	22	233	169
Less Urbanized	246	201	6	3	239	198	47	36	192	162
Completely Rural	30	12	*	*	30	12	*	2	26	10
POVERTY LEVEL¹
Less Than 100%	710	615	25	16	684	599	176^a	97	509	502
100-199%	842	759	37	31	804	729	181	120	624	609
200% or More	2,130	2,321	50	65	2,080	2,257	390^a	262	1,689	1,994
HEALTH INSURANCE²
Private	1,923	2,041	54	72	1,869	1,969	448^a	283	1,421	1,686
Medicaid/CHIP	1,204	924	60	34	1,143	890	196	136	947	754
Other³	726	672	3	11	724	661	53	24	671	637
No Coverage	366	453	*	2	366	451	66	64	300	388
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.98B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.3	1.3	0.4	0.4	1.4	1.4	2.1^b	1.4	1.3	1.4
GEOGRAPHIC REGION
Northeast	1.4	1.3	0.1	0.2	1.5	1.4	1.8	1.2	1.4	1.4
Midwest	1.2	1.0	0.4	0.5	1.3	1.1	2.5^a	1.4	1.1	1.0
South	1.4	1.6	0.5	0.4	1.5	1.7	2.2	1.5	1.3	1.7
West	1.2	1.1	0.6	0.6	1.3	1.1	2.0	1.4	1.2	1.1
COUNTY TYPE
Large Metro	1.3	1.4	0.4	0.4	1.4	1.5	2.0	1.4	1.3	1.5
Small Metro	1.3	1.3	0.6	0.5	1.4	1.4	2.4^b	1.5	1.2	1.3
Nonmetro	1.5	1.1	0.5	0.2	1.6	1.2	2.2	1.4	1.5	1.1
Urbanized	1.8	1.3	0.6	0.3	1.9	1.4	2.2	1.1	1.9	1.4
Less Urbanized	1.3	1.0	0.4	0.2	1.4	1.1	2.4	1.7	1.3	1.1
Completely Rural	1.1	0.4	*	*	1.2	0.4	*	0.7	1.1	0.4
POVERTY LEVEL¹
Less Than 100%	1.7	1.4	0.5	0.3	1.9	1.5	2.2^a	1.2	1.8	1.6
100-199%	1.5	1.4	0.6	0.6	1.6	1.5	2.1	1.5	1.5	1.5
200% or More	1.2	1.3	0.3	0.4	1.2	1.3	2.1^a	1.5	1.1	1.3
HEALTH INSURANCE²
Private	1.1	1.2	0.4	0.5	1.2	1.3	2.3^a	1.5	1.0	1.2
Medicaid/CHIP	2.0	1.5	0.6	0.3	2.4	1.8	2.1	1.4	2.4	1.9
Other³	0.9	0.9	0.2	0.8	0.9	0.9	1.9	0.8	0.9	0.9
No Coverage	1.5	1.9	*	0.2	1.6	2.0	1.4	1.4	1.6	2.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.99A – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	74,052	74,506	3,191^b	3,804	70,861	70,702	6,504	6,516	64,358	64,187
GEOGRAPHIC REGION
Northeast	10,866	11,347	395^b	611	10,471	10,735	892^a	1,129	9,579	9,606
Midwest	16,018	15,406	684	758	15,335	14,647	1,465^a	1,234	13,870	13,413
South	30,086	30,935	1,366^b	1,713	28,720	29,223	2,690	2,698	26,030	26,525
West	17,083	16,819	746	722	16,336	16,097	1,457	1,455	14,879	14,642
COUNTY TYPE
Large Metro	38,987	38,623	1,624^b	2,080	37,364	36,543	3,483	3,433	33,880	33,110
Small Metro	23,923	24,841	1,139	1,241	22,784	23,600	2,222	2,229	20,562	21,371
Nonmetro	11,141	11,042	428	484	10,714	10,559	799	853	9,915	9,705
Urbanized	4,563	4,550	176	188	4,386	4,361	369	366	4,017	3,995
Less Urbanized	5,613	5,613	213	252	5,400	5,361	379	434	5,021	4,927
Completely Rural	965	879	38	*	928	836	*	*	877	783
POVERTY LEVEL¹
Less Than 100%	11,663	12,598	682	827	10,981	11,771	1,461	1,659	9,520	10,112
100-199%	15,878	14,993	782	831	15,095	14,162	1,680	1,529	13,415	12,632
200% or More	46,511	46,913	1,726^b	2,146	44,785	44,767	3,362	3,325	41,423	41,442
HEALTH INSURANCE²
Private	41,461	43,588	1,622^a	1,957	39,840	41,632	3,700	3,708	36,139	37,924
Medicaid/CHIP	18,171	18,398	1,484	1,705	16,686	16,693	1,954	2,012	14,732	14,681
Other³	25,912	25,505	209	242	25,703	25,263	496	547	25,207	24,716
No Coverage	5,077	4,490	134	173	4,943	4,317	749	717	4,194	3,600
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription pain relievers. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.99B – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	26.3	26.3	12.4^b	14.7	27.6	27.5	18.7	19.1	29.1	28.7
GEOGRAPHIC REGION
Northeast	22.2	23.2	9.7^b	15.0	23.3	23.9	15.1^b	19.7	24.5	24.5
Midwest	27.5	26.4	12.7	14.0	29.1	27.7	20.1^a	17.3	30.5	29.4
South	27.8	28.3	13.5^b	16.7	29.3	29.5	20.2	20.6	30.8	30.9
West	25.6	25.1	12.2	11.7	27.0	26.5	17.7	18.1	28.4	27.7
COUNTY TYPE
Large Metro	25.0	24.6	11.0^b	14.6	26.5	25.6	18.2	18.7	27.8	26.6
Small Metro	26.8	27.9	14.3	15.0	28.0	29.2	19.0	19.5	29.5	30.9
Nonmetro	30.3	29.3	14.6	14.3	31.7	30.8	20.1	20.0	33.2	32.4
Urbanized	29.5	30.0	14.2	15.4	30.8	31.3	21.0	19.4	32.2	33.1
Less Urbanized	30.5	29.0	15.1	13.5	31.8	30.7	19.2	20.8	33.4	32.0
Completely Rural	33.8	28.3	13.6	*	36.0	29.8	*	*	37.7	31.2
POVERTY LEVEL¹
Less Than 100%	28.1	27.9	12.9	14.5	30.3	29.8	18.1	19.7	33.8	32.6
100-199%	28.5	27.6	13.5	15.5	30.3	28.9	19.8	19.4	32.4	30.7
200% or More	25.2	25.5	11.8^b	14.5	26.3	26.5	18.4	18.8	27.3	27.4
HEALTH INSURANCE²
Private	24.4	25.5	11.5^b	14.0	25.6	26.5	18.6	19.4	26.6	27.5
Medicaid/CHIP	30.9	30.3	13.9	15.6	34.7	33.5	21.1	21.1	38.0	36.4
Other³	33.1	32.5	13.9	17.4	33.5	32.7	17.7	19.4	34.1	33.3
No Coverage	20.9	18.9	13.3	13.8	21.3	19.2	16.2	16.0	22.5	19.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription pain relievers. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.100A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	8,918	8,902	406^a	574	8,513	8,328	1,120^b	846	7,393	7,482
GEOGRAPHIC REGION
Northeast	1,457	1,278	49	77	1,408	1,202	145	118	1,264	1,083
Midwest	1,701	1,717	65^a	114	1,636	1,603	256^b	147	1,380	1,455
South	3,590	3,874	189	271	3,401	3,602	451	390	2,951	3,212
West	2,170	2,033	103	111	2,067	1,921	269	190	1,798	1,731
COUNTY TYPE
Large Metro	4,929	4,880	203^a	313	4,726	4,566	598	453	4,127	4,113
Small Metro	2,879	2,713	165	186	2,714	2,527	404^a	290	2,310	2,238
Nonmetro	1,111	1,309	38	75	1,073	1,234	117	103	956	1,131
Urbanized	454	523	12	29	442	494	47	49	395	445
Less Urbanized	572	692	21	44	552	649	62	52	490	597
Completely Rural	85	94	*	2	79	92	8	2	71	90
POVERTY LEVEL¹
Less Than 100%	2,233	1,837	92	136	2,140^a	1,701	255	246	1,885^a	1,455
100-199%	1,993	1,815	110	124	1,883	1,691	270	225	1,613	1,466
200% or More	4,692	5,250	203^a	314	4,489	4,936	594^b	375	3,895	4,561
HEALTH INSURANCE²
Private	4,022	4,367	211	268	3,811	4,099	580^a	407	3,231	3,692
Medicaid/CHIP	3,431^a	2,802	187^a	294	3,243^b	2,508	358	304	2,885^a	2,204
Other³	2,168	2,179	23	41	2,145	2,139	78	74	2,067	2,064
No Coverage	947	860	8	9	939	852	163	139	776	712
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.100B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	3.2	3.1	1.6^a	2.2	3.3	3.2	3.2^a	2.5	3.3	3.3
GEOGRAPHIC REGION
Northeast	3.0	2.6	1.2	1.9	3.1	2.7	2.4	2.1	3.2	2.8
Midwest	2.9	2.9	1.2^a	2.1	3.1	3.0	3.5^b	2.1	3.0	3.2
South	3.3	3.5	1.9	2.6	3.5	3.6	3.4	3.0	3.5	3.7
West	3.3	3.0	1.7	1.8	3.4	3.2	3.3	2.4	3.4	3.3
COUNTY TYPE
Large Metro	3.2	3.1	1.4^a	2.2	3.3	3.2	3.1	2.5	3.4	3.3
Small Metro	3.2	3.0	2.1	2.2	3.3	3.1	3.5	2.5	3.3	3.2
Nonmetro	3.0	3.5	1.3	2.2	3.2	3.6	2.9	2.4	3.2	3.8
Urbanized	2.9	3.4	0.9	2.4	3.1	3.5	2.7	2.6	3.2	3.7
Less Urbanized	3.1	3.6	1.5	2.3	3.2	3.7	3.2	2.5	3.3	3.9
Completely Rural	3.0	3.0	*	0.7	3.1	3.3	3.3	0.7	3.1	3.6
POVERTY LEVEL¹
Less Than 100%	5.4^b	4.1	1.8	2.4	5.9^b	4.3	3.2	2.9	6.7^b	4.7
100-199%	3.6	3.3	1.9	2.3	3.8	3.5	3.2	2.9	3.9	3.6
200% or More	2.5	2.9	1.4^a	2.1	2.6	2.9	3.3^b	2.1	2.6^a	3.0
HEALTH INSURANCE²
Private	2.4	2.6	1.5	1.9	2.4	2.6	2.9^a	2.1	2.4	2.7
Medicaid/CHIP	5.8^b	4.6	1.8^a	2.7	6.7^b	5.0	3.9	3.2	7.4^b	5.5
Other³	2.8	2.8	1.5	2.9	2.8	2.8	2.8	2.6	2.8	2.8
No Coverage	3.9	3.6	0.8	0.7	4.0	3.8	3.5	3.1	4.2	3.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.101A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	2,944	2,442	117	147	2,827	2,295	221	174	2,606	2,121
GEOGRAPHIC REGION
Northeast	615^a	330	10	19	605^a	311	22	11	582^a	300
Midwest	530	414	15	35	515	379	47	26	468	352
South	1,176	1,102	60	59	1,115	1,043	113	90	1,003	953
West	623	597	31	34	592	563	39	47	553	516
COUNTY TYPE
Large Metro	1,626	1,372	68	74	1,558	1,299	94	94	1,464	1,204
Small Metro	905	725	39	61	867	664	92	61	775	603
Nonmetro	413	345	10	13	402	332	35	19	367	313
Urbanized	156	130	1^a	11	155	120	11	4	145	116
Less Urbanized	231	208	9	1	222	207	22	15	200	192
Completely Rural	25	7	*	1	25	6	*	*	*	6
POVERTY LEVEL¹
Less Than 100%	886^a	585	42	53	844^a	532	57	58	787^a	474
100-199%	690	564	17	24	673	540	72	42	601	498
200% or More	1,368	1,293	58	70	1,310	1,223	92	74	1,218	1,149
HEALTH INSURANCE²
Private	1,039	1,071	61	55	978	1,016	100	82	877	934
Medicaid/CHIP	1,428^a	1,041	50	101	1,378^a	940	58	66	1,320^a	874
Other³	709	458	5	7	704	451	20	14	684	437
No Coverage	313	237	6	3	307	234	47	28	260	206
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.101B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.0	0.9	0.5	0.6	1.1	0.9	0.6	0.5	1.2	0.9
GEOGRAPHIC REGION
Northeast	1.3^a	0.7	0.3	0.5	1.3^a	0.7	0.4	0.2	1.5^a	0.8
Midwest	0.9	0.7	0.3	0.7	1.0	0.7	0.6	0.4	1.0	0.8
South	1.1	1.0	0.6	0.6	1.1	1.1	0.8	0.7	1.2	1.1
West	0.9	0.9	0.5	0.6	1.0	0.9	0.5	0.6	1.1	1.0
COUNTY TYPE
Large Metro	1.0	0.9	0.5	0.5	1.1	0.9	0.5	0.5	1.2	1.0
Small Metro	1.0	0.8	0.5	0.7	1.1	0.8	0.8	0.5	1.1	0.9
Nonmetro	1.1	0.9	0.3	0.4	1.2	1.0	0.9	0.4	1.2	1.0
Urbanized	1.0	0.9	0.1^a	0.9	1.1	0.9	0.6	0.2	1.2	1.0
Less Urbanized	1.3	1.1	0.6	<0.1	1.3	1.2	1.1	0.7	1.3	1.2
Completely Rural	0.9	0.2	*	0.4	1.0	0.2	*	*	*	0.2
POVERTY LEVEL¹
Less Than 100%	2.1^b	1.3	0.8	0.9	2.3^b	1.3	0.7	0.7	2.8^b	1.5
100-199%	1.2	1.0	0.3	0.4	1.4	1.1	0.8	0.5	1.5	1.2
200% or More	0.7	0.7	0.4	0.5	0.8	0.7	0.5	0.4	0.8	0.8
HEALTH INSURANCE²
Private	0.6	0.6	0.4	0.4	0.6	0.6	0.5	0.4	0.6	0.7
Medicaid/CHIP	2.4^a	1.7	0.5	0.9	2.9^b	1.9	0.6	0.7	3.4^b	2.2
Other³	0.9	0.6	0.3	0.5	0.9	0.6	0.7	0.5	0.9	0.6
No Coverage	1.3	1.0	0.6	0.2	1.3	1.0	1.0	0.6	1.4	1.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.102A – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	24,425	24,686	1,889	1,835	22,536	22,850	4,581	4,298	17,956	18,552
GEOGRAPHIC REGION
Northeast	3,822	4,019	227	283	3,595	3,736	769	758	2,826	2,978
Midwest	5,595	5,066	435	417	5,161	4,648	1,181	1,018	3,980	3,630
South	9,034	9,830	836	762	8,198	9,068	1,566	1,454	6,632^a	7,613
West	5,975	5,771	392	372	5,583	5,399	1,065	1,068	4,517	4,331
COUNTY TYPE
Large Metro	13,321	13,445	1,071	985	12,251	12,460	2,443	2,206	9,808	10,254
Small Metro	8,189	7,914	600	661	7,589	7,253	1,622	1,609	5,967	5,644
Nonmetro	2,915	3,327	219	189	2,697	3,137	516	483	2,181	2,654
Urbanized	1,303	1,369	103	76	1,200	1,293	264	263	936	1,030
Less Urbanized	1,404	1,753	96	95	1,308	1,658	224	197	1,084	1,461
Completely Rural	208	204	19	18	189	186	28	23	162	163
POVERTY LEVEL¹
Less Than 100%	3,911	4,196	237	236	3,674	3,960	963	966	2,711	2,993
100-199%	4,773	4,572	431^a	314	4,342	4,258	959	970	3,383	3,287
200% or More	15,739	15,914	1,221	1,285	14,518	14,629	2,656	2,357	11,862	12,272
HEALTH INSURANCE²
Private	14,210	14,748	1,164	1,162	13,046	13,586	3,059	2,820	9,987	10,766
Medicaid/CHIP	6,759	6,519	685	609	6,074	5,910	1,085	1,004	4,988	4,906
Other³	4,264	3,992	144	130	4,120	3,863	340	362	3,781	3,500
No Coverage	2,072	2,229	30	49	2,042	2,181	313	359	1,729	1,821
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.102B – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	8.7	8.7	7.3	7.1	8.8	8.9	13.2	12.6	8.1	8.3
GEOGRAPHIC REGION
Northeast	7.8	8.2	5.6	7.0	8.0	8.3	13.0	13.2	7.2	7.6
Midwest	9.6	8.7	8.1	7.7	9.8	8.8	16.2	14.3	8.8	7.9
South	8.4	9.0	8.3	7.4	8.4	9.2	11.7	11.1	7.8^a	8.9
West	9.0	8.6	6.4	6.1	9.2	8.9	12.9	13.3	8.6	8.2
COUNTY TYPE
Large Metro	8.5	8.6	7.2	6.9	8.7	8.7	12.8	12.0	8.0	8.3
Small Metro	9.2	8.9	7.5	8.0	9.3	9.0	13.9	14.1	8.6	8.1
Nonmetro	7.9	8.8	7.5	5.6	8.0	9.2	13.0	11.3	7.3	8.9
Urbanized	8.4	9.0	8.3	6.2	8.4	9.3	15.0	14.0	7.5	8.5
Less Urbanized	7.6	9.1	6.8	5.1	7.7	9.5	11.4	9.5	7.2^a	9.5
Completely Rural	7.3	6.6	6.7	6.0	7.4	6.6	11.1	7.9	6.9	6.5
POVERTY LEVEL¹
Less Than 100%	9.4	9.3	4.5	4.1	10.1	10.0	12.0	11.5	9.6	9.6
100-199%	8.6	8.4	7.4	5.9	8.7	8.7	11.3	12.3	8.2	8.0
200% or More	8.5	8.7	8.3	8.7	8.5	8.7	14.6	13.3	7.8	8.1
HEALTH INSURANCE²
Private	8.4	8.6	8.3	8.3	8.4	8.6	15.4	14.8	7.3	7.8
Medicaid/CHIP	11.5	10.7	6.4	5.6	12.6	11.9	11.7	10.5	12.9	12.2
Other³	5.5	5.1	9.6	9.3	5.4	5.0	12.1	12.8	5.1	4.7
No Coverage	8.5	9.4	3.0	3.9	8.8	9.7	6.8	8.0	9.3	10.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.103A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	10,188	9,659	272	285	9,916	9,374	2,272^a	1,895	7,644	7,479
GEOGRAPHIC REGION
Northeast	1,623	1,568	54	31	1,569	1,537	373	335	1,196	1,202
Midwest	2,209	1,884	38	67	2,171	1,818	577^a	408	1,594	1,410
South	3,268	3,523	94	126	3,174	3,396	716	617	2,458	2,779
West	3,088	2,685	86	61	3,002	2,623	606	535	2,396	2,088
COUNTY TYPE
Large Metro	5,918	5,456	148	176	5,770	5,280	1,306	1,027	4,464	4,253
Small Metro	3,184	2,981	102	92	3,082	2,889	764	669	2,318	2,220
Nonmetro	1,086	1,223	22	18	1,064	1,205	202	199	862	1,006
Urbanized	459	489	7	7	452	482	106	82	346	400
Less Urbanized	535	666	9	8	526	658	88	104	438	554
Completely Rural	92	68	*	*	86	65	9	13	77	52
POVERTY LEVEL¹
Less Than 100%	2,039	2,133	22	32	2,018	2,101	513	455	1,505	1,646
100-199%	2,265	1,825	71	51	2,194	1,774	475	467	1,719	1,307
200% or More	5,881	5,701	180	203	5,701	5,498	1,281^a	972	4,421	4,525
HEALTH INSURANCE²
Private	5,041	4,830	171	180	4,870	4,650	1,496	1,223	3,374	3,427
Medicaid/CHIP	3,407	2,980	89	91	3,318	2,889	496	404	2,822	2,485
Other³	1,618	1,383	25	26	1,592	1,357	177	159	1,416	1,198
No Coverage	1,118	1,359	5	6	1,113	1,354	181	212	932	1,142
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.103B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	3.6	3.4	1.1	1.1	3.9	3.6	6.5^a	5.6	3.5	3.3
GEOGRAPHIC REGION
Northeast	3.3	3.2	1.3	0.8	3.5	3.4	6.3	5.8	3.1	3.1
Midwest	3.8	3.2	0.7	1.2	4.1	3.4	7.9^a	5.7	3.5	3.1
South	3.0	3.2	0.9	1.2	3.2	3.4	5.4	4.7	2.9	3.2
West	4.6	4.0	1.4	1.0	5.0	4.3	7.4	6.7	4.6	4.0
COUNTY TYPE
Large Metro	3.8	3.5	1.0	1.2	4.1	3.7	6.8	5.6	3.7	3.4
Small Metro	3.6	3.4	1.3	1.1	3.8	3.6	6.5	5.9	3.3	3.2
Nonmetro	3.0	3.3	0.8	0.5	3.1	3.5	5.1	4.7	2.9	3.4
Urbanized	3.0	3.2	0.6	0.6	3.2	3.5	6.0	4.4	2.8	3.3
Less Urbanized	2.9	3.4	0.6	0.4	3.1	3.8	4.4	5.0	2.9	3.6
Completely Rural	3.2	2.2	*	*	3.4	2.3	3.6	4.4	3.3	2.1
POVERTY LEVEL¹
Less Than 100%	4.9	4.7	0.4	0.6	5.6	5.3	6.4	5.4	5.3	5.3
100-199%	4.1	3.4	1.2	1.0	4.4	3.6	5.6	5.9	4.2	3.2
200% or More	3.2	3.1	1.2	1.4	3.3	3.3	7.0^a	5.5	2.9	3.0
HEALTH INSURANCE²
Private	3.0	2.8	1.2	1.3	3.1	3.0	7.5	6.4	2.5	2.5
Medicaid/CHIP	5.8	4.9	0.8	0.8	6.9	5.8	5.4	4.2	7.3	6.2
Other³	2.1	1.8	1.7	1.8	2.1	1.8	6.3	5.6	1.9	1.6
No Coverage	4.6	5.7	0.5	0.4	4.8	6.0	3.9	4.7	5.0	6.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.104A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	4,469	4,175	40	72	4,429	4,103	767^a	546	3,662	3,557
GEOGRAPHIC REGION
Northeast	702	685	7	4	695	681	142	105	553	576
Midwest	936	850	8	16	928	834	193	123	736	710
South	1,430	1,434	16	41	1,414	1,393	276	193	1,138	1,200
West	1,400	1,206	9	10	1,391	1,196	156	125	1,235	1,071
COUNTY TYPE
Large Metro	2,676	2,420	20	37	2,656	2,382	449	309	2,207	2,074
Small Metro	1,253	1,198	19	34	1,234	1,164	252	183	983	981
Nonmetro	540	557	2	<1	538	557	67	54	472	502
Urbanized	252	264	<1	<1	251	264	32	28	219	237
Less Urbanized	244	283	1	<1	243	283	35	26	208	257
Completely Rural	*	9	*	*	*	9	*	*	*	9
POVERTY LEVEL¹
Less Than 100%	1,046	1,147	3	3	1,043	1,145	165	160	878	984
100-199%	1,113	833	8	22	1,104	812	181	124	923	688
200% or More	2,309	2,194	29	48	2,280	2,147	420^a	262	1,861	1,885
HEALTH INSURANCE²
Private	1,762	1,779	24	47	1,737	1,732	496^a	340	1,241	1,391
Medicaid/CHIP	1,903	1,524	17	22	1,886	1,502	171	118	1,715	1,384
Other³	838	756	1	1	837	755	39	61	797	695
No Coverage	512	622	1	3	511	619	76	65	435	554
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.104B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	1.6	1.5	0.2	0.3	1.7	1.6	2.2^a	1.6	1.7	1.6
GEOGRAPHIC REGION
Northeast	1.4	1.4	0.2	0.1	1.5	1.5	2.4	1.8	1.4	1.5
Midwest	1.6	1.5	0.1	0.3	1.8	1.6	2.6	1.7	1.6	1.6
South	1.3	1.3	0.2	0.4	1.4	1.4	2.1	1.5	1.3	1.4
West	2.1	1.8	0.2	0.2	2.3	2.0	1.9	1.6	2.4	2.0
COUNTY TYPE
Large Metro	1.7	1.5	0.1	0.3	1.9	1.7	2.3	1.7	1.8	1.7
Small Metro	1.4	1.3	0.2	0.4	1.5	1.4	2.2	1.6	1.4	1.4
Nonmetro	1.5	1.5	0.1	<0.1	1.6	1.6	1.7	1.3	1.6	1.7
Urbanized	1.6	1.7	<0.1	<0.1	1.8	1.9	1.8	1.5	1.8	2.0
Less Urbanized	1.3	1.5	0.1	<0.1	1.4	1.6	1.8	1.3	1.4	1.7
Completely Rural	*	0.3	*	*	*	0.3	*	*	*	0.4
POVERTY LEVEL¹
Less Than 100%	2.5	2.5	<0.1	<0.1	2.9	2.9	2.0	1.9	3.1	3.2
100-199%	2.0	1.5	0.1	0.4	2.2	1.7	2.1	1.6	2.2	1.7
200% or More	1.2	1.2	0.2	0.3	1.3	1.3	2.3^a	1.5	1.2	1.2
HEALTH INSURANCE²
Private	1.0	1.0	0.2	0.3	1.1	1.1	2.5	1.8	0.9	1.0
Medicaid/CHIP	3.2	2.5	0.2	0.2	3.9	3.0	1.8	1.2	4.4	3.4
Other³	1.1	1.0	0.1	0.1	1.1	1.0	1.4	2.1	1.1	0.9
No Coverage	2.1	2.6	0.1	0.2	2.2	2.7	1.7	1.5	2.3	3.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.105A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	24,692	24,882	1,343	1,522	23,348	23,361	5,092^b	4,343	18,256	19,017
GEOGRAPHIC REGION
Northeast	4,006	4,291	171	214	3,835	4,077	797	845	3,037	3,232
Midwest	4,870	4,474	242	301	4,628	4,174	1,122^b	847	3,506	3,326
South	8,592	9,486	555	680	8,038	8,806	1,704	1,494	6,334^a	7,312
West	7,223	6,631	375	327	6,848	6,304	1,469^a	1,157	5,379	5,147
COUNTY TYPE
Large Metro	13,991	14,230	744	826	13,247	13,405	2,840^a	2,360	10,407	11,044
Small Metro	7,816	7,699	445	511	7,371	7,188	1,702	1,539	5,669	5,649
Nonmetro	2,884	2,953	155	185	2,730	2,768	550	444	2,179	2,324
Urbanized	1,248	1,199	57	79	1,192	1,119	266	199	925	920
Less Urbanized	1,382	1,563	72	86	1,310	1,477	270	228	1,040	1,249
Completely Rural	255	191	*	*	228	172	15	17	214	155
POVERTY LEVEL¹
Less Than 100%	4,660	4,690	231	285	4,429	4,405	1,092	1,054	3,338	3,351
100-199%	5,060	4,605	347	357	4,713	4,248	1,175	1,049	3,538	3,199
200% or More	14,968	15,577	765	880	14,203	14,697	2,823^b	2,230	11,380	12,467
HEALTH INSURANCE²
Private	13,282	13,568	764	776	12,517	12,792	3,178^b	2,623	9,339	10,169
Medicaid/CHIP	7,321	6,753	523^a	684	6,798	6,070	1,213	1,078	5,585	4,992
Other³	4,589	4,423	90	109	4,500	4,314	364	333	4,136	3,981
No Coverage	2,722	2,871	48	53	2,674	2,817	558	549	2,116	2,269
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.105B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	8.8	8.8	5.2	5.9	9.1	9.1	14.6^b	12.8	8.2	8.5
GEOGRAPHIC REGION
Northeast	8.2	8.8	4.2	5.3	8.5	9.1	13.5	14.7	7.8	8.3
Midwest	8.4	7.7	4.5	5.5	8.8	7.9	15.4^b	11.9	7.7	7.3
South	7.9	8.7	5.5	6.6	8.2	8.9	12.8	11.4	7.5	8.5
West	10.8	9.9	6.1	5.3	11.3	10.4	17.8	14.4	10.3	9.7
COUNTY TYPE
Large Metro	9.0	9.1	5.0	5.8	9.4	9.4	14.9^a	12.9	8.5	8.9
Small Metro	8.8	8.7	5.6	6.2	9.1	8.9	14.6	13.5	8.1	8.2
Nonmetro	7.9	7.8	5.3	5.5	8.1	8.1	13.8^a	10.4	7.3	7.8
Urbanized	8.1	7.9	4.6	6.5	8.4	8.0	15.1^a	10.6	7.4	7.6
Less Urbanized	7.5	8.1	5.1	4.6	7.7	8.4	13.7	10.9	6.9	8.1
Completely Rural	8.9	6.2	*	*	8.9	6.1	5.8	5.7	9.2	6.2
POVERTY LEVEL¹
Less Than 100%	11.2	10.4	4.4	5.0	12.2	11.2	13.6	12.5	11.9	10.8
100-199%	9.1	8.5	6.0	6.7	9.5	8.7	13.9	13.3	8.6	7.8
200% or More	8.1	8.5	5.2	5.9	8.3	8.7	15.5^b	12.6	7.5^a	8.2
HEALTH INSURANCE²
Private	7.8	7.9	5.4	5.5	8.0	8.1	16.0^a	13.8	6.9	7.4
Medicaid/CHIP	12.5^a	11.1	4.9^a	6.2	14.1^b	12.2	13.1	11.3	14.4^a	12.4
Other³	5.9	5.6	5.9	7.8	5.9	5.6	13.0	11.8	5.6	5.4
No Coverage	11.2	12.1	4.8	4.2	11.5	12.5	12.1	12.2	11.4	12.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.106A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	9,560	9,210	399	442	9,161	8,768	1,531	1,372	7,630	7,396
GEOGRAPHIC REGION
Northeast	1,683	1,609	54	43	1,629	1,566	281	263	1,347	1,303
Midwest	1,933	1,635	69	90	1,865	1,545	325	264	1,539	1,281
South	3,321	3,431	174	201	3,147	3,229	575	480	2,572	2,749
West	2,623	2,535	103	107	2,520	2,428	349	365	2,171	2,063
COUNTY TYPE
Large Metro	5,598	5,272	248	215	5,350	5,057	834	763	4,517	4,294
Small Metro	2,707	2,805	106^a	186	2,601	2,619	540	507	2,060	2,112
Nonmetro	1,255	1,133	46	41	1,210	1,092	157	102	1,053	990
Urbanized	605	529	22	17	583	512	85	48	498	464
Less Urbanized	510	580	23	23	487	557	70	53	417	504
Completely Rural	140	25	*	2	140	23	*	1	*	22
POVERTY LEVEL¹
Less Than 100%	2,002	2,033	88	99	1,914	1,933	307	373	1,607	1,560
100-199%	2,093	1,760	76	99	2,017	1,661	394	330	1,624	1,331
200% or More	5,464	5,413	235	244	5,229	5,169	830	664	4,399	4,505
HEALTH INSURANCE²
Private	4,386	4,538	221	209	4,165	4,329	944	819	3,221	3,510
Medicaid/CHIP	3,523	3,001	146	222	3,377^a	2,779	357	359	3,020^a	2,420
Other³	1,918	1,618	23	17	1,896	1,601	82	112	1,814	1,489
No Coverage	1,040	1,138	29	27	1,011	1,111	190	153	821	957
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.106B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
TOTAL	3.4	3.2	1.6	1.7	3.6	3.4	4.4	4.0	3.4	3.3
GEOGRAPHIC REGION
Northeast	3.4	3.3	1.3	1.1	3.6	3.5	4.8	4.6	3.5	3.3
Midwest	3.3	2.8	1.3	1.7	3.5	2.9	4.5	3.7	3.4	2.8
South	3.1	3.1	1.7	2.0	3.2	3.3	4.3	3.7	3.0	3.2
West	3.9	3.8	1.7	1.7	4.2	4.0	4.2	4.5	4.1	3.9
COUNTY TYPE
Large Metro	3.6	3.4	1.7	1.5	3.8	3.5	4.4	4.2	3.7	3.5
Small Metro	3.0	3.2	1.3^a	2.2	3.2	3.2	4.6	4.4	3.0	3.0
Nonmetro	3.4	3.0	1.6	1.2	3.6	3.2	3.9	2.4	3.5	3.3
Urbanized	3.9	3.5	1.8	1.4	4.1	3.7	4.8	2.6	4.0	3.8
Less Urbanized	2.8	3.0	1.7	1.2	2.9	3.2	3.5	2.5	2.8	3.3
Completely Rural	4.9	0.8	*	0.6	5.4	0.8	*	0.3	*	0.9
POVERTY LEVEL¹
Less Than 100%	4.8	4.5	1.7	1.7	5.3	4.9	3.8	4.4	5.7	5.0
100-199%	3.8	3.2	1.3	1.8	4.0	3.4	4.6	4.2	3.9	3.2
200% or More	3.0	2.9	1.6	1.6	3.1	3.1	4.5	3.7	2.9	3.0
HEALTH INSURANCE²
Private	2.6	2.7	1.6	1.5	2.7	2.8	4.7	4.3	2.4	2.5
Medicaid/CHIP	6.0^a	4.9	1.4	2.0	7.0^a	5.6	3.9	3.8	7.8^a	6.0
Other³	2.5	2.1	1.5	1.2	2.5	2.1	2.9	4.0	2.5	2.0
No Coverage	4.3	4.8	2.8	2.2	4.4	4.9	4.1	3.4	4.4	5.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.107A – Any Fentanyl Use, Fentanyl Misuse, and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic	Any Fentanyl Use¹ (2022)	Any Fentanyl Use¹ (2023)	Fentanyl Misuse² (2022)	Fentanyl Misuse² (2023)	IMF Use (2022)	IMF Use (2023)
TOTAL	3,086	2,894	991	828	686	627
GEOGRAPHIC REGION
Northeast	566	405	181	129	136	104
Midwest	630	669	169	187	111	117
South	1,034	1,044	384	295	293	217
West	856	776	257	218	146	189
COUNTY TYPE
Large Metro	1,359	1,593	522	454	320	361
Small Metro	1,199	915	304	254	231	190
Nonmetro	529	386	164	120	136	76
Urbanized	248	191	50	56	37	29
Less Urbanized	247	183	96	63	80	47
Completely Rural	34	12	*	1	*	*
POVERTY LEVEL³
Less Than 100%	666	758	370	333	239	239
100-199%	783	663	291	208	212	193
200% or More	1,638	1,471	330	288	235	194
HEALTH INSURANCE⁴
Private	1,348	1,297	215	226	150	141
Medicaid/CHIP	1,283	1,128	678	505	458	407
Other⁵	1,116	841	228	87	192^a	46
No Coverage	201	238	114	96	96	73
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. ³ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ⁴ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁵ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.107B – Any Fentanyl Use, Fentanyl Misuse, and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic	Any Fentanyl Use¹ (2022)	Any Fentanyl Use¹ (2023)	Fentanyl Misuse² (2022)	Fentanyl Misuse² (2023)	IMF Use (2022)	IMF Use (2023)
TOTAL	1.1	1.0	0.4	0.3	0.2	0.2
GEOGRAPHIC REGION
Northeast	1.2	0.8	0.4	0.3	0.3	0.2
Midwest	1.1	1.1	0.3	0.3	0.2	0.2
South	1.0	1.0	0.4	0.3	0.3	0.2
West	1.3	1.2	0.4	0.3	0.2	0.3
COUNTY TYPE
Large Metro	0.9	1.0	0.3	0.3	0.2	0.2
Small Metro	1.3	1.0	0.3	0.3	0.3	0.2
Nonmetro	1.4	1.0	0.4	0.3	0.4	0.2
Urbanized	1.6	1.3	0.3	0.4	0.2	0.2
Less Urbanized	1.3	0.9	0.5	0.3	0.4	0.2
Completely Rural	1.2	0.4	*	<0.1	*	*
POVERTY LEVEL³
Less Than 100%	1.6	1.7	0.9	0.7	0.6	0.5
100-199%	1.4	1.2	0.5	0.4	0.4	0.4
200% or More	0.9	0.8	0.2	0.2	0.1	0.1
HEALTH INSURANCE⁴
Private	0.8	0.8	0.1	0.1	0.1	0.1
Medicaid/CHIP	2.2	1.9	1.2	0.8	0.8	0.7
Other⁵	1.4	1.1	0.3	0.1	0.2^a	0.1
No Coverage	0.8	1.0	0.5	0.4	0.4	0.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. ³ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ⁴ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁵ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.108A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2022 and 2023
Drug or Method of Administration	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
HALLUCINOGENS	48,850	48,438	533	518	48,316	47,920	5,889^b	5,259	42,427	42,661
PCP	6,394	5,883	28	33	6,366	5,849	180	135	6,186	5,715
LSD	31,074	30,247	283	250	30,791	29,997	3,583^b	3,000	27,207	26,997
Peyote¹	5,604^a	4,723	3	13	5,601^a	4,710	173^a	98	5,428	4,613
Mescaline¹	7,796^b	6,299	11	8	7,785^b	6,291	133	103	7,652^b	6,188
Psilocybin/Mushrooms¹	31,825	31,610	345	344	31,480	31,266	4,229	3,925	27,252	27,341
Ecstasy	22,103	22,276	124	131	21,979	22,145	2,628^b	2,151	19,351	19,995
Ketamine	4,702	5,283	36	44	4,666	5,239	649	625	4,016	4,614
DMT, AMT, or 5-MeO-DIPT/Foxy	3,943	4,188	39	49	3,904	4,139	656	631	3,248	3,508
Salvia divinorum	5,515	5,067	23	22	5,492	5,044	372	282	5,120	4,762
INHALANTS	27,242	26,031	1,940	1,911	25,302	24,120	3,073	2,936	22,229	21,184
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush¹	8,829	8,372	81	85	8,749	8,287	743	778	8,006	7,509
Correction Fluid, Degreaser, or Cleaning Fluid¹	1,739	1,509	204	150	1,534	1,359	164	117	1,370	1,242
Gasoline or Lighter Fluid¹	3,024	3,453	397	421	2,627	3,032	326	343	2,300	2,689
Glue, Shoe Polish, or Toluene¹	2,856	2,764	420	409	2,436	2,354	325	316	2,111	2,038
Halothane, Ether, or Other Anesthetics¹	1,197	915	13	42	1,185	874	82	55	1,103	818
Lacquer Thinner or Other Paint Solvents¹	1,577	1,448	106	89	1,471	1,360	147	106	1,323	1,253
Lighter Gases¹	844	901	95	131	749	770	129	131	621	638
Nitrous Oxide or Whippits¹	13,915	13,069	111	116	13,804	12,953	1,177	1,029	12,627	11,924
Felt-Tip Pens or Felt-Tip/Magic Markers¹	6,894	6,692	1,453	1,488	5,441	5,204	1,357	1,324	4,084	3,879
Spray Paints¹	1,910	1,974	362	325	1,548	1,649	230	216	1,318	1,433
Computer Cleaner/Air Duster¹	3,081	2,833	172	117	2,910	2,716	290	262	2,619	2,453
Other Aerosol Sprays¹	1,429	1,518	113	108	1,316	1,411	141	136	1,175	1,275
NEEDLE USE^1,2	5,691	5,521	30	36	5,661	5,485	193	134	5,468	5,351
Heroin Needle Use¹	3,274	3,083	1	14	3,272	3,068	84	58	3,188	3,011
Cocaine Needle Use¹	2,897	2,530	6	4	2,891	2,526	34	26	2,857	2,500
Methamphetamine Needle Use¹	2,978	2,778	*	4	2,978	2,774	94	59	2,884	2,716
Illegally Made Fentanyl Needle Use^1,2	619^a	385	15	10	604^a	376	47	38	557^a	338
HEROIN	6,558	6,210	10	18	6,549	6,191	218	224	6,331	5,967
Smoke Heroin¹	2,998	2,807	2	14	2,996	2,793	111	118	2,885	2,675
Sniff or Snort Heroin¹	4,644	4,243	6	15	4,638	4,228	169	179	4,469	4,049
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.108B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Percentages, 2022 and 2023
Drug or Method of Administration	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
HALLUCINOGENS	17.3	17.1	2.1	2.0	18.9	18.6	16.9^a	15.5	19.2	19.1
PCP	2.3	2.1	0.1	0.1	2.5	2.3	0.5	0.4	2.8	2.6
LSD	11.0	10.7	1.1	1.0	12.0	11.6	10.3^b	8.8	12.3	12.1
Peyote¹	2.0^a	1.7	<0.1	<0.1	2.2^a	1.8	0.5	0.3	2.5^a	2.1
Mescaline¹	2.8^b	2.2	<0.1	<0.1	3.0^b	2.4	0.4	0.3	3.5^b	2.8
Psilocybin/Mushrooms¹	11.3	11.2	1.3	1.3	12.3	12.1	12.2	11.5	12.3	12.2
Ecstasy	7.8	7.9	0.5	0.5	8.6	8.6	7.6^b	6.3	8.7	8.9
Ketamine	1.7	1.9	0.1	0.2	1.8	2.0	1.9	1.8	1.8	2.1
DMT, AMT, or 5-MeO-DIPT/Foxy	1.4	1.5	0.2	0.2	1.5	1.6	1.9	1.9	1.5	1.6
Salvia divinorum	2.0	1.8	0.1	0.1	2.1	2.0	1.1	0.8	2.3	2.1
INHALANTS	9.7	9.2	7.5	7.4	9.9	9.4	8.8	8.6	10.0	9.5
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush¹	3.1	3.0	0.3	0.3	3.4	3.2	2.1	2.3	3.6	3.4
Correction Fluid, Degreaser, or Cleaning Fluid¹	0.6	0.5	0.8	0.6	0.6	0.5	0.5	0.3	0.6	0.6
Gasoline or Lighter Fluid¹	1.1	1.2	1.5	1.6	1.0	1.2	0.9	1.0	1.0	1.2
Glue, Shoe Polish, or Toluene¹	1.0	1.0	1.6	1.6	1.0	0.9	0.9	0.9	1.0	0.9
Halothane, Ether, or Other Anesthetics¹	0.4	0.3	<0.1	0.2	0.5	0.3	0.2	0.2	0.5	0.4
Lacquer Thinner or Other Paint Solvents¹	0.6	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.6	0.6
Lighter Gases¹	0.3	0.3	0.4	0.5	0.3	0.3	0.4	0.4	0.3	0.3
Nitrous Oxide or Whippits¹	4.9	4.6	0.4	0.4	5.4	5.0	3.4	3.0	5.7	5.3
Felt-Tip Pens or Felt-Tip/Magic Markers¹	2.4	2.4	5.7	5.7	2.1	2.0	3.9	3.9	1.8	1.7
Spray Paints¹	0.7	0.7	1.4	1.3	0.6	0.6	0.7	0.6	0.6	0.6
Computer Cleaner/Air Duster¹	1.1	1.0	0.7	0.5	1.1	1.1	0.8	0.8	1.2	1.1
Other Aerosol Sprays¹	0.5	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.5	0.6
NEEDLE USE^1,2	2.0	1.9	0.1	0.1	2.2	2.1	0.6	0.4	2.5	2.4
Heroin Needle Use¹	1.2	1.1	<0.1	0.1	1.3	1.2	0.2	0.2	1.4	1.3
Cocaine Needle Use¹	1.0	0.9	<0.1	<0.1	1.1	1.0	0.1	0.1	1.3	1.1
Methamphetamine Needle Use¹	1.1	1.0	*	<0.1	1.2	1.1	0.3	0.2	1.3	1.2
Illegally Made Fentanyl Needle Use^1,2	0.2^a	0.1	0.1	<0.1	0.2^a	0.1	0.1	0.1	0.3^a	0.2
HEROIN	2.3	2.2	<0.1	0.1	2.6	2.4	0.6	0.7	2.9	2.7
Smoke Heroin¹	1.1	1.0	<0.1	0.1	1.2	1.1	0.3	0.3	1.3	1.2
Sniff or Snort Heroin¹	1.6	1.5	<0.1	0.1	1.8	1.6	0.5	0.5	2.0	1.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.109A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2022 and 2023
Drug or Method of Administration	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
HALLUCINOGENS	8,509	8,795	358	387	8,151	8,408	2,676^a	2,276	5,475	6,132
PCP	204	135	15	22	190	113	13	*	177	113
LSD	2,322^b	1,698	169	144	2,154^b	1,554	894^b	501	1,259	1,053
Ecstasy	2,109	2,153	63	75	2,046	2,078	639	521	1,407	1,557
Ketamine	762	943	18	26	744	917	210	215	534	701
DMT, AMT, or 5-MeO-DIPT/Foxy	678	618	13	37	665	581	127	87	539	494
Salvia divinorum	140	94	7	9	133	85	70	24	63	61
INHALANTS	2,254	2,602	554	564	1,700	2,038	647	694	1,053	1,344
NEEDLE USE^1,2	1,054	878	12	20	1,042	857	69	31	973	826
Heroin Needle Use¹	438	389	*	11	438	378	16	5	422	373
Cocaine Needle Use¹	184	114	*	4	184	110	*	3	184	107
Methamphetamine Needle Use¹	620	535	*	4	620	531	24	13	597	518
Illegally Made Fentanyl Needle Use^1,2	243	175	10	8	233	167	20	12	213	155
HEROIN	1,049^b	660	3	4	1,046^b	656	55	27	991^a	629
Smoke Heroin¹	381^a	206	*	4	381^a	202	21	14	360^a	188
Sniff or Snort Heroin¹	741^a	434	*	11	741^a	423	32	25	709^a	398
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.109B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, Percentages, 2022 and 2023
Drug or Method of Administration	Aged 12+ (2022)	Aged 12+ (2023)	Aged 12-17 (2022)	Aged 12-17 (2023)	Aged 18+ (2022)	Aged 18+ (2023)	Aged 18-25 (2022)	Aged 18-25 (2023)	Aged 26+ (2022)	Aged 26+ (2023)
HALLUCINOGENS	3.0	3.1	1.4	1.5	3.2	3.3	7.7^a	6.7	2.5	2.7
PCP	0.1	<0.1	0.1	0.1	0.1	<0.1	<0.1	*	0.1	0.1
LSD	0.8^b	0.6	0.7	0.6	0.8^b	0.6	2.6^b	1.5	0.6	0.5
Ecstasy	0.7	0.8	0.2	0.3	0.8	0.8	1.8	1.5	0.6	0.7
Ketamine	0.3	0.3	0.1	0.1	0.3	0.4	0.6	0.6	0.2	0.3
DMT, AMT, or 5-MeO-DIPT/Foxy	0.2	0.2	0.1	0.1	0.3	0.2	0.4	0.3	0.2	0.2
Salvia divinorum	<0.1	<0.1	<0.1	<0.1	0.1	<0.1	0.2	0.1	<0.1	<0.1
INHALANTS	0.8	0.9	2.2	2.2	0.7	0.8	1.9	2.0	0.5	0.6
NEEDLE USE^1,2	0.4	0.3	<0.1	0.1	0.4	0.3	0.2	0.1	0.4	0.4
Heroin Needle Use¹	0.2	0.1	*	<0.1	0.2	0.1	<0.1	<0.1	0.2	0.2
Cocaine Needle Use¹	0.1	<0.1	*	<0.1	0.1	<0.1	*	<0.1	0.1	<0.1
Methamphetamine Needle Use¹	0.2	0.2	*	<0.1	0.2	0.2	0.1	<0.1	0.3	0.2
Illegally Made Fentanyl Needle Use^1,2	0.1	0.1	<0.1	<0.1	0.1	0.1	0.1	<0.1	0.1	0.1
HEROIN	0.4^b	0.2	<0.1	<0.1	0.4^b	0.3	0.2	0.1	0.4^b	0.3
Smoke Heroin¹	0.1^a	0.1	*	<0.1	0.1^a	0.1	0.1	<0.1	0.2^a	0.1
Sniff or Snort Heroin¹	0.3^a	0.2	*	<0.1	0.3^a	0.2	0.1	0.1	0.3^a	0.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.110A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Pain Reliever Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2023)
ANY PRESCRIPTION PAIN RELIEVER	73,833	74,347	8,457	8,578	11.5	11.5
Hydrocodone Products¹	36,598^b	33,819	3,735	3,611	10.2	10.7
Oxycodone Products¹	20,773	21,003	2,547	2,641	12.3	12.6
OxyContin^®	7,793	7,796	984	998	12.6	12.8
Tramadol Products¹	14,658	14,891	1,379	1,339	9.4	9.0
Codeine Products¹	19,839	19,658	1,850	2,001	9.3	10.2
Morphine Products¹	5,230	4,911	375	284	7.2	5.8
Prescription Fentanyl Products²	2,665	2,614	507	479	19.0	18.3
Buprenorphine Products¹	3,505	2,992	679	610	19.5	20.4
Oxymorphone Products¹	1,068	785	113	137	10.7	17.5
Demerol^®1	644	484	53	80	*	*
Hydromorphone Products¹	1,268	1,565	99	221	7.9	*
Methadone¹	1,405	1,435	206	206	14.8	14.3
Any Other Prescription Pain Reliever^1,3	21,512^a	23,093	660	471	3.1	2.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.110B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 or Older; Percentages, 2022 and 2023
Pain Reliever Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2023)
ANY PRESCRIPTION PAIN RELIEVER	26.2	26.2	3.0	3.0	11.5	11.5
Hydrocodone Products¹	13.0^b	12.0	1.3	1.3	10.2	10.7
Oxycodone Products¹	7.4	7.4	0.9	0.9	12.3	12.6
OxyContin^®	2.8	2.8	0.3	0.4	12.6	12.8
Tramadol Products¹	5.2	5.3	0.5	0.5	9.4	9.0
Codeine Products¹	7.1	7.0	0.7	0.7	9.3	10.2
Morphine Products¹	1.9	1.7	0.1	0.1	7.2	5.8
Prescription Fentanyl Products²	0.9	0.9	0.2	0.2	19.0	18.3
Buprenorphine Products¹	1.2	1.1	0.2	0.2	19.5	20.4
Oxymorphone Products¹	0.4	0.3	<0.1	<0.1	10.7	17.5
Demerol^®1	0.2	0.2	<0.1	<0.1	*	*
Hydromorphone Products¹	0.5	0.6	<0.1	0.1	7.9	*
Methadone¹	0.5	0.5	0.1	0.1	14.8	14.3
Any Other Prescription Pain Reliever^1,3	7.6	8.2	0.2	0.2	3.1	2.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.111A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2022 and 2023
Pain Reliever Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2023)
ANY PRESCRIPTION PAIN RELIEVER	3,191^b	3,800	406^a	570	12.7	15.0
Hydrocodone Products¹	633	668	70	73	11.1	10.9
Oxycodone Products¹	522	568	89	112	17.1	19.8
OxyContin^®	229	230	53	47	23.2	*
Tramadol Products¹	250	282	33	18	*	6.2
Codeine Products¹	1,207^a	1,442	147^a	255	12.3	17.7
Morphine Products¹	251	210	18	29	7.2	*
Prescription Fentanyl Products²	129	129	14	26	*	*
Buprenorphine Products¹	107	74	3	13	*	*
Oxymorphone Products¹	91	45	2	16	*	*
Demerol^®1	32	24	*	*	*	*
Hydromorphone Products¹	31	9	2	3	*	*
Methadone¹	59	40	2	14	*	*
Any Other Prescription Pain Reliever^1,3	1,385^b	1,682	36	76	2.7	4.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.111B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 to 17; Percentages, 2022 and 2023
Pain Reliever Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2023)
ANY PRESCRIPTION PAIN RELIEVER	12.4^b	14.7	1.6^a	2.2	12.7	15.0
Hydrocodone Products¹	2.5	2.6	0.3	0.3	11.1	10.9
Oxycodone Products¹	2.0	2.2	0.3	0.4	17.1	19.8
OxyContin^®	0.9	0.9	0.2	0.2	23.2	*
Tramadol Products¹	1.0	1.1	0.1	0.1	*	6.2
Codeine Products¹	4.7^a	5.6	0.6^a	1.0	12.3	17.7
Morphine Products¹	1.0	0.8	0.1	0.1	7.2	*
Prescription Fentanyl Products²	0.5	0.5	0.1	0.1	*	*
Buprenorphine Products¹	0.4	0.3	<0.1	0.1	*	*
Oxymorphone Products¹	0.4	0.2	<0.1	0.1	*	*
Demerol^®1	0.1	0.1	*	*	*	*
Hydromorphone Products¹	0.1	<0.1	<0.1	<0.1	*	*
Methadone¹	0.2	0.2	<0.1	0.1	*	*
Any Other Prescription Pain Reliever^1,3	5.4^a	6.5	0.1	0.3	2.7	4.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.112A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Pain Reliever Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2023)
ANY PRESCRIPTION PAIN RELIEVER	70,642	70,547	8,051	8,008	11.4	11.4
Hydrocodone Products¹	35,965^b	33,152	3,665	3,538	10.2	10.7
Oxycodone Products¹	20,252	20,435	2,457	2,530	12.2	12.4
OxyContin^®	7,565	7,566	931	951	12.3	12.6
Tramadol Products¹	14,408	14,609	1,346	1,321	9.4	9.0
Codeine Products¹	18,632	18,216	1,703	1,746	9.2	9.6
Morphine Products¹	4,979	4,701	358	255	7.2	5.4
Prescription Fentanyl Products²	2,535	2,485	494	453	19.5	18.2
Buprenorphine Products¹	3,398	2,918	676	597	20.0	20.5
Oxymorphone Products¹	977	741	112	121	11.6	16.4
Demerol^®1	612	460	53	80	*	*
Hydromorphone Products¹	1,237	1,556	97	218	7.9	*
Methadone¹	1,346	1,395	203	192	15.2	13.7
Any Other Prescription Pain Reliever^1,3	20,127	21,411	624^a	395	3.1^a	1.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.112B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 or Older; Percentages, 2022 and 2023
Pain Reliever Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2023)
ANY PRESCRIPTION PAIN RELIEVER	27.6	27.4	3.1	3.1	11.4	11.4
Hydrocodone Products¹	14.1^b	12.9	1.4	1.4	10.2	10.7
Oxycodone Products¹	7.9	8.0	1.0	1.0	12.2	12.4
OxyContin^®	3.0	2.9	0.4	0.4	12.3	12.6
Tramadol Products¹	5.6	5.7	0.5	0.5	9.4	9.0
Codeine Products¹	7.3	7.1	0.7	0.7	9.2	9.6
Morphine Products¹	1.9	1.8	0.1	0.1	7.2	5.4
Prescription Fentanyl Products²	1.0	1.0	0.2	0.2	19.5	18.2
Buprenorphine Products¹	1.3	1.1	0.3	0.2	20.0	20.5
Oxymorphone Products¹	0.4	0.3	<0.1	<0.1	11.6	16.4
Demerol^®1	0.2	0.2	<0.1	<0.1	*	*
Hydromorphone Products¹	0.5	0.6	<0.1	0.1	7.9	*
Methadone¹	0.5	0.5	0.1	0.1	15.2	13.7
Any Other Prescription Pain Reliever^1,3	7.9	8.3	0.2^a	0.2	3.1^a	1.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.113A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2022 and 2023
Pain Reliever Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2023)
ANY PRESCRIPTION PAIN RELIEVER	6,489	6,515	1,099^b	841	16.9^b	12.9
Hydrocodone Products¹	2,403	2,364	531^b	327	22.2^b	13.9
Oxycodone Products¹	1,818	1,762	401	344	22.3	19.5
OxyContin^®	593	706	119	150	20.0	21.3
Tramadol Products¹	829	876	152	129	18.5	14.7
Codeine Products¹	1,779	1,749	233	301	13.2	17.3
Morphine Products¹	497	497	38	21	7.8	4.2
Prescription Fentanyl Products²	237	279	41	63	*	22.4
Buprenorphine Products¹	238	201	65	47	*	*
Oxymorphone Products¹	108	111	23	32	*	*
Demerol^®1	41	15	12	*	*	*
Hydromorphone Products¹	79	64	15	10	*	*
Methadone¹	72	83	8	23	*	*
Any Other Prescription Pain Reliever^1,3	2,307	2,370	106	50	4.7	2.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.113B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 to 25; Percentages, 2022 and 2023
Pain Reliever Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2023)
ANY PRESCRIPTION PAIN RELIEVER	18.7	19.1	3.2^a	2.5	16.9^b	12.9
Hydrocodone Products¹	6.9	7.0	1.5^b	1.0	22.2^b	13.9
Oxycodone Products¹	5.2	5.2	1.2	1.0	22.3	19.5
OxyContin^®	1.7	2.1	0.3	0.4	20.0	21.3
Tramadol Products¹	2.4	2.6	0.4	0.4	18.5	14.7
Codeine Products¹	5.1	5.2	0.7	0.9	13.2	17.3
Morphine Products¹	1.4	1.5	0.1	0.1	7.8	4.2
Prescription Fentanyl Products²	0.7	0.8	0.1	0.2	*	22.4
Buprenorphine Products¹	0.7	0.6	0.2	0.1	*	*
Oxymorphone Products¹	0.3	0.3	0.1	0.1	*	*
Demerol^®1	0.1	<0.1	<0.1	*	*	*
Hydromorphone Products¹	0.2	0.2	<0.1	<0.1	*	*
Methadone¹	0.2	0.2	<0.1	0.1	*	*
Any Other Prescription Pain Reliever^1,3	6.6	7.0	0.3	0.1	4.7	2.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.114A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Pain Reliever Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2023)
ANY PRESCRIPTION PAIN RELIEVER	64,153	64,032	6,953	7,167	10.8	11.2
Hydrocodone Products¹	33,562^b	30,788	3,135	3,211	9.3	10.4
Oxycodone Products¹	18,434	18,673	2,056	2,185	11.2	11.7
OxyContin^®	6,972	6,860	812	801	11.7	11.7
Tramadol Products¹	13,579	13,733	1,194	1,193	8.8	8.7
Codeine Products¹	16,854	16,467	1,470	1,445	8.7	8.8
Morphine Products¹	4,482	4,204	320	234	7.2	5.6
Prescription Fentanyl Products²	2,299	2,206	453	391	19.7	17.7
Buprenorphine Products¹	3,160	2,716	612	550	19.4	20.3
Oxymorphone Products¹	869	630	89	90	10.2	*
Demerol^®1	571	445	42	80	*	*
Hydromorphone Products¹	1,158	1,493	83	208	7.1	*
Methadone¹	1,274	1,312	195	169	15.4	12.8
Any Other Prescription Pain Reliever^1,3	17,820	19,041	518	345	2.9	1.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.114B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 26 or Older; Percentages, 2022 and 2023
Pain Reliever Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Pain Reliever Subtypes (2023)
ANY PRESCRIPTION PAIN RELIEVER	29.0	28.6	3.1	3.2	10.8	11.2
Hydrocodone Products¹	15.2^b	13.8	1.4	1.4	9.3	10.4
Oxycodone Products¹	8.3	8.4	0.9	1.0	11.2	11.7
OxyContin^®	3.1	3.1	0.4	0.4	11.7	11.7
Tramadol Products¹	6.1	6.2	0.5	0.5	8.8	8.7
Codeine Products¹	7.6	7.4	0.7	0.6	8.7	8.8
Morphine Products¹	2.0	1.9	0.1	0.1	7.2	5.6
Prescription Fentanyl Products²	1.0	1.0	0.2	0.2	19.7	17.7
Buprenorphine Products¹	1.4	1.2	0.3	0.2	19.4	20.3
Oxymorphone Products¹	0.4	0.3	<0.1	<0.1	10.2	*
Demerol^®1	0.3	0.2	<0.1	<0.1	*	*
Hydromorphone Products¹	0.5	0.7	<0.1	0.1	7.1	*
Methadone¹	0.6	0.6	0.1	0.1	15.4	12.8
Any Other Prescription Pain Reliever^1,3	8.1	8.5	0.2	0.2	2.9	1.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). ³ Includes use or misuse of pain relievers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.115A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Stimulant Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	19,674	19,816	4,298	3,922	21.8	19.8
Amphetamines or Methylphenidate Products¹	15,332	15,430	4,000	3,681	26.1	23.9
Amphetamines¹	13,154	13,340	3,799	3,520	28.9	26.4
Methylphenidate Products¹	3,970	4,171	563^a	381	14.2^a	9.2
Anorectic (Weight-Loss) Stimulants¹	2,728	2,914	189	170	6.9	5.8
Provigil^®1	413	379	92	70	*	*
Any Other Prescription Stimulant^1,2	2,976	2,838	26	58	0.9	2.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.115B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Percentages, 2022 and 2023
Stimulant Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	7.0	7.0	1.5	1.4	21.8	19.8
Amphetamines or Methylphenidate Products¹	5.4	5.4	1.4	1.3	26.1	23.9
Amphetamines¹	4.7	4.7	1.3	1.2	28.9	26.4
Methylphenidate Products¹	1.4	1.5	0.2^a	0.1	14.2^a	9.2
Anorectic (Weight-Loss) Stimulants¹	1.0	1.0	0.1	0.1	6.9	5.8
Provigil^®1	0.1	0.1	<0.1	<0.1	*	*
Any Other Prescription Stimulant^1,2	1.1	1.0	<0.1	<0.1	0.9	2.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.116A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2022 and 2023
Stimulant Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	1,845	1,807	226	230	12.2	12.8
Amphetamines or Methylphenidate Products¹	1,574	1,610	218	187	13.9	11.6
Amphetamines¹	1,109	1,174	202	158	18.3	13.5
Methylphenidate Products¹	712	680	39	44	5.4	6.4
Anorectic (Weight-Loss) Stimulants¹	126	76	4	15	*	*
Provigil^®1	25	15	*	*	*	*
Any Other Prescription Stimulant^1,2	337	320	*	25	0.4	*
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.116B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Percentages, 2022 and 2023
Stimulant Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	7.2	7.0	0.9	0.9	12.2	12.8
Amphetamines or Methylphenidate Products¹	6.1	6.2	0.8	0.7	13.9	11.6
Amphetamines¹	4.3	4.5	0.8	0.6	18.3	13.5
Methylphenidate Products¹	2.8	2.6	0.1	0.2	5.4	6.4
Anorectic (Weight-Loss) Stimulants¹	0.5	0.3	<0.1	0.1	*	*
Provigil^®1	0.1	0.1	*	*	*	*
Any Other Prescription Stimulant^1,2	1.3	1.2	*	0.1	0.4	*
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.117A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Stimulant Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	17,830	18,009	4,072	3,692	22.8	20.5
Amphetamines or Methylphenidate Products¹	13,758	13,820	3,782	3,494	27.5	25.3
Amphetamines¹	12,045	12,166	3,596	3,361	29.9	27.6
Methylphenidate Products¹	3,258	3,491	525^a	337	16.1^b	9.7
Anorectic (Weight-Loss) Stimulants¹	2,602	2,837	185	155	7.1	5.5
Provigil^®1	388	364	91	69	*	*
Any Other Prescription Stimulant^1,2	2,639	2,518	25	33	1.0	1.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.117B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Percentages, 2022 and 2023
Stimulant Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	7.0	7.0	1.6	1.4	22.8	20.5
Amphetamines or Methylphenidate Products¹	5.4	5.4	1.5	1.4	27.5	25.3
Amphetamines¹	4.7	4.7	1.4	1.3	29.9	27.6
Methylphenidate Products¹	1.3	1.4	0.2^a	0.1	16.1^b	9.7
Anorectic (Weight-Loss) Stimulants¹	1.0	1.1	0.1	0.1	7.1	5.5
Provigil^®1	0.2	0.1	<0.1	<0.1	*	*
Any Other Prescription Stimulant^1,2	1.0	1.0	<0.1	<0.1	1.0	1.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.118A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2022 and 2023
Stimulant Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	3,794	3,660	1,278	1,066	33.7	29.1
Amphetamines or Methylphenidate Products¹	3,564	3,370	1,257^a	1,032	35.3	30.6
Amphetamines¹	3,093	2,912	1,173	993	37.9	34.1
Methylphenidate Products¹	1,012	943	234^b	96	23.1^b	10.3
Anorectic (Weight-Loss) Stimulants¹	153	185	13	33	*	*
Provigil^®1	35^a	4	4	4	*	*
Any Other Prescription Stimulant^1,2	422	434	12	7	*	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.118B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Percentages, 2022 and 2023
Stimulant Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	10.9	10.8	3.7	3.1	33.7	29.1
Amphetamines or Methylphenidate Products¹	10.3	9.9	3.6	3.0	35.3	30.6
Amphetamines¹	8.9	8.6	3.4	2.9	37.9	34.1
Methylphenidate Products¹	2.9	2.8	0.7^b	0.3	23.1^b	10.3
Anorectic (Weight-Loss) Stimulants¹	0.4	0.5	<0.1	0.1	*	*
Provigil^®1	0.1^a	<0.1	<0.1	<0.1	*	*
Any Other Prescription Stimulant^1,2	1.2	1.3	<0.1	<0.1	*	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.119A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Stimulant Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	14,035	14,349	2,794	2,626	19.9	18.3
Amphetamines or Methylphenidate Products¹	10,194	10,450	2,526	2,462	24.8	23.6
Amphetamines¹	8,952	9,254	2,423	2,368	27.1	25.6
Methylphenidate Products¹	2,245	2,548	291	241	13.0	9.5
Anorectic (Weight-Loss) Stimulants¹	2,449	2,652	172	122	7.0	4.6
Provigil^®1	353	360	87	65	*	*
Any Other Prescription Stimulant^1,2	2,217	2,084	13	26	0.6	1.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.119B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Percentages, 2022 and 2023
Stimulant Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	6.3	6.4	1.3	1.2	19.9	18.3
Amphetamines or Methylphenidate Products¹	4.6	4.7	1.1	1.1	24.8	23.6
Amphetamines¹	4.0	4.1	1.1	1.1	27.1	25.6
Methylphenidate Products¹	1.0	1.1	0.1	0.1	13.0	9.5
Anorectic (Weight-Loss) Stimulants¹	1.1	1.2	0.1	0.1	7.0	4.6
Provigil^®1	0.2	0.2	<0.1	<0.1	*	*
Any Other Prescription Stimulant^1,2	1.0	0.9	<0.1	<0.1	0.6	1.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.120A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Tranquilizer Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	32,783	31,384	4,153	3,993	12.7	12.7
Benzodiazepine Tranquilizers¹	24,774^a	22,861	3,603	3,530	14.5	15.4
Alprazolam Products¹	13,851	12,845	2,717	2,485	19.6	19.4
Lorazepam Products¹	6,599	6,361	630	577	9.5	9.1
Clonazepam Products¹	6,008	5,365	640	850	10.7^a	15.8
Diazepam Products¹	4,833	4,185	610^a	390	12.6	9.3
Muscle Relaxants¹	7,207	7,017	597	580	8.3	8.3
Cyclobenzaprine¹	6,552	6,496	492	447	7.5	6.9
Soma^®1	738	671	103	158	*	*
Any Other Prescription Tranquilizer^1,2	5,173	5,473	80	90	1.6	1.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.120B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Percentages, 2022 and 2023
Tranquilizer Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	11.6	11.1	1.5	1.4	12.7	12.7
Benzodiazepine Tranquilizers¹	8.8^a	8.1	1.3	1.2	14.5	15.4
Alprazolam Products¹	4.9	4.5	1.0	0.9	19.6	19.4
Lorazepam Products¹	2.3	2.2	0.2	0.2	9.5	9.1
Clonazepam Products¹	2.1	1.9	0.2	0.3	10.7^a	15.8
Diazepam Products¹	1.7	1.5	0.2^a	0.1	12.6	9.3
Muscle Relaxants¹	2.6	2.5	0.2	0.2	8.3	8.3
Cyclobenzaprine¹	2.3	2.3	0.2	0.2	7.5	6.9
Soma^®1	0.3	0.2	<0.1	0.1	*	*
Any Other Prescription Tranquilizer^1,2	1.8	1.9	<0.1	<0.1	1.6	1.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.121A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2022 and 2023
Tranquilizer Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	717	731	115	119	16.1	16.3
Benzodiazepine Tranquilizers¹	464	387	110	110	23.6	28.5
Alprazolam Products¹	348	274	82	95	23.6	34.7
Lorazepam Products¹	62	72	19	20	*	*
Clonazepam Products¹	127	80	15	12	*	*
Diazepam Products¹	113	81	10	10	*	*
Muscle Relaxants¹	95^a	31	3	9	*	*
Cyclobenzaprine¹	75	22	3	8	*	*
Soma^®1	21	9	*	*	*	*
Any Other Prescription Tranquilizer^1,2	247	337	*	8	0.5	*
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.121B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Percentages, 2022 and 2023
Tranquilizer Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	2.8	2.8	0.4	0.5	16.1	16.3
Benzodiazepine Tranquilizers¹	1.8	1.5	0.4	0.4	23.6	28.5
Alprazolam Products¹	1.4	1.1	0.3	0.4	23.6	34.7
Lorazepam Products¹	0.2	0.3	0.1	0.1	*	*
Clonazepam Products¹	0.5	0.3	0.1	<0.1	*	*
Diazepam Products¹	0.4	0.3	<0.1	<0.1	*	*
Muscle Relaxants¹	0.4^a	0.1	<0.1	<0.1	*	*
Cyclobenzaprine¹	0.3	0.1	<0.1	<0.1	*	*
Soma^®1	0.1	<0.1	*	*	*	*
Any Other Prescription Tranquilizer^1,2	1.0	1.3	*	<0.1	0.5	*
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.122A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Tranquilizer Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	32,066	30,653	4,038	3,874	12.6	12.6
Benzodiazepine Tranquilizers¹	24,310^a	22,474	3,493	3,420	14.4	15.2
Alprazolam Products¹	13,502	12,572	2,635	2,389	19.5	19.0
Lorazepam Products¹	6,536	6,289	611	557	9.3	8.9
Clonazepam Products¹	5,881	5,285	625	838	10.6^a	15.9
Diazepam Products¹	4,720	4,104	601^a	380	12.7	9.2
Muscle Relaxants¹	7,112	6,986	593	571	8.4	8.2
Cyclobenzaprine¹	6,478	6,473	489	439	7.6	6.8
Soma^®1	717	662	103	157	*	*
Any Other Prescription Tranquilizer^1,2	4,926	5,136	79	82	1.6	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.122B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Percentages, 2022 and 2023
Tranquilizer Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	12.5	11.9	1.6	1.5	12.6	12.6
Benzodiazepine Tranquilizers¹	9.5^a	8.7	1.4	1.3	14.4	15.2
Alprazolam Products¹	5.3	4.9	1.0	0.9	19.5	19.0
Lorazepam Products¹	2.6	2.4	0.2	0.2	9.3	8.9
Clonazepam Products¹	2.3	2.1	0.2	0.3	10.6^a	15.9
Diazepam Products¹	1.8	1.6	0.2^a	0.1	12.7	9.2
Muscle Relaxants¹	2.8	2.7	0.2	0.2	8.4	8.2
Cyclobenzaprine¹	2.5	2.5	0.2	0.2	7.6	6.8
Soma^®1	0.3	0.3	<0.1	0.1	*	*
Any Other Prescription Tranquilizer^1,2	1.9	2.0	<0.1	<0.1	1.6	1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.123A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2022 and 2023
Tranquilizer Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	2,592^a	2,228	779^b	522	30.1^a	23.4
Benzodiazepine Tranquilizers¹	2,106^b	1,679	744^b	459	35.3^a	27.5
Alprazolam Products¹	1,505^b	1,052	643^b	369	42.7	35.4
Lorazepam Products¹	510	510	116	85	22.7	16.6
Clonazepam Products¹	485^a	338	91	91	18.7	26.9
Diazepam Products¹	332	301	72	49	21.6	16.1
Muscle Relaxants¹	287	304	35	40	12.3	*
Cyclobenzaprine¹	271	280	28	28	10.3	*
Soma^®1	19	25	8	12	*	*
Any Other Prescription Tranquilizer^1,2	442	431	7	13	1.7	3.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.123B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Percentages, 2022 and 2023
Tranquilizer Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	7.5^a	6.5	2.2^b	1.5	30.1^a	23.4
Benzodiazepine Tranquilizers¹	6.1^b	4.9	2.1^b	1.3	35.3^a	27.5
Alprazolam Products¹	4.3^b	3.1	1.8^b	1.1	42.7	35.4
Lorazepam Products¹	1.5	1.5	0.3	0.2	22.7	16.6
Clonazepam Products¹	1.4^a	1.0	0.3	0.3	18.7	26.9
Diazepam Products¹	1.0	0.9	0.2	0.1	21.6	16.1
Muscle Relaxants¹	0.8	0.9	0.1	0.1	12.3	*
Cyclobenzaprine¹	0.8	0.8	0.1	0.1	10.3	*
Soma^®1	0.1	0.1	<0.1	<0.1	*	*
Any Other Prescription Tranquilizer^1,2	1.3	1.3	<0.1	<0.1	1.7	3.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.124A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Tranquilizer Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	29,474	28,425	3,259	3,351	11.1	11.8
Benzodiazepine Tranquilizers¹	22,204	20,795	2,749	2,961	12.4	14.2
Alprazolam Products¹	11,998	11,519	1,992	2,020	16.6	17.5
Lorazepam Products¹	6,026	5,779	495	472	8.2	8.2
Clonazepam Products¹	5,396	4,947	534	747	9.9^a	15.1
Diazepam Products¹	4,388	3,803	529	331	12.1	8.7
Muscle Relaxants¹	6,825	6,682	558	531	8.2	8.0
Cyclobenzaprine¹	6,207	6,194	461	411	7.4	6.7
Soma^®1	699	637	95	145	*	*
Any Other Prescription Tranquilizer^1,2	4,484	4,705	71	68	1.6	1.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.124B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Percentages, 2022 and 2023
Tranquilizer Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	13.3	12.7	1.5	1.5	11.1	11.8
Benzodiazepine Tranquilizers¹	10.0^a	9.3	1.2	1.3	12.4	14.2
Alprazolam Products¹	5.4	5.2	0.9	0.9	16.6	17.5
Lorazepam Products¹	2.7	2.6	0.2	0.2	8.2	8.2
Clonazepam Products¹	2.4	2.2	0.2	0.3	9.9^a	15.1
Diazepam Products¹	2.0	1.7	0.2	0.1	12.1	8.7
Muscle Relaxants¹	3.1	3.0	0.3	0.2	8.2	8.0
Cyclobenzaprine¹	2.8	2.8	0.2	0.2	7.4	6.7
Soma^®1	0.3	0.3	<0.1	0.1	*	*
Any Other Prescription Tranquilizer^1,2	2.0	2.1	<0.1	<0.1	1.6	1.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.125A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Sedative Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	15,399	14,666	959	1,063	6.2	7.2
Zolpidem Products¹	7,403	6,789	597	678	8.1	10.0
Eszopiclone Products¹	1,045	905	16	50	1.6^a	5.6
Zaleplon Products¹	401	250	26	*	*	*
Benzodiazepine Sedatives¹	1,649	1,677	98	57	5.9	3.4
Flurazepam¹	115	136	15	*	*	*
Temazepam Products¹	758	830	32	49	4.2	5.9
Triazolam Products¹	857	786	59	*	*	1.7
Barbiturates¹	744	487	23	19	3.1	*
Any Other Prescription Sedative^1,2	6,568	6,493	183	264	2.8	4.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.125B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Percentages, 2022 and 2023
Sedative Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	5.5	5.2	0.3	0.4	6.2	7.2
Zolpidem Products¹	2.6	2.4	0.2	0.2	8.1	10.0
Eszopiclone Products¹	0.4	0.3	<0.1	<0.1	1.6^a	5.6
Zaleplon Products¹	0.1	0.1	<0.1	*	*	*
Benzodiazepine Sedatives¹	0.6	0.6	<0.1	<0.1	5.9	3.4
Flurazepam¹	<0.1	<0.1	<0.1	*	*	*
Temazepam Products¹	0.3	0.3	<0.1	<0.1	4.2	5.9
Triazolam Products¹	0.3	0.3	<0.1	*	*	1.7
Barbiturates¹	0.3	0.2	<0.1	<0.1	3.1	*
Any Other Prescription Sedative^1,2	2.3	2.3	0.1	0.1	2.8	4.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.126A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2022 and 2023
Sedative Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	521	583	27	68	5.3	11.6
Zolpidem Products¹	121	88	4	31	*	*
Eszopiclone Products¹	28	5	*	*	*	*
Zaleplon Products¹	13	12	*	*	*	*
Benzodiazepine Sedatives¹	42	83	*	7	*	*
Flurazepam¹	20	16	*	1	*	*
Temazepam Products¹	14	30	*	5	*	*
Triazolam Products¹	36	38	*	*	*	*
Barbiturates¹	43	34	2	*	*	*
Any Other Prescription Sedative^1,2	366	408	4	15	1.0	3.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.126B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Percentages, 2022 and 2023
Sedative Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	2.0	2.2	0.1	0.3	5.3	11.6
Zolpidem Products¹	0.5	0.3	<0.1	0.1	*	*
Eszopiclone Products¹	0.1	<0.1	*	*	*	*
Zaleplon Products¹	<0.1	<0.1	*	*	*	*
Benzodiazepine Sedatives¹	0.2	0.3	*	<0.1	*	*
Flurazepam¹	0.1	0.1	*	<0.1	*	*
Temazepam Products¹	0.1	0.1	*	<0.1	*	*
Triazolam Products¹	0.1	0.1	*	*	*	*
Barbiturates¹	0.2	0.1	<0.1	*	*	*
Any Other Prescription Sedative^1,2	1.4	1.6	<0.1	0.1	1.0	3.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.127A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Sedative Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	14,878	14,083	931	995	6.3	7.1
Zolpidem Products¹	7,282	6,700	593	647	8.1	9.7
Eszopiclone Products¹	1,017	900	16	50	1.5^a	5.6
Zaleplon Products¹	388	239	26	*	*	*
Benzodiazepine Sedatives¹	1,607	1,593	97	50	6.1	3.2
Flurazepam¹	94	120	15	*	*	*
Temazepam Products¹	744	800	31	44	4.1	5.5
Triazolam Products¹	821	748	59	14	*	1.8
Barbiturates¹	701	454	21	19	*	*
Any Other Prescription Sedative^1,2	6,202	6,085	179	249	2.9	4.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.127B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Percentages, 2022 and 2023
Sedative Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	5.8	5.5	0.4	0.4	6.3	7.1
Zolpidem Products¹	2.8	2.6	0.2	0.3	8.1	9.7
Eszopiclone Products¹	0.4	0.3	<0.1	<0.1	1.5^a	5.6
Zaleplon Products¹	0.2	0.1	<0.1	*	*	*
Benzodiazepine Sedatives¹	0.6	0.6	<0.1	<0.1	6.1	3.2
Flurazepam¹	<0.1	<0.1	<0.1	*	*	*
Temazepam Products¹	0.3	0.3	<0.1	<0.1	4.1	5.5
Triazolam Products¹	0.3	0.3	<0.1	<0.1	*	1.8
Barbiturates¹	0.3	0.2	<0.1	<0.1	*	*
Any Other Prescription Sedative^1,2	2.4	2.4	0.1	0.1	2.9	4.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.128A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2022 and 2023
Sedative Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	1,082^a	875	93	90	8.6	10.3
Zolpidem Products¹	285	239	39	59	13.9	*
Eszopiclone Products¹	71	67	*	11	*	*
Zaleplon Products¹	30	15	*	*	*	*
Benzodiazepine Sedatives¹	132	112	8	7	*	*
Flurazepam¹	11	20	*	*	*	*
Temazepam Products¹	43^b	4	6	*	*	*
Triazolam Products¹	95	90	2	7	*	*
Barbiturates¹	85	55	5	6	*	*
Any Other Prescription Sedative^1,2	695	582	21	10	3.2	1.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.128B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Percentages, 2022 and 2023
Sedative Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	3.1	2.6	0.3	0.3	8.6	10.3
Zolpidem Products¹	0.8	0.7	0.1	0.2	13.9	*
Eszopiclone Products¹	0.2	0.2	*	<0.1	*	*
Zaleplon Products¹	0.1	<0.1	*	*	*	*
Benzodiazepine Sedatives¹	0.4	0.3	<0.1	<0.1	*	*
Flurazepam¹	<0.1	0.1	*	*	*	*
Temazepam Products¹	0.1^b	<0.1	<0.1	*	*	*
Triazolam Products¹	0.3	0.3	<0.1	<0.1	*	*
Barbiturates¹	0.2	0.2	<0.1	<0.1	*	*
Any Other Prescription Sedative^1,2	2.0	1.7	0.1	<0.1	3.2	1.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.129A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Sedative Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	13,797	13,208	839	905	6.1	6.9
Zolpidem Products¹	6,997	6,461	554	588	7.9	9.1
Eszopiclone Products¹	945	833	14	40	1.5	4.8
Zaleplon Products¹	358	223	26	*	*	*
Benzodiazepine Sedatives¹	1,475	1,481	89	44	6.1	2.9
Flurazepam¹	83	101	15	*	*	*
Temazepam Products¹	701	796	25	44	3.6	*
Triazolam Products¹	726	658	57	*	*	*
Barbiturates¹	616	398	16	13	*	*
Any Other Prescription Sedative^1,2	5,507	5,503	158	239	2.9	4.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.129B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Percentages, 2022 and 2023
Sedative Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	6.2	5.9	0.4	0.4	6.1	6.9
Zolpidem Products¹	3.2	2.9	0.2	0.3	7.9	9.1
Eszopiclone Products¹	0.4	0.4	<0.1	<0.1	1.5	4.8
Zaleplon Products¹	0.2	0.1	<0.1	*	*	*
Benzodiazepine Sedatives¹	0.7	0.7	<0.1	<0.1	6.1	2.9
Flurazepam¹	<0.1	<0.1	<0.1	*	*	*
Temazepam Products¹	0.3	0.4	<0.1	<0.1	3.6	*
Triazolam Products¹	0.3	0.3	<0.1	*	*	*
Barbiturates¹	0.3	0.2	<0.1	<0.1	*	*
Any Other Prescription Sedative^1,2	2.5	2.5	0.1	0.1	2.9	4.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.130A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Benzodiazepine Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	25,703^a	23,894	3,681	3,696	14.3	15.5
Benzodiazepine Tranquilizers¹	24,774^a	22,861	3,603	3,530	14.5	15.4
Alprazolam Products¹	13,851	12,845	2,717	2,485	19.6	19.4
Lorazepam Products¹	6,599	6,361	630	577	9.5	9.1
Clonazepam Products¹	6,008	5,365	640	850	10.7^a	15.8
Diazepam Products¹	4,833	4,185	610^a	390	12.6	9.3
Benzodiazepine Sedatives¹	1,649	1,677	98	57	5.9	3.4
Flurazepam¹	115	136	15	*	*	*
Temazepam Products¹	758	830	32	49	4.2	5.9
Triazolam Products¹	857	786	59	*	*	1.7
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	132	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.130B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Percentages, 2022 and 2023
Benzodiazepine Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	9.1^a	8.4	1.3	1.3	14.3	15.5
Benzodiazepine Tranquilizers¹	8.8^a	8.1	1.3	1.2	14.5	15.4
Alprazolam Products¹	4.9	4.5	1.0	0.9	19.6	19.4
Lorazepam Products¹	2.3	2.2	0.2	0.2	9.5	9.1
Clonazepam Products¹	2.1	1.9	0.2	0.3	10.7^a	15.8
Diazepam Products¹	1.7	1.5	0.2^a	0.1	12.6	9.3
Benzodiazepine Sedatives¹	0.6	0.6	<0.1	<0.1	5.9	3.4
Flurazepam¹	<0.1	<0.1	<0.1	*	*	*
Temazepam Products¹	0.3	0.3	<0.1	<0.1	4.2	5.9
Triazolam Products¹	0.3	0.3	<0.1	*	*	1.7
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	<0.1	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.131A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2022 and 2023
Benzodiazepine Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	480	456	113	111	23.5	24.4
Benzodiazepine Tranquilizers¹	464	387	110	110	23.6	28.5
Alprazolam Products¹	348	274	82	95	23.6	34.7
Lorazepam Products¹	62	72	19	20	*	*
Clonazepam Products¹	127	80	15	12	*	*
Diazepam Products¹	113	81	10	10	*	*
Benzodiazepine Sedatives¹	42	83	*	7	*	*
Flurazepam¹	20	16	*	1	*	*
Temazepam Products¹	14	30	*	5	*	*
Triazolam Products¹	36	38	*	*	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.131B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Percentages, 2022 and 2023
Benzodiazepine Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	1.9	1.8	0.4	0.4	23.5	24.4
Benzodiazepine Tranquilizers¹	1.8	1.5	0.4	0.4	23.6	28.5
Alprazolam Products¹	1.4	1.1	0.3	0.4	23.6	34.7
Lorazepam Products¹	0.2	0.3	0.1	0.1	*	*
Clonazepam Products¹	0.5	0.3	0.1	<0.1	*	*
Diazepam Products¹	0.4	0.3	<0.1	<0.1	*	*
Benzodiazepine Sedatives¹	0.2	0.3	*	<0.1	*	*
Flurazepam¹	0.1	0.1	*	<0.1	*	*
Temazepam Products¹	0.1	0.1	*	<0.1	*	*
Triazolam Products¹	0.1	0.1	*	*	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.132A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Benzodiazepine Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	25,223^a	23,437	3,569	3,585	14.1	15.3
Benzodiazepine Tranquilizers¹	24,310^a	22,474	3,493	3,420	14.4	15.2
Alprazolam Products¹	13,502	12,572	2,635	2,389	19.5	19.0
Lorazepam Products¹	6,536	6,289	611	557	9.3	8.9
Clonazepam Products¹	5,881	5,285	625	838	10.6^a	15.9
Diazepam Products¹	4,720	4,104	601^a	380	12.7	9.2
Benzodiazepine Sedatives¹	1,607	1,593	97	50	6.1	3.2
Flurazepam¹	94	120	15	*	*	*
Temazepam Products¹	744	800	31	44	4.1	5.5
Triazolam Products¹	821	748	59	14	*	1.8
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	132	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.132B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Percentages, 2022 and 2023
Benzodiazepine Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	9.8^a	9.1	1.4	1.4	14.1	15.3
Benzodiazepine Tranquilizers¹	9.5^a	8.7	1.4	1.3	14.4	15.2
Alprazolam Products¹	5.3	4.9	1.0	0.9	19.5	19.0
Lorazepam Products¹	2.6	2.4	0.2	0.2	9.3	8.9
Clonazepam Products¹	2.3	2.1	0.2	0.3	10.6^a	15.9
Diazepam Products¹	1.8	1.6	0.2^a	0.1	12.7	9.2
Benzodiazepine Sedatives¹	0.6	0.6	<0.1	<0.1	6.1	3.2
Flurazepam¹	<0.1	<0.1	<0.1	*	*	*
Temazepam Products¹	0.3	0.3	<0.1	<0.1	4.1	5.5
Triazolam Products¹	0.3	0.3	<0.1	<0.1	*	1.8
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	0.1	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.133A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2022 and 2023
Benzodiazepine Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	2,178^b	1,739	747^b	480	34.3^a	27.6
Benzodiazepine Tranquilizers¹	2,106^b	1,679	744^b	459	35.3^a	27.5
Alprazolam Products¹	1,505^b	1,052	643^b	369	42.7	35.4
Lorazepam Products¹	510	510	116	85	22.7	16.6
Clonazepam Products¹	485^a	338	91	91	18.7	26.9
Diazepam Products¹	332	301	72	49	21.6	16.1
Benzodiazepine Sedatives¹	132	112	8	7	*	*
Flurazepam¹	11	20	*	*	*	*
Temazepam Products¹	43^b	4	6	*	*	*
Triazolam Products¹	95	90	2	7	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.133B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Percentages, 2022 and 2023
Benzodiazepine Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	6.3^b	5.1	2.1^b	1.4	34.3^a	27.6
Benzodiazepine Tranquilizers¹	6.1^b	4.9	2.1^b	1.3	35.3^a	27.5
Alprazolam Products¹	4.3^b	3.1	1.8^b	1.1	42.7	35.4
Lorazepam Products¹	1.5	1.5	0.3	0.2	22.7	16.6
Clonazepam Products¹	1.4^a	1.0	0.3	0.3	18.7	26.9
Diazepam Products¹	1.0	0.9	0.2	0.1	21.6	16.1
Benzodiazepine Sedatives¹	0.4	0.3	<0.1	<0.1	*	*
Flurazepam¹	<0.1	0.1	*	*	*	*
Temazepam Products¹	0.1^b	<0.1	<0.1	*	*	*
Triazolam Products¹	0.3	0.3	<0.1	<0.1	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	*	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.134A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2022 and 2023
Benzodiazepine Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	23,045	21,699	2,822	3,105	12.2	14.3
Benzodiazepine Tranquilizers¹	22,204	20,795	2,749	2,961	12.4	14.2
Alprazolam Products¹	11,998	11,519	1,992	2,020	16.6	17.5
Lorazepam Products¹	6,026	5,779	495	472	8.2	8.2
Clonazepam Products¹	5,396	4,947	534	747	9.9^a	15.1
Diazepam Products¹	4,388	3,803	529	331	12.1	8.7
Benzodiazepine Sedatives¹	1,475	1,481	89	44	6.1	2.9
Flurazepam¹	83	101	15	*	*	*
Temazepam Products¹	701	796	25	44	3.6	*
Triazolam Products¹	726	658	57	*	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	132	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

240429

Table 1.134B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Percentages, 2022 and 2023
Benzodiazepine Subtype	Any Use in Past Year (2022)	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2022)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2022)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	10.4	9.7	1.3	1.4	12.2	14.3
Benzodiazepine Tranquilizers¹	10.0^a	9.3	1.2	1.3	12.4	14.2
Alprazolam Products¹	5.4	5.2	0.9	0.9	16.6	17.5
Lorazepam Products¹	2.7	2.6	0.2	0.2	8.2	8.2
Clonazepam Products¹	2.4	2.2	0.2	0.3	9.9^a	15.1
Diazepam Products¹	2.0	1.7	0.2	0.1	12.1	8.7
Benzodiazepine Sedatives¹	0.7	0.7	<0.1	<0.1	6.1	2.9
Flurazepam¹	<0.1	<0.1	<0.1	*	*	*
Temazepam Products¹	0.3	0.4	<0.1	<0.1	3.6	*
Triazolam Products¹	0.3	0.3	<0.1	*	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	0.1	da	da
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.